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ABSTRACT 
 
Pseudomonas syringae pv. DC3000 is a gram-negative bacterium that infects the model 
plant Arabidopsis thaliana. Pathogenicity is achieved via secretion of effector proteins into 
the host cytoplasm through a Type III Secretion System (T3SS). In Ps. DC3000 the T3SS (and 
associated effector proteins) are dependent on HrpL for their transcription. hrpL 
transcription is sigma54-dependent and requires two co-dependent enhancer binding 
proteins, HrpR and HrpS (HrpRS), for activation. HrpRS are regulated by two hrpL-dependent 
proteins, HrpV and HrpG, where HrpV negatively affects HrpRS activity and HrpG relieves 
this repression.  
 
Here the mechanism of HrpV and HrpG’s action on HrpRS activity was tested in vivo and in 
vitro; and the molecular determinants of HrpV and HrpG functionality were characterised by 
in silico and mutational analysis. Whole-gene deletion mutants of hrpV and hrpG in Ps. 
DC3000 revealed complications associated with inserting marker cassettes in 
transcriptionally-antagonistic orientations. Truncation mutants of HrpV and HrpG showed 
that C-terminal helices in both proteins play a functional and/or structural role. Alanine 
mutants indicated a structural role for residues 108-110 in HrpV and a functional role for 
residues 111-113 in HrpG (NQR motif). HrpV was demonstrated to form a dimer and 
represses the activity of HrpRS (in vivo and in vitro) but not via inhibiting ATPase activity or 
destabilising open promoter complexes. HrpG was shown to destabilise the HrpV dimer 
(potentially via the C-terminal NQR motif). Findings from this study were used to propose a 
revised model of hrpL regulation in which an active dimer of HrpV binds two adjacent HrpS 
subunits of a HrpRS hexamer to “lock” the hexamer in an unfavourable conformation. HrpG 
acts by destabilising the HrpV dimer into an inactive monomeric form. Additional 
experiments to confirm this model include creating an artificially linked dimer of HrpV and 
testing its repressive action on HrpRS in the presence or absence of HrpG. 
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32P  Radio-labelled Phosphate 
A Adenine 
a.a. amino acid 
AAA+  ATPases Associated with Various Cellular Activities 
AMP Adenosine 5'-monophosphate 
Avr Avirulence 
BACTH Bacterial Two-Hybrid 
bp(s) Base pair(s) 
CAP/CRP  Catabolite Activator Protein (cAMP Receptor Protein) 
CEL Conserved effector locus 
cfu Colony-forming units 
C Cysteine 
dNTP deoxy nucleotide triphosphate 
DTT Dithiothreitol 
E. coli Escherichia coli 
bEBP  Bacterial Enhancer Binding Protein 
ECF Extracytoplasmic factor 
EDTA Ethylenediaminetetraacetic acid 
EEL Exchangeable effector locus 
EMSA Electrophoretic mobility shift assay 
g Relative centrifugal force 
g gram 
G Guanine 
HIM hrp-inducing medium 
Hop hrp-dependent outer protein 
HR hypersensitive response 
hrc hypersensitive response conserved 
hrp hypersensitive response and pathogenesis 
HTH  helix-turn-helix 
IHF  Integration Host Factor 
kb Kilobase 
λ Symbol for ladders on SDS and agarose gels and immunoblots 
M Molar 
min Minute(s) 
ml Millilitres 
mM Millimolar 
MS  Mass Spectroscopy 
OD Optical density 
nESI-MS Nano electrospray ionisation mass spectrometry 
p Promoter 
PAI Pathogenicity island 
Ps. DC3000 Pseudomonas syringae pv. tomato DC3000 
PspF  Phage Shock Protein F 
pv. pathovar 
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RBS Ribosome binding site 
R-finger  Arginine Finger 
RNA Ribonucleic acid 
RNAP DNA-dependent RNA-polymerase 
SDS Sodium dodecyl sulfate 
spp. species 
T Thymine 
T4 PNK  T4 Polynucleotide Kinase 
T3SS Type III Secretion System 
TBS Tris-buffered saline 
TEMED N,N,N¢, N¢,-Tetramethylethylenediamine 
Tris Tris(hydroxymethyl)aminomethane 
UAS Upstream activator sequences 
v/v Volume:Volume 
w/v Weight:Volume 
α anti 
α RNAP  Alpha Subunit (RpoA) 
β RNAP  Beta Subunit (RpoB) 
β’ RNAP  Beta Prime Subunit (RpoC) 
N Nano, 10-9 
µ Micro, 10-6 
σ54  Sigma 54 (RpoN) 
σ70  Sigma70 (RpoD) 
ω  RNAP Omega Subunit (RpoZ) 
  
Amino Acid    3-Letter Code  1-Letter Code 
Alanine    Ala    A 
Arginine    Arg    R 
Asparagine    Asn    N 
Aspartate    Asp    D 
Cysteine    Cys   C 
Glutamine    Gln    Q 
Glutamate    Glu    E 
Glycine    Gly    G 
Histidine    His    H 
Isoleucine    Ile    I 
Leucine   Leu    L 
Lysine    Lys    K 
Methionine   Met    M 
Phenylalanine    Phe    F 
Proline    Pro    P 
Serine    Ser   S 
Threonine    Thr    T 
Tryptophan   Trp    W 
Tyrosine   Tyr    Y 
Valine    Val    V 
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CHAPTER ONE 
1. Introduction 
1.1. Foreword 
This study focuses on the actions of two proteins, HrpV and HrpG, and the proteins that 
they regulate, HrpR and HrpS, designated HrpRS. The regulators HrpRS are AAA+ family 
enhancer binding proteins that activate sigma54-dependent transcription at the hrpL 
promoter. HrpL is an alternative sigma factor from the phytopathogen Pseudomonas 
syringae pv. tomato DC3000 that leads to the transcription of genes encoding proteins 
forming the pathogenesis-associated Type III Secretion System (T3SS) and secreted effector 
proteins, as well as the regulators HrpV and HrpG. 
1.2. Pseudomonas syringae pv. tomato DC3000 
P. syringae pv. tomato DC3000 (Ps. DC3000) is a gram-negative bacterium that is pathogenic 
on Arabidopsis thaliana and tomato (Whalen et al., 1991). Ps. DC3000 infects plants usually 
via entry through stomata or wounds and subsequent colonisation of the intracellular space 
(apoplast). It secretes effectors directly into the plant cell via the T3SS causing necrotic 
lesions on both leaves and tomato fruit. Its genome has been fully sequenced (Buell et al., 
2003) and Ps. DC3000 is considered a model pathogen for a number of reasons. Firstly, A. 
thaliana is a model plant species, also fully sequenced and extensively studied (Arabidopsis-
Genome-Initiative, 2000). Studying both Ps. DC3000 and A. thaliana has allowed detailed 
analysis into the evolution and molecular basis for plant-microbe interactions, host 
resistance and specificity (Preston, 2000, Lindeberg et al., 2009). Secondly, Ps. DC3000 is 
also a pathogen of tomato, causing the economically important bacterial speck disease, and, 
with one mutation (deletion of the effector hopQ1-1), it is pathogenic on another model 
plant Nicotiana benthamiana (Wei et al., 2007). Bacterial speck disease of tomato has a 
worldwide economic impact and is representative of numerous other bacterial plant 
diseases that are still not effectively controlled (Wilson et al., 2002). Thirdly, Ps. DC3000 
employs many of the same infection strategies as the human pathogen Yersinia pestis, most 
notably the T3SS (Anderson et al., 1999). Interestingly, Ps. DC3000 is now rarely isolated 
from diseased tomatoes in the field, where the predominant strain is Ps. tomato T1 
(Lindeberg et al., 2009). 
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1.3. Disease in plants and the immune response 
Plant pathogens include bacteria, viruses, fungi, nematodes and aphids. They 
infect/invade/parasitize their host plants by a variety of strategies; commonly involving 
evasion of the innate and adaptive immunity of the plant. The zigzag model of plant 
immunity  explains how plant pathogens trigger plant immune responses (Jones & Dangl, 
2006). In phase one microbes trigger the plant innate immune response by commonly 
occurring microbial molecules known as MAMPs or PAMPs (microbial/pathogen associated 
molecular patterns). This response is also known as PAMP triggered immunity (PTI) and 
includes the induction of callose deposition, stomatal closure, mitogen-activated protein 
kinase (MAPK) cascades, reactive oxygen species (ROS) production and transcriptional 
activation. In phase two, successful pathogens deliver effectors via the T3SS that may 
interfere with PTI. In phase three, plants that can recognise effectors respond with effector 
triggered immunity (ETI) and the hypersensitive response. The hypersensitive response is 
programmed cell death of infected and neighbouring cells which limits the spread of a 
disease and renders the plant immune. So pathogens are successful if they evade or 
suppress PTI or ETI and plants are successful if they can trigger PTI or ETI.  
 
One of the most well-studied PAMPs is bacterial flagellin (FliC in Figure 1). Interestingly, 
flagellin is also involved in eukaryotic disease responses, e.g. mouse resistance to Legionella 
is achieved through flagellin recognition by macrophages (Ren et al., 2006). PTI can be 
triggered with a highly conserved 22 amino-acid peptide from flagellin, flg22 (Gomez-Gomez 
et al., 1999). Flg22 is recognised by the plasma-membrane-localised leucine-rich-repeat 
receptor kinase plant protein FLS2 that dimerises with another protein, BAK1, upon flg22 
binding to trigger PTI (Chinchilla et al., 2007). The T3SS-dependent bacterial effector of Ps. 
DC3000, AvrPto, binds FLS2 in vivo  (Zipfel & Rathjen, 2008) and has an inhibitory effect. 
Plants that have the proteins Pto and Prf are able to overcome inhibition by AvrPto (Lin & 
Martin, 2007). The recognition cascade: Flg22 (PAMP) – FLS2 (PTI) – AvrPto (effector) – Pto 
and Prf (ETI) neatly exemplifies the zigzag model of plant immunity, although the situation is 
more complicated in practice. Other PAMPs include elongation factor thermo unstable (EF-
Tu; a prokaryotic elongation factor involved in translation) (Zipfel et al., 2006), 
lipopolysaccharides (Desaki et al., 2006), harpin (HrpZ; an abundant protein secreted 
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through the T3SS involved which has membrane-binding and pore-forming activities) 
(Haapalainen et al., 2011) and fungal chitin (Eckardt, 2008).  
 
Plant pathogen effectors are often recognised by immune receptors containing nucleotide-
binding leucine rich repeat (NB-LRR) domains. These can have additional N-terminal 
domains, for example Toll interleukin 1 receptor homology (TIR) and coiled-coil (CC) 
domains. TIR-NB-LRRs share structural and functional homology to the TOLL immune 
receptor in Drosophila and Toll-like receptors (TLR) in mammals, which is thought to be due 
to convergent evolution (Caplan et al., 2008). Plants possess a great number of diverse NB-
LRRs that recognise specific effectors in one of two ways; (i) directly or (ii) via an 
intermediary host factor which may first bind the effector or be constitutively associated 
with the NB-LRR. The NB-LRRs recognise effectors from all plant pathogens, for example the 
CC-NB-LRR NRG1 mediates resistance to tobacco mosaic virus (Peart et al., 2005) and RLM3, 
a TIR-NB-LRR, gives Arabidopsis  immunity to necrotrophic fungi (Staal et al., 2008). 
1.3.1. Disease elicitation by phytopathogenic bacteria 
The major groups of plant pathogenic bacteria are Pseudomonas, 
Xanthomonas, Erwinia, Burkholderia and Ralstonia and they cause diseases of significant 
agricultural and economic importance with a wide-range of symptoms including wilts, 
cankers, specks, rots and blights. Infections caused by bacteria can be asymptomatic, elicit 
the hypersensitive response in non-host plants or cause disease in host plants (Bertolini et 
al., 2003). There are three major classes of genes involved in bacterial infection of plants; 
hrp, hrc and hop. Hrp means hypersensitive response and pathogenicity and hrc means hrp-
conserved. Effectors are either named avr for the avirulence phenotypes they confer on the 
bacteria (i.e. without a certain avr gene the bacteria becomes virulent), or hops, for hrp 
outer protein; depending on whether they are primarily involved in a plant reaction (avr) or 
secretion behaviour (hop) (Fouts et al., 2002).  
 
In many bacteria, genes associated with virulence are found on a pathogenicity island (PAI); 
a discrete cluster of genes that is capable of being transferred horizontally between bacteria 
and of retaining its deterministic character. In P. syringae the PAI is organised in three 
sections; the conserved effector locus (CEL), hrp/hrc cluster, and exchangeable effector 
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locus (EEL). The EEL is highly variable between different pathovars of P. syringae (Cunnac et 
al., 2009). This reflects the co-evolution of the pathogen with its specific host plant. No 
effector has been found that is solely responsible for virulence, indeed combinations of 
effectors can be deleted without fully compromising the pathogenic properties of the 
bacteria (Cunnac et al., 2011). Ps. DC3000 has 28 effectors with functions including PTI 
suppression, hormone manipulation and cell death regulation (Schechter et al., 2006).  
1.4. Type Three Secretion Systems (and the hrp pilus) 
Secretion is used by both prokaryotes and eukaryotes to move proteins, DNA and chemical 
molecules (e.g. toxins) across cell walls and membranes. Gram-negative bacteria have six 
major secretion systems, the most extensively studied of which is the T3SS. The T3SS is 
central to the pathogenesis of numerous important clinical pathogens of humans and 
animals (e.g. Salmonella enterica, Shigella flexneri, Burkholderia mallei, Yersinia pestis, 
Escherichia coli and Pseudomonas aeruginosa) and to pathogens of crops and ornamental 
plants. The T3SS and the bacterial flagella share sequence similarities in their basal bodies 
and assembly machinery (Blocker et al., 2003) (see Figure 1).  
 
Figure 1: Structure of flagella and three Type III secretion systems 
Schematic of flagella structure (a) and structure of three Type III secretion systems (T3SS) showing component proteins and 
dimensions. (b) The Yersinia Ysc injectisome; (c) injectisome from enteropathogenic E. coli; (d) Hrp pilus T3SS from plant 
pathogens. Figure from (Cornelis, 2006). 
The hrc genes of P. syringae encode some of the elements that are conserved among other 
T3SSs. The T3SS from different organisms tend to differ predominately in their cell-surface 
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needle/pilus/filament which reflects the host cell that must be penetrated and the 
extracellular environment (Cornelis, 2006). In plant pathogens the pilus can be up to several 
micrometres long so that the pilus can penetrate through the plant cell wall. Figure 2 shows 
an immunogold labelled hrp pilus from Ps. DC3000 with a pilus length of approximately 4 
µm (Li et al., 2002).  
 
Figure 2: Immunoelectron microscopy of the growing hrp pilus 
Immunoelectron microscopy of the growing hrp pilus 30 min after induction of FLAG-HrpA. The pilus is composed of HrpA 
subunits. The FLAG epitope is decorated by immunogold labelling at the distal end of the pilus. Bar: 0.5 µm. (Li et al., 2002). 
T3SS structural and regulatory proteins are encoded by the hrp/hrc cluster and effectors 
(hop and avr genes) are encoded by CEL and EEL or at other loci in bacterial genomes. In P. 
syringae, Erwinia spp., Pantoea spp., and Dickeya spp. (Group I type plant pathogens) the 
majority of hrp, hrc, hop and avr genes, as well as other virulence factors, are dependent on 
a specialised subunit of bacterial RNA polymerase called HrpL for gene expression (see 
section 1.6). In Group II plant pathogens, including Xanthomonas spp. and Ralstonia 
solanacearum the T3SS-associated genes are under the control of an AraC-type 
transcriptional regulator (which binds to DNA in a repressive fashion).  
1.5. Regulation of gene expression 
DNA replication, RNA synthesis (transcription) and protein synthesis (translation) are three 
processes fundamental to life across all three domains, Eubacteria, Archaea and Eukarya 
and are collectively known as gene expression. This is a highly regulated, flexible and 
adaptive procedure which must respond to life-cycle stages as well as environmental 
conditions. Regulation can be achieved at the synthesis stages of replication, transcription 
and translation as well as post-synthesis. Transcription, the process by which permanent 
information stored within the DNA is converted to RNA is divided into three stages; 
initiation, elongation and termination. Transcription is a critical step in regulation of gene 
expression, particularly in bacteria, where initiation is the most highly regulated step.  
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RNA most probably pre-dates DNA as it is less inert and can perform many functions 
including enzymatic, structural and regulatory (e.g. ribosomal, transfer, small nuclear and 
micro RNAs), as well as the main role it plays as the template for protein synthesis 
(messenger RNA, mRNA). Conversely DNA is a stable molecule which is the permanent store 
of the organism’s genetic code. The enzyme responsible for carrying out transcription is 
DNA-dependent RNA polymerase (RNAP). RNAP binds promoter DNA and melts DNA; these 
processes often require accessory factors. It then catalyses the stepwise addition of 
nucleoside monophosphates to a growing polyribonucleotide chain according to Watson-
Crick base pairing using one of the DNA strands as a template. The nucleotides are linked in 
an Mg2+-dependent reaction and all functioning RNAPs contain two magnesium ions at their 
active centre.  
1.5.1. RNAP 
There are two families of RNAP, single-subunit and multi-subunit. Single-subunit RNAPs exist 
in mitochondria, chloroplasts and bacteriophage (e.g. T7 RNAP) and are biochemically 
similar to multi-subunit RNAPs, yet their architecture closely resembles DNA polymerases 
(Cramer, 2002a, Cheetham & Steitz, 2000). The sequences of single- versus multi-subunit 
RNAPs are unrelated although the relative location of nucleic acids and amino acids is 
equivalent (Cramer, 2002a). Multi-subunit RNAPs are evolutionarily conserved between 
Eubacteria, Archaea and Eukarya with clear sequence and structural conservation (Opalka et 
al., 2010, Lane & Darst, 2010). The structures of Thermus aquaticus bacterial RNAP and 
Saccharomyces cerevisiae yeast RNAP are shown in Figure 3. They both have the distinctive 
“crab-claw” structure, also seen in archeal RNAP (Darst et al., 2002, Hirata et al., 2008). 
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Figure 3: Crystal structures of T. aquaticus RNAP and S. cerevisiae RNA polymerase II 
Corresponding subunits are coloured the same. The active site metal ion A is shown as a pink sphere. Zinc ions are shown 
as blue spheres. Figure from (Cramer, 2002). 
Bacterial RNAP consists of five core subunits plus an additional factor, the σ factor (see 
section 1.5.2) with archaea having an additional six subunits (without a σ factor). Eukaryotes 
have three forms of RNAP, each with a distinct function; Pol I for rRNA, Pol II for mRNA (and 
a number of small nuclear RNAs) and Pol III for tRNA (and small nuclear RNAs). Pol I has nine 
additional subunits, Pol II has seven and Pol III has eleven (Ebright, 2000) (See Figure 4).  
 
Figure 4: Composition of RNA polymerases from bacteria, archea and eukarya 
Homologous subunits are colour coded. Increased subunit complexity is denoted by the grey arrow. Archaea sometimes 
have a fused B subunit (B″–B′). Modified from (Werner, 2007). 
The five core subunits in bacterial RNAP; two identical alpha subunits (αI and αII), beta (β), 
beta prime (β’) and omega (ω) are collectively known as the catalytic core, or E (α2ββ’ω, 
~400 kDa) (Ebright, 2000). The α subunits form a dimer with their N-terminal domains (NTD) 
and the CTDs recognise upstream elements of promoter sequences. β and β’ form the 
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catalytic core of RNAP and are the targets of numerous transcriptional activators and 
inhibitors, e.g. rifampicin (Ho et al., 2009, Darst, 2004). ω has been shown to play a role in 
bRNAP assembly (Mathew & Chatterji, 2006). An additional subunit, the sigma factor (σ) is 
not required for the transcription reaction per se but is absolutely required for sequence 
recognition and specificity – hence is ultimately required for transcription initiation (see 
section 1.5.2).  
1.5.2. σ factors 
σ factors direct core RNAP to a specific subset of gene promoters, ensuring that the correct 
sets of genes are transcribed at a particular time or under certain environmental conditions 
(Gross et al., 1992). All σ factors bind the same RNAP, to form the holoenzyme (Eσ). The 
number of σ factors that a particular organism has varies considerably; from 65 in 
Streptomyces coelicolor to one in Mycoplasma gentalium (Mittenhuber, 2002).  σ factors are 
grouped into two family classes based on sequence similarity and mechanism of action. The 
σ70-class, named after the major housekeeping σ70 factor of Escherichia coli, contains the 
majority of σ factors. In E. coli there are seven σ factors, six of which are in the σ70 class. The 
seventh σ factor, σ54, is known as the major variant form and is different from σ70-like σ 
factors in terms of both its sequence and mode of operation – hence this factor belongs to a 
class of its own, the σ54 class (Merrick, 1993) (see section 1.7.1). Binding to and/or 
interaction with the β and β′ subunits is important for both σ70 and σ54 (Katayama et al., 
2000, Wigneshweraraj et al., 2006) and the core binding site of both classes overlap 
(Svergun et al., 2000). 
 
The σ70 class can be further subdivided into the σ70 subfamily and the extracytoplasmic 
function, ECF, subfamily (Mittenhuber, 2002). ECF-type σ factors function as effector 
molecules responding to extracytoplasmic stimuli; one member of this family, HrpL, is 
discussed in more detail in section 1.6. Four conserved domains have been identified for 
σ70-type sigma factors with the E. coli housekeeping σ70 having all four and other σ factors 
having varied combinations of these domains either present or absent. As previously 
mentioned, σ factors bind to promoter DNA, in the context of the holoenzyme, upstream of 
the genes they are required to transcribe. These promoters therefore have sequence 
conservation to recruit the σ factors. The conserved sites of DNA contact for σ70-type σ 
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factors in promoter DNA sequences are centred at positions -35 and -10 (with respect to the 
start site of transcription, +1). The promoter recognition sites for the six E. coli σ70-type 
factors are shown in Table 1. 
σ Factor Gene name -35 site -10 site 
σ70 rpoD TTGACA TATAAT 
σ38 rpoS - CTATACT 
σ32 rpoH TNtCNCCCTTGAA CCCCATtTA 
σ24 rpoF GAACTT TCTGAT 
σ28 rpoE TAAA GCCGATAA 
σ19 fecI AAGGAAAAT TCCTTT 
Table 1: σ
70
 factors of E. coli 
1.1 1.2 2.1 2.2 2.3 2.4 3.0 3.1 3.2 4.1 4.2
NH2 COOH
inhibition of
DNA binding
-10 promoter
recognition
extended -10
promoter
recogniton
promoter
melting
-35 promoter
recognition
 
Figure 5: Schematic of the domain organisation of the σ
70
 factor from E. coli 
The conserved regions, 1.1, 1.2, 2.1, 2.2, 2.3, 2.4, 3.0, 3.1, 3.2, 4.1 and 4.2 are boxed and coloured shades of grey. Region 
1.1 is unique to σ
70
. Dashed lines above some regions highlight a role in core polymerase binding. Other functions; 
inhibition of DNA binding, promoter melting and promoter recognition, are indicated with arrows. 
The four domains of σ70 can be further subdivided into: 1.1, 1.2, 2.1, 2.2, 2.3, 2.4, 3.0, 3.1, 
3.2, 4.1 and 4.2, illustrated in Figure 5. Specific roles of these subdomains have been 
identified. Region 1.1, which is unique to σ70, contains mostly negatively charged residues 
that can affect the kinetics of transcription at some promoters (Murakami & Darst, 2003). 
Region 1.1 modulates the activity of the DNA binding by regions 2.4 and 4.2 when core 
RNAP is absent, as well as occupying the channel that that holds single-stranded DNA in the 
open complex. Therefore, region 1.1 must move for transcription to take place (Bowers & 
Dombroski, 1999, Hook-Barnard & Hinton, 2009). σ70 contacts core RNAP via regions 2.1 and 
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2.2 and region 2.4 is involved in -10 promoter element recognition (alongside region 3.0). 
Region 3.2 is described as a flexible linker identified by Campbell et al (2002) (Campbell et 
al., 2002) and is susceptible to proteolysis. This linker is proposed to allow regions 2.4 and 
4.2 to position correctly, with respect to the required promoter distance, for contacting 
their respective DNA elements (Murakami & Darst, 2003, DeHaseth & Gott, 2009). Region 
4.2 recognises the -35 element (Campbell et al., 2002). Regions 4.1 and 4.2 form the 
recognition site of the anti-σ factor, AsiA, from bacteriophage T4 (Urbauer et al., 2001). 
Structural studies of σ70 have revealed that σ70 forms a series of compact domains joined by 
flexible linkers (Campbell et al., 2002).  
 
RNAP binds to DNA and must make a number of interactions with the promoter in order to 
form a stable complex. This complex is then in a state that favours DNA isomerisation, 
leading to DNA strand separation from approximately -12 to +3 with respect to the 
transcription start site, at +1. Initial recognition of the promoter by RNAP often involves 
interaction of so-called UP elements (a component of bacterial promoters located upstream 
of the −35 element) with the αCTDs and binding of the σ factor to the -35 and -10 
sequences. In the next stage, the DNA becomes distorted and DNA melting ensues (i.e. 
strand separation). In the final isomerisation step, the downstream DNA is enclosed within 
the β/β’ jaws and a transcriptionally active complex (known as the open complex) is formed 
(Sclavi et al., 2005). With σ70-bound RNAP these isomerisation steps often occur 
simultaneously, however, in the case of σ54-RNAP, these steps require the action of an 
additional transcriptional activation protein (see section 1.7.2). 
1.6. HrpL – an alternative σ factor 
The identity of hrpL as an alternative σ factor, and its role in inducing expression of hrp and 
hop genes was determined by Xiao et al (1994). They showed that E. coli carrying a hrp/hrc 
cluster cosmid clone could activate expression of a hrmA-lacZ fusion (hrmA is now known as 
hopA1) and that without hrpL in the cosmid, hrmA expression was reduced. 
Complementation with hrpL restored expression of the hrmA-lacZ fusion and the same 
result was seen with hrpZ and hrpJ fusions (Xiao et al., 1994). A similar result was observed 
for HrpL from E. amylovora (Wei & Beer, 1995). The sequence of HrpL shares close 
homology to AlgU of P. aeruginosa, a σ factor that contributes to tolerance of osmotic, 
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oxidative, and heat stresses (Schnider-Keel et al., 2001). HrpL and AlgU, as well as RpoE (see 
Table 1) belong to the subfamily of σ factors known as extracytoplasmic function σ factors, 
due to their role in expression of proteins residing in the outer membrane or periplasmic 
space (Brooks & Buchanan, 2008).  
 
Various features distinguish the ECF subfamily from the σ70 subfamily, in particular ECF have 
a comparatively short region 3. Regions 1 and 3 exhibit lower conservation and are acidic 
and regions 2 and 4 tend to be very basic (Missiakas & Raina, 1998). In addition to their role 
in regulating and responding to extracytoplasmic functions, ECF σ factors also tend to be 
regulated by anti-σ factors and most of them control a relatively small regulon (Bashyam & 
Hasnain, 2004). 
 
As σ factors confer promoter specificity to RNAP there is always a consensus promoter 
element associated with a particular σ factor (see Table 1). For HrpL the consensus 
sequence is 5’-GGAACCNA-N13-14CCACNNA-3’ and is known as the ‘hrp box’ (Xiao & 
Hutcheson, 1994). The majority of genes encoding the confirmed secreted effectors contain 
the hrp box promoter sequence, as well as other conserved protein features such as high 
serine content in their N-terminal region (Schechter et al., 2004). Knowledge of HrpL’s role, 
conserved promoter sequences and effector motifs led to bioinformatics-based and 
expression-based screening of P. syringae genomes to establish complete or near-complete 
libraries of secreted effectors and other hrpL-dependent genes (Fouts et al., 2002, Ferreira 
et al., 2006, Schechter et al., 2006, Vencato et al., 2006, Lan et al., 2006, Chang et al., 2005).  
Fouts et al (2002) found candidate effectors that had non-canonical ‘hrp box’ sequences 
using a reporter transposon-based screen for hrpL-dependent gene expression. They 
screened the Ps. DC3000 genome for additional hrpL promoters that incorporated the 
promoter variation and found approximately 17 candidate effectors. They also found that 
expression of the coronatine regulon is hrpL-dependent (coronatine is a phytotoxin 
employed by some pathogens, discussed later in section 1.9.1). Using whole-genome 
microarray analysis and bioinformatics techniques Ferreira et al (2006) compared the 
expression profiles of wild-type Ps. DC3000 and a ΔhrpL in hrp inducing minimal media and 
found hrpL-dependent genes that agreed with the findings of Fouts et al (2002) and Chang 
et al (2005), as well as some additional hrpL-dependent candidate effectors. Ps. DC3000 
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appears to actively secrete 28 HrpL-dependent effectors and encodes additional 
pseudogenes (Schechter et al., 2006).  
 
It is also clear that HrpL regulates or coordinates expression of other virulence and growth-
promoting factors that enable P. syringae to attack and grow within plants. These T3SS-
independent factors include a phytotoxin biosynthesis homolog (indoleacetate-lysine ligase) 
and a regulator of coronatine biosynthesis (CorR) (Vencato et al., 2006). As more genomes 
are fully sequenced the methods established by the authors above, for identification of 
HrpL-regulated genes, are being used to create inventories of other pathogens that rely on 
HrpL, e.g. Dickeya dadantii, a necrotrophic bacterium: its inventory differs from biotrophic 
pathogens (Yang et al., 2010), and Ps. phaseolicola (Zumaquero et al., 2010). 
1.7. Regulation of HrpL 
Group I hrp clusters (Alfano & Collmer, 1997) i.e. those of P. syringae pathovars, Erwinia 
spp., Pantoea spp., Dickeya spp. and Pectobacterium spp. (Pantoea, Dickeya and 
Pectobacterium are all former Erwinia spp.) depend on HrpL, an extracytoplasmic function σ 
factor, for expression of their T3SS-dependent structural proteins and secreted effectors. In 
all these groups expression of hrpL has been shown to be dependent on σ54-RNAP (Frederick 
et al., 1993, Chatterjee et al., 2002, Wei et al., 2000b, Wei & Beer, 1995, Hendrickson et al., 
2000, Hutcheson et al., 2001). σ54-dependent gene expression requires activation by 
specialised ATPases known as enhancer binding proteins (EBPs). In Erwinia spp. (and the 
former Erwinia spp.) only one EBP, HrpS, is required for expression of hrpL. Additional 
regulation is imposed by the two-component signal transduction system, HrpX/HrpY. In this 
system HrpX phosphorylates and activates HrpY; HrpY is required for expression of hrpS and 
autoregulates the hrpXY operon; where HrpS activates expression of hrpL (Merighi et al., 
2003). In P. syringae two EBPs, HrpR and HrpS, activate expression of hrpL (Hutcheson et al., 
2001).  
1.7.1. σ54-dependent transcription 
σ54 is unrelated to σ70-type σ factors (including HrpL) in terms of its sequence. Its mode of 
function also differs markedly and has been referred to as a second paradigm for gene 
activation in bacteria (Wigneshweraraj et al., 2005, Buck et al., 2006). σ54, historically known 
as σN for its role in nitrogen regulation (Dixon et al., 1987, Merrick, 1993), is encoded by the 
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rpoN gene in E. coli and other organisms. It is now known to be responsible for many 
processes in a diverse range of bacteria, both gram-negative and gram-positive (termed SigL 
in gram-positive bacteria). For example: P. aeruginosa – pili and flagella synthesis and 
quorum sensing (Ishimoto & Lory, 1989, Totten et al., 1990); Mesorhizobium ciceri – C4-
dicarboxylate transport (Gautam et al., 2007);  Bacillus subtilis – carbon metabolism (Ali et 
al., 2001); E. coli K-12 – phage shock response and maintenance of the proton motif force , 
Klebsiella pneumoniae – nitrogen regulation and fixation (Wong et al., 1987, Rombel et al., 
1998, Wedel et al., 1990);  Borrelia burgdorferi – σ38 transcription (Smith et al., 2007); P. 
syringae – Type III secretion and pathogenesis via HrpL (Hendrickson et al., 2000); Geobacter 
sulfurreducens - ammonia assimilation (Leang et al., 2009). σ54 is usually not vital for cell 
viability but is in the case of G. sulfurreducens (Leang et al., 2009). Approximately 60% of 
bacterial genomes contain at least one rpoN gene (Wigneshweraraj et al., 2008). Therefore 
the system clearly provides an advantage to some organisms while being sufficiently 
disadvantageous to warrant its absence from about 40% of genomes. For example, it is 
absent from Mycobacterium tuberculosis (Studholme & Buck, 2000) and an inactive 
truncated form is present in Neisseria gonorrhoeae (Laskos et al., 1998).  
 
Comparisons have been made between the transcription initiation mechanism of Eσ54 and 
that of eukaryotic Pol II. Both require ATPase activity for promoter opening (Lin et al., 2005) 
and rely on cis-acting enhancer elements (Kim et al., 2000). An advantageous feature of the 
Eσ54 system is that it can be tightly controlled at the level of transcription initiation with 
minimal promoter leakage. The inactive Eσ54 can remain bound to its cognate promoter in 
readiness for the signal which triggers activator binding and thereby allowing the 
transcriptional efficiency at a given promoter to vary widely without the use of a separate 
repressor (Buck et al., 2000). The main disadvantage, and the reason some bacteria seem to 
have eschewed this system all together, is that the system relies on long, intergenic 
stretches of DNA (for both IHF and activator binding). Many bacterial organisms are known 
to have compacted their genomes (Vissa & Brennan, 2001, Cole et al., 2001) and loss of the 
σ54 system might be one way of achieving this (given that loss of σ54 is usually not fatal).     
 
In contrast to Eσ70, which, when it binds promoter DNA often spontaneously isomerises to 
form a transcriptionally competent open complex (OC), promoter DNA bound by Eσ54 
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remains double-stranded, i.e. Eσ54 remains in a ‘closed complex’ (CC) state until activated by 
a bacterial enhancer-binding protein (EBP). EBPs bind to regions of DNA approximately 100-
150 bp upstream of the transcription start site (Wigneshweraraj et al., 2008) (known as 
upstream activator sequences, UAS). Figure 6 illustrates the difference between the two Eσ 
transcription initiation pathways.  
 
Figure 6: Transcription initiation by Eσ
70 
and Eσ
54
 
Upon σ
70
 binding, RNAP is directed to promoters containing the -35 and -10 consensus sites. Formation of the closed 
complex (CC) is often simultaneously followed by isomerisation in which the promoter DNA is melted and the single-
stranded DNA fed into the active site of the RNAP – initiating transcription. σ
54
 binds the same core RNAP but requires an 
enhancer binding protein (EBP) (that binds to upstream activator sequences, UAS) and often requires integration host 
factor (IHF) to bend the DNA (thus bringing the EBP into contact with the Eσ
54
 CC). Only upon ATP hydrolysis does 
isomerisation of the Eσ
54
 CC occur to form the transcriptionally competent open complex (Joly et al., 2010b). 
As can be seen in Figure 6, Eσ54 binds to DNA elements centred at positions -24 and -12 
relative to the +1 start site of transcription. The consensus sequences are GC (-24) and CC (-
12) (Barrios et al., 1999). This is in contrast to Eσ70 which binds -35 and -10 promoter 
elements (see Table 1). Another notable contrast is the ability of σ54 to bind certain 
promoter DNA in the absence of core RNAP (Cannon et al., 2000). However, core-binding 
does alter the conformation of σ54 (Morris et al., 1994). σ54 has been less well-studied than 
σ70 however; its domains, their organisation and roles, and its structure have now been 
determined, although the complete structure has only been determined by cryoelectron 
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microscopy within the context of Eσ54 (Bose et al., 2008). The NMR structure of two domains 
of σ54 have been determined; one with a positively charged surface region, which could 
possibly interact with DNA; but the complete structure has not been determined by NMR as 
it is too unfolded (Hong et al., 2009). The advantage of studying σ54-dependent transcription 
is that the intermediate complexes that form between the CC and OC states can be studied 
independently (as the CC is very stable, in contrast to the Eσ70 CC).  
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Figure 7: Schematic of the domain organisation of the σ
54
 factor 
Conserved regions are labelled I, II and III. Region I has been shown to interact with EBPs and have weak core binding. 
Region II is highly variable in length and sequence and is absent in some cases. Region III contains a core binding domain, a 
region shown to cross-link to DNA (X-link) and a putative helix-turn-helix motif (HTH). There is also a -24 promoter element 
recognition region known as the RpoN box, which is common to all σ
54
 factors. Based on the σ
54
 factor from K. Pneumonia. 
Region I is the main binding target for the activator EBP (Wigneshweraraj et al., 2005, Syed 
& Gralla, 1998), as well as containing the -12 promoter recognition elements. It is thought 
that σ54 imposes kinetic and thermodynamic constraints on RNAP, mainly via region I, that 
lock Eσ54 in the CC state (Wigneshweraraj et al., 2008, Cannon et al., 2001).   Region III 
residues 120-215 form the major core RNAP binding site (see Figure 7) (Wigneshweraraj et 
al., 2005). Region III contains the σ54 signature motif, termed the RpoN box, which has been 
shown to interact with the -24 promoter element. Region III also contains an X-link region 
(residues 329-326), identified because it cross-links to DNA (Chaney et al., 2000). There is 
also a putative helix-turn-helix motif (HTH) (residues 366-386) which was proposed to bind 
the -12 promoter element (Merrick & Chambers, 1992) however, proximity based 
footprinting showed that residues within this region (specifically R383) do not establish a 
direct contact with -12 DNA (Wigneshweraraj et al., 2001). Region II is variable in length and 
sequence and is sometimes greatly reduced or absent (Wigneshweraraj et al., 2005). 
 
Upon Eσ54 binding to DNA there is localised DNA melting (about 2 bp) immediately 
downstream of the -12 promoter element. In Eσ70 localised melting also occurs, creating a 
repressive fork junction (Morris et al., 1994, Wang et al., 1997). In Eσ54 Region I of σ54 binds 
tightly to the template strand fork junction structure of this transiently melted DNA 
‘bubble’. Binding of the -12 fork junction is thought to inhibit open complex formation. The 
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ATP-hydrolysis dependent activity of a bacterial EBP is required to reorganise Region I of σ54 
(within the context of Eσ54) such that the repressive interactions with the fork junction 
structure are no longer evident; this rearrangement is thought to allow access to the DNA 
binding cleft and therefore support open complex formation (Wang et al., 1999, Cannon et 
al., 1999, Bose et al., 2008). 
1.7.2. AAA+ proteins, EBPs and HrpRS 
ATPases asscociated with various cellular activities (AAA/AAA+) belong to the much larger 
group of proteins known as P-loop NTPases (Iyer et al., 2004). These proteins harness the 
energy from nucleotide hydrolysis (generally by catalysing the hydrolysis of the β−γ 
phosphate bond of the nucleotide triphosphate) to direct work in many biological processes. 
They are defined by two conserved domains; the P-loop or Walker A motif and the less well 
conserved Walker B motif. The Walker A motif has the 7 (or 8) residue consensus sequence 
GX4GK[S/T] (where X is any residue and the S/T position is not as well conserved as GX4GK). 
Walker B is hhhh[D/E] (where h is any hydrophobic residue). Both are involved in binding 
and hydrolysing nucleotides, which are typically ATP or GTP (Snider & Houry, 2008). 
Structural and functional studies led to the expansion of the AAA family (to include many 
other proteins) to become the AAA+ superfamily. There is little functional evidence that can 
separate classic AAA from AAA+ proteins so they are generally now considered together 
(Hanson & Whiteheart, 2005) although there are some distinguishing features e.g. two 
arginine residues (present as arginine (R) fingers) are conserved in the classic AAA whereas 
only one R finger is found in all AAA+ (Hanson & Whiteheart, 2005).  
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Figure 8: AAA+ domain key elements 
A schematic showing the key elements of an AAA+ domain with approximate positions of the N-linker, Walker A and B 
motifs, pore loop region, Sensor I and II and the second region of homology (SRH). Conserved residues within these motifs 
are shown as single letter amino acid codes above the motif. Figure adapted from (Hanson & Whiteheart, 2005). 
A diverse range of proteins contain an AAA+ domain (see Figure 8), some containing more 
than one, e.g. p97, which has two and dynein, which has six (White & Lauring, 2007). In 
order to generate specificity and diversity of functioning additional domains are sometimes 
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added or motifs within the AAA+ domain itself can be modified. The functions of AAA+ 
proteins include; protein unfolding and degredation, protein disaggregation, membrane 
fusion, cytochrome assembly, regulation of enzymatic activity, bacterial sporulation and 
transcription activation (as in the case of hrpL,) (Snider & Houry, 2008).  AAA+ proteins 
generally assemble into oligomers, usually hexamers, although heptamers have also been 
reported (Lee et al., 2003). This is the active form of the enzyme and gives these proteins 
their unique characteristics. For example, (i) the ATP binding and hydrolysis sites lie at the 
interface between two adjacent subunits (Joly et al., 2006a) and (ii) the central cavity, or 
pore, is created upon ring formation. Notably, functional loops have been observed to 
project into this pore feature (Lee et al., 2003) and  have been implicated in the functioning 
of several AAA+ proteins (see Figure 8 for the position of the pore loop in the AAA domain) 
(Hanson & Whiteheart, 2005).  
 
Two well studied AAA+ proteins are ClpX and ClpA, which are both involved in proteolysis. 
ClpX and ClpA form homohexamers which bind to, and interact with, a second unrelated 
protease, ClpP (which assembles as two heptomeric rings to form a barrel). The energy 
derived from ATP hydrolysis is used to unfold/unwind proteins that are then fed through the 
pore into the ClpP barrel where proteolysis takes place (Kirstein et al., 2009). ClpA can also 
function independently of ClpP (using the same unfolding process) as a chaperone (Wickner 
et al., 1994).  
 
Enhancer-binding proteins (EBPs) belonging to the AAA+ superfamily are only found in 
bacteria. They generally have three domains; a central AAA+ domain, an N-terminal 
regulatory domain and a C-terminal DNA-binding domain (see Figure 9). They use the energy 
derived from ATP hydrolysis to remodel the Eσ54 closed complex to a transcriptionally 
competent open complex (see Figure 6). Their AAA+ domain differs from classical AAA+ 
domains by the insertion of two loops; the L1 loop, which contains the highly conserved σ54-
interacting GAFTGA motif (Bordes et al., 2003a) and the L2 loop (or pre-sensor I insertion, 
Pre-SIi), which is thought to co-ordinate the movement of the L1 loop (Joly et al., 2010b, 
Burrows et al., 2009c, Chen et al., 2010). The presence of these loops defines AAA+ proteins 
as EBPs and also serve as the σ54-contacting elements (Rappas et al., 2005b). 
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Figure 9: The domain organisation of EBPs 
EBPs are usually composed of three domains: (1) a regulatory domain ‘R’, which senses the environment and regulates the 
activity of, (2) the central catalytic AAA+ domain and (3) a DNA-binding domain ‘D’, which is responsible for promoter 
recognition. EBPs can lack the regulatory and/or the DNA-binding domain, but the AAA+ domain is conserved. It contains 
seven conserved motifs, C1-C7, including: the σ
54
-interacting motif (GAFTGA) contained within Loop 1 (C3), Walker A (C1) 
and B (C4) motifs for ATP binding and hydrolysis, Sensor I (SI) (C6) and Sensor II (SII) (C7) and a second region of homology 
(SRH) containing the R-finger residue(s) (C6) (Joly et al., 2010b, Morett & Segovia, 1993). 
The GAFTGA motif, within L1 is highly conserved amongst EBPs and is directly involved in 
contacting σ54 (Bordes et al., 2003a). Activity of this GAFTGA motif is dependent on an 
invariant T residue at position 86 (in PspF). Interestingly, F at position 85 can tolerate a Y 
subsitiution, which is naturally observed in some EBPs e.g. HrpS of P. syringae and E. 
amylovora (see Figure 67). EBP structures have been shown to have three alternative states 
relative to the ATP hydrolysis cycle and nucleotide bound. These are apo (without 
nucleotide), ADP and ATP. The conformation of the subunits within the oligomeric structure 
changes dependent on the nucleotide bound (Rappas et al., 2006, Wang et al., 2003). 
Structural studies revealed that L1 loops are in a buried conformation in the ADP-bound 
state but move to an exposed position, projecting from the centre of the ring in the ATP-
bound state (Rappas et al., 2006). It is in the ATP-bound state that they contact σ54. 
Residues within and adjacent to the conserved Walker A and B motifs are able to sense the 
state of the nucleotide bound and to cause the movement from (and thereby cycle 
between) buried to exposed, back to buried conformations (Rappas et al., 2006, Burrows et 
al., 2009c, Chen et al., 2010).  
 
EBPs, like all ATPases, can employ different mechanisms of ATP hydrolysis; stochastic, where 
all subunits are independent; synchronised, where all the subunits are active and occupied 
by the same nucleotide form at the same time; rotational, where only three subunits are 
active and always occupied by a different nucleotide form at the same time; and sequential, 
where all the subunits are active and opposite subunits are occupied by the same nucleotide 
37 
 
form at the same time (Joly et al., 2010b). It has also been shown that within the hexamer of 
one EBP (PspF) a mixed nucleotide population can exist (Joly et al., 2006a). PspF, therefore, 
is proposed to employ either a rotational or sequential ATP hydrolysis cycle (Joly et al., 
2006a). 
 
Regulation of EBPs is commonly achieved through their N-terminal regulatory domain (see 
Figure 9), but sometimes occurs via the DNA-binding domain. More rarely, regulation acts 
through an additional protein that acts on the AAA+ domain, e.g. PspA regulation of the 
ATPase activity of PspF and HrpV regulation of HrpS (Elderkin et al., 2002, Preston et al., 
1998). The N-terminal regulatory domains sense the environment and hence adjust the 
activity of the AAA+ domain, often by altering the oligomeric state (recall that to be active 
EBPs must form higher-order oligomers, either hexamers or heptamers) – either negatively 
(as in NtrC1 and DctD) or positively (as in NtrC and ZraR). The inactive NtrC1 dimer is 
maintained by a tight interaction between N-terminal regulatory domains that prevents 
oligomerisation. Phosphorylation of the N-terminal regulatory domain alters its 
conformation and orientation promoting formation of the hexamer/heptamer. In NtrC the 
N-terminal regulatory domain is monomeric and phosphorylation exposes a hydrophobic 
patch in this domain, which stabilises an alternative dimer formation. These alternative 
dimers then associate to form the hexamer. 
 
EBPs, via their interaction with σ54, are known to regulate many systems. One interesting 
role is activating the expression of other alternative σ factors. Two examples are, (i) RpoS in 
Borrelia burgdorferi (the causal agent of Lyme disease) where σS regulates expression of 
outer surface lipoproteins, essential for virulence (Smith et al., 2007). (ii) HrpL in 
Pseudomonas syringae pathovars, Erwinia spp. and organisms formerly described as Erwinia 
spp. (collectively known as Group I plant pathogens) (Xiao et al., 1994, Wei & Beer, 1995, 
Frederick et al., 1993); (ii) HrpL regulates the expression of many pathogenesis related 
genes, including the structural components of the Type III secretion system (T3SS). 
 
Activation of σ54-dependent hrpL expression requires EBPs HrpR and HrpS (sometimes 
referred to as HrpRS) in P. syringae (Xiao et al., 1994, Hutcheson et al., 2001a). They are 
tandemly arranged and expressed as a single operon. They are similar to PspF in that they 
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do not have a regulatory domain, see Figure 9. Studies have shown that they are both 
required for full-activation of hrpL, however, significant overexpression of hrpS alone allows 
minimal hrpR-independent activation (2.5% of wild-type) (Grimm et al., 1995, Hutcheson et 
al., 2001a). Lan et al (2006) found that a ΔhrpRS mutation had a much broader regulatory 
role than ΔhrpL, with many more genes either upregulated or down regulated in the ΔhrpRS 
mutant (Lan et al., 2006). Hence activation of hrpL is not the only role of HrpR and HrpS. 
Importantly, in Erwinia spp. and former Erwinia spp. (defined above), a singly-acting HrpS 
activates hrpL expression (in addition to HrpX/HrpY) (Wei et al., 2000b, Merighi et al., 2003). 
Also, within the Erwinia hrp/hrc cluster, genes annotated as hrpV and hrpG are present. This 
raises the question, why does a dual EBP system exist in P. syringae where as in Erwinia a 
single EBP is sufficient? And, do HrpV and HrpG play the same role in Erwinia as they do in P. 
syringae? These questions will be addressed in this study. 
1.8. Regulation of HrpRS 
HrpRS regulation is emerging as a complex network of interactions. In P. syringae hrpL 
seems to be solely regulated by HrpRS, therefore HrpRS are indirectly responsible for 
regulating all ‘hrp-box’ promoter operons, i.e. the majority of secreted effectors and T3SS 
structural proteins. Regulators of HrpRS include LonB protease and the T3SS pilin protein, 
HrpA. Global regulation and response to environmental signals is thought to occur through 
the two-component system GacA and GacS, where GacA production in Ps. DC3000 is 
regulated by growth phase and stress conditions (Chatterjee et al., 2003). A summary of the 
known regulation involved in T3SS of Ps. DC3000 is depicted in Figure 10. 
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Figure 10: Regulation of hrpL-dependent genes in Ps. DC3000 and other P. syringae pathovars 
HrpR and HrpS bacterial EBPs bind to an upstream activator sequence to activate expression at the σ
54
-dependent hrpL-
promoter. HrpL is σ factor which specifies transcription from promoters with a ‘hrp-box’ (depicted in yellow). Hrp-boxes 
are found in the promoters of the hrp/hrc gene cluster (shown) and other genes encoding T3SS-dependent effectors. HrpV 
negatively regulates HrpRS via binding to HrpS and HrpG negatively affects HrpV. HrpA, which forms the T3SS pilus, 
positively effects transcription of hrpRS as does the GacA/GacS two-component system. Lon protease degrades HrpR. 
(Bretz et al., 2002, Hutcheson et al., 2001, Preston et al., 1998, Wei et al., 2005, Wei et al., 2000a, Chatterjee et al., 2003). 
Chatterjee et al (2003) analysed RNA transcript levels from a gacA deletion mutant of Ps. 
DC3000. They found that levels of hrpL, rpoS (encoding σ38), rpoN (encoding σ54), hrpR and 
hrpS were all reduced in the gacA mutant. Since expression of hrpL requires σ54, HrpR and 
HrpS, GacA does not directly impact hrpL expression. Interestingly, levels of hrpL were not 
reduced in a gacA mutant of Ps. syringae B728a, implying that some differences exist 
between regulatory systems in P. syringae pathovars. Deletion of gacA had an effect on the 
virulence of Ps. DC3000, although Ortiz-Martín et al (2010a) demonstrated that this is 
entirely hrpL-dependent (Chatterjee et al., 2003, Ortiz-Martín et al., 2010a). 
 
Lon protease is one of four cytosolic ATP-dependent proteases found in bacteria; two others 
are ClpX/ClpP and ClpA/ClpP. They are members of the AAA+ family and function similarly. 
Lon is involved in degrading unfolded proteins and naturally unstable regulators (Tsilibaris et 
al., 2006). In Ps. syringae a lon mutant caused constitutive expression of hrp/hrc genes in 
non-inducing media (rich media), through accumulation of HrpR, probably due to the 
increased instability of HrpR found in rich media (Bretz et al., 2002b). Lan et al (2007) 
proposed that in inducing media Lon has a role in upregulating hrp/hrc gene expression (Lan 
et al., 2007). However, Ortiz-Martín et al (2010b) report that Lon is a negative regulator of 
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hrp/hrc genes under these conditions. They found increased expression of hrpL, hrpA, hrcC, 
and hrpZ genes in the Δlon mutant and saw that the effects of Lon correlated with amounts 
of hrpR, i.e. the effect of Lon was more exaggerated when hrpR levels were low. 
 
HrpA subunits form the hrp pilus structure in P. syringae and E. amylovora, see Figure 2 
(Roine et al., 1997, Koebnik, 2001). HrpA also plays a role in T3SS regulation – a hrpA mutant 
had reduced accumulation of the structural components of the T3SS. Wild-type levels were 
restored in this mutant with ectopic expression of hrpRS. Therefore it is thought that HrpA 
upregulates expression of hrpRS (Wei et al., 2000a).  
1.9. hrpC operon 
The hrpC operon is comprised of hrpF, hrpG, hrcC, hrpT and hrpV; and within the operon 
these genes always appear in the above order, with hrpF at the 5’ promoter end (Deng et 
al., 1998, Frederick et al., 2001, Kim et al., 1997), see Figure 11.  
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Figure 11: Schematic of hrpC operon showing hrpL-dependent promoter. 
HrcC is a homolog of YscC of Yersinia (see Figure 1) and is related to PulD, the secretin of the 
T2SS pathway and PilQ, involved in T4SS pilus formation. These are outer membrane pore 
secretin proteins that form channels in the outer membrane through which other proteins 
can pass. Monomers of the YscC family assemble into ring-shaped multimeric complexes 
that form the upper part of the T3SS basal body (Koster et al., 1997). hrcC mutants are 
unable to secrete other T3SS components and effectors and are therefore unable to cause 
disease or the hypersensitive response and generally multiply poorly in the host (Deng et al., 
1998, Rantakari et al., 2001, Hauck et al., 2003). 
 
Preston et al (1998) and Ortiz-Martín et al (2010b) describe ΔhrpT mutations in Ps. syringae 
and Ps. phaseolicola respectively (Deng et al., 1998, Ortiz-Martín et al., 2010b, Preston et 
al., 1998). In both Ps. syringae and Ps. phaseolicola, HrpT is necessary for secretion and 
ΔhrpT mutants have reduced HR in non-host plants and grow poorly in host plants. In Ps. 
phaseolicola the ΔhrpT mutant accumulated more hrpL transcripts than wild-type under 
hrp-inducing conditions, whereas a ΔhrpV mutant showed no difference. This implies that 
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HrpT has a more significant role in down-regulating hrp gene expression than HrpV in Ps. 
phaseolicola and the authors conclude that both are probably involved (Ortiz-Martín et al., 
2010b). HrpT could act as a negative regulator via interacting with HrcC, perhaps in a 
chaperone-like manner. Notably, a FLAG-tagged HrpT was located in the outer membrane, 
co-localising with HrcC (Lin et al., 2006), and because HrpT is a putative lipoprotein (like 
other chaperones of HrcC), it could be acting as a chaperone of HrcC (Preston et al., 1998).  
 
HrpF seems to play an important role in T3SS-dependent pathogenesis in P. syringae. Deng 
et al (1998), Preston et al (1998) and Ramos et al (2007) examined hrpF mutants of Ps. 
syringae and found that ΔhrpF mutants were unable to secrete HrpZ or translocate AvrPto. 
They also multiplied poorly in host plants and failed to cause disease, and were not able to 
elicit HR in non-host plants. HrpF was shown to be secreted and its N-terminus shows 
sequence similarity to HrpA of Ps. DC3000, which is the pilus-forming protein. Real-time PCR 
analysis showed that a ΔhrpF mutant had reduced expression of hrpA2, hrpP and hrpL 
(Ramos et al., 2007). Further, HrpF is the second most divergent Hrp protein after HrpA, 
suggesting specialisation in the host proteins with which it may react. In addition, It has 
been suggested that HrpF may have a regulatory function involving HrpV and HrpG (Ramos 
et al., 2007). 
1.9.1. HrpV 
HrpV is encoded by the last ORF in the hrpC operon and varies in length between 115 and 
136 a.a (13.4 kDa – 15.1 kDa). It has been shown to inhibit the activity of HrpR and HrpS 
(Preston et al., 1998). Work within Ps. syringae by Deng et al (1998) showed that a hrpV 
mutant had reduced growth and disease symptom development in bean but wild-type 
elicitation of HR on tobacco. This mutant, when complemented with plasmid-borne hrpV, 
had severely reduced HR levels. Preston et al (1998), using the same mutant showed that 
accumulation and/or expression of HrpZ, HrcC, HrcJ and HrpQB was greater than wild-type 
and that when hrpV was overexpressed there was no detectable accumulation of HrcC, hrcJ 
or HrpQB. Preston et al (1998) also demonstrated that constitutive expression of hrpL or 
hrpRS bypasses the negative effect of overexpressing hrpV thus concluding that HrpV is a 
negative regulator of the hrp/hrc genes – acting at a regulatory level upstream of HrpL and 
HrpRS.  
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The phytotoxin, coronatine, is a virulence factor produced by some, but not all, 
P.
 
syringae pathovars; including Ps. DC3000. Penaloza-Vazquez et al (2000) examined the 
effect of mutating members of the hrp/hrc cluster on coronatine production in Ps. DC3000 
(Penaloza-Vazquez et al., 2000). They found that a polar mutant of hrcC (where hrpT and 
hrpV are disrupted) had increased levels of coronatine. In trans expression of hrpV restored 
wild-type levels of coronatine; implying that hrpV is involved in the negative regulation of 
coronatine biosynthesis and that there may be cross-talk between the hrp/hrc cluster and 
coronatine cluster genes, which is not unlikely considering their respective roles in 
virulence. 
 
Ortiz-Martín et al (2010b) studied mutations in Ps. phaseolicola, initially using a mutant 
(IOM9) that was deleted for hrpV and the last three amino acids of HrpT. They compared 
the results of this mutant to one deleted for just hrpV (IOM48). Interestingly, IOM9 had 
growth defects in rich and minimal media and in bean with reduced symptom development 
and a slightly reduced HR-causing ability. However, IOM48 had wild-type growth in all 
conditions and stronger and faster HR in tobacco than wild-type. Notably, IOM9 could only 
be complemented by a construct carrying hrpT and hrpV. Both IOM9 and IOM48 had higher 
than wild-type levels of hrpA and hrpL transcripts in rich media and had reduced rates of hrp 
gene induction in minimal media; showing that HrpV (and HrpT) is required for repression of 
hrp/hrc genes under non-inducing conditions (Ortiz-Martín et al., 2010b).  
 
The phenotypes seen for IOM9 seem to correlate closer to the results seen in hrpV mutants 
of Ps. syringae which indicates that in Ps. phaseolicola HrpT is also important for negative 
regulation of the hrp/hrc genes. It is important to note that the sequences of HrpV plus the 
last three amino acids of HrpT of Ps. syringae 61 and Ps. phaseolicola are 90% identical and 
97% similar. Another difference seen between Ps. syringae and Ps. phaseolicola is that 
Preston et al (1998) reported that if cultures were grown to higher densities before 
induction the hrpV mutant secreted more HrpZ, whereas Ortiz-Martín et al (2010b) did not 
detect any difference when using stationary vs. midlog cells for induction in terms of 
transcript levels of hrpA, hrpL and hrpF. This means that growth phase at the time of 
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induction can have influence on the effect of the mutation so this should be taken into 
account when comparing data from different experiments. 
 
A potential hrpV homolog from P. fluorescens SWB25 (rspV) was tested for its ability to 
repress the HrpL and HrpS homologues RspL and RspR (Jackson et al., 2005). In 
the rspV mutant strain overexpression of RspR did not result in a further increase 
in rspU transcription compared to the wild type overexpressing RspR. However, in a 
bacterial growth assay the rspV mutant had significantly reduced fitness compared to wild-
type (Jackson et al., 2005) so RspV does have a role to play in P. fluorescens, though perhaps 
not the same as in P. syringae. 
 
As Preston et al (1998) showed that HrpV acts upstream of HrpL and HrpRS and Wei et al 
(2005) showed that HrpV binds HrpS it is assumed that HrpV acts to repress HrpS activity. 
HrpS (like HrpR) lacks an N-terminal regulatory domain. The activity of HrpRS must be 
regulated at some level, presumably by hexamer formation or composition, ATPase activity 
or UAS DNA binding. For example, NifL reduces the ATPase activity of NifA by diminishing its 
ability to bind UAS DNA (Barrett et al., 2001, Money et al., 1999); PspA inhibits ATPase 
activity of bEBP PspF (Elderkin et al., 2002a, Joly et al., 2009a); NtrC1 is kept in an “off 
dimer” assembly until phosphorylation allows hexamer formation (Doucleff et al., 2005).  
 
1.9.2. HrpG 
HrpG is encoded by the second ORF in the hrpC operon, flanked by hrpF and hrcC and varies 
in length between 136 and 146 a.a (15.4 kDa – 15.8 kDa) (not including RspG of P. 
fluorescens, 130 a.a.). It has been shown to interact with HrpV and suppress the negative 
effect of HrpV (Wei et al., 2005). 
 
Using the 3D-PSSM program (http://www.sbg.bio.ic.ac.uk/) Wei et al (2005) found that the 
tertiary structure of HrpG is predicted to be similar to chaperones of T3SS effectors; SicP, 
SycE and CesT. HrpG of P. syringae is a small, acidic cytoplasmic protein: characteristics 
typical of some chaperones. Therefore it is formally possible that HrpG has a HrpV-
independent role as an effector chaperone. It is also possible that HrpG acts on HrpV in a 
chaperone-like manner. Although HrpG is the only known potential example of a regulatory 
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chaperone of T3SS in plant pathogenic bacteria (Buttner & Bonas, 2006) there are examples 
of chaperones that regulate the T3SS in animal bacteria and examples of chaperones 
regulating other systems in plant pathogenic bacteria. The translocator complex chaperone, 
IpgC (Shigella) regulates the expression of genes encoding putative T3SS secreted late 
effectors (Blocker et al., 2003). In Yersinia spp. LcrH/SycH (chaperones of YopD) assist in the 
export of negative regulators LcrQ/YscM1 and M2 resulting in the upregulation of yop genes 
(Cambronne et al., 2004). The HrpG-HrpV-HrpS system also similar to the ExsC-ExsD-ExsA 
cascade of P. aeruginosa where the chaperone-like protein ExsC binds to and represses 
ExsD, thus freeing ExsA to promote transcription of the T3SS (Hovey & Frank, 1995, McCaw 
et al., 2002, Dasgupta et al., 2004).  
 
Deng et al (1998) used a functionally non-polar mutant of hrpG from Ps. syringae made with 
a terminatorless nptII cassette inserted within the hrpG coding sequence (with the cassette 
orientated in the same direction as the operon and carrying its own promoter). They found 
that the abilities to cause (i) HR on tobacco, (ii) to cause disease in beans and (iii) to multiply 
in beans were all reduced to an intermediate level in the hrpG mutant somewhere between 
wild-type levels and complete abolishment of plant reaction phenotypes (as seen in the hrcC 
mutant). The phenotypes were all restored to wild-type levels by complementation. Using 
the same mutant strain Preston et al (1998) found that the hrpG mutant, when grown to 
early log phase (before induction), produced, but was unable to secrete, HrpZ. However, 
when grown to stationary phase (before induction) the hrpG mutant did not produce HrpZ. 
Higher levels of HrcC but not HrcQB were seen in the HrpG mutant; this was attributed to 
constitutive expression of hrpV driven by the nptII promoter (Wei et al, 2005). Using the 
same mutant strain as Deng et al (1998) and Preston et al (1998), Ramos et al (2007) found 
that the HrpG mutant had a reduced ability to cause HR in N. tabacum but elicited wild-type 
HR in N. benthamiana. The mutant translocated twice as much AvrPto-Cya into N. 
benthamiana cells but secreted wild-type levels of AvrPto1-FLAG into culture medium.  
 
Wei et al (2005) compared two hrpG deletion mutants; one with a promoter-driven nptII 
cassette, the other without a promoter (i.e. expression is driven by the native promoter 
upstream of hrpF). They found that the one without a promoter elicited wild-type levels of 
HR on tobacco and wild-type levels of expression and production of HrpZ, HrpJ and HrpQB as 
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well as wild-type levels of HrpZ secretion. The hrpG deletion mutant with a promoter-driven 
nptII cassette elicited a delayed HR response on tobacco and had severely reduced levels of 
expression and production of HrpZ, HrpJ and HrpQB. However, the mutant could still secrete 
HrpZ implying that HrpG is not responsible for the correct assembly of the T3SS. This mutant 
was also found to have elevated levels of hrpV transcript, as well as the other downstream 
operon genes hrpT and hrcC. The wild-type phenotypes were fully restored by 
complementation with plasmid-borne hrpG but the hrpV transcript levels remained 
elevated. Therefore the presence of HrpG can counteract increased levels of HrpV; the 
conclusion being that it is a negative regulator of HrpV activity. Wei et al (2005) also 
demonstrated that HrpG binds HrpV using a yeast two-hybrid system, an affinity binding 
pull-down assay and far Western blotting. 
 
From these four studies (Wei et al., 2005, Deng et al., 1998, Preston et al., 1998, Ramos et 
al., 2007) it seems that when only hrpG is deleted and no other genes are affected then the 
phenotypes examined are at wild-type levels. These findings do not correlate well with 
studies by Ortiz-Martín et al (2010b) and Hojo et al (2008). Hojo et al (2008) made a random 
transposon mutagenesis library in P. cichorii and selected two mutants for further study that 
lost virulence on eggplant but remained able to cause disease on lettuce. One mutant had a 
transposon inserted in its hrpG gene and could be complemented by plasmid borne hrpC 
operon from both P. cichorii and P. viridiflava S-PAI. However, the authors did not confirm 
that expression of other operon genes were not affected nor did they demonstrate that the 
hrpG mutant could be complemented by hrpG alone. This leaves open the possibility that it 
is not simply the disruption of hrpG that caused the observed phenotypes but perhaps 
effects on other genes, e.g. hrcC.  
 
Ortiz-Martín et al (2010b) used a mutant with the nptII cassette in the same direction as the 
operon; i.e. equivalent to those used in numerous other experiments (Wei et al., 2005, Deng 
et al., 1998, Preston et al., 1998, Ramos et al., 2007). They found wild-type levels of HR and 
autoagglutination (an assay demonstrating that T3SS assembly has occurred). Contrasting a 
mutant with the cassette in the opposite direction to the operon (created so as to not 
increase levels of downstream operon genes), which was severely impaired in its ability to 
elicit HR on tobacco and disease in bean. They found that this mutant had high basal levels 
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of hrcC and hrpF but that their levels remained largely unaltered after induction, implying 
that HrpG is necessary for ‘properly ordered’ induction of the hrpC operon. This mutant 
could not be complemented by plasmid-borne hrpG but could be complemented by 
expressing the entire hrp/hrc cluster. The authors concluded that HrpG is not fully functional 
unless produced as part of the hrpC operon. However, they also demonstrate that the hrpG 
mutant can be complemented when both hrpG and hrcC are expressed; from which they 
conclude that HrcC overexpression can complement for the loss of HrpG. Finally Ortiz-
Martín et al (2010b) demonstrated that HrpG has a HrpV-independent role in virulence by 
constructing a double mutant with both hrpG (cassette in the opposite direction to the 
operon) and hrpV deleted. This mutant was similar to the hrpG single deletion mutant in 
terms of expression of the hrpC operon and its HR and virulence phenotypes.  
 
In summary, the phenotypic effects of deleting hrpG (when there is no upregulation of hrpV) 
in P. syringae pathovars appears to differ; either there is no effect (Wei et al 2005) or there 
is a severe effect (Ortiz-Martín et al (2010b). However, studies agree that HrpG acts to 
suppress HrpV and Ortiz-Martín et al (2010b) demonstrate an additional HrpV-independent 
role for HrpG. It should be noted that Preston et al (1998) showed that growth phase at 
time of hrp induction had an effect on the hrpG mutant.  Wei et al (2005) induced cells at 
log phase but Ortiz-Martín et al (2010b) induced cells at stationary phase. There could also 
be a chaperone-like mode of activity for HrpG. Further, there does appear to be a significant 
role for HrpG in the Erwinia group as Hojo et al (2008) created mutants by random 
transposon mutagenesis and found that one mutant with interesting phenotypes had an 
insertion in the hrpG gene. 
1.10. Objectives 
This study is primarily concerned with furthering the current understanding of the roles that 
HrpV and HrpG play in regulating HrpR and HrpS in three contexts: (i) in Ps. DC3000, (ii) in a 
heterologous E. coli in vivo system and (iii) in vitro using purified components. As HrpV and 
HrpG represent novel proteins, both having no recognised domains, they will be examined 
at a molecular level to delineate functional motifs and residues. In silico analysis will be used 
to guide mutational analysis. Chapter 3 will examine mutants of Ps. DC3000 harbouring 
either hrpV or hrpG deletions. Chapter 4 uses an in vivo activity assay and a two-hybrid 
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assay to analyse truncated mutants of HrpV and HrpG based on secondary structure 
predictions and alanine substitution mutants based on sequence alignment analysis. 
Chapter 5 examines interactions between HrpV and HrpG in vitro and their effects on HrpR 
and HrpS activity, as well as looking at the HrpRS sequences in detail.  
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CHAPTER TWO 
2. Methods 
2.1. General methods 
2.1.1. Composition of growth media 
All bacterial growth media were autoclaved for sterilisation at 120oC for 20 min. The media 
used and their composition are shown in Table 2. 
Media Composition (1L) Use/Reference 
Luria-Bertani (LB) 10 g peptone, 5 g yeast 
extract, 5 g NaCl 
General 
Ausubel et al (1995) 
Luria-Bertani Agar (LA) 10 g peptone, 5 g yeast 
extract, 5 g NaCl, 20 g agar 
General 
Ausubel et al (1995) 
 hrp-inducing media (HIM) 
(made with sterilised 
components) 
50 mM potassium phosphate 
buffer (pH 7.0), 1.7 mM 
MgCl2, 1.7 mM NaCl, 7.6 mM 
(NH4)SO4, 10 mM Fructose 
Chapter 3 – hrp induction 
Huynh et al (1989) 
Table 2: Composition of growth media 
The sterilised media were supplemented with appropriate antibiotics to select for the 
bacterial strain or plasmid of interest. The antibiotics were filter sterilised before use, 
summarised in Table 3. Unless otherwise stated E. coli plates and media were incubated at 
37oC and Ps. DC3000 at 25oC.  
Antibiotic Stock concentration Final Concentration Storage Abbreviation 
Ampicillin 100 mg/ml, in ethanol 100 µg/ml -20oC AmpR 
Chloramphenicol 25 mg/ml, in ethanol 25 µg/ml -20 oC ChlR 
Kanamycin 50 mg/ml, in H2O  50 µg/ml 4
 oC KanR 
Rifampicin 50 mg/ml, in methanol 80 µg/ml 4 oC RifR 
Spectinomycin 50 mg/ml, in H2O 50 µg/ml -20
 oC SpecR 
Tetracyclin 15 mg/ml, in H2O 15 µg/ml -20
 oC TetR 
Table 3: Summary of antibiotics used in this work 
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2.1.2. General laboratory reagents and solutions 
Acrylamide Proto gel (Solution I): 30% (w/v) acrylamide, 0.8% (w/v) bis-acrylamide 
(National diagnositics)     stock solution (37.5:1) 
Acrylamide (PAGE) Solution II: 1.5 M Tris-HCl, pH 8.8, 0.3% (w/v) SDS. 
Acrylamide (PAGE) Solution III: 0.5 M Tris-HCl, pH 6.8, 0.4% (w/v) SDS. 
Protein Buffer A : 50 mM sodium phosphate buffer pH 7.0, 500 mM 
NaCl, 0.1 mM EDTA, 5% glycerol 
Protein Buffer B : 50 mM sodium phosphate buffer pH 7.0, 500 mM 
NaCl, 0.1 mM EDTA, 5% glycerol, 1M imidazole 
Coomassie De-stain: 45% (v/v) methanol, 10% (v/v) acetic acid. 
Native Loading Buffer x5: 312.5 mM Tris-HCl, pH 6.8, 50% (v/v) glycerol, 0.05% 
(w/v) Bromophenol Blue. 
ONPG (ortho-Nitrophenyl-β-galactoside):  
4 mg/mL in Z-buffer without β-mercaptoethanol. 
Phosphate Buffer Saline (PBS) x10: 80 g NaCl, 2 g KCl, 11.5 g Na2HPO4•7H2O, 2 g KH2PO4. 
(For 2 L) 
STA (standard transcription assay) Buffer x1:  
25 mM Tris acetate, pH 8.0, 10 mM KCl, 8 mM 
magnesium acetate, 1 mM DTT, 3.5% (w/v) PEG 8000. 
Tris Buffered Saline (TBS) x10: 50 mM Tris, 150 mM NaCl. 
TBSTT x10: As above with 0.3% (v/v) Tween 20. 
TGED protein storage buffer: 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 mM DTT, 10-
50% (v/v) glycerol. 
1M Tris-HCL stock: 121 g Tris base in 800 ml water, adjust to desired pH 
with concentrated HCl. (Mix and make up to 1 L) 
TTH Buffer x1: 10 mM Tris-HCl, pH 7.5, 70 mM KCl, 5 mM MgCl2, 1 
mM DTT, 1 mM EDTA, 12.5% glycerol and 0.1% w/v 
Triton X-100 
Z-buffer: 0.06M Na2HPO4.7H2O, 0.04M NaH2PO4.H2O, 0.01M 
KCl, 0.001M MgSO4, 0.05M β-mercaptoethanol. 
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2.1.3. Bacterial strains and plasmids 
Bacterial strains used for cloning, in vivo activity assays and protein expression are listed in 
Table 4. The plasmids with antibiotic resistances are listed in Table 5 and the constructed 
vectors are listed in Appendix B, Table 13. 
Strain Genotype Reference 
E. coli B834 (DE3) F- ompT hsdSB (rB-mB-) gal dcm met (DE3) Novagen 
E. coli BL21 (DE3) F– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
Stratagene 
E. coli 
NovaBlue(DE3) 
endA1 hsdR17(rK12– mK12+) supE44 thi-1 
recA1 gyrA96relA1 lac F’[proA+B+ 
lacIqZΔM15::Tn10] (TetR) 
Novagen 
E. coli AcellaTM F-ompT hsdSB(rB-mB-) gal dcm (DE3) ∆endA 
∆recA 
Edge Bio 
E. coli Rosetta(DE3) F– ompT hsdSB(rB– mB–) gal dcm (DE3) pRARE 
(CamR) 
Novagen 
E. coli XL1 blue recA1 endA1 gyrA96 thi-
1 hsdR17 supE44 relA1 lac 
Stratagene 
E. coli MC1061 araD139 Δ(araA-leu)7697 ΔlacX74 galK16 
galE15(GalS) λ- e14- mcrA0 relA1 rpsL150(strR) 
spoT1 mcrB1 hsdR2 
(Casadaban & 
Cohen, 1980) 
E. coli MC4100 F- [araD139]B/r Δ(argF-lac)169 λ
- e14-  flhD5301 
Δ(fruK-yeiR)725 (fruA25) relA1 rpsL150(strR) 
rbsR22 Δ(fimB-fimE)632(::IS1) deoC1 
Casadaban (1976) 
E. coli MJ2806 MC4100 (attL hrpL::lacZ bla attR) Jovanovic et al 
(2011) 
E. coli BTH101 F-, cya-99, araD139, galE15, galK16, rpsL1 
(Strr), hsdR2, mcrA1, mcrB1. 
Karimova et al 
(1998) 
E. coli K12 ER2925 ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 
galT22 mcrA dcm-6 hisG4 rfbD1 
R(zgb210::Tn10)TetS endA1 rpsL136 
dam13::Tn9 xylA-5 mtl-1 thi-1 mcrB1 hsdR2 
NEB 
Ps. DC3000  Wild-type strain (rifampicin resistant) Whalen et al (1991) 
Ps. DC3000 ΔhrpV ΔhrpV, carrying a deletion of the entire hrpV 
(Kmr) 
Gift from C. Beuzón 
and I Ortiz-Martín 
Ps. DC3000 ΔhrpG ΔhrpG, carrying a hrpG deletion and contains 
the nptII gene with the opposite orientation as 
the hrpC operon (kanamycin resistant) 
Gift from C. Beuzón 
and I Ortiz-Martín 
Ps. DC3000 ΔhrpG ΔhrpG, carrying a hrpG deletion and contains 
the nptII gene with the same orientation as the 
hrpC operon (kanamycin rseistant) 
Gift from C. Beuzón 
and I Ortiz-Martín 
Table 4: Bacterial strains used in this work 
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Vector Resistance Strain(s) 
used 
Use Inducer Reference 
pGEM-T 
Easy 
ampicillin JM109,  
K12 ER2925 
Cloning N/A Promega 
pBAD18 chloramphenicol MC4100Ø8 In vivo activity arabinose (Guzman et al., 
1995) 
pAPT110 kanamycin MC4100Ø8 In vivo activity IPTG (Polard and 
Chandler, 1995) 
pKT25 kanamycin BTH101 Bacterial 2-
hybrid assay 
IPTG (Karimova et al., 
1998) 
pUT18c ampicillin BTH101 Bacterial 2-
hybrid assay 
IPTG (Karimova et al., 
1998) 
pET28b+ kanamycin B834 (DE3), 
BL21 (DE3) 
Protein 
expression 
IPTG Novagen 
pREP4 spectinomycin B834 (DE3), 
BL21 (DE3) 
Protein 
expression 
N/A Qiagen 
pQE30 ampicillin B834 (DE3), 
BL21 (DE3) 
Protein 
expression 
IPTG Qiagen 
pBBR1MCS 
4 
ampicillin Ps. DC3000 broad-host-
range cloning 
vector 
N/A (Kovach et al., 
1994) 
pTE103 ampicillin MC1061 In vitro 
transcription 
N/A (Elliott & 
Geiduschek, 
1984) 
Table 5: Background plasmids used in this work  
Background plasmids used in this work with their corresponding resistance, strain used in, inducer and use. See Appendix A 
for vector maps of pBAD18, pGEM-T Easy, pUT18C, pKT25, pBBR1MCS and pET28b
+
. 
2.2. General DNA methods 
2.2.1. Purification of chromosomal DNA 
Ps. DC3000 was grown overnight at 25oC in 5 ml LB with rifampicin (80 µg/ml). 0.5 ml 
overnight culture was pelleted and washed with 1 ml TNE (10 mM Tris-HCl, pH 8.0, 10 mM 
NaCl, 10 mM EDTA, pH 8.0). Cells were pelleted then resuspended for lysis in 270 µl TNEX 
(as TNE with 1% Triton-X 100), 30 µl lysozyme (5 mg/ml in H2O) and 7.5 µl proteinase K (20 
mg/ml in H2O). Resuspended cells were incubated for 2 hours at 37
oC then for 2 hours at 
65oC (to inactivate the proteinase K). 15 µl NaCl (5 M) was then added and mixed by 
inversion followed by 1 ml 96% ethanol (added slowly). After 3 min the sample was mixed 
slowly by inversion and then spun down in a microcentifuge for 5 min at 18,000 x g. The 
DNA pellet was washed once with 1 ml 96% ethanol. Ethanol was removed carefully then 
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residual ethanol evaporated by leaving the tube open for 5-7 min at 37oC. The DNA pellet 
was resuspended in 100 µl TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0) and left at room 
temperature overnight to dissolve the DNA. The DNA was subsequently stored at -20oC. 
2.2.2. Purification of plasmid DNA 
Plasmid DNA for transformation into competent cells was acquired using QIAGEN’s QIAprep 
miniprep system. Bacterial cultures of 5 ml were grown overnight to saturation, pelleted 
and the supernatant discarded. The pelleted cells were then processed according to the 
manufacturer’s instructions to yield the plasmid DNA. Briefly, the cell pellets were 
resuspended in three solutions to lyse the cells. Cell debris was pelleted 18,000 x g in a 
microcentrifuge for 10 minutes (subsequent steps required 1 min centrifugation at 18,000 x 
g). The supernatant was transferred to an anion exchange column and the DNA bound to 
the column’s membrane following centrifugation. The DNA was washed using a salt solution 
containing ethanol and finally eluted from the column with 50 µl water. The purified DNA 
was analysed using agarose gel electrophoresis and stored at -20oC. pET103 containing the 
S. meliloti nifH promoter and/or Ps. DC3000 hrpL promoter was prepared Qiagen Maxi Prep 
plasmid purification kit as per manufacturer’s instructions which follows the same steps as 
above with 200 ml of cell culture. 
2.2.3. Restriction analysis of DNA 
Restriction analysis was typically carried out with a final reaction volume of 20 µl containing 
7 µl of plasmid DNA (as prepared in section 2.2.1), 0.5 U of restriction enzyme(s) and 2 µl 
x10 reaction buffer. Reactions were incubated at 37oC for 2 hours and analysed using 
agarose gel electrophoresis. The enzymes and buffers were from New England Biolabs.  
Typically, 20 μl of reaction was mixed with 2 μl of 6x agarose gel loading dye (10 mM Tris-
HCl, pH 7.5, 50 mM EDTA, pH 8.0, 10% (v/v) glycerol, 0.4% (w/v) bromophenol blue). 
2.2.4. Agarose gel electrophoresis 
Depending on expected size of DNA to be visualised either 1% or 1.5% (w/v) agarose 
(Merck) gel prepared in x1 TBE buffer (National Diagnostics) was used. For sizes less than 
200 bp 1.5% agarose was commonly used. The solution was heated in a microwave to 
dissolve the agarose then left to cool before adding 1:10,000 dilution of SYBR® Safe DNA gel 
stain (Invitrogen). The solution was set in a gel-casting tray. Samples were loaded then the 
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gel was run at 100 V in x1 TBE for approximately 25 min. The gel was visualised using a blue 
light transilluminator (Invitrogen).  
2.2.5. DNA gel purification 
DNA was purified from agarose gels using QIAGEN PCR purification kit according to the 
manufacturer’s instructions. Briefly, the band of interest was excised from the gel using a 
clean scalpel blade. This piece was then melted at 50oC with x3 v/v solubilisation and 
binding buffer (with pH indicator). Isopropanol (x1 v/v) was added if the DNA fragment of 
interest was smaller than 200 bp. The solution was then bound to the column by 
centrifugation in a microfuge at maximum speed for 1 min. The sample was then washed 
with a salt solution containing ethanol and eluted from the column using 30 µl water. 
Samples were stored at -20oC. 
2.2.6. Polymerase chain reaction (PCR) 
Ps. DC3000 genes of interest were amplified from chromosomal DNA by PCR using Go-taq 
(Promega) polymerase which polyadenylates linear DNA ends. This enabled direct ligation 
into pGEM-T easy vector (Promega). Once wild-type genes had been cloned into a pGEM-T 
easy vector (see section 2.2.9) this recombinant DNA was used as template DNA in later PCR 
reactions.  
Standard PCR Protocol: The oligonucleotides (primers) were synthesised by Eurofins Operon 
or Sigma. A list of oligonucleotides used in this work can be found in Appendix B, Table 11. 
The parental plasmid DNA was prepared as highlighted in section 2.2.1 from E. coli JM109 or 
XL1 blue cells. Typically, in a total reaction volume of 50 μl, 50 ng parental/template DNA, 
125 ng of each oligonucleotides/primer, 25 mM dATP, dCTP, dGTP, and dTTP, 5 μl x10 
reaction buffer and 2.5 units of Taq DNA polymerase were mixed. The reactions were then 
temperature cycled in two parts as follows, (1) 95°C for 5 min and (2) 95°C for 30 sec, 55°C 
for 30 sec (this temperature depended on the Tm of the oligos), 72°C for 1 min and repeat 
stage (2) 28 times.  
 
PCR was also used to confirm the presence of cloned genes within individual colonies 
(known as colony PCR). This was done by resuspending a single colony in 50 µl LB and using 
2 µl of this suspension in a 50 µl reaction (as described above). Primers used corresponded 
to the gene of interest. 2 µl of the colony suspension was spotted onto a master LB agar 
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plate with appropriate antibiotics to use as a record for DNA recovery from confirmed 
colonies. 
2.2.7. Site Directed mutagenesis 
Principle: Site directed mutagenesis was carried out using two enzymes (1) Pfu DNA 
polymerase – from the hyperthermophilic archae Pyrococcus furiosus (PfuUltra II, 
Stratagene), a high fidelity enzyme; and (2) DpnI restriction enzyme (Fermentas), which 
specifically digests methylated DNA with the target sequence 5'-GmGATC-3'. The PCR 
reaction contains plasmid DNA as a template (containing the gene of interest), and two 
complementary oligonucleotides (primers) harbouring the desired mutation. After the PCR 
temperature cycling has taken place the reaction mixture (containing the parental 
methylated DNA and the new PCR DNA) is subjected to DpnI, which will digest the parental 
DNA strands due to the presence of methylated bases. 
Protocol: The mutagenic oligonucleotides can be seen in Appendix B, Table 11. The parental 
plasmid DNA was prepared as highlighted in section 2.2.2 usually from E. coli MC1061. 
Typically, in a total reaction volume of 50 μl, 50 ng parental/template DNA, 125 ng of each 
oligonucleotide, 25 mM dNTPs, 5 μl x10 reaction buffer and 2.5 units of Pfu DNA polymerase 
were mixed. The reactions were then temperature cycled in two parts as follows, (1) 95°C 
for 5 min and (2) 95°C for 30 sec, 59°C for 30 sec, 68°C for 3 min and repeat stage (2) 16 
times. Following the PCR the PCR clean-up protocol was followed (as section 2.2.8) and DNA 
eluted into 50 µl water. Restriction digestion of DNA was performed as section 2.2.3 with 2 
U of DpnI restriction enzyme. The reactions were then transferred to 37°C for 1 hr to digest 
the parental DNA. After such time, 10 μl of the reaction mixture were used to transform 
competent E. coli MC1061 cells (see section 2.2.13).  Plasmids purified from single colonies 
were sequenced (see section 2.2.10) to confirm the presence of the desired mutation. This 
protocol was used to create HrpGNQR and HrpVLAG used in Chapters 4 and 5. 
2.2.8. PCR purification 
Following PCR amplification the DNA was purified using QIAGEN’s  QIAquick PCR Purification 
Kit according to the manufacturer’s instructions. Briefly, x5 v/v binding buffer was added to 
PCR DNA. The solution was then bound to the column by centrifugation in a microfuge at 
maximum speed for 1 min. The sample was then washed with a salt solution containing 
ethanol and eluted from the column using 30 µl deionised water.  
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2.2.9. pGEM-T easy vector ligation 
Purified DNA from a PCR reaction using Promega Go-taq was ligated into linear pGEM-T easy 
vector (which has poly-thiamine tails) using T4 DNA ligase (Promega). The reaction typically 
consisted of 1 µl pGEM-T easy vector, 1 µl T4 DNA ligase, 5 µl x2 ligase buffer, 3 µl insert 
DNA. The reaction was left overnight at 4oC then used in a transformation into competent 
cells (sections 2.2.12 and 2.2.13). 
2.2.10. DNA sequencing 
Sequencing of amplified DNA was typically performed after ligation into pGEM-T easy 
vectors using the Imperial College Core Sequencing Service. A 7 µl sample of recombinant 
vector DNA together with 3 µl forward/reverse primer oligonucleotide (10 µM) was sent to 
the sequencing service. The reactions are performed using Applied Biosystems BigDye 
version 3.1. Sequences were analysed using BioEdit Sequence Alignment Editor (Hall, 1999). 
2.2.11. Vector ligation 
After sequence confirmation inserts were cut from pGEM-T easy vectors using appropriate 
restriction enzymes (Table 5, section 2.2.3). These were purified after agarose gel 
electrophoresis (sections 2.2.4 and 2.2.5). Working vectors were also cut by appropriate 
restriction enzymes and dephosphorylated using shrimp alkaline phosphatase (Promega). 
Ligation reactions contained approximately 3:1 insert to vector ratio, 2 µl x10 ligase buffer 
and 1 µl T4 DNA ligase (Promega). These were made up to a final volume of 20 µl and left 
overnight at 4oC. Half this reaction was then used for transformation into competent cells 
(sections 2.2.12 and 2.2.13). See Table 2.4 for which vectors were transformed into which 
cell strains. 
2.2.12. Competent cell preparation 
Competent cells were prepared for transformation by heat shock using the calcium chloride 
method. Cell cultures of 5 ml containing appropriate antibiotics inoculated from a single 
colony were grown overnight. This primary culture was used to inoculate a 200 ml culture 
again containing appropriate antibiotics. These were grown to mid-log phase (OD 600 nm ~ 
0.5) and centrifuged at 4oC and 4500 rpm for 15 min. Cell pellets were resupended in 25 ml 
ice-cold calcium chloride solution (50 mM CaCl2, 15% (v/v) glycerol). Cells were incubated on 
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ice for 3 hours, centrifuged as before and resuspended in 2 ml calcium chloride solution. 
Competent cells were stored at -80oC in 100 μl aliquots.  
2.2.13. Heat-shock transformation 
For transformation typically 50 µl competent cells were incubated on ice for 30 min with 
either 1 µl plasmid DNA or 10 µl ligation reaction (Sections 2.2.9 and 2.2.11). Cells were then 
heat shocked at 42oC for 1 min and returned to ice for a further 2 min. To recover, cells 
were supplemented with 500 µl LB and left to shake at 37oC for 1 hour. For plasmid 
transformations 100 µl of the total was spread onto LA plates containing appropriate 
antibiotics. For ligation transformation the cells were pelleted and resuspended in 100 µl LB, 
they were then spread onto LA plates containing appropriate antibiotics. LA plates were 
incubated for 12-16 hours at 37oC. 
2.2.14. Electroporation 
Electroporation was used in Chapter 3 to transform pBBR1MCS-based plasmids into Ps. 
DC3000 strains. Electroporation was performed according the protocol described by Choi et 
al (2006) (Choi et al., 2006). Briefly, 5 ml of cells were grown to mid-log phase (OD 600 nm ~ 
0.5) (rather than overnight as is published) in LB with appropriate antibiotics. Cells were 
pelleted by centrifugation and washed twice with 1 ml sucrose (300 mM) then resuspended 
in 100 µl 300 mM sucrose. Prior to electroporation cells were diluted 100-fold (this was 
optimised from the published protocol for this study). Approximately 1 ng of plasmid DNA 
was incubated on ice for 30 min with 100 µl of diluted cells. The mixture was transferred to 
a 2 mm gap width electroporation cuvette and pulsed using a Bio-RAD Micropulser with the 
standard settings Ec1. 1 ml of LB was immediately added and cells were transferred to a 1.5 
tube and shaken at 25oC for 2 hours. Cells were then pelleted and resuspended in 100 µl 
which was plated onto LB agar plates containing appropriate antibiotics and left to grow 
until visible colonies formed at 25oC. 
2.3. General protein methods 
2.3.1. Protein overexpression 
Proteins over-expressed and purified in this work are HrpG, HrpV and HrpR/HrpS (purified 
together). HrpG and HrpV were cloned into a pET vector. HrpR/HrpS were cloned into a pQE 
vector (Qiagen) (see Appendix B and Table 5). 
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2.3.2. The pET system 
As with all pET vectors, pET28b+ contains a T7 promoter region, which is specifically 
recognised by the bacteriophage T7 DNA dependent RNA polymerase (T7 RNAP).  Therefore 
any gene cloned into the MCS is under direct control of the T7 promoter. The pET28b+ 
vector also encodes a six-histidine tag (6-his tag) which is expressed at the N-terminus of the 
protein and can be subsequently removed by thrombin cleavage. The 6-his tag allows the 
target protein to be purified by metal-affinity chromatography (see section 2.3.5), 
specifically in this case, nickel-affinity chromatography. The chromosomally located T7 RNAP 
is under control of a lac promoter (lacUV5). A lac repressor gene, encoded in pET vector, 
binds irreversibly to the lac operator site upstream of the lacUV5 promotor and hence halts 
transcription of the T7 RNAP and the target gene. Addition of the molecular mimic of 
allolactose, isopropyl β-D-1-thiogalactopyranoside (IPTG) displaces the lac repressor and 
thus T7 RNAP is produced which then binds to the T7 promotor of the pET vector and the 
target gene is transcribed. IPTG is non-hydrolysable, unlike allolactose, so its concentration 
remains constant. A basal level of transcription will occur in the absence of inducer, due to 
the dynamic equilibrium that exists between operator sites occupied and unoccupied by 
repressor protein.  This system was used to purify HrpG and HrpV. 
2.3.3. The pQE system 
In pQE vectors the expression of 6-his tagged proteins is based on the T5 promoter 
transcription-translation system. A promoter/operator element is present in the vector 
which consists of phage T5 promoter (recognised by E. coli RNAP) and two lac operator 
sequences. The T5 promoter ensures a very high transcription rate and the two operator 
sequences increase lac repressor binding to control the powerful T5 promoter. Expression of 
the lac repressor protein comes from an additional plasmid, pREP4, which has a compatible 
origin of replication to pQE vectors and encodes the lacI gene. Multiple copies of the pREP4 
plasmid mean that high levels of lac repressor are available to bind the operator sequences 
and tightly regulate recombinant protein expression. Addition of IPTG induces rapid 
expression of the recombinant protein by binding the lac repressor. This system is designed 
to ensure tight control at the transcriptional level. This system was used to purify co-
expressed HrpR and HrpS. 
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2.3.4. Confirmation of overexpression 
To test for over-expression and protein production “small-scale” over-expression tests were 
performed for each protein before “large-scale” over-expression and protein purification 
proceeded. A single colony from a fresh transformation plate was used to inoculate a 5 ml 
LB culture containing appropriate antibiotics. This culture was grown at 37oC to mid-log 
phase (OD 600 nm ~ 0.5) and used to inoculate a 100 ml LB culture containing appropriate 
antibiotics. This was grown to mid-log phase and a 1 ml sample was taken, pelleted and kept 
on ice to be used as the non-induced sample. IPTG was then added to a final concentration 
of 0.5 mM and the culture left at 37oC for 3 hours. After such time the OD 600 nm was 
recorded and a sample taken adjusted to the same OD 600 nm of the non-induced sample. 
The two samples of pelleted cells were then resuspended in 25 µl water and 25 µl x2 
laemmli buffer (see section 0). These were then analysed by SDS-PAGE (section 2.3.5). 
2.3.5. SDS denaturing polyacrylamide gel electrophoresis 
Protein samples were analysed using SDS-PAGE with Bio-Rad mini-protean gel II system. A 
15% acrylamide resolving gel (HrpG and HrpV) or a 12.5% acrylamide resolving gel 
(HrpR/HrpS) and a 4% acrylamide stacking gel were composed as follows: 
 
Resolving gel 
(7.5%) 
Resolving gel 
(12.5%) 
Resolving gel 
(15%) 
Stacking gel 
(4%) 
Acrylamide Solution I 2.5 ml 4.1 ml 5.0 ml 0.6 ml 
Acrylamide Solution II 2.5 ml 2.5 ml 2.5 ml - 
Acrylamide Solution III - - - 1 ml 
Water 5.0 ml 3.4 ml 2.5 ml 2.4 ml 
10% (w/v) APS 100 µl 100 µl 100 μl 40 μl 
TEMED (Sigma) 10 µl 10 µl 10 μl 4 μl 
Table 6: Composition of SDS-PAGE gels used in this work 
Protein samples were mixed with 2x Laemmli Buffer (Sigma) and denatured at 100oC for 3 
min and centrifuged briefly prior to loading in the gel. A protein molecular weight marker, 
used to determine protein size, was run alongside. Gels were run at 200 V in Tris-glycine-SDS 
buffer (National Diagnostics) for approximately 50 min. Gels were stained in coomassie 
Brilliant Blue G stain (Sigma) for 30 min then de-stained in 5:5:1 – methanol:dH2O:acetic 
acid. For greater sensitivity some gels were stained by silver-staining. Briefly, the gel is first 
fixed in a solution containing 40% (v/v) ethanol and 10% (v/v) acetic acid for at least 30 min.  
The gels were then sensitised for a further 30 min in a 0.008 M sodium thiosulphate, 0.8 M 
sodium acetate anhydrous, 30% (v/v) ethanol and 0.125% (v/v) glutaraldehyde solution.  
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After such time, the gels were washed three times for 5 min in distilled water, and then 
incubated in 15 mM silver nitrate and 0.0148% (v/v) formaldehyde for 20 min.  Excess silver 
nitrate was removed by two 1 min wash steps.  The gels were then developed in 0.2 M 
sodium carbonate anhydrous and 0.0074% (v/v) formaldehyde until the protein bands were 
observed.  The developing reaction was quenched and stopped upon addition of 40 mM 
EDTA. Some gels were stained for quantitative analysis with SYPRO Ruby Stain (Invitrogen) 
according to the manufacturer’s basic protocol. Briefly, the gel is fixed in 50% methanol, 7% 
acetic acid for 2X 30 min. The gel was covered with approximately 25 ml SYPRO stain and 
left on an orbital shaker overnight. The gel was then placed in wash solution, 10% methanol, 
7% acetic acid for 30 min and rinsed in ultrapure water for 5 min before imaging. Gels were 
imaged using a Fuji FLA-5000 PhosphorImager. The Coomassie and silver-stained gels were 
sometimes dried using the Bio-Rad gel drying system as per manufacturer’s guidelines. 
2.3.6. Protein purification 
Proteins purified in this study (HrpG, HrpV and HrpR/HrpS) were purified in two broadly 
different ways. HrpG was purified from the insoluble fraction and HrpV and HrpR/HrpS were 
purified from the soluble fraction (see later). All proteins were purified ultimately by using 
nickel-affinity (Ni-affinity) chromatography on a fast protein liquid chromatography (FPLC) 
machine (ÄKTA FPLC™). The 6-His tag, fused to the proteins via the specific vector system 
(section 2.3.2 and 2.3.3), allows purification of the desired protein through binding to nickel 
in a sepharose bead column (5ml Hi-Trap™ HP Column, GE Healthcare). Nickel is able to 
strongly bind histidine (his). The desired His-tagged protein is likely to bind more strongly to 
the nickel than other proteins in the fraction thus yielding a relatively pure sample. The 
desired protein is finally eluted from the column using a gradient of imidazole, a molecular 
mimic of the histidine imidazole ring side-chain. At a certain concentration of imidazole the 
desired His-tagged protein will be displaced by imidazole, which binds to nickel, and eluted 
from the column.  
 
Expression protocol, HrpG: Transformation of pET28b+-hrpG into BL21 cells was performed 
as per section 2.2.13. A 2L conical flask containing 1L LB media containing appropriate 
antibiotics was inoculated with all the transformed cell colonies using a sterile metal loop. 
The cells were grown at 37oC to mid-log phase, (OD 600 nm ~ 0.5) and induced to produce 
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HrpG by adding 0.5 mM IPTG. The cells were left for 3 hours at 37oC then pelleted by 
centrifugation at 6000 x g for 15 min. Pellets were stored at -20oC overnight. Pellets were 
allowed to thaw at room temperature and resuspended with buffer A (50 mM sodium 
phosphate buffer pH 7.0, 500 mM NaCl, 0.1 mM EDTA, 5% glycerol) to a final volume of 30 
ml (from starting culture of 1L). A protease inihibitor cocktail tablet (Roche) was added to 
the cell suspension to prevent protein degredation. To break open the cells, thus releasing 
the cytoplasmic proteins, the cells were sonicated on ice using (Sonics Vibra CellTM Model 
VCX 130) at 40% amplitude for two rounds of 10 min with a pulse rate of 2 seconds on, 2 
seconds off. The sonicated cells were then centrifuged using Beckman-Coulter Avanti J-26 
XP with rotor JA-25.50 for 30 min at 18,000 rpm. This separated the soluble protein fraction 
(found in the supernatant) from the insoluble fraction (found in the pellet). Preliminary 
work found that the majority of HrpG was to be found in the insoluble fraction (this is 
described in Chapter 5). This lead to a protocol being designed that purified HrpG by urea 
denaturation and subsequent re-folding. The pellet was resuspended with buffer A, 
containing 8 M urea. This solution was again centrifuged using Beckman-Coulter Avanti J-26 
XP with rotor JA-25.50 for 30 min at 18,000 rpm and the supernatant injected into the 
superloop of the FPLC system. Prior to loading the protein onto the column (GE Health – 
HiTrapTM 5ml Chelating HP Column) the column was washed and charged by injected 
through, at an approximate rate of 2 ml/min, i) 2 column volumes (CV) H2O, ii) 2 CV buffer A, 
iii) 2 CV 20 mg/ml NiCl2 in H2O, iv) 2 CV 1:1 buffer A:buffer B (buffer A with 1 M imidazole) 
and v) 1 CV buffer A. This column was fitted to the FPLC and buffer A run through at a rate 
of 1 ml/min until the superloop was connected. The protein solution was then loaded onto 
the column at 0.5 ml/min. The column was then washed with buffer A at 1 ml/min until the 
absorbance became constant. The column was then washed with buffer A and 4% buffer b 
until absorbance became constant. A gradient of increasing buffer B from 4% to 100% (40 
mM – 1000 mM imidazole) over 40 min was initiated, with the FPLC collecting 1 ml 
fractions. Important to note is that only the buffer used to resuspend the insoluble fraction 
pellet contained urea, all subsequent steps were done in the absence of urea. Fractions 
containing HrpG were pooled and transferred to dialysis membrane (Spectra/Por, 3,300 
MWCO) and dialysed overnight against a storage buffer (TGED). Proteins were stored at -
80oC. 
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Expression protocol, HrpV and HrpRS: these proteins were purified as HrpG (above) with the 
following modifications. (I) Cells were grown to mid-log phase then cooled to 16oC before 
being induced with 0.5 mM IPTG. (II) Cells were then left overnight at 16oC to produce 
protein. (III) Cells were pelleted then resuspended in Buffer A and sonicated (as above) but 
never frozen. (IV) HrpV and HrpRS were purified from the soluble fraction so no urea was 
necessary. HrpV column wash was performed with 70 mM imidazole (7%). HrpRS column 
wash was performed with 60 mM imidazole. HrpV was dialysed with Spectra/Por 3,500 
MWCO membrane and HrpRS with 15,000 MWCO. 
 
HrpG, HrpV and HrpRS were usually dialysed against protein storage buffer TGED with 5-
10% glycerol then concentrated using Amicon Ultra-15 Centrifugal Filter Units (with 3 kDa 
cut-off for HrpG and HrpV and 10 kDa cut-off for HrpRS). Proteins were then dialysed 
against TGED containing 50% glycerol for permanent storage at -80oC. Other proteins used 
in this study (PspF1-275 from E. coli and σ
54 from Klebsiella pneumoniae) were kindly given by 
other members of the laboratory. PspF1-275 was purified as described (Joly et al., 2006) and 
σ54 was purified as described (Cannon et al., 2000). RNAP core enzyme was purchased from 
Epicentre. 
2.3.7. Determination of protein concentration by Bio-Rad Folin Lowry method 
The Bio-Rad DC Protein Assay Microplate Assay Protocol was followed. BSA protein 
standards of 0.05, 0.125, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75 and 2 mg/ml were prepared in 
the same buffer as the sample. A standard curve was prepared each time the assay was 
performed. Standards and samples (5 μl) were pipetted into a clean, dry microtiter plate 
(standards in duplicate and samples in triplicate). If the predicted concentration of the 
sample was relatively high samples were diluted in sample buffer 1:5 and/or 2:5. Reagent A 
(25 μl) was added to each well and then 200 μl of reagent B subsequently added. The plate 
was gently agitated to mix the reagents. If bubbles formed, they were popped with a clean, 
dry pipette tip. After 15 minutes, absorbances were read at 750 nm using a plate reader. 
2.3.8. Antibody clean-up 
Polyclonal antibodies (found in rabbit sera) were raised against HrpG, which was purified 
from E. coli BL21, and could potentially contain anti-BL21 antibodies as well as anti-HrpG. To 
remove the anti-BL21, thus limiting background cross-reactivity, the sera was cleaned using 
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BL21 cell extract. A overnight 200 ml culture of BL21 containing pET28b+ was pelleted and 
cells resuspended in 2 ml 1x PBS (phosphate buffered saline). Cells were sonicated in two 
rounds of 5 min (2 seconds on/off) at 40% amplitude. Final bleed rabbit sera (100 µl) was 
added to 1 ml of sonicated cells and left at 37oC for 1 hour. Mixture was then centrifuged at 
18,000 x g for 30 min at 4oC. The supernatant was removed and added to the remaining 1 
ml sonicated cells. This was again left for 1 hour at 37oC and then centrifuged at 18,000 x g 
for 30 min at 4oC. The supernatant was kept and used as anti-HrpG, stored at 4oC. 
2.3.9. Immunoblotting 
SDS gels were run as 2.3.5 with samples, either purified protein or cell pellets, in 1:1 ratio 
with laemmli buffer and heated at 95-100oC for 3-5 min. A marker, Invitrogen Magic Mark, 
was run alongside the samples. After running, the gel, a similar sized piece of methanol 
soaked PVDF membrane (Bio-Rad) and eight gel sized pieces of 3 MM Whatmann filter 
paper were equilibrated in transblot buffer (25 mM Tris, 192 mM glycine, 20% (v/v) 
methanol) for 10 min.  Four pieces of filter paper, the PVDF membrane, gel slice and the 
remaining four pieces of filter paper were assembled on the Trans-blot SD semi-dry transfer 
cell (Bio-Rad) in that order making sure there were no air bubbles present.  The transfer cell 
was then run for 60 min at 25V. The membrane was removed, stained with Ponceau S to 
confirm efficient protein transfer and destained with deionised water. The membrane was 
then blocked for 1 hour at room temperature in TBS containing 5% fat-free milk powder. 
The membrane was then washed twice, for 10 min per time, with TBSTT buffer, followed by 
10 min with TBS. The membrane was then incubated with primary antibody diluted in TBS 
with 5% fat-free milk powder at antibody-specific concentrations (HrpS, 1:5,000; HrpV, 
1:1,000; HrpG, 1:250-500; T18, 1:500; T25, 1:250) for 1 hour. The membrane was then 
washed twice, for 10 min per time, with TBSTT buffer, followed by 10 min with TBS. It was 
then incubated for 1 hour at room temperature with the secondary antibody anti-rabbit 
horseradish peroxidase conjugated antibody (Amersham Pharmacia) diluted 1:10,000 in TBS 
with 5% fat-free milk powder. It was then washed five times with TBSTT (10 min each time) 
and placed protein side down on premixed ECL detection reagents (Amersham ECL plus 
regent A, 2ml and reagent B, 50 µl). It was incubated for 1 min then dried between sheets of 
tissue paper, wrapped in SaranWrap and placed protein side up in an x-ray film cassette. 
Under red light a piece of x-ray film was placed on the wrapped membrane and exposed for 
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30 sec, 1 min, 5 min or 30 min (as required) then developed using Sigma developing 
machine. Films were scanned to create a digital image.  
2.4. Specific methods used in Chapter Three  
2.4.1. Arabidopsis inoculations 
Ps. DC3000 strains were grown overnight in LB at 25°C, supplemented with the appropriate 
antibiotic. Cells were washed twice in 10 mM MgCl2 and adjusted to appropriate optical 
densities. Col-0 plants were grown with 16 hour days for approximately 5 weeks. Bacteria 
were infiltrated into A. thaliana Col-0 leaves using a needleless syringe at leaf sites (abaxial 
surface) scored lightly with a scalpel blade. 
2.4.2. Bean inoculation 
To study the hypersensitive response, Ps. DC3000 strains were suspended in 10 mM MgCl2 
and adjusted to OD 600 nm 0.05, 0.1, 0.2 and 0.4. Commercially purchased French beans 
were infiltrated with bacteria by dropping 10 µl onto the bean surface and stabbing through 
the droplet into the bean with a syringe needle. Six beans per concentration were 
inoculated and per bean the four strains were infiltrated (DC, ∆HrpV, ∆HrpG and 
∆HrpG) plus a mock control (10 mM MgCl2) at randomised positions (i.e. the bean was 
divided laterally into five sections and strains infiltrated so that, for example, DC was not 
always infiltrated at the stem end). The HR response was recorded after 24 hours and 
scored as either present (p), limited response (l) or absent (a). Full details can be seen in 
Appendix C, Table 14. 
2.4.3. Determining population growth of bacteria from Arabidopsis leaves 
A. thaliana leaves were infiltrated with resuspended bacteria as described in section 2.4.1. 
and adjusted to OD 600 nm 0.0005. Per day per strain 3 replicates were sampled. For each 
replicate 2x 5 mm diameter discs (each disc from one leaf) were homogenised with a plastic 
pestle in a 1.5 ml Eppendorf tube with 1 ml 10 mM MgCl2. Populations were calculated as 
colony forming units per cm2. Each day after inoculation (0, 1, 2 and 5) 6x 5 µl samples of 
homogenised leaf discs were dropped onto LB plates supplemented with appropriate 
antibiotics. Serial dilutions (10 fold dilutions) of homogenised leaf samples were made (in 10 
mM MgCl2) which depended on the progress of population growth. Colonies formed per 
spot (usually after 2 days’ growth at 25oC) were counted if they numbered between 1-20 
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colonies. Counts were adjusted for dilution factor and averaged. Average colony count per 5 
µl was adjusted for colonies per 1 ml (i.e. colonies per 2x 5 mm discs). Final calculation gave 
colony forming units per cm2. 
2.4.4. Symptom development 
A. thaliana leaves were infiltrated with resuspended bacteria as described in section 2.4.1 
adjusted to OD 600 nm 0.01, 0.005 and 0.0025. Four leaves were inoculated per strain per 
concentration. Symptoms on each leaf were scored 2, 3 and 5 days after inoculation on a 9 
point scale. 1 – very pale yellow; 2 – pale yellow; 3 – yellow; 4 – bright yellow; 5 – pale 
yellow, part collapse; 6 – yellow, part collapse; 7 – part collapse; 8 – collapse of majority of 
leaf; 9 – complete collapse of whole leaf.  
2.4.5. In vitro induction of hrp gene expression 
Ps. DC3000 strains were grown overnight in LB at 25°C, supplemented with the appropriate 
antibiotic. Cells were washed twice in 10 ml of 10 mM MgCl2 and adjusted to OD 600 nm 0.5 
in hrp-inductive minimal medium (HIM), containing 10 mM fructose (Huynh et al. 1989) and 
pH 7.0. 10 ml cultures of cells were grown at 25°C. For real-time PCR experiment (section 
2.4.8) three replicate cultures were grown for each strain taken from individual single 
colonies. 
2.4.6. Extraction of total bacterial RNA from in vitro cultures 
Following in vitro induction (section 2.4.5) 0.5 ml samples were taken after 2 and 4 hours as 
well as 0.2 ml from the culture after being washed in MgCl2 (this is the LB sample, i.e. non-
induced). Samples were immediately mixed with 1 ml RNA protect reagent (Qiagen) to halt 
RNA synthesis and degradation, left for 5 min and pelleted by centrifugation for 10 min in a 
microfuge at 5000 x g. Pellets were frozen at -80°C until RNA extraction was performed. 
Prior to RNA extraction pellets were resuspended in 100 μl of Tris-EDTA (TE) containing 80 
μg of lysozyme and incubated for 10 min at room temperature to lyse cells. RNA was 
extracted using Qiagen RNeasy mini kit following manufacturer’s instructions for purification 
of total RNA from bacteria, including on-column DNase digestion step incubate at 30°C for 
15 min (DNAse I – Qiagen RNase-Free DNase Set). RNA was eluted from column in 50 µl 
RNase-free water. A second DNase step was performed using Promega RQ1 RNase-Free 
DNase. The RNA sample (50 µl) was incubated with 4 µl DNase and 6 µl 10x reaction buffer 
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for 30 min at 37oC and then stopped with stop solution. The sample was then incubated at 
65oC for 10 min to heat inactivate DNase. Samples were quantified using a Nanodrop ND-
1000 UV-Vis spectrophotometer.  
2.4.7. Synthesis of cDNA 
Following quantification 0.8 µg RNA from each sample was reverse transcribed to create 
cDNA using Qiagen Omniscript reverse transcriptase and Promega random primers 
following manufacturer’s instructions. cDNA samples were subsequently diluted 1:20 with 
water and stored at -20oC. 
2.4.8. TaqMan real-time PCR 
All target genes for RT-PCR analysis were amplified by PCR (2.2.6) and cloned into pGEM-T 
easy (2.2.9). Plasmid clones containing target vectors were quantified by spectrophotometry 
for use as quantitative standards in RT-PCR (clones for 16S, avrPto and hrcC were made by 
R. Thwaites). Initially, 16S expression was tested for all samples as a control for synthesis of 
cDNA and for standardising subsequent experiments. cDNA was diluted a further 1:10 for 
16S RT-PCR due to high abundancy of 16S transcript. Also RNA samples were tested for 
presence of DNA and were found to be DNA-free. For each sample (triplicate biological 
replicates) two technical replicates were used for each RT-PCR reaction; giving six samples 
per strain per time point. Probes were labelled with FAM (5’) and TAMRA (3’), generated by 
Sigma or Eurogentec. Sequences of RT-PCR primers and probes are listed in Appendix B, 
Table 12. Reactions were performed at a final volume of 25 µl containing 12.5 µl Eurogentec 
2x Goldstar Mix, 2.5 µl of each forward and reverse primers (at 3 µM), 2.5 µl probe (at 1 µM) 
and 5 µl cDNA sample, vector standard or control. PCR program - 2 min at 50°C, 10 min at 
95°C, and 40 cycles of 95°C (15 s) and 60°C (1 min). RT-PCR reaction was performed in an 
ABI PRISM 7700 sequence detection system and data were collected at all isothermal 
stages. In each experiment three standard concentrations (usually 0.05, 0.005 and 0.0005 
ng/µl for non-16S genes and 6, 0.6 and 0.06 ng/µl for 16S) and a non-template control were 
run. Threshold detection parameters (baseline and cycle threshold limit) were calculated 
automatically to give standard curves which were linear over the concentrations tested. 
Quantity of non-16S mRNA was calculated relative to 16S mRNA (after 16S mRNA levels 
were multiplied 10 fold to account for the additional dilution, see above). 
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2.5. Specific methods used in Chapter Four  
2.5.1. Identification of sequences 
Known sequences, e.g. those of HrpG from Ps. DC3000, were used as query sequences in 
BLASTp searches of the non-redundant protein sequences database on 
blast.ncbi.nlm.nih.gov. All potential homologues were collated and aligned. Duplicate 
sequences from the same organism and sequences from different organisms having 100% 
identity to all sequences from another organism were excluded (e.g. Ps. aesculi – bleeding 
canker of horse chestnut – was excluded given that its HrpR, HrpS, HrpV and HrpG were all 
100%, or 98%, two a.a. different, in the case of HrpG, identical to Ps. tabaci). A specific 
identity score was not used as a criterion to include sequences; rather sequences from an 
organism were included if they were from bacteria, if they contained a reasonable 
complement of other hrp genes and if they contained motifs that were shown to be 
conserved. 
 
In some cases the nucleic acid coding sequence of a particular amino acid sequence was 
required for analysis. The NCBI Reference Sequence page for each protein with an accession 
number shows the nucleic acid source of that protein and bases it is coded by within that 
sequence, e.g. "coded_by=NC_004578.1:1528457..1528888". The specific nucleic acid 
sequence can then be displayed, and also if necessary, bases upstream or downstream of 
the coded protein sequence. This method can be used to identify missing amino acid 
residues or mis-translated codons (for example, see section 4.4.3.1, where the sequence of 
Pectobacterium carotovorum subsp. atroseptica hrpG was corrected). 
2.5.2. Translation of DNA to amino acids 
The Expasy translate tool (http://expasy.org/tools/dna.html) allows the translation of a 
nucleotide (DNA/RNA) sequence to a protein sequence. It uses the standard genetic code 
and gives an output of each of the potential three frames in both the 5’-3’ and 3’-5’ 
directions. A frame is then selected and a virtual Swiss-Prot entry, comprising the residues 
from the chosen start position (methionine) up to the following Stop codon is created. 
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2.5.3. Alignments 
Alignments were generated within BioEdit version 7.0.5.3 (Hall, 1999) with the default 
colour table for amino acids shown in Figure 12. Amino acids with similar properties are 
given similar colours. 
 
Figure 12: Colour table referring to the labelling of amino acids (single letter code) used in ClustalW alignments 
The accessory application within BioEdit, ClustalW (Thompson et al., 1994) with default 
parameters (gap open penalty, 10; gap extension penalty, 0.05) was used to generate the 
alignments. Some alignments were subsequently adjusted manually for clarity.  
2.5.4. Weblogos 
Weblogos were generated at http://weblogo.berkeley.edu/ (Crooks et al., 2004). They give 
a graphical version of a consensus sequence; where the height of the letter stack indicates 
conservation and the height of each letter (within a stack) indicates the relative frequency 
of that residue at each position. Amino acids in are coloured according to their chemical 
properties: polar amino acids (G,S,T,Y,C,Q,N) are green; basic (K,R,H) blue; acidic (D,E) red 
and hydrophobic (A,V,L,I,P,W,F,M) black.  
2.5.5. Secondary structure predictions 
Secondary structure predictions were generated with Jpred3 (Cole et al., 2008) where 'H' 
represent an alpha helix, 'E' a beta sheet and '-' a random coil. The software uses 
homologous proteins present in the databases (which cannot be chosen by the user) to 
generate the predicted secondary structure.  
2.5.6. β-galactosidase assay 
β-galactosidase is encoded by the lacZ gene and cleaves the synthetic substrate, o-
nitrophenyl-β-D-galactosidase (ONPG) to yield galactose and o-nitrophenyl which has a 
yellow colour with an absorbance of 420 nm. Therefore the amount of absorbance at 420 
nm reflects the expression of lacZ. In this study, lacZ is fused to different promoters to assay 
activity at that promoter. In the Ps. DC3000 assay in section 3.5 of Chapter 3 and in the in 
vivo activity assay (Chapter 4) lacZ is fused to the hrpL promoter to record HrpRS activity. In 
the bacterial two-hybrid assay (BACTH) (Chapter 4 and 2.5.7) lacZ is under the control of a 
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catabolite activator protein (CAP) that requires cyclic adenosine monophosphate (cAMP). 
The BACTH is described in more detail below. For each sample 3 overnight cultures were 
made using individual colonies. Day cultures were made using 100 µl of overnight culture 
and cells were grown to mid-log phase (OD 600 nm ~ 0.5) then expression of the trigger of 
lacZ production was induced by adding 0.5 mM IPTG and/or 0.2% arabinose (or transferring 
cells to HIM). Cells were left for 1 hour then the OD 600 nm was recorded for each sample. 
An appropriate volume of cells (depending on the predicted intensity of the reaction) was 
made up to 1 ml with Z-buffer in an 1.5 ml tube and vortexed for 20 seconds with 60 µl 
chloroform and 30 µl 0.1% SDS to lyse the cells. The reaction was kept at 28oC for 10 min 
before 200 µl ONPG (4 mg/ml) was added to the reaction. The reaction was timed and 500 
µl Na2CO3 (1 M) was added to stop the reaction. A blank reaction was included that 
contained the same volume of growth media added. 1 ml of each sample was transferred to 
a cuvette and absorbance at 420 nm and 550 nm was recorded. The absorbance at 550 nm 
is the scatter from the cell debris. This was multiplied by 1.75 in the equation (below) to 
approximate the scatter observed at 420 nm. Miller Units – a standardised measurement of 
β-galactosidase activity – are measured as follows: 
 
The time of the reaction was recorded in minutes, Abs means absorption and volume is the 
volume of cells used in the reaction. 
 
All experiments were performed with three biological replicates (unless otherwise 
mentioned). In the Ps. DC3000 assay in Chapter 3, cells were induced by transferring them 
to minimal media (HIM). In the in vivo activity assay cells (strain MJ2806) were induced by 
adding 0.5 mM IPTG (for the pAPT vector) and 0.2% arabinose (for the pBAD vector). In the 
BACTH assay cells were induced by adding 0.5 mM IPTG.  
2.5.7. Bacterial two-hybrid system (BACTH) 
This assay exploits the activity of the catalytic domain of adenylate cyclase from Bordetella 
pertussis. The E. coli strain used in this assay, BTH101, is deleted for cya which encodes 
adenylate cyclase (which produces cAMP). The two complementary domains (T18 and T25) 
that make up the adenylate cyclase are not active when physically separated. When these 
two fragments are fused to interacting polypeptides, X and Y, heterodimerisation of these 
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hybrid proteins results in functional complementation between T18 and T25, and therefore 
cAMP synthesis (Karimova et al., 1998). This ultimately leads to production of lacZ via CAP 
and cAMP activation of lacZ transcription (see Figure 13). 
 
This assay is used in Chapter 4 of this study to examine the interactions between HrpV and 
HrpG and mutant forms of those proteins. The experiment is performed as described above 
in section 2.5.6. Fusion proteins were created by cloning hrpV and hrpG into plasmids pKT25 
and pUT18C both of which create fusions where the adenylase cyclase subunit is at the N-
terminus.  
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cAMP
T25
T18
N C
X Y
T25 T18
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ATP
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+cAMP
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cAMP cAMP
cAMP/CAP dependent
promoter
Reporter Gene
e.g. lacZ  
Figure 13: Schematic of the BACTH assay 
The two fragments of adenylate cyclase from Bortedella pertussis, T25 and T18, are able to synthesise cAMP. When 
expressed as independent polypeptides they are unable to interact and no cAMP synthesis occurs. When T25 and T18 are 
fused to proteins (X and Y) that interact they are brought into close proximity and cAMP can be synthesised. The 
synthesised cAMP binds to CAP and can recognise specific promoters, for example, the promoter of the lac operon. The 
lacZ gene is then expressed and β-galactosidase produced. This can cleave ONPG to give a yellow product (o-nitrophenyl) 
or X-gal to produce a blue pigment (5-bromo-4-4’-dichloro-indigo) – used to report the interaction between X and Y. 
 
2.6. Specific methods used in Chapter Five 
2.6.1. In Vitro Transcription Assay 
Full-length transcription assays were performed in STA buffer (standard transcription assay, 
see Jovanovic et al (2011b) (25 mM Tris-acetate, pH 8.0, 8 mM Mg-acetate, 10 mM KCl and 
3.5% w/v PEG 6000) buffer (for the nifH promoter) in a 10 µl volume containing 100 nM σ54-
RNAP (reconstituted at a 1:5 ratio RNAP:σ54), 20 nM supercoiled promoter DNA (pTE103) 
and where stated 4 mM dATP. For open complex formation 2 µM PspF1-275 or 2 µM HrpRS 
were used (unless otherwise stated). Where added, HrpV and HrpG were at equimolar 
concentrations to HrpRS dimer. The elongation mixture contained 100 µg/ml heparin, 100 
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nM ATP, CTP and GTP and 50 nM UTP (0.25 µCi of [α-32P]UTP (800 Ci/mmol)). Activation 
with PspF1-275 or HrpRS was performed at 25
oC and elongation performed at 37oC. Reactions 
were stopped with 4 µl of formamide dye mixture (0.3 mg/ml xylene cyanol, 0.3 mg/ml 
bromophenol blue, 20 mM EDTA in deionised formamide).  7 µl of the samples were run on 
a 4% denaturing sequencing gel for 2 hr at 50 W.  50 ml denaturing sequencing gel consists 
of 8 ml National Diagnostics UreaGel system concentrate, 37 ml National Diagnostics 
UreaGel system diluent and 5 ml 10x TBE buffer. Gels were dried and transcripts visualised 
and quantified using a Fuji FLA-5000 PhosphorImager. 
2.6.2. Closed complex and open complex DNA binding assay 
This assay was performed to assess the ability of PspF1-275 to activate the formation of 
transcriptionally competent open complexes (RNAP + σ54) on the hrpL promoter (see 
Appendix C) and to test whether HrpV or a HrpRS-HrpV complex destabilises PspF-
dependent open complexes on the nifH promoter (Chapter 5).  
 
DNA homo- and hetero-duplex formation 
The template for the DNA binding assays is a 32P-end labelled double-stranded DNA 
fragment consisting of the -60 to +28 S. meliloti nifH or Ps. DC3000 hrpL promoter sequence.  
Double-stranded DNA is constructed as either a homoduplex (with complementary template 
and non-template strands) or a heteroduplex (where there is a strand mismatched).  The 
template strand oligonucleotide (supplied in PAGE purified form from Sigma) is 32P-end 
labelled with [γ-32P]ATP as follows: a standard 20 μl kinase reaction contained 20 pmoles of 
10 pmol/μl stock of the oligonucleotide to be labelled, 3.5 μl of [γ-32P]ATP (500 Ci/mmol, 
Amersham), 10 units of T4 polynucleotide kinase, T4 PNK (Amersham) and 2 μl x10 T4 PNK 
reaction buffer.  The kinasing reaction was initiated by incubating at 37°C for 30 min and 
quenched by denaturing the kinase at 70°C for 10 min.  The duplex is prepared by mixing the 
labelled strand with two-fold molar excess of un-labelled (cold) complementary strand in 
TM buffer (10 mM Tris-HCl, pH 8.0, 10 mM MgCl2).  The two strands are annealed by heating 
for 5 min at 95°C and then cooled rapidly in ice for 10 minutes or over night at room 
temperature.  The DNA duplex is then stored at -20°C. 
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Native Mobility Shift Assays (EMSA)  
Closed complexes were formed in a total reaction volume of 10 µl, 20 nM DNA and 200 nM 
holoenzyme (reconstituted at a ratio of 1:3 core:σ54) in STA buffer were incubated for 10 
min at 37°C.  The free/unbound DNA and the holoenzyme bound DNA was separated on a 
non-denaturing polyacrylamide gel. Open complexes were formed as above with the 
addition of 10 µM PspF and 5 mM dATP. The heparin stability of the DNA-complexes can be 
assayed by addition of heparin (final concentration 100 µg/ml) for 2 min, after the 10 min 
incubation period at 37°C prior to gel loading. Where stated HrpV (10 µM) or a pre-formed 
HrpV-HrpRS complex (10 µM) was added to the open complex prior to heparin. 
Intermediate promoter complexes were formed by incubating the pre-formed Eσ54-DNA 
complex either with and 2 mM ATPγS or ADP.AlFx (formed in situ by the addition of 0.2 mM 
AlCl3 to a mixture containing 0.2 mM ADP and 5 mM NaF detailed in Chaney et al., 2001) for 
10 min.  The reactions were analysed on a 4.5% native polyacrylamide gel run for 80 min at 
80 V in 25 mM Tris, 200 mM glycine buffer (pH 8.6) at room temperature. The dried gel was 
visualised using a Fuji FLA-5000 PhosphorImager. 
 
2.6.3. Non denaturing (native) polyacrylamide gel electrophoresis 
Native gels with a 4.5% acrylamide composition were used to examine protein complexes in 
EMSA (1.5 ml Acrylamide Solution I, 1 ml x10 Tris-glycine buffer (National Diagnostics), 7.5 
ml sterile water, 100 μl 10% (w/v) APS, 10 μl TEMED). Samples of 10 µl with x5 native 
loading buffer were run at 100 V for such time as appropriate for specific samples. 
Complexes were visualised using Coomassie blue stain and de-stain techniques, silver-
staining, SYPRO staining or dried and exposed (as 2.3.5).   
 
2.6.4. In vitro glutaraldehyde cross-linking 
Assays were conducted in a total reaction volume of 10 µl, in HGNED buffer (25 mM HEPES, 
pH 8.0, 1 mM DTT, 100 mM NaCl, 0.2 mM EDTA, 0.05% (v/v) NP-40 and 10% glycerol) (apart 
from when HGNED buffer was compared to ATPase buffer – this consists of 20 mM Tris pH 
8.0, 50 mM NaCl, 0.1 mM EDTA and 5% glycerol) containing specified concentrations of 
proteins. Final volume of 10 µl was made by adding protein storage buffer (TGED) to 
account for differences between reactions being due to total amount of TGED present. 
Where present, ADP was added at a final concentration of 0.4 mM. Samples were left at 
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room temperature (RT) for 20 min. Final samples were treated with glutaraldehyde (at a 
final concentration 0.1%) and incubated at RT for 20 min (unless otherwise specified). 
Reactions were stopped by addition of 2 µl stop solution (200 mM Tris-HCl pH 7.5, 200 mM 
glycine). Cross-linked protein complexes were separated by either 7.5% or 12.5% SDS-PAGE 
and analysed by SYPRO staining. 
 
2.6.5. Native complex formation 
HrpV, HrpG and HrpGNQR were tested for their ability to form complexes when pre-
incubated and run on non-denaturing gels (as section 2.6.3). Specified concentrations of 
HrpV, HrpG and HrpGNQR were incubated together in STA buffer in the presence of α-
lactalbumin (0.01 mg/ml) in a 10 µl reaction for 20 min at RT. Preliminary experiments 
showed that α-lactalbumin increased the ability of proteins to run into the gel. Gels were 
also run at 4oC to increase proportion of protein entering the gel. Gels were stained with 
SYPRO and visualised using a Fuji FLA-5000 fluorescence reader. Relative intensities of bands 
were quantified using AIDA software where each band was corrected for background 
intensities specific to each gel lane. 
 
2.6.6. Gel filtration 
Gel filtration chromatography with HrpRS was carried out at room temperature in running 
buffer (20 mM Tris pH 8.0, 50 mM NaCl, 15 mM MgCl2, 0.02% (w/v) azide) at a 0.7 ml per 
min flow rate using a BioCad Sprint HPLC system and a Bio-Sep-S 3000 column 
(Phenomenex). The column was calibrated using molecular weight standards (Sigma): Blue 
Dextran (200 kDa), Thyroglobulin (669 kDa), Ferritin (440 kDa), Catalase (232 kDa), Aldolase 
(158 kDa), Albumin (67 kDa), Ovalbumin (43 kDa), Chymotrypsin (25 kDa) and Ribonuclease 
(13.5 kDa) (Burrows et al., 2009b). Fractions were analysed by SDS-PAGE using SYPRO ruby 
stain (Invitrogen) and quantified using a Fuji FLA-5000 fluorescence reader. ATPase activity 
of fractions was determined by J. Schumacher exactly as described (Jovanovic et al., 2011). 
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CHAPTER THREE 
3. Analysis of hrpG and hrpV deletion mutants of Ps. DC3000 
3.1. Introduction 
Strains of P. syringae grow on leaf surfaces and exist in aquatic habitats e.g. rivers, clouds 
and snow (Morris et al., 2008). Pathogenic strains, including Ps. DC3000, enter plant leaves 
through wounds or stomata and multiply within the intercellular space (apoplast) (Hirano & 
Upper, 2000). However, the precise environmental signals involved in regulating hrp gene 
(hypersensitivity response and pathogenicity) expression are not yet understood. Numerous 
loci are induced upon infiltration of Ps. DC3000 into the plant, including those associated 
with virulence such as hrp and coronatine biosynthesis genes, as well genes involved in 
carbon metabolism, amino acid assimilation, stress tolerance and nutrient uptake (Boch et 
al., 2002). Rahme et al (1992) showed that hrp gene expression is under the control of 
multiple plant signals including pH, osmotic strength and that catabolite repression is 
operating. Two-component response regulation systems (TCS) sense environmental signals 
and relay this information to regulate responsive gene expression. The GacA/GacS two-
component system controls many phenotypes including pathogenicity, production of 
secondary metabolites such as quorum sensing signals and toxins, motility, biofilm 
formation and secretion systems (Chatterjee et al., 2003). The hrp regulatory genes rpoN, 
hrpL, hrpR and hrpS were shown to be regulated by GacA in Ps. DC3000 (Chatterjee et al., 
2003), see Figure 10. Another TCS, RhpR/RhpS, has also been shown to regulate T3SS in Ps. 
DC3000. RhpR represses T3SS genes in a phosphorylation-dependent manner and this 
repression is relieved by RhpS under T3SS-inducing conditions (Xiao et al., 2007).  
 
A hrp-inducing minimal media (HIM) (Huynh et al., 1989) is thought to mimic the apoplast 
environment by providing low pH, low nitrogen content and a plant-derived sugar (i.e. 
fructose). Thwaites et al (2004) compared in planta expression of hrp genes to expression in 
HIM (Thwaites et al., 2004) using TaqMan real-time PCR (RT-PCR). They found that 
expression was delayed in planta compared to HIM, but after 120 minutes expression levels 
were significantly higher than in HIM. This increase was shown to be, in part, due to 
bacterial contact with plant cell walls. However, both methods of hrp gene induction were 
sufficient to identify variation in expression of different genes; for example, hrpR was the 
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most rapidly induced gene in planta and in HIM. Ramos et al (2007) and Ferreira et al (2006) 
also used RT-PCR (SYBR green) and HIM to analyse hrp gene expression. Ferreira et al (2006) 
used microarray technology to compare expression of genes between a ΔhrpL mutant and 
wild-type Ps. DC3000. Genes that were identified as hrpL-dependent were analysed by RT-
PCR to refine a model used to predict hrp promoters. Many of these expressed genes 
agreed with earlier findings by Fouts et al (2002). Ramos et al (2007) compared expression 
of genes to determine the effect of deleting hrpF on expression of hrpA2, hrpP and hrpL. 
They found that the hrpF mutant had severely reduced expression of these three genes. 
3.1.1. Objectives 
This chapter aims to explore the effects of gene-knockout mutations of hrpV and hrpG in Ps. 
DC3000. Two hrpG mutations will be analysed – one where the kanamycin resistance gene 
insertion (nptII) with its constitutive promoter is placed in the hrpC operon so that 
transcription takes place in the native direction (ΔhrpG). The other mutation has nptII 
orientated in the opposite direction to the operon (ΔhrpG). These mutations are 
equivalent to those analysed by Ortiz-Martín et al (2010b) in Ps. phaseolicola and were 
generated by I. Ortiz- Martín (C.R. Beuzón’s laboratory, Málaga) for the following analyses. 
Figure 14 shows the orientation of the mutants with respect to the hrpC operon. The hrpV 
mutation (ΔhrpV) has an nptII cassette placed in the same direction as the operon. 
 
Figure 14: Genetic and transcriptional organisation of the hrp/hrc cluster of Ps. DC3000.  
Genes are organised into operons indicated by arrows and their activating sigma factors are shown above. The hrpC 
operon is enlarged and placement of nptII cassette in the three knockout mutants (ΔhrpG, ΔhrpG and ΔhrpV), with 
respect to the orientation of transcription in the operon, is indicated. ΔhrpG is the equivalent of IOM71; ΔhrpG is the 
equivalent of IOM57 and ΔhrpV is the equivalent of IOM48 (Ortiz-Martín et al., 2010b). 
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Previous studies using hrpV deletion mutants have yielded somewhat conflicting results. 
Deng et al (1998) and Preston et al (1998) found that a hrpV mutant of Ps. syringae had 
growth defects and reduced symptom development on host plants whereas Ortiz-Martín et 
al (2010b) found that the equivalent mutation in Ps. phaseolicola had wild-type symptoms; 
though studies agree that HrpV acts as a negative regulator. A consensus as to the effect of 
mutating hrpG has also to be agreed; either there is no effect (Wei et al 2005) or there is a 
severe effect (Hojo et al., 2008b, Ortiz-Martín et al., 2010b).   
 
Specifically this chapter aims to: 
 
I. Confirm that mutations have not disrupted the coding sequence of flanking genes. 
II. Explore the phenotypic effects of the three mutations in terms of (i) population 
growth in rich media, (ii) population growth in planta, (iii) symptom development on 
host plants and (iv) HR response on non-host tissue. 
III. Examine the effects on the mRNA levels of 16S, hrpV, hrpG, hrcC, hrpF, hrpR, hrpS, 
hrpL, corR and avrPto with the three mutant strains grown in HIM using TaqMan RT-
PCR.  
IV. Create a lacZ reporter construct to analyse activity at the hrpL promoter in vivo with 
Ps. DC3000 mutants. 
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3.2. Sequencing of mutated loci 
Confirmation that mutant hrpG strains have flanking genes intact. 
The coding sequence for hrpG was replaced with an nptII cassette by I Ortiz-Martín using a 
suicide vector method. Briefly four primers (A, B C and D; see appendix) were designed to 
amplify 500 bp flanking regions of hrpG. Primers B and C contained a BamHI restriction site. 
The two flanking regions were annealed and amplified using primers A and D. This was 
ligated into pGEM-T (Promega). The pGEM-T vector containing the flanking sites was 
digested with BamHI and an nptII cassette was ligated at this site. This was then 
transformed by electroporation into Ps. DC3000. pGEM-T cannot replicate in Ps. DC3000, 
therefore only when recombination has occurred will cells survive. If the cells were both 
ampicillin (amp) and kanamycin (kan) resistant then a single cross-over event occurred 
(pGEM-T is amp and nptII is kan), whereas if they are only kan resistant then a double cross-
over event occurred - indicating hrpG was replaced by nptII. The genes flanking hrpG are 
hrpF (upstream) and hrcC (downstream). These genes must remain intact and in-frame so 
that only the effects of deleting hrpG can be studied. Annotated sequences can be seen in 
Figure 15 and Figure 16. The inserted sequence (coloured blue) originates from the pKD4 
plasmid and is the same in ΔhrpG and ΔhrpG. The stop codon of hrpF and the start 
codon of hrcC have not been altered so the translation of these genes should not be 
affected by the insertion. 
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hrpF hrpF/hrpG hrpG
GCAGTCATCGATGGAATTCAGTGAATTCACCGAGATACTGGCCGTCGTTTTACGGATCCCATATGAATATCCTCC
TTAGTTCCTATTCCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTCAGAGCGCTTTTGAAGCTGGGGTGGGCG
AAGAACTCCAGCATGAGATCCCCGCGCTGGAGGATCATCCAGCCGGCGTCCCGGAAAACGATTCCGAAGCCCAAC
CTTTCATAGAAGGCGGCGGTGGAATCGAAATCTCGTGATGGCAGGTTGGGCGTCGCTTGGTCGGTCATTTCGAAC
CCCAGAGTCCCGCTCAGAAGAACTCGTCAAGAAGGCGATAGAAGGCGATGCGCTGCGAATCGGGAGCGGCGATAC
CGTAAAGCACGAGGAAGCGGTCAGCCCATTCGCCGCCAAGCTCTTCAGCAATATCACGGGTAGCCAACGCTATGT
CCTGATAGCGGTCCGCCACACCCAGCCGGCCACAGTCGATGAATCCAGAAAAGCGGCCATTTTCCACCATGATAT
TCGGCAAGCAGGCATCGCCATGGGTCACGACGAGATCCTCGCCGTCGGGCATGCGCGCCTTGAGCCTGGCGAACA
GTTCGGCTGGCGCGAGCCCCTGATGCTCTTCGTCCAGATCATCCTGATCGACAAGACCGGCTTCCATCCGAGTAC
GTGCTCGCTCGATGCGATGTTTCGCTTGGTGGTCGAATGGGCAGGTAGCCGGATCAAGCGTATGCAGCCGCCGCA
TTGCATCAGCCATGATGGATACTTTCTCGGCAGGAGCAAGGTGAGATGACAGGAGATCCTGCCCCGGCACTTCGC
CCAATAGCAGCCAGTCCCTTCCCGCTTCAGTGACACGTCCGAGCACAGCTGCGCAAGGGAACGCCCGTCGTGACC
AGCCACGATAGCCGCGCTGCCTCGTCCTGCAGTTCATTCAGGGCACCGGGACAGGTCGGTCTTGACAAAAAGAAC
CGGGCGCCCTGCGCTGACAGCCGGAACACGGCGGCATCAGAGCAGCCGATTGTCTGTTGTGCCCAGTCATAGCCG
AATAGCCTCTCCACCCAAGCGGCCGGAGAACCTGCGTGCAATCCATCTTGTTCAATCATGCGAAACGATCCTCAT
CCTGTCTCTTGATCAGATCTTGATCCCCTGCGCCATCAGATCCTTGGCGGCAAGAAAGCCATCCAGTTTACTTTG
CAGGGCTTCCCAACCTTACCAGAGGGCGCCCCAGCTGGCAATTCCGGTTCGCTTGCTGTCCATAAAACCGCCCAG
TCTAGCTATCGCCATGTAAGCCCACTGCAAGCTACCTGCTTTCTCTTTGCGCTTGCGTTTTCCCTTGTCCAGATA
GCCCAGTAGCTGACATTCATCCGGGGTCAGCACCGTTTCTGCGGACTGGCTTTCTACGTGTTCCGCTTCCTTTAG
CAGCCCTTGCGCCCTGAGTGCTTGCGGCAGCGTGGGGGATCTTGAAGTTCCTATTCCGAAGTTCCTATTCTCTAG
AAAGTATAGGAACTTCGAAGCAGCTCCAGCCTACACGGATCCAGTGTGAAATGCGCAAGGCCTTAATGTGGTTGC
CTTTATTGTTGATCGGGGTGATCC
primer B
hrpG
primer C
hrcC
nptII gene
insert
 
Figure 15: An annotated sequence of ΔhrpG 
An annotated sequence of ΔhrpG with the insert going against the direction of the operon. Colour-coding: hrpF – pink, 
hrpF/hrpG overlap – green, hrpG – yellow, insert – blue and hrcC – grey. Also underlined in black are the primer sequences 
(note that within primers B and C are the BamHI restriction sites GGATCC) used to clone in the insert and the coding 
sequence of nptII. 
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hrpF hrpF/hrpG hrpG insert
GCAGTCATCGATGGAATTCAGTGAATTCACCGAGATACTGGCCGTCGTTTTACGGATCCGTGTAGGCTGGAGCTG
CTTCGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTTCAAGATCCCCTCACGCTGCCGCAA
GCACTCAGGGCGCAAGGGCTGCTAAAGGAAGCGGAACACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCG
GATGAATGTCAGCTACTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTAGCTTGCAGTGG
GCTTACATGGCGATAGCTAGACTGGGCGGTTTTATGGACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTC
TGGTAAGGTTGGGAAGCCCTGCAAAGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGGGGATC
AAGATCTGATCAAGAGACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGC
CGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCG
GCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGA
GGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGG
AAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGT
ATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAA
ACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCA
GGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCA
TGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGG
TGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGA
CCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTT
CTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGAGATTTCGATTCC
ACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGG
GATCTCATGCTGGAGTTCTTCGCCCACCCCAGCTTCAAAAGCGCTCTGAAGTTCCTATACTTTCTAGAGAATAGG
AACTTCGGAATAGGAACTAAGGAGGATATTCATATGGGATCCAGTGTGAAATGCGCAAGGCCTTAATGTGGTTGC
CTTTATTGTTGATCGGGGTGATCC
primer B
hrpG hrcC
primer C
nptII gene
 
Figure 16: An annotated sequence of ΔhrpG 
An annotated sequence of ΔhrpG with the insert going with the direction of the operon. Colour-coding: hrpF – pink, 
hrpF/hrpG overlap – green, hrpG – yellow, insert – blue and hrcC – grey. Also underlined in black are the primer sequences 
(note that within primers B and C are the BamHI restriction sites GGATCC) used to clone in the insert and the coding 
sequence of nptII. 
The sequencing results above imply that any differences observed between the two hrpG 
mutant strains cannot be attributed to the sequence of the insertion, per se. However, it is 
noted that due to the opposing orientations of the two nptII cassettes found in the two 
hrpG mutants, the sequences downstream of hrpF and upstream of hrcC are different in the 
two mutants. The correct sequence of ΔhrpV was confirmed by I. Ortiz-Martín (personal 
communication). 
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3.3. Phenotypic effects of hrpG and hrpV mutant strains 
Exploring the phenotypic effects of the three mutations in terms of (i) population growth in 
rich media, (ii) population growth in planta, (iii) symptom development on host plants and 
(iv) HR response on non-host tissue. 
 
Bacteria were grown in rich media at 25oC over night (up to 14 hours) and their growth 
recorded by measuring absorbance at OD 600 nm. Figure 17 shows that, when compared to 
wild-type, none of the mutants grew significantly differently. All strains grew to 
approximately OD 600 nm ~ 3.0. 
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Figure 17: Ps. DC3000 wild-type and mutants growth in LB 
Four strains, DC, ΔhrpV, ΔhrpG and ΔhrpG, were grown in LB media at 25
o
C for 14 hours with measurements of 
absorbance at OD 600 nm taken at hourly or bihourly intervals. Graphs show each mutant strain compared to the wild-type 
DC strain.. Error bars represent standard deviation from triplicate samples. 
To measure growth in planta bacterial strains were inoculated into A. thaliana leaves and 
the number of colony forming units recorded over a 5 day period (section 2.4.3). Figure 18 
shows that ΔhrpV and ΔhrpG did not differ significantly from wild-type. However, 
ΔhrpG failed to increase in population size after 1 day, although the population size did 
not fall, indicating that the bacteria did not die. After 5 days ΔhrpG had a population size 
three orders of magnitude lower than DC, ΔhrpV and ΔhrpG. 
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Figure 18: Ps. DC3000 wild-type and mutants growth in Arabidopsis 
Population dynamics: Four strains, DC, ΔhrpV, ΔhrpG and ΔhrpG, were grown over-night and inoculated into 
Arabidopsis thaliana leaf tissue adjusted to OD 600 nm = 0.0005. Two 5 mm diameter leaf discs were taken per sample 
after 0, 1, 2 and 5 days. These were ground and serial dilutions spotted onto King’s B media plates. Colonies formed were 
counted and adjusted for the dilution factor. Error bars represent standard deviation from triplicate samples. 
The ability of the mutants to cause disease in the host plant A. thaliana was tested by 
inoculating bacteria into leaf tissue and scoring disease progression on a 9 point scale over 5 
days. Three dilutions of bacteria were infiltrated: 0.01, 0.005 and 0.0025 OD 600 nm. All 
three dilutions yielded similar results. Figure 19 depicts the results from the 0.01 dilution. 
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Figure 19: Ps. DC3000 wild-type and mutants disease symptoms in Arabidopsis 
Disease progression: Four strains, DC, ΔhrpV, ΔhrpG and ΔhrpG, were grown over-night, diluted to OD 600 nm = 0.01, 
and inoculated into Arabidopsis thaliana leaf tissue.. Symptoms were scored on a 9 point scale. Error bars represent 
standard deviation from four replicates – where each replicate is one leaf from a plant inoculated with each strain (see 
section 2.4.4). 
The disease progressed severely over the 5 days in the wild-type strain (DC) and in the 
ΔhrpV and ΔhrpG mutants. Symptoms went from an average of “pale yellow” (point 2) on 
day 2 to either “collapse of majority of leaf” (point 8) or “complete collapse of the whole 
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leaf” (point 9) on day 5. In contrast to this, the ΔhrpG strain did not cause symptoms to 
develop past the “pale yellow” stage (on average). ΔhrpG is clearly deficient in its ability 
to cause disease, which is in line with its inability to establish a wild-type sized population in 
the leaf (Figure 18).  
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Figure 20: Ps. DC3000 wild-type and mutants HR in bean 
Hypersensitive response (HR): Four strains, DC, ΔhrpV, ΔhrpG and ΔhrpG were resuspended in 10 mM MgCl2. Bacteria 
were infiltrated into commercially purchased French beans by the stab inoculation procedure (section 2.4.2)  A mock 
treatment where only 10 mM MgCl2 was infiltrated was included as a control. Each bean was inoculated with the four 
strains plus the mock control at randomised positions along the bean length. Six beans were inoculated per dilution of cells 
(OD 600 nm = 0.05, 0.1, 0.2 and 0.4). Four representative beans are shown, see Appendix table Table 14 for full details).  
French beans were inoculated with the four strains to test elicitation of HR (Figure 20). As 
with the population dynamics and disease progression tests, ΔhrpG failed to elicitate HR, 
whereas ΔhrpV and ΔhrpG exhibited a wild-type-like HR. Deng et al (1998) also found that 
a hrpV mutant elicited a wild-type HR response and a mutant equivalent to ΔhrpG 
retained significant HR-eliciting ability. Ortiz-Martín (2010b), who analysed both ΔhrpG 
and ΔhrpG in Ps. phaseolicola, detected similar results to this study (Ortiz-Martín et al., 
2010b).  
Minimal media is known to mimic the in planta environment in order to induce hrp gene 
expression. Since growth in planta was severely attenuated with the ΔhrpG strain, the 
growth of this strain and the wild-type strain were assayed in hrp-inducing media (HIM) to 
determine whether the effects seen in planta could be due to general growth defects or 
problems relating to formation of an intact T3SS and/or secretion of effectors. Interestingly, 
Figure 21 demonstrates that growth of the ΔhrpG strain was not significantly different 
from wild-type up to 50 hours after inoculation into HIM (approximately 0.6 OD 600 nm).  
This result implies that it is a failure to interact with the plant, possibly through disruption of 
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the T3SS, that is responsible for the in planta phenotypes of ΔhrpG, rather than a failure 
to grow under in planta conditions per se. 
 
Figure 21: Ps. DC3000 wild-type and ΔhrpG growth in HIM 
Ps. DC3000 strains wild-type (light grey) and ΔhrpG (black) were grown in LB overnight and washed twice in 10 mM 
MgCl2 then inoculated into HIM at 0.01 OD 600 nm. Cell density was recorded at 2, 4, 6, 8, 12, 24, 30 and 48 hours after 
inoculation. Only one replicate was used in this experiment. 
In summary, the three mutants do not differ from wild-type growth in rich media. However, 
ΔhrpG, which has the nptII cassette in the opposite orientation to the operon, is deficient 
in its ability to (i) grow in planta, (ii) cause disease on a host plant and (iii) elicit HR in non-
host tissue; but is not defective for growth in HIM. ΔhrpV was not significantly different 
from wild-type in the three in planta tests. This implies that a lack of HrpV has not drastically 
reduced the fitness of the bacteria. ΔhrpG also had wild-type levels of in planta growth, 
disease and HR. Therefore, it cannot simply be the deletion of hrpG that is responsible for 
the phenotypes seen in the ΔhrpG strain. 
3.4. Expression of genes in inducing media 
Examining the effects on the mRNA levels of 16S, hrpV hrcC, hrpF, corR and avrPto with the 
three mutant strains over time using Taqman polymerase real-time PCR.  
 
It has been well established that hrp-inducing minimal medium (HIM) will induce expression 
of hrp/hrc genes by mimicking the in planta environment either directly by pH or nutrient 
content, or indirectly by inducing specific stress (Huynh et al., 1989). Here HIM was used to 
induce expression of hrp/hrc genes from three mutant strains of Ps. DC3000 (and wild-type) 
and real-time PCR was used to detect expression of specific genes up to 240 minutes post 
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induction (mpi). Initially, levels of 16S rRNA gene expression were measured as an internal 
control to give a background that is correlated to growth rate. This should be constant 
across all the samples being analysed and the other genes analysed in this study are then 
normalised relative to this background (in order that any differences in growth between the 
mutants (and wild-type) do not artificially skew the expression data of the other genes 
analysed). Importantly, 16S levels should only respond to growth and not HIM, although 
expression of the other genes being tested should be induced by inoculation into HIM. 
Levels of 16S expression were somewhat different between the four strains grown in LB 
(prior to induction in HIM) with values of approximately 0.3 ng/µl (DC), 0.7 ng/µl (ΔhrpV), 
0.4 ng/µl (ΔhrpG) and 0.2 ng/µl (ΔhrpG) (see Figure 22).  After 120 mpi in HIM levels of 
16S cDNA dropped to approximately 10 fold less on average (values between 0.03 – 0.05 
ng/µl) with no significant difference between strains. This fall was probably due to the 
change in nutrient levels resulting in slower growth. At 240 mpi levels remained between 
0.02 – 0.04 ng/µl for all strains (Figure 22).  
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Figure 22: Ps. DC3000 wild-type and mutants 16S expression 
Expression of 16S in hrpV and hrpG mutants (ΔhrpV, ΔhrpG and ΔhrpG in light grey) showing comparison to wild-type 
Ps. DC3000 expression (in dark grey). Expression levels are shown before induction in LB and 120 and 240 minutes post 
inoculation in minimal media (HIM). Y-axis shows readings in ng/µl of cDNA. Error bars represent standard deviation from 
triplicate biological replicates. 
Having established the relative background levels it was then possible to assess the impact 
of the hrpV and hrpG deletions on expression of other key hrp and virulence genes. hrpV 
expression was tested as it lies in the same operon as hrpG so differences in its expression 
may reflect common operon-wide differences between the two hrpG mutants. Levels of 
hrcC were analysed because hrcC mutants do not produce a functional T3SS and hence 
cannot secrete effectors that enable them to survive in plant hosts. hrcC is in the same 
operon as the mutant genes hrpV and hrpG (downstream of hrpG) and Ortiz-Martín et al 
(2010b) found that hrcC expression was not induced in the ΔhrpG mutant, although levels 
of hrcC in LB were 17-fold higher than wild-type in this mutant. hrpF is also in the same 
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operon as hrpV and hrpG (upstream of hrpG), and, as mentioned above, expression of 
certain hrp genes were attenuated in a hrpF deletion mutant suggesting that HrpF may have 
a role in HrpRS regulation (since hrpL levels are reduced in a ΔhrpF strain) (Ramos et al., 
2007b). Notably, Ortiz-Martín et al (2010b) found that the ΔhrpG mutant had 2000-fold 
more hrpF transcript than wild-type before inoculation in HIM. Coronatine is a phytotoxin 
produced by several pathovars of P. syringae, e.g. glycinea (Penaloza-Vazquez & Bender, 
1998) and DC3000 (Penaloza-Vazquez et al., 2000) but not tomato T1. Expression of the 
genes involved in coronatine biosynthesis are regulated by a two-component regulator 
system where CorR is the DNA-binding transcriptional response regulator and CorS is the 
sensor histidine kinase. Expression of corR was analysed because Sreedharan et al (2006) 
suggested that CorL regulates hrpL and HrpL regulates corR in Ps. DC3000, implying that 
there is overlap in the regulation of these two pathways (Sreedharan et al., 2006). In line 
with this observation, HrpV has been suggested to have a negative effect on coronatine 
biosynthesis (Penaloza-Vazquez et al., 2000). Expression of avrPto was also measured as it 
encodes a T3SS and hrpL-dependent secreted effector, so its expression, at a site away from 
the hrp cluster, will be affected by differences in hrpL regulation. Additionally, 
determination of expression levels of hrpG, hrpR, hrpS and hrpL was attempted. These 
genes are important because they form the core components of the regulatory system 
under examination in this study. Initial attempts failed so primers and fluorescent probes 
were redesigned using Primer3 (frodo.wi.mit.edu/primer3/) which allows a defined 
amplicon size, oligo size and Tm range to be specified (in this case the amplicon size was set 
at between 70 and 120 bp, oligo size of approximately 20 bp and Tm of approximately 50oC 
(see Appendix B, Table 12). However, neither the standards nor the samples were amplified 
consistently or successfully so further attempts were not made and expression of these 
genes (examined by real-time RTPCR in the context of these mutant strains) is not discussed 
further. 
Initially, induction of genes in HIM was established for the wild-type strain (DC). Figure 23 
shows that all genes were induced by inoculation into HIM. Interestingly, hrcC expression 
appears to be induced later than the other genes, with expression levels only significantly 
increasing at 240 mpi. This could reflect additional regulation acting upon hrcC expression 
other than the signals imposed by induction into HIM. Levels of hrcC at 240 mpi are 
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significantly higher than hrpF, avrPto, and corR (hrcC is 0.15 ng/µl relative to 16S levels 
whereas hrpF, avrPto, and corR are 0.001, 0.008 and 0.003 respectively). hrpV expression 
levels are considerably higher than the other genes examined, with the highest point at 120 
mpi reaching 0.22 ng/µl relative to 16S. This could reflect the important role HrpV plays in 
regulating HrpRS, and thus in regulating all hrpL-dependent genes. hrpV, hrpF, avrPto, and 
corR increase significantly above the LB levels at 120 mpi and hrpV, hrpF, avrPto appear to 
fall back towards background levels by 240 mpi (corR is, on average, decreasing at 240 mpi 
but the levels are not significantly different from levels at 120 mpi). This could mean that by 
120 mpi these genes have reached their expression level peaks and other genes are then 
expressed (e.g. hrcC). In order to present the results obtained so that clear comparisons can 
be drawn between gene expression in the mutant and wild-type strains, data from the wild-
type (DC) are given in each of the sets of graphs presented for each mutant (ΔhrpV, 
ΔhrpG and ΔhrpG). 
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Figure 23: Ps. DC3000 wild-type gene expression relative to 16S  
Analysis of wild-type strain DC. Expression of 16S, hrpV, hrcC, hrpF, avrPto and corR in the wild-type (dark grey) and the 
ΔhrpV strain (light grey) at 120 and 240 mpi and before induction (LB). hrpV, hrcC, hrpF, avrPto and corR are shown relative 
to 16S Y-axis shows readings in ng/µl of DNA relative to 16S. Error bars represent standard deviation from triplicate 
samples. 
Figure 24 shows expression of hrpV, hrcC, hrpF, avrPto and corR from the ΔhrpV strain. 
Results of hrpV expression confirm that the mutant does not express hrpV. In Ps. DC3000 
the levels of hrpV expression were at least an order of magnitude higher than hrpF, avrPto 
and corR. Surprisingly, expression of hrcC was significantly lower than wild-type (5-fold less) 
at 240 mpi. This is surprising given that this mutant establishes wild-type HR and disease 
progression – both of which are dependent on HrcC. However, it would appear that the 
expression levels of hrcC cannot be limiting and are increasing with time in HIM so it cannot 
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be discounted that hrcC expression levels could reach the levels observed in the wild-type 
strain, given a longer inoculation time. Expression of hrpF (in the same operon as hrcC and 
hrpV) was significantly higher in ΔhrpV than wild-type at 120 and 240 mpi with levels 
remaining constant between these two time points (an average of 6-fold greater than wild-
type). This implies that without regulation by HrpV, expression of hrpF is significantly 
increased. Expression of avrPto was not significantly different from wild-type at any time 
point; however, the average levels at 120 and 240 mpi were higher in the ΔhrpV strain. 
Expression of corR was significantly higher at 240 mpi (approximately 6-fold greater than 
wild-type) in the ΔhrpV strain which implies that without HrpV corR expression increases – 
results in agreement with those obtained by Penaloza-Vazquez (2000). 
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Figure 24: Ps. DC3000 ΔhrpV gene expression relative to 16S  
Analysis of ΔhrpV. Expression of 16S, hrpV, hrcC, hrpF, avrPto and corR in the wild-type (dark grey) and the ΔhrpV strain 
(light grey) at 120 and 240 mpi and before induction (LB). hrpV, hrcC, hrpF, avrPto and corR are shown relative to 16S Y-axis 
shows readings in ng/µl of DNA relative to 16S. Error bars represent standard deviation from triplicate samples. 
Figure 25 shows expression of 16S, hrpV, hrcC, hrpF, avrPto and corR from the ΔhrpG 
strain (where expression from the nptII cassette is driven in the opposite direction to the 
operon). Expression of both hrpV and hrcC (which lie downstream of the cassette) are 
severely attenuated in ΔhrpG compared to wild-type. At 240 mpi, levels of hrcC are 40-
fold lower than wild-type (compare ΔhrpV levels – 5-fold lower than wild-type). This is in 
marked contrast to hrpF expression (which lies upstream of the cassette). In the case of hrpF 
expression, levels are significantly higher than wild-type before induction (LB) and remain 
higher at 120 and 240 mpi (9-fold and 13-fold higher respectively). The levels of hrpF seen 
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for this mutant at 120 and 240 mpi are comparable with those of ΔhrpV at the same time 
points. This implies that expression of the operon from the hrpL-promoter upstream of hrpF 
is not properly regulated in rich media in the absence of HrpG (and HrpV). Expression levels 
of avrPto and corR are both significantly higher than wild-type at 240 mpi (30-fold and 8-fold 
higher respectively) suggesting that without HrpG, expression of these genes is unregulated 
at later time points. This is similar to results seen with ΔhrpG (Figure 26). 
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Figure 25: Ps. DC3000 ΔhrpG gene expression relative to 16S  
Expression of 16S, hrpV, hrcC, hrpF, avrPto and corR in the wild-type (dark grey) and the ΔhrpG strain (light grey) at 120 
and 240 mpi and before induction (LB). hrpV, hrcC, hrpF, avrPto and corR are shown relative to 16S Y-axis shows readings in 
ng/µl of DNA relative to 16S. Error bars represent standard deviation from triplicate samples. 
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Figure 26 shows expression levels of 16S, hrpV, hrcC, hrpF, avrPto and corR from ΔhrpG 
(in which expression from the nptII cassette is in the same direction as the operon 
expression). Expression levels of hrpV were significantly lower than wild-type at 120 mpi but 
return to wild-type levels at 240 mpi. This implies that hrpV expression is slower to induce in 
this mutant. It also appears that expression of hrpV in the wild-type is falling at 240 mpi. 
This is also the case for hrpF, avrPto and corR in the wild-type strain (see Figure 23). In 
contrast to this, hrpV expression in ΔhrpG is increasing between 120 and 240 mpi. Later 
time points may reveal that levels rise above those of wild-type, which would be in line with 
expression levels of hrpF, avrPto and corR expression in this mutant. In this mutant, unlike 
ΔhrpV and ΔhrpG, hrcC levels are wild-type at all three time points. Results for hrcC and 
hrpV expression also imply that genes downstream of the nptII cassette are not affected in 
this mutant. Expression levels at 240 mpi for hrpF, avrPto and corR are all above those of 
wild-type – 47-fold, 16-fold and 17-fold respectively, suggesting that HrpG may have a role 
in regulating expression of these genes, possibly indirectly. Also corR levels are 6-fold higher 
than wild-type (DC) at 120 mpi. This could be due to a regulatory effect of HrpG on hrp-
dependent genes (excluding genes downstream of hrpG within its operon) at later time 
points – both ΔhrpG and ΔhrpG have elevated levels of hrpF, avrPto and corR at 240 
mpi. 
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Figure 26: Ps. DC3000 ΔhrpG gene expression relative to 16S 
Expression of 16S, hrpV, hrcC, hrpF, avrPto and corR in the wild-type (dark grey) and the ΔhrpG strain (light grey) at 120 
and 240 mpi and before induction (LB). hrpV, hrcC, hrpF, avrPto and corR are shown relative to 16S Y-axis shows readings in 
ng/µl of DNA relative to 16S. Error bars represent standard deviation from triplicate samples. 
In summary, none of the three mutant strains tested have wild-type expression levels for all 
genes tested – hrpV, hrcC, hrpF, avrPto and corR – suggesting that regulation of these genes 
is clearly complicated. A table summarising the changes in gene expression, relative to wild-
type is shown below (Table 7). Interestingly, Table 7 shows that across all genes and 
mutants, most differences are present at 240 mpi. This implies that regulation of hrp/hrc 
and virulence genes by HrpV and HrpG does not occur immediately upon inoculation into 
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HIM (or in planta); rather they play a role at later stages, probably after initial signalling 
events have occurred and after expression of hrpRS has been induced. 
Gene 
Time 
Strain LB 120 240 
16S 
higher same same ΔhrpV 
lower same same ΔhrpG 
higher same same ΔhrpG 
hrpV 
lower lower lower ΔhrpV 
same lower lower ΔhrpG 
same lower same ΔhrpG 
hrcC 
lower higher lower ΔhrpV 
lower same lower ΔhrpG 
lower same same ΔhrpG 
hrpF 
same higher higher ΔhrpV 
higher higher higher ΔhrpG 
same same higher ΔhrpG 
avrPto 
same same same ΔhrpV 
same same higher ΔhrpG 
same same higher ΔhrpG 
corR 
same same higher ΔhrpV 
same same higher ΔhrpG 
same higher higher ΔhrpG 
Table 7: Summary of changes in gene expression 
Changes in gene expression of 16S, hrpV, hrcC, hrpF, avrPto and corR for the three mutant strains, ΔhrpV, ΔhrpG and 
ΔhrpG relative to wild-type (Ps. DC3000) collated from Figure 24, Figure 25 and Figure 26. Changes are given as same, 
higher or lower based on data collected from triplicate samples where standard deviation is used to measure error. Where 
error bars overlap, data points are treated as not significantly different (i.e. the same).  
HrpV and HrpG are known to regulate HrpRS activity. HrpRS activates expression of hrpL, 
which encodes HrpL – an alternative σ-factor that activates expression of hrpV, hrcC, hrpF 
and avrPto. This scheme implies that regulation of HrpRS by HrpV and HrpG has a direct 
influence on expression of hrpL-dependent genes. Expression of corR is also affected by 
deletion of hrpV and hrpG which means there is overlap in the regulation of coronatine 
biosynthesis and hrp genes. This agrees with the findings of Sreedharan et al (2006) and 
Penaloza-Vazquez et al (2000). The results obtained in this study indicate that there may be 
differences between regulation of hrpC operon genes downstream of hrpF (hrpG, hrcC, hrpT 
and hrpV) and regulation of other hrpL-dependent genes (including corR). A comparison of 
expression of hrpV and hrcC from ΔhrpG and ΔhrpG shows that there is a significant 
difference between these two mutants which could be due to the different orientations of 
the nptII cassette (this is discussed further in section 3.6). The lack of HrcC is the most likely 
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explanation for the attenuated in planta phenotypes seen for the ΔhrpG strain (Figure 18, 
Figure 19 and Figure 20). It is possible that in ΔhrpG expression of hrpT is also severely 
attenuated. HrpT has been implicated in negative regulation of hrp gene expression in Ps. 
phaseolicola (Ortiz-Martín et al., 2010b). This could be having some effect in the ΔhrpG 
strain and may explain the elevated levels of hrpF in LB seen for this strain but not for 
ΔhrpG (where hrpT expression is presumably unaffected). Results for expression of hrpF, 
avrPto and corR are all significantly higher than wild-type at 240 mpi in all three mutant 
strains (excluding avrPto in ΔhrpV, although the average is higher). Given the observation 
that deleting hrpF reduces hrpL expression (Ramos et al., 2007b), the results from the RT-
PCR assays imply that HrpF may regulate HrpRS activity in a hrpV and/or hrpG dependent 
manner. Therefore there is some overlap between the effect of deleting hrpV and of 
deleting hrpG, especially at 240 mpi. There could also be a combinational effect when both 
hrpG and hrpV are not expressed – the ΔhrpV strain is missing hrpV, the ΔhrpG strain is 
only missing hrpG but the ΔhrpG strain is missing hrpG and has very low levels of hrpV. 
The high level of hrpF seen at 120 mpi in ΔhrpV and ΔhrpG could be due to the low level 
of hrpV. Perhaps at this time point the presence of hrpV is important for down-regulating 
hrpF expression. The hypothesis for deletion of hrpV, from previously reported evidence, 
would be increased expression of hrpL-dependent genes (due to HrpV’s role as a negative 
regulator) and deletion of hrpG would be hypothesised to result in a decrease in hrpL-
dependent gene expression due to its roles as a HrpV-negative regulator. This simple 
explanation is not evident from the results in this study; therefore (many) other factors may 
play a role in the regulation of hrpL-dependent gene expression. These results highlight the 
difficulties of the examination of mutations within complex operons. It is difficult to identify 
effects that may be due to the disruption of expression outside that of the gene carrying the 
mutation. The nptII cassette has commonly been used for disruption but unmarked 
deletions may be a more appropriate method. Nevertheless, even with gene deletions there 
is always the possibility of purely physical effects within an operon. 
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3.5. hrpLp::lacZ reporter 
Creation of a lacZ reporter construct to analyse activity at the hrpL promoter in vivo with Ps. 
DC3000 mutants. 
 
Work in this section was carried out in conjunction with Arif Chishti, a visiting Master’s 
student. The ampicillin resistant plasmid vector pBBR1MCS (Kovach et al., 1994) was chosen 
for this study due to its compatibility with E. coli and Pseudomonas systems and its 
extensive use in a number of applications. This vector contains a lacZ gene therefore 
primers were designed to clone the hrpL-promoter lacZ fusion (hrpLp::lacZ) from pRS415 (a 
vector created by M. Jovanovic used for creating the E. coli chromosomal hrpL-promoter 
lacZ fusion strain – used in Chapter 4) flanked by XbaI and SphI restriction sites. These 
restriction enzymes cut the original vector either side of the lacZ gene so that this gene was 
excised and replaced with hrpLp::lacZ.  
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Figure 27: pBBR1MCS hrpLp::lacZ reporter in E. coli MC4100 
β-galactosidase assay in MC4100 cells containing the hrpLp::lacZ reporter in pBBR1MCS either alone, with the pAPT vector 
or with pAPT-HrpRS (pMJRS). Expression from pAPT vectors was induced with IPTG. 
Figure 27 demonstrates that the hrpLp::lacZ construct reports elevated expression from the 
hrpL promoter fusion (in E. coli) in the presence of HrpR and HrpS.  
 
The construct was then transferred to Ps. DC3000 wild-type and mutant strains by 
electroporation. Wild-type (DC) (as shown in Figure 28) in the presence of the hrpLp::lacZ 
fusion construct expressed lacZ, when inoculated into HIM, reaching approximately 6000 
Miller Units. In the absence of the fusion construct and in LB (data not shown) no lacZ was 
expressed. This demonstrates that the fusion construct reports specifically activity of HrpRS 
under hrp-inducing conditions. The wild-type strain (DC) was then compared to the mutant 
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strains (ΔhrpV, ΔhrpG and ΔhrpG). The wild-type strain (DC) and ΔhrpG activity levels 
were not significantly different.  This is probably because in this strain there is significantly 
lower levels of hrpV (see Figure 25). This would prevent the negative regulation upon HrpRS 
imposed by HrpV. Interestingly ΔhrpV had significantly higher (approximately 2-fold) activity 
levels than wild-type. Presumably because without HrpV, HrpRS activity is not experiencing 
the same level of negative regulation as appears in the wild-type.  ΔhrpG levels were 
significantly lower than wild-type (approximately 20-fold). This is because wild-type levels of 
hrpV are present (see Figure 26), however, in the absence of HrpG, HrpV is unregulated. This 
would result in an increased amount of HrpV-imposed negative regulation on HrpRS. Clearly, 
this is a highly sensitive reporter system, capable of showing the effects on HrpRS activity in 
the presence and absence of the regulators HrpV and HrpG. 
 
 
Figure 28: pBBR1MCS hrpLp::lacZ reporter in Ps. DC3000 and mutant strains 
β-galactosidase activity of Ps. DC3000 mutants in the presence (light grey) and absence (dark grey) of the hrpLp::lacZ 
reporter construct. (The activity in the absence of the reporter(dark grey bars) was consistently less than 10 Miller Units). 
Cells were grown over-night in LB, washed in 10 mM MgCl2 and then placed in HIM to grow over-night before being 
assayed. Error bars report standard deviation from triplicate samples. 
Huynh et al (1989) showed that different carbon sources have an effect on the amount of 
hrp gene expression. They showed that fructose was the favoured carbon source, with other 
sugars also eliciting high hrp gene expression levels. Citrate, glutamate and peptone 
repressed hrp gene induction. Preliminary results with this reporter show that when hrpL 
induction is measured (rather than a gene encoding a secreted effector, avrB), citrate is 
capable of stimulating hrp gene expression (see Figure 29). 
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Figure 29: hrpLp::lacZ reporter gene expression in different carbon sources. 
β-galactosidase activity of Ps. DC3000 containing the pBBR1MCS hrpLp::lacZ reporter construct (pAC01) grown for 4 hours 
in HIM made with different carbon sources. All carbon sources at 10 mM except peptone, 2% (w/v). Error bars report 
standard deviation from duplicate samples. 
In summary, a construct has been created that can report activity of HrpR and HrpS at the 
hrpL-promoter in the native background. This can be used to assess the effect of different 
growth conditions (such as carbon and nitrogen sources) on the hrpL-activation activites of 
HrpR and HrpS. Other studies have used reporters that monitor hrp gene expression via 
secreted effectors, e.g. avrB (Huynh et al., 1989), however reporting from upstream 
activators of the T3SS (i.e. HrpRS) may provide an improved method for assessing the 
effects of different environmental conditions on T3SS-mediated virulence. 
3.6. Conclusions 
The purpose of examining deletion mutants is to determine a possible role for that 
particular gene. The Ps. DC3000 mutants analysed in this chapter were constructed by Ortiz-
Martín and are exactly equivalent to the Ps. phaseolicola mutants analysed by Ortiz-Martín 
et al (2010b) (ΔhrpV = IOM48, ΔhrpG = IOM57 and ΔhrpG = IOM71). The phenotypic 
studies of population growth, disease symptoms and HR indicate that deletion of hrpV does 
not confer major defects. This result is broadly consistent with Ortiz-Martín et al (2010b) 
and Deng et al (1998).  Ortiz-Martín et al (2010b) report that IOM48 displayed wild-type 
growth and symptom induction, and stronger and faster HR. Deng et al (1998) report that 
mutation of hrpV in Ps. syringae had no effect on timing or intensity of HR, although they 
found that its ability to multiply and produce disease symptoms was somewhat impaired. 
These differences could be attributed to variations between the three strains (Ps. pvs 
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DC3000, phaseolicola and syringae) and experimental conditions used in these assays. This 
study and Ortiz-Martín et al (2010b) used bacteria from cultures grown overnight in liquid 
LB, whereas Deng et al (1998) inoculated plants with cells grown overnight on King’s B 
media plates. 
 
This study examined two insertion inactivation mutants of hrpG (ΔhrpG and ΔhrpG). 
They cannot strictly be called deletion mutants since Figure 15 and Figure 16 show that 
some of the hrpG sequence remains. These mutants were examined to elucidate a possible 
role for HrpG in Ps. DC3000 and to determine whether HrpG had a similar role to that seen 
in Ps. syringae and Ps. phaseolicola (Wei et al, 2005 and Ortiz-Martín et al, 2010b 
respectively). The ability of HrpG to negatively affect HrpV was determined by Wei et al 
(2005) in Ps. syringae by overexpressing hrpG in a hrpG mutant that was upregulating hrpV. 
A hrpG mutant that did not upregulate hrpV showed wild-type HR (and wild-type expression 
and production of hrpZ, hrcJ and hrcQb). These wild-type-like phenotypes were observed for 
ΔhrpG in this study (Figure 18, Figure 19 and Figure 20) and by Ortiz-Martín (2010b) using 
the strain IOM71. Surprisingly, ΔhrpG and IOM57 were severely defective for growth in 
planta, symptom development and HR. This can be explained by the effect of placing the 
nptII cassette in the opposite orientation to the hrpC operon, thus leading to reduced 
expression of hrcC, see Figure 25 and Figure 30. In ΔhrpG and IOM71 transcription can 
initate from the hrpC operon promoter (hrpCp) and/or the nptII promoter (nptIIp) without 
the two sets of transcription machinery interfering with each other. In ΔhrpG and IOM57 
the two sets of transcription machinery head towards each other with the chance that one 
or both sets are dislodged from the DNA by head-on collisions. If transcription from the 
nptIIp is distrupted then there would be no resistance to kanamycin, creating a selection 
pressure for cells growing in culture media – this would theoretically lead to increased 
transcription from this promoter. However, this selection pressure would not exist for cells 
growing in planta. If transcription from the hrpCp is distrupted then either none of the hrpC 
operon genes are transcribed or only hrpF (but no other downstream genes) is transcribed. 
Ortiz-Martín et al (2010b) reported wild-type mRNA levels of hrpF at 240 mpi. In line with 
this observation, Figure 25 shows that in this study transcription of hrpF is not decreased in 
ΔhrpG. Ortiz-Martín et al (2010b) were also able to complement IOM57 with constitutive 
expression of hrpG and hrcC, thus eliminating interference of hrpF expression. This leaves 
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one possible explanation – the transcription machinery from hrpCp is dislodged or 
interfered with after transcription of hrpF has occurred but prior to transcription of hrcC and 
hrpT and hrpV). This explains the result seen in Figure 25; which itself explains Figure 18, 
Figure 19 and Figure 20. It also accounts for the inability of IOM57 to be complemented by 
in trans expression of hrpG alone (recall that wild-type levels were only restored when hrpG 
and hrcC were expressed) (Ortiz-Martín et al 2010b). However, it is important to note that 
the ΔhrpV strain also had reduced levels of hrcC (Figure 24). The reason for this is unclear, 
given that in other cases (hrpF and corR) levels were above wild-type or equivalent to wild-
type (avrPto). The ΔhrpV strain is able to cause disease and HR despite its low level of hrcC. 
However, it has only 5-fold less hrcC compared to 40-fold less hrcC in the ΔhrpG strain. 
Therefore it is possible that a minimum threshold of hrcC required for full pathogenicity is 
reached by ΔhrpV but not ΔhrpG. It could also be the case that the ΔhrpV strain slowly 
accumulates enough hrcC for pathogenicity – phenotype observations were made a 
minimum of 24 hours after induction whereas gene expression levels were recorded a 
maximum of 4 hours after induction.  
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Figure 30: Transcriptional interference cartoon 
Cartoon illustrating how transcriptional interference may occur in ΔhrpG but not in ΔhrpG; resulting in reduced hrcC 
(and downstream genes) in ΔhrpG and thus accounting for its severely defective phenotypes. In ΔhrpG transcription 
takes place from the two promoters, hrpCp and nptIIp, and proceeds from them in the same direction. The two sets of 
transcription machinery will not meet; however, this may result in an increase in the mRNA levels of downstream genes. In 
ΔhrpG, because the two sets of transcription machinery are heading in opposite directions, one from hrpCp and the 
other from nptIIp, there is a chance that they will meet. This could prevent transcription that began at hrpCp from reaching 
hrcC, although hrpF mRNA may still be generated. A severe reduction in hrcC mRNA (as is seen with ΔhrpG, Figure 25) 
will cause the phenotypes seen for this mutant (Figure 18, Figure 19 and Figure 20). 
Interestingly, in both hrpG mutants the mRNA levels of hrpF, avrPto and corR are above 
wild-type at 240 mpi suggesting a possible role for HrpG in down-regulating hrp gene 
expression. This would seem to contradict its role as a suppressor of HrpV’s negative action 
on hrp gene expression, but may reflect the complex network involved in regulating T3SS 
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and a possible HrpV-independent role for HrpG. This is in agreement with the conclusions of 
Ortiz-Martín et al (2010b), though for different reasons. The ΔhrpG strain, which does not 
express hrpV, has similar expression patterns for avrPto and corR as does the ΔhrpG 
strain. This is a clear indicator of a HrpV-independent role of HrpG in regulation. 
 
The role of HrpV as a negative regulator is demonstrated in this study by the results seen in 
Figure 28 (increased HrpRS activity compared to wild-type for ΔhrpV) and in the expression 
patterns of hrpF and corR in Figure 24 (increased expression compared to wild-type for 
ΔhrpV). However, expression of hrcC is reduced in the ΔhrpV strain compared to wild-type. 
This may reflect a HrpRS-independent role for HrpV. Jackson et al (2005) found that in a P. 
fluorescens strain overexpressing rspR (a hrpS homolog) expression of rspU (a T3SS 
structural protein) increased compared to wild-type (148 nM compared to 2.8 nM) but this 
increase was reduced in a ΔrspV strain over expressing rspR (69 nM) (Jackson et al., 2005). 
rspV is a potential homolog of hrpV so perhaps in some cases the roles of HrpV is to increase 
expression of some hrp genes (maybe structural components of T3SS; recall that HrcC is a 
T3SS structural protein), possibly indirectly. Perhaps HrpV acts as a negative regulator for a 
protein whose role is to repress hrcC expression. Or alternatively, HrpV negatively effects a 
protein that specifically degrades hrcC mRNA. In those cases, in the absence of HrpV, there 
would be reduced hrcC expression or increased hrcC degradation. It may be that increased 
hrpF at 120 mpi (but not at 240 mpi) leads to low hrcC expression (at 240 mpi) (compare 
hrpF expression at 120 mpi and hrcC expression at 240 mpi in Figure 24, Figure 25 and 
Figure 26 – where hrpF is higher than wild-type at 120 mpi, hrcC expression is lower than 
wild-type at 240 mpi).  
 
The hrpLp::lacZ reporter construct shows that in the absence of HrpV-imposed negative 
regulation, HrpR/HrpS activity is significantly greater than wild-type (Figure 28). Other 
studies that have analysed hrpV deletion mutants have not seen significant increases in hrp 
gene expression (Preston et al., 1998b, Ortiz-Martín et al., 2010b); the role for HrpV was 
determined primarily by overexpression of hrpV resulting in decreased hrp gene expression 
or decreased Hrp protein production. This reporter, unlike other studies, looks directly at 
expression from the hrpL promoter, i.e. the activity of HrpR and HrpS (the direct target for 
HrpV) from which it is possible to show a clear negative role for HrpV. This increase in 
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HrpR/HrpS activity may not translate to an increase in other hrp gene production, due to 
other regulatory steps/factors downstream of hrpL transcription. It is also possible that the 
effect seen may only be observed under certain induction conditions – cells were left to 
grow overnight in order to reach a suitable optical density for assaying β-galactosidase 
activity, rather than for 1 hour as in other β-galactosidase assays (and up to 4 hours in RT-
PCR assays). The two hrpG deletion mutants show different effects on HrpR/HrpS activity. 
Where low levels of expression are observed (ΔhrpG, Figure 25), activity levels of 
HrpR/HrpS are similar to wild-type. This agrees with Wei et al (2005) who found that a hrpG 
deletion mutant with a promoter-less nptII cassette did not have increased levels of hrpV, 
and showed wild-type like phenotypes. In hrpG mutants that have two potential promoters 
driving hrpV transcription (depicted in Figure 30), decreases in hrp gene 
expression/production have been observed (Wei et al., 2005, Preston et al., 1998, Deng et 
al., 1998), consistent with results obtained in this study where ΔhrpG exhibits significantly 
lower levels of HrpR/HrpS activity. Although hrpV expression from this mutant was not 
significantly above wild-type at the time points assayed (Figure 26) it has been noted that 
hrpV levels are slightly increasing in this mutant at 240 mpi such that it may exhibit higher 
than wild-type levels at later time points (not assayed here). 
In conclusion, the results in this chapter have shown that a negative role for HrpV can be 
demonstrated if activity of the target is reported. The study has also highlighted the 
importance of orientation of reporter cassettes on expression of downstream genes, which 
affects interpretation of results. However, the results show that HrpG may have a role as a 
transcriptional repressor of hrpL-dependent gene expression (that could be HrpV-
independent), but only after initial hrp induction has occurred (i.e. this effect is seen at 240 
mpi but not at 120 mpi).  
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CHAPTER FOUR 
4. Analysing the roles and determining functional domains of HrpV and 
HrpG using in silico and in vivo methodologies 
4.1. Introduction 
HrpL, the extracytoplasmic function sigma factor, controls the expression of almost all the 
hrp genes from Group I-type plant pathogens (P. syringae pathovars, Erwinia spp. and 
former Erwinia spp.) and P. fluorescens (Jackson et al., 2005). HrpL-dependent genes include 
Type III Secretion system (T3SS) structural components, secreted effector proteins and T3SS 
regulatory proteins. In Ps. DC3000 regulation of hrpL is focused on the interplay between 
four proteins – HrpR, HrpS, HrpV and HrpG. Studies have shown that HrpR and HrpS are a 
pair of strictly co-dependent enhancer binding proteins (EBPs). Members of the EBP family 
are found in all plant pathogens (Group I and Group II - Ralstonia and Xanthomonas species) 
and, more broadly, in many bacteria including E. coli, Shigella, Yersinia and Salmonella. HrpR 
and HrpS are similar in domain architecture to the well studied EBP PspF of E. coli 
(Hutcheson 2001). HrpV and HrpG are less well studied, have no recognisable conserved 
domains and are confined to the genomes of Group I plant pathogens; however HrpV has 
been shown to negatively regulate the activity of HrpRS and HrpG has been shown to relieve 
the inhibitory effect of HrpV in vivo (Ortiz-Martín et al., 2010b, Preston et al., 1998, Wei et 
al., 2005). Regulation of hrpL transcription is a vital step in Ps. DC3000 pathogenicity and it is 
necessarily a complex process involving response to environmental stimuli which can be 
mediated by, for example, two-component systems (TCS). Understanding the role that HrpV 
and HrpG play in this complicated regulatory system is important as they are under direct 
control of HrpL themselves and thus they form a feedback mechanism, unlike the more 
global TCS regulators (which act upstream of HrpL). Their role may be subtle – knockout 
mutants of hrpV and hrpG do not always have severe phenotypic effects (Preston et al., 
1998, Wei et al., 2005) and see Chapter 3. As HrpV and HrpG both share no clear homology 
with proteins whose structure and function is known (apart from the suggestion that HrpG 
is similar to a chaperone protein, Wei et al (2005)), they may represent proteins with novel 
functions and novel protein folds.  
 
103 
 
The role of HrpV as a negative regulator of HrpR and HrpS has been shown indirectly using 
knockout mutants in P. syringae and subsequent overexpression of hrpV or hrpG. Wei et al 
(2005) showed direct protein-protein interactions of HrpV to HrpS and HrpG using a yeast 
two-hybrid assay and direct binding of HrpG to HrpV was also confirmed using a pull-down 
assay and far-western blotting (Wei et al., 2005). In this chapter an in vivo activity assay is 
used to confirm the roles of HrpV and HrpG in terms of their effect on HrpRS activity. This 
assay is performed in E. coli where there can be no influence of other P. syringae-specific 
factors other than those being studied. This assay therefore provides a method to show the 
direct influences of HrpR and HrpS on hrpL transcription and the additional effects of 
including HrpV and HrpG. A bacterial two-hybrid (BACTH) system may be more appropriate 
to test interactions between bacterial proteins than a yeast two-hybrid system because 
bacterial proteins are more likely to be appropriately folded (and possibly post-
translationally modified) in bacteria than in yeast.  Also in this system the interaction 
between the hybrid proteins does not need to take place near the transcription machinery 
as is the case with yeast or other bacterial two-hybrid systems. Therefore this chapter will 
use a BACTH system based on the two subunits of adenylate cyclase (Karimova et al., 1998) 
to probe interactions between HrpV and HrpG and mutated forms of these proteins.  
 
HrpV and HrpG have not been studied at the structural or sequence level in vivo. Wei et al 
(2005) used a 3D structural comparison program to conclude that HrpG has more similarity 
to a chaperone protein of Salmonella than to any other proteins in that database but HrpG’s 
role as a chaperone has not been determined. There is a large discrepancy between the 
amount of available structural information and number of protein sequences, and 
secondary structure predictions can be useful when examining proteins with no known 
functional domains. Active sites may lie within alpha-helices, beta-sheets and coiled motifs 
and knowing where these are in the sequence is a useful guide for designing truncated 
mutants. Identifying conserved residues within sequences, even highly divergent ones, can 
also be a useful guide for designing mutants. As well as the P. syringae pathovars, other 
plant pathogens from Group I contain putative hrpV and hrpG genes. These have been 
described as having no homology to those of P. syringae. However, they all lie in the same 
locus position within the hrpC operon and are present in a regulon (the hrp/hrc cluster) with 
highly conserved genes with known identical functions. It is possible that even though 
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significant divergence has occurred, some conserved motifs remain to provide evidence of 
homology in function. It is not unreasonable to assume that if HrpV exists to regulate HrpRS 
that HrpV from the Erwinia group regulates HrpS; and HrpG regulates the Erwinia version of 
HrpV. Therefore, this chapter will use all available sequences of HrpV and HrpG to help form 
a more complete picture of these proteins and to determine motifs that may be used to 
unite these proteins in terms of their function within their respective hrp/hrc clusters. 
 
4.1.1. Objectives 
This chapter aims to use an in vivo activity assay that reports activity from the hrpL 
promoter to analyse the roles for HrpV and HrpG in regulating HrpR and HrpS. Also a 
bacterial two-hybrid assay will be used to identify protein-protein interactions between 
HrpV and HrpG. These assays will also be used to explore the functional domains and 
residues of HrpV and HrpG using mutants based on secondary structure predictions and 
sequence alignments. In this chapter ‘HrpS’ from organisms with HrpR and HrpS will be 
denoted as HrpSRS and ‘HrpS’ from organisms containing only HrpS (or RspR in P. 
fluorescens) will be denoted as HrpSS (see section 5.3 for more information). 
 
Specifically this chapter aims to: 
I. Establish the known roles for HrpV and HrpG using an in vivo activity assay and a 
bacterial two-hybrid assay. 
II. Use secondary structure prediction software to design truncated mutants of HrpV 
and HrpG and to analyse these mutants using the above mentioned assays. 
III. Identify all potential HrpV and HrpG sequences in the UniProt database and to 
confirm their relevance to this study (i.e. do they lie within a hrpC operon in a 
hrp/hrc cluster?). 
IV. Further identify functional domains of HrpV and HrpG using sequence alignments 
and design and analyse mutants based on the alignments. 
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4.2. Interactions of HrpV and HrpG with HrpR and HrpS 
Wei et al (2005) used a yeast-two hybrid assay to test for interactions between HrpS, HrpV 
and HrpG from Ps. syringae 61. They showed that HrpV interacts with both HrpS and HrpG 
but not with itself. They also showed that HrpG only interacts with HrpV, not with HrpS or 
itself. This result, along with other HrpV-HrpG binding interactions and in vivo expression 
data and phenotypes of hrpG mutants (see Chapter 3) helped to confirm the roles of HrpV 
and HrpG in this P. syringae pathovar. In Chapter 3 a reporter construct consisting of the 
hrpL promoter of Ps. DC3000 fused to lacZ was transformed into Ps. DC3000 (and mutant 
strains). This reporter construct, which is a multi-copy number plasmid, was used to report 
the ability of HrpRS to activate transcription at the hrpL promoter. In this case native levels 
of HrpRS are present with numerous copies of the hrpL promoter. In this chapter the same 
hrpL promoter region is fused to lacZ but is present as a single copy on the chromosome in 
E. coli. HrpRS are expressed from a multicopy number plasmid, pAPT110.   
4.2.1. In vivo activity assay 
In order to examine the effects of HrpG on in vivo activity of HrpV and HrpRS PCR 
amplification of Ps. DC3000 genomic DNA, was successfully used to generate hrpG for 
cloning into pMJV1 (pBAD-hrpV). In the hrpC operon, hrpG is expressed ahead of hrpV so 
pEJ2 was designed to contain hrpG upstream of hrpV. Only SacI and KpnI restriction sites 
were available within the multiple cloning site of pMJV1 and KpnI was chosen because the 
combination XbaI-KpnI has been used successfully for all BACTH cloning (see below). 
However, many unsuccessful attempts were made to ligate hrpG into pMJV1, subsequently, 
hrpG was successfully cloned into pGEM-T easy – confirmed by restriction digest using EcoRI 
(which has two sites flanking the multiple cloning site in pGEM) and by sequencing. 
However, hrpG could not be cut from pGEM using KpnI and XbaI. Single digestions to 
generate linear DNA confirmed that XbaI was not cutting pGEM-hrpG although XbaI could 
linearise pBAD and pMJV1. Investigation into the properties of XbaI showed that it is 
sensitive to DNA methylation by Dam which methylates N6 of adenine in the sequence 
GATC. XbaI was used as the 3’ restriction site for cloning hrpG into pMJV1 purely because 
XbaI was the 5’ restriction site used to clone hrpV into pBAD. Analysis of the primers used to 
generate the KpnI-XbaI hrpG fragment showed that there is a ‘GATC’ sequence created by 
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the overlap between the XbaI restriction site ‘TCTAGA’ and the reverse-complemented stop 
codon of hrpG ‘TCA’. (hrpG reverse primer TGCTCTAGATCATCACACTCCCGGTTGCCG). All 
subsequent cloning was therefore performed in the dam-/dcm- E. coli strain ER2925 
(previous cloning was carried out in the E. coli strain XL1-blue, which methylates DNA). DNA 
generated in ER2925 was successfully cut with KpnI-XbaI and hrpG was ligated into pMJV1 
to create pEJ2 (see Figure 31). 
600
bp
hrpG + hrpV 824 bp
pBAD18
 
Figure 31: pBAD-hrpG-hrpV (pEJ2) DNA 
Restriction digestion using enzymes KpnI and HindIII of pEJ2 (pBAD-hrpG-hrpV) analysed by agarose gel electrophoresis. 
Image shows hrpG and hrpV tandemly arranged cloned into pBAD18. The size, 824 bp, refers to the combined size of hrpG 
and hrpV plus ribosomal binding sites. 
The chromosomal hrpL promoter-lacZ fusion strain, MJ2806, was constructed by M. 
Jovanovic as described (Jovanovic et al 2011; Yu and Court 1998). HrpRS expressed as a 
single operon from the IPTG inducible lacUV5 promoter in pAPT110 (pMJRS) were shown by 
M. Jovanovic (Jovanovic et al 2011) to activate expression of lacZ from the chromosomal 
hrpL promoter fusion. Control reactions demonstrated that neither HrpR nor HrpS alone 
stimluated lacZ expression, although β-galactosidase activity was detected if the plasmids 
containing HrpR and HrpS were co-expressed within the cell (pBAD18 – arabinose inducible 
and pAPT). hrpV was cloned into pBAD as an XbaI-HindIII fragment by M. Jovanovic (pMJV1) 
and the inhibitory effect of HrpV on HrpRS was demonstrated (as measured by decreased β-
galactosidase activity) by co-expressing pMJV1 and pMJRS (Jovanovic et al., 2011). 
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Figure 32: In vivo transcription activation with HrpRS, HrpV and HrpG 
In vivo transcription activation activities measured from the chromosomal promoter hrpLp::lacZ reporter strain MJ2806. 
Cells were grown to OD 0.4 at 600 nm at 25
o
C before addition of 0.5 mM IPTG and 0.2% arabinose. Cells were then grown 
for an hour before being tested for β-galactosidase activity. Error bars represent standard deviation. 
The in vivo activity assay, described above, was then used to show the effect of co-
expressing hrpG and hrpV in the presence of HrpRS. Figure 32 shows that HrpG partly 
relieves the inhibitory effect of HrpV on the activity of HrpRS. HrpRS activity in the presence 
of HrpV and HrpG is approximately a third of activity in the absence of HrpV (32%).  
4.2.2. Bacterial Two-Hybrid (BACTH) analysis 
Jovanovic et al (2011) confirmed the findings of Wei et al (2005), showing that HrpV binds 
HrpS using a bacterial two-hybrid system (BACTH) (using vectors pVAM11 and pVAM32). 
They also show that HrpV does not bind HrpR (pVAM1), thus demonstrating a distinct 
affinity for HrpS. It is tempting to speculate that HrpV from Erwinia and former Erwinia 
species could potentially interact with HrpS (from those species) and information yielded 
from this study could be extrapolated to regulation of HrpL in Erwinia (where HrpS, HrpV 
and HrpG homologues are present). hrpG was cloned into the BACTH vectors pUT18C and 
pKT25 (pEJ17 and pEJ18) and tested for self-association and interaction with HrpV (see 
Figure 33) and HrpR and HrpS. 
 
108 
 
0
500
1000
1500
2000
2500
HrpG-T18Cvs.
HrpG-T25
HrpV-T18C vs.
HrpV-T25
HrpG-T18C vs.
HrpV-T25
HrpV-T18C vs.
HrpG-T25
zip-T18Cvs.
zip-T25 T18c vs. T25
M
ill
e
r 
U
n
it
s
 
Figure 33: BACTH with HrpG and HrpV 
Cells containing T18C and T25 fusion vectors (as indicated) were grown to OD 0.4 at 600 nm and induced with IPTG for 1 
hour before being assayed. Protein fusions on T18C and T25 fragments of adenylate cyclase that interact will express lacZ, 
those that do not interact do not express lacZ. In zip-T18C vs. zip-T25 represents the positive control – the two zip 
sequences interact to create a leucine zipper motif. T18C vs. T25 is the negative control, with no protein fusions. Error bars 
represent standard deviation. 
Figure 33 confirms the findings of Wei et al (2005) that HrpG and HrpV can bind each other 
in vivo. In this BACTH no difference in binding affinity is detected when HrpV or HrpG are 
expressed from either of the two fusion vectors, pUT18C (high copy number) and pKT25 
(low copy number).  This assay also found that neither HrpV nor HrpG self-associate. Further 
BACTH were performed that showed HrpG does not detectably bind HrpS or HrpR (data not 
shown). 
4.3. Finding functional domains with secondary structure predictions 
HrpV and HrpG are both small proteins (in Ps. DC3000 13.9 kDa and 15.4 kDa, respectively). 
Nothing in their sequence can be identified as a recognised functional domain from the 
Conserved Domains Database (ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml). For example, 
there are no obvious DNA binding domains, ATP binding sites, helix-turn-helix motifs, coiled 
coil motifs or leucine zipper motifs. Therefore, to elucidate their mode of function and 
potential active sites, it was necessary to examine the sequence using a secondary structure 
prediction tool. Because functional domains often lie within helical structures, strands or 
loops knowing the secondary structure can aid the design of truncated mutants. Such 
mutants are designed so that they are missing one or more of these predicted secondary 
structures. If the proteins lose activity when missing a predicted helix (for example), then 
this helix is potentially important for the full-functionality of the protein. In this study JPred 
(compbio.dundee.ac.uk/www-jpred/index.html) was used to predict the secondary 
structures of HrpV and HrpG from Ps. DC3000. This prediction was performed in late 
2006/early 2007. Since this time the software has been updated and improved and only 
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JPred3 now remains available (Cole et al., 2008). The figures in the sections below were 
made from predictions using JPred3, not the earlier version of the software. Because of this 
one of the truncations of HrpG lies within a predicted structural feature although in the 
original prediction it did not. The aim of this process of analysing truncated mutants of HrpV 
and HrpG was to narrow down or focus in on functional regions of the protein (in terms of 
ability to interact with one another and ability of HrpV to interact with and/or repress HrpS) 
with the future aim of analysing these regions on a single-residue basis.  
4.3.1. Secondary structure prediction of HrpV 
The Jpred3 (Cole et al., 2008) software used to make the secondary structure predictions 
creates a consensus sequences from homologous proteins from which it makes the 
prediction. For HrpV of Ps. DC3000 the software used homologous proteins from P. 
viridiflava S-PAI, P. mendocina ymp, Dickeya zeae, Pantoea stewartii pv. stewartii, E. 
tasmaniensis, P. fluorescens and Pectobacterium carotovorum subsp. carotovorum (see 
Appendix C, Table 15). This means that the predicted secondary structures take into account 
the sequences of all the above proteins, not just the query sequence. The secondary 
structure prediction of HrpV showed three predicted alpha helices (H) and four extended 
regions (E) (or beta-strands) interspersed with loops or coils (-) (see Figure 34).  
 
Figure 34: Secondary structure prediction of HrpV 
Secondary structure prediction of HrpV from Ps. DC3000 showing the ‘simple output’ from JPred3 software. The amino 
acid residue numbers, sequence and structure predictions are aligned where ‘H’ = helix, ‘E’ = extended (or beta-strand) and 
‘-‘ = coil or loop. The secondary structure prediction is also depicted graphically, where horizontal black line represents ‘-‘, 
red box = ‘H’ and blue box = ‘E’. Key residues are highlighted (40 and 94). The mutants HrpV1-40 and HrpV1-94 are shown in 
the graphical style. 
Based on these predictions two truncated mutants of HrpV, HrpV1-40 and HrpV1-94, were 
designed. HrpV1-40 includes one of the three predicted helices and HrpV1-94 includes two of 
the three helices (see Figure 34).  
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4.3.2. HrpV C-terminal deletions in in vivo activity 
HrpV mutants HrpV1-40 and HrpV1-94 were constructed and tested for their ability to repress 
HrpRS activity using the chromosomal hrpL promoter-lacZ fusion reporter system described 
above (using vectors pEJ4 and pEJ5 – see Figure 35). 
hrpV1-94 303 bp
600
bp
hrpV1-40  141 bp
600
bp
 
Figure 35: pBAD-hrpV1-94 and -hrpV1-40 (pEJ4 and pEJ5) DNA  
Colony PCR of pEJ4 and pEJ5 (pBAD-hrpV1-94 and –hrpV1-40) analysed by agarose gel electrophoresis. Image shows hrpV1-94 
and hrpV1-40 cloned into pBAD18. The sizes, 303 bp and 141 bp, refer to the sizes of hrpV1-94 and hrpV1-40 (respectively) plus 
ribosomal binding sites. DNA ladder in Appendix Figure 100. 
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Figure 36: In vivo transcription activation activities of HrpV mutants 
In vivo transcription activation activities of HrpV mutants measured from the chromosomal promoter hrpL::lacZ reporter 
strain MJ2806. Cells were grown to OD 600 nm 0.4 at 25
o
C before addition of 0.5 mM IPTG and 0.2% arabinose. Cells were 
then grown for an hour before being tested for beta-galactosidase activity. Results are shown as percentage of wild-type 
(WT) activity – i.e. activity of HrpRS in the absence of HrpV = 100%. Error bars represent standard deviation. 
Neither HrpV1-40 nor HrpV1-94 were able to repress HrpRS activity – levels were not 
significantly different from wild-type (Figure 36). An immunoblot to detect expression of the 
truncated proteins using antibodies raised against HrpV was performed and showed that 
the two mutant proteins were not expressed (data not shown). This is presumably due to a 
gross protein instability issue.  
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4.3.3. HrpV C-terminal deletions in BACTH 
It was thought that the stability of the truncated mutants of HrpV may be increased by 
fusion to the BACTH subunits. Therefore, HrpV1-40 and HrpV1-94 were cloned into the BACTH 
vectors (to create pEJ6, pEJ7, pEJ8 and pEJ9 – see Figure 37) and tested for their ability to 
interact with HrpG. 
 
Figure 37: pUT18C-hrpV, -hrpV1-94 and -hrpV1-40 (pMJV1, pEJ6 and pEJ8) 
Restriction digestion using enzymes XbaI and KpnI of pEJ6 and pEJ8 (pUT18C-hrpV1-94 and -hrpV1-40) analysed by agarose gel 
electrophoresis. Image shows hrpV which is 360 bp, hrpV1-94 which is 282 bp and hrpV1-40 which is 120 bp cloned into 
pUT18C. DNA ladder in Appendix Figure 100. 
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Figure 38: BACTH with HrpG versus HrpV, HrpV1-40 and HrpV1-94 
Protein fusions on T18C and T25 fragments of adenylate cyclase that interact will express lacZ. T18C vs. T25 is the negative 
control, with no protein fusions. Error bars represent standard deviation. Immunoblotting using antibodies against HrpV 
indicates whether proteins are expressed (or not). Arrow indicates HrpV fused to T18. Full gel can be seen in Appendix C, 
Figure 101. 
As shown in Figure 38 HrpV1-40 and HrpV1-94 could not be assayed meaningfully for binding to 
HrpG since the proteins fusions were not overexpressed. The result did not differ depending 
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on which fusion was used (T18 or T25). This could be due to deletion of the C-terminal 
predicted helical domain which is potentially critical for stability and function of HrpV. 
4.3.4. HrpV N-terminal deletions in BACTH 
N-terminal truncation mutants of HrpV (HrpV41-119 and HrpV95-119) were designed to be 
counterparts to the C-terminal deletion mutants (HrpV1-40 and HrpV1-94). See Figure 39. 
V41-119
V95-119 
Figure 39: Graphical illustrations of HrpV41-119 and HrpV95-119 
HrpV41-119 and HrpV95-119 (in vectors pEJ10, pEJ11, pEJ12 and pEJ13 – see Figure 40) were 
tested for interaction with HrpG in the BACTH assay (see Figure 41).  
 
Figure 40: pUT18C-hrpV95-119 and -hrpV41-119 (pEJ10 and pEJ12) DNA 
Colony PCR of pEJ10 and pEJ12 (pUT18C-hrpV95-119 and -hrpV41-119) analysed by agarose gel electrophoresis. Image shows 
hrpV95-119 which is 78 bp and hrpV41-119 which is 240 bp cloned into pUT18C. DNA ladder in Appendix Figure 100. 
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Figure 41: BACTH with HrpG versus HrpV95-119 and HrpV41-119. 
Protein fusions on T18C and T25 fragments of adenylate cyclase that interact will express lacZ. T18C vs. T25 is the negative 
control, with no protein fusions. Error bars represent standard deviation. Immunoblotting using antibodies against HrpV 
indicates whether proteins are expressed (or not). Arrows indicate HrpV and HrpV95-119 fused to T18 (all other visible bands 
are background). Full gel can be seen in Appendix C, Figure 102. 
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Figure 41 shows that HrpV95-119 (which comprises the predicted C-terminal helix of HrpV) 
can interact with HrpG and is expressed as a fusion protein. HrpV41-119 (which is longer than 
HrpV95-119) is not stably expressed and therefore its ability to interact with HrpG cannot be 
deduced. This is probably due to a protein folding issue created by truncating the protein at 
amino acid position 40. This is discussed further in section 4.5. It is probable that the specific 
residues involved in HrpG-binding lie within the C-terminal helix of HrpV. 
4.3.5. Secondary structure prediction of HrpG 
For HrpG of Ps. DC3000 the prediction software, JPred3, used sequences from Ps. 
phaseolicola and P. mendocina to create the consensus sequence. This is far fewer 
homologous sequences than were used for HrpV (see above). For full output see Appendix 
C, Figure 106. In the HrpG sequence four helices and five extended regions are predicted.  
 
Figure 42: Secondary structure prediction of HrpG 
Secondary structure prediction of HrpG from Ps. DC3000 showing the ‘simple output’ from JPred3 software. The amino 
acid residue numbers, sequence and structure predictions are aligned where ‘H’ = helix, ‘E’ = extended (or beta-strand) and 
‘-‘ = coil or loop. The secondary structure prediction is also depicted graphically, where horizontal black line represents ‘-‘, 
red box = ‘H’ and blue box = ‘E’. Key residues are highlighted (55, 98, 111 and 123). The mutants HrpG1-55, HrpG1-98 and 
HrpG1-123 are shown in the graphical style. 
Three initial truncated mutants of HrpG, HrpG1-55, HrpG1-98 and HrpG1-123, were designed. 
HrpG1-123 was designed to include all predicted helices and extended regions and was based 
on a prediction made using an earlier version of the software than the one used to create 
Figure 42. In Figure 42 the C-terminal helix appears to extend from residue 99 to 124, 
whereas in the original prediction it extended from 99 to 123.  
4.3.6. HrpG C-terminal deletions in BACTH 
HrpG truncated mutants HrpG1-55, HrpG1-98 and HrpG1-123 (creating vectors pEJ19, pEJ20, 
pEJ23, pEJ24, pEJ25 and pEJ26 – see Figure 43) were tested for interaction with HrpV 
(pVAM31 and pVAM32) using the BACTH system. Results can be seen in Figure 44. 
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Figure 43: pUT18C-hrpG, -hrpG1-123, -hrpG1-98 and -hrpG1-55 (pEJ17, pEJ19, pEJ23 and pEJ25) DNA 
Restriction digestion using enzymes XbaI and KpnI of pEJ17, pEJ19, pEJ23 and pEJ25 (pUT18C-hrpG, -hrpG1-123, -hrpG1-98 and 
-hrpG1-55) analysed by agarose gel electrophoresis. Image shows hrpG which is 432 bp, hrpG1-123 which is 369 bp, hrpG1-98 
which is 294 bp and hrpG1-55 which is 165 bp cloned into pUT18C. DNA ladder in Appendix Figure 100. 
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Figure 44: BACTH with HrpV versus HrpG, HrpG1-123, HrpG1-98 and HrpG1-55 
Protein fusions on T18C and T25 fragments of adenylate cyclase that interact will express lacZ. T25 is the negative control, 
with no protein fusions. Error bars represent standard deviation. Immunoblotting using antibodies against HrpG indicates 
whether proteins are expressed (or not). Arrows indicate HrpG and HrpG1-123. Asterisks represent background proteins. Full 
gel can be seen in Appendix C, Figure 104. 
Figure 44 shows that when the truncated protein is expressed (i.e. HrpG1-123) it can interact 
with HrpV. Only HrpG1-123 was stably expressed and this truncation is deleted for the C-
terminal 20 amino acids which do not lie within any predicted helices or beta strands 
(extended regions). It was therefore decided to create an additional C-terminal truncation 
mutant that truncated the protein between amino acids 98 and 123 so as to disrupt the 
predicted C-terminal helix (see Figure 45) 
 
G1-111  
Figure 45: Graphical illustration of HrpG1-111 
115 
 
 
HrpG1-111 was tested in the BACTH assay (using vectors pEJ21 and pEJ22 – see Figure 46) and 
did not interact with HrpV (pVAM31 and pVAM32). Immunoblotting showed that the fusion 
protein did not stably express (see Figure 47). 
 
Figure 46: pUT18C-hrpG and - hrpG1-111 (pEJ17 and pEJ21) 
Restriction digestion using enzymes XbaI and KpnI of pEJ21 (pUT18C-hrpG1-111) analysed by agarose gel electrophoresis. 
Image shows hrpG which is 432 bp, hrpG1-111 which is 333 bp cloned into pUT18C. DNA ladder in Appendix Figure 100. 
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Figure 47: BACTH with HrpV versus HrpG and HrpG1-111 
Protein fusions on T18C and T25 fragments of adenylate cyclase that interact will express lacZ. T18C vs. T25 is the negative 
control, with no protein fusions. Error bars represent standard deviation. Immunoblotting using antibodies against HrpG 
indicates whether proteins are expressed (or not).  Arrow indicates HrpG. Asterisks represent background proteins. Full gel 
can be seen in Appendix C, Figure 104. 
The results above suggest that if the C-terminal helix of HrpG is disrupted then the protein is 
unable to stably fold. The interaction site with HrpV could lie within this helix since when 
this helix is not disrupted (as in HrpG and HrpG1-123) binding with HrpV occurs. However, this 
needs to be tested. 
4.3.7. HrpG N-terminal deletions in BACTH 
N-terminal truncation mutants of HrpG, HrpG56-143, HrpG99-143, HrpG112-143 and HrpG124-143 
(creating vectors pEJ27, pEJ28, pEJ29, pEJ30, pEJ31, pEJ32, pEJ33 and pEJ34) were designed 
to complement the C-terminal deletion mutants (HrpG1-55, HrpG1-98, HrpG1-111 and HrpG1-
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123). Figure 48 shows a graphical illustration of the truncations and Figure 49 shows the 
truncated genes cloned into pUT18C. 
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G112-143
G99-143
G56-143
 
Figure 48: Graphical illustrations HrpG56-143, HrpG99-143, HrpG112-143 and HrpG124-143 
 
Figure 49: pUT18C-hrpG, hrpG56-143, hrpG99-143, hrpG112-143 and -hrpG124-143  (pEJ17, pEJ33, pEJ31, pEJ29 and pEJ27) DNA 
Restriction digestion using enzymes XbaI and KpnI of pEJ33, pEJ31, pEJ29 and pEJ27 (pUT18C- hrpG56-143, hrpG99-143, hrpG112-
143 and -hrpG124-143) analysed by agarose gel electrophoresis. Image shows hrpG which is 432 bp, hrpG56-143 which is 267 bp, 
hrpG99-143 which is 138 bp, hrpG112-143 which is 99 bp and hrpG124-143 which is 63 bp cloned into pUT18C. DNA ladder in 
Appendix Figure 100. 
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Figure 50: BACTH with HrpV versus HrpG, HrpG56-143, HrpG99-143, HrpG112-143 and HrpG124-143 
Protein fusions on T18C and T25 fragments of adenylate cyclase that interact will express lacZ. T18C vs. T25 is the negative 
control, with no protein fusions. Error bars represent standard deviation. Immunoblotting using antibodies against HrpG 
indicates whether proteins are expressed (or not). Arrow indicates HrpG. Asterisks represent background proteins. Full gel 
can be seen in Appendix C, Figure 104. 
Figure 50 shows that none of the HrpG N-terminal deletion mutants were stably expressed 
and therefore could not be tested for interaction with HrpV. Since HrpG56-143 and HrpG99-143 
did not stably express it seems that it is not simply the C-terminal helix that is responsible 
for full protein stability. HrpG is probably folded such that it cannot support truncation of 
significant sections of the protein. 
4.3.8. Summary of results using truncated mutants  
Many of the truncations that were made of HrpV and HrpG were not expressed, probably 
due to instability, perhaps because of protein folding issues or degredation by Lon protease. 
However, HrpG1-123 was expressed and did interact with HrpV. This shows that the C-
terminal 20 amino acids are not important for protein stability or for HrpV interactions. 
HrpG1-111, which is truncated for the C-terminal 32 amino acids was not expressed. This 
mutant was designed to disrupt a predicted helical structure. It is therefore possible that 
this helix is important for both HrpV binding interactions and for protein stability. HrpV95-119 
was expressed and interacted with HrpG. This mutant comprises solely the C-terminal helix 
of HrpV. Therefore, this helix probably contains the HrpG-binding region. 
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4.4. Alternative approach – in silico analysis alignments with all available G and V 
sequences 
The truncated mutant analysis of HrpV and HrpG indicated that within both proteins a 
predicted alpha helix in the C-terminus is important for binding interactions and for protein 
stability. The N-terminus is also required for full stability of both proteins. HrpG and HrpV 
proteins exist in all P. syringae pathovars and there are potential homologues within other 
plant pathogens (e.g. E. amylovora – Kim et al, 1997). In order to further elucidate the 
functional domains of HrpV and HrpG their amino acid sequences (from Ps. DC3000) were 
compared to all other potential homologues. 
4.4.1. Identification of sequences 
Using the sequences of HrpV and HrpG from Ps. DC3000 acquired from the Pseudomonas 
Genome Database (www.pseudomonas.com) a BLASTp (blast.ncbi.nlm.nih.gov) search was 
performed to identify other possible HrpV and HrpG homologues. There are some 
limitations to this approach: firstly, the database is not extensive; secondly, many of the 
protein sequences are automatically predicted from nucleotide sequences and remain 
unverified and in some cases incorrect; thirdly, there are numerous identical proteins 
entered in the database which complicates the search for unique instances of the protein in 
question; and finally, proteins below a certain level of homology will be undetected unless 
parameters are changed.  
 
A preliminary list of approximately fifty potential homologues of both HrpV and HrpG was 
refined to leave a final list of twenty organisms. This list is based on sequences from 
organisms with a taxonomy identity number (www.ncbi.nlm.nih.gov/taxonomy) and, as far 
as possible, unique sequences from as divergent a range of organisms as possible. Notably, 
P. viridiflava populations contain two forms of pathogenicity islands (PAI) named tripartite 
PAI (T-PAI) and single PAI (S-PAI) (Araki et al., 2006) where one organism will only ever have 
one of the two PAIs. One example of each of the P. viridiflava PAIs has therefore been 
included in this study. 
  
As HrpV and HrpG are less well conserved, compared to HrpR and HrpS, the sequences of 
HrpR and HrpS used in this study were chosen based upon those chosen for HrpV and HrpG 
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(i.e. from the same twenty organisms). From these organisms the other hrpC operon genes 
(hrpT, hrcC and hrpF), hrpL and hrpA were subsequently identified. The complete list of 
protein accession numbers and taxonomic IDs used in this study can be found in Appendix C, 
Table 15.  All residue numbering used in this chapter refers to the amino acid positions in 
the alignments and not to specific residue positions from individual protein sequences. 
4.4.2. HrpV sequences 
HrpV is a small protein (13.9 kDa, Ps. DC3000) with limited functionalities – binding to HrpS 
and HrpG has been confirmed by BACTH analysis (see above). Therefore it may be expected 
that, if all HrpV proteins have the same function, there will only be one or two conserved 
regions, perhaps with defined structural features and size. Early work on HrpV involved 
characterising the hrpC operons of both E. amylovora and Ps. syringae (Deng et al., 1998, 
Kim et al., 1997). Kim et al (1997) indicated that HrpV of E. amylovora shows no homology 
to other proteins in the database, while Deng et al (1998) state that HrpV of Ps. syringae 
shows significant homology to HrpV of E. amylovora. Later studies by Frederick et al (2001) 
stated that HrpV of Pantoea stewartii subsp. stewartii (formerly E. stewartii) showed no 
significant homology to HrpV of Ps. syringae (15% identical, 26% similar). Clearly, a 
consensus has yet to be reached on the homology of HrpV from the two groups (P. syringae 
vs. Erwinia).  The majority of functional information regarding HrpV focuses on P. syringae 
pathovars (e.g. (Deng et al., 1998, Ortiz-Martín et al., 2010b, Ortiz-Martín et al., 2010a, 
Preston et al., 1998)). Therefore, comparing HrpV from all hrpC operon-containing 
organisms may yield more information regarding functional regions that would otherwise be 
overlooked when analysing HrpV from P. syringae alone. 
4.4.2.1. HrpV alignment 
Clearly in 1998 there was far less sequence information available than there is today. In 
1998 Deng et al compared the HrpV sequences of Ps. syringae 61, Ps. glycinea, Ps. DC3000 
and E. amylovora. Their alignment is shown in Figure 51. 
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Figure 51: Alignment of HrpV from Ps. syringae 61, glycinea and DC3000 and E. amylovora 
Alignment of the predicted amino acid sequences of HrpV from Ps. syringae 61, Ps. glycinea, Ps. DC3000 and E. amylovora. 
Alignments were made using the PILEUP algorithm. Open boxes indicate identical amino acids. (Deng et al., 1998) 
The major difference between this alignment and the alignment shown in Figure 52 is that 
in Figure 51 E. amylovora has a gap of four spaces between S98 and D99  (PESAMS––––
DK), whereas in Figure 52 this gap is only three spaces between S96 and A100 
(corresponding to S95 and A96 in the E. amylovora sequence (PES–––AMSDK)). This shifts 
the alignment so that in Figure 51 the C-terminal HLA residues of Ps. syringae 61, Ps. 
glycinea and E. amylovora align whereas in Figure 52 the C-terminal LAG residues of all 20 
sequences align.  
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10        20        30        40        50        60        70
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|
DC3000 ----MIEVTEKSAFYAQVAAQSPAVWPVANGVAFVSRRE-HHDWGIALHIEGRALRPDQLRDALQRRFME 65
tomato T1 ----MIEVTEKSAFYAQVAAQSPAVWPVANGVAFVSRRE-HHDWGIALHIEGRALRPDQLRDALQRRFME 65
oryzae ----MIEVTEKLAFYAQVAAQHPAVWPVANGVAFVSRRE-HHDWGIALHIEGRALRPEQLREALQRRFME 65
tagetis ----MIEVMEKAAFYAQVAAQSPAVWPVAKGVAFVSRRE-HHDWGIALHIEGRALRPEQLREALQRRFME 65
phaseolicola ----MIEVKEKAAFYYNVAAQSPAVWPVANGVSFVSRRE-HHDWGIALHIEGRALRPEQLREALQMRFSE 65
glycinea ----MIEVKEKAAFYYNVAAQSPAVWPVANGVSFVSRRE-HHDWGIALHIEGRALRPEQLREALQMRFSE 65
tabaci ----MIEVKEKAAFYYNVAAQSPAVWPVANGVSFVSRRE-HHDWGIALHIEGRALRPEQLREALQMRFSE 65
syringae B728a ----MIEVEEKTAFYYNVAAQSPAVWPVANGVSFVSRRE-HHDWGIALHIEGRALRPEQLREALQLRFSE 65
viridiflava T-PAI ----MIEVTEKVAFYSQVAAQNPAVWPVASGVAFVSRRE-YHDWGIALHIEGRALRPEQLREALQLRFSE 65
mendocina ----MKQVSQKLAFYEHVAAERSAVWPVASGVTFVSRRE-HQDWGIALHVESLAMSPEQLRNALERRFVE 65
cichorii MTETILRSTDQRDFLVSIGEQQPSTWQWAPGIDFVYRRD-SVGWGLALMIERQAQRPNLFSDTLKRRFEN 69
viridiflava S-PAI MTETILRSNDQRDFFVSIGQQRPSTWQWAPGIDFVHRKD-SVGWGLSLMIERRAQRPDLFSDALKRRFEN 69
E. amylovora MNNPCPQVTSLSALLSLLQLRQSCRWPVQQGVELLALCG-ERGRELMLNLQPAFQPSGLYQRLLSRRAQQ 69
E. pyrifoliae MNNPCPQVTSLPALLSLLQLRQSCRWPVQQGVELLALCG-ERGPEVMLNLQPAFQPAGLYQRLLSRRAQQ 69
E. tasmaniensis MNNPCPQVTSLAALLSLLQLRQSCRWQVAQGVELHALCG-ERGREVMLNLQTTFQPPGFYQQLLTRRAQR 69
Pantoea stewartii MNETCPQVNSLSAVLDVLKLQQNCRWTVLQGVELVVLSG-THGRELMLNLYPPFQAPGIFQRLLRRRAQH 69
P. carotovorum MSEVAAVFDNQHDFLMALETTPTACWVVQPGVTLWFTAISARQAALVLVLAPAHHYPGMLRQILQRRFLE 70
P. atrosepticum MSEPTEVFDNQHDFLSALETTPTACWSVQPGVRLWFTVVSARQVELILTLAPARHYPGMLRQILQRRFLE 70
Dickeya zeae MTDSITVFDTVTAFMAAMNRHQAARWSPQSGVDLVFQFG-DTGRELMMQIQPGQQYPGMLRSLLARRYQQ 69
fluorescens -----MPDDQRKVFLDNLVSGTAAHLPLAPGIKVSALHA-GDRPGLALQVAREALQTGQLQRVLELRCEH 64
 80        90       100       110       120
                   ....|....|....|....|....|....|....|....|....|....|....|
DC3000 SERFNHYFLFLDVRRDFVVWHAVNEKPGSYASLDDIRRHELMLAGLDHLSEEMH  119
tomato T1 SERFNHYFLFLDVRRDFVVWHAVNEKPGSYASLDDIRRHELMLAGLDHLSEEMH  119
oryzae AERFSQYFLFLDIRRDFVVWRAVNATPDAVFNLDEIRRQELMLAGLEHLSEELH  119
tagetis AERFSRYFLFLDVRRDFVVWHAVNDTPDSFASLDEIRRHELMLAGLEHLNEELH  119
phaseolicola AERFRNYFLFLDVQRDFVVWHAVSDAPDAVTNLDDIRRHELMLAGLEHLA  115
glycinea AERFRNNFCFLDVQRDFVVWHAVSDAPDAVTNLDDIRRHELMLAGVEHLA  115
tabaci AERFRNYFLFLDVQRDFVVWHAVSDAPDAVTNLDDIRRHELMLAGLEHLA  115
syringae B728a AERFNDYFLFLDMRRDFVVWHAVSDAPHAVTNLDDIRRNELILAGLDHLA  115
viridiflava T-PAI AERFNNYFLFLDVQRDFVVWHAVSDAPDSVTNLDDIRRNELILAGLVHLA  115
mendocina SDRYSDYFLFLNVQQDFVVWHASPDVEGVGDSLDDICREQLQLAGLGHLQS  116
cichorii VESYDGYYLCLDNQQRFVVWHELGRDYRREESLHGLLSEFLTLTGFKH  117
viridiflava S-PAI IESYDGYYICLDSQQRFVVWHELDPEYRREDALQELVGEFLMLAGFNN  117
E. amylovora LEIYDGCYLCLNHDRVLSCWRQLPES---AMSDKQHIAQLFSLAGIHLAD  116
E. pyrifoliae LEVWDGCFLCLNRDRVLSCWRQLPES---AMSDKQHIAQLFSLAGIPLSD  116
E. tasmaniensis LDVYDGCYLCLNRDRVVSCWRQLPES---AVNDKLHIAPLFSLAGIFLAD  116
Pantoea stewartii PDYYDGCYLCLNSENILSCWYQLREE---GADDKHQIAQLFQLAGIETEVWI  118
P. carotovorum ADALPACSLSLDEQQHLRLRRTLSTL---SES-LTAIDELWRLAGLPPR  115
P. atrosepticum ADTLPACSLSLDEQHTLRLRRSLSIL---TDS-VAAIDELWRLAGLPPR  115
Dickeya zeae AAECDGCHLCLNGSDVLILWWPLPSD---PGSYPQVIERLFELAGMTLPSVSIAP 121
fluorescens ALAFDGCFVYLDAQYALVIWHALPAS---NSALDKILSRMLSLAGLQALDTSSIR 116
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Figure 52: HrpV multiple sequence alignment 
HrpV multiple sequence alignment generated by ClustalW (Thompson et al., 1994). Organisms above the black line have 
HrpSRS, below have HrpSS. Residues highlighted in yellow have 100% conservation (apart from P. cichorii which has a T not 
A at position 114). Residues highlighted in blue are broadly conserved but not 100%. Residues in boxes are possible 
conserved motifs.  
Figure 52 indicates three possible conserved motifs in HrpV, namely the LAG (113-115) and 
LxRR (64-67) motifs and the region of 5 residues containing 3 alternate hydrophobic residues 
(46-50). These motifs could be involved in HrpS repression and HrpG interactions. 
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4.4.2.2. HrpV defining motifs 
To highlight two of the conserved regions of HrpV Weblogos have been created.  
 
Figure 53: HrpV “LAG” motif weblogo 
Amino acid preference for each of the positions 111-116 (from Figure 52) shown in Weblogo form. 
Figure 53 shows the conserved LAG region of HrpV (positions 113-115). Notably P. cichorii 
has the only deviation from this conserved region, containing a ‘T’ instead of an ‘A’ residue. 
It is possible, due to the fact that many sequences are added to the database and not all are 
fully verified, that this may be an error given that the triplet codon for this threonine residue 
in P. cichorii is ACG which only a one base change (to GCG) would make this reside an 
alanine.  
 
Figure 54: HrpV “LxRR” motif weblogo 
Amino acid preference for each of the positions 63-68 (from Figure 52) shown in Weblogo form. 
100% of the 20 HrpV sequences examined have a conserved ‘LxxR’ motif and 70% have a 
conserved ‘LxRR’ motif (Figure 54). Arginine has a long, flexible, positively charged side chain 
that plays an important role in many functional features, for example they form the 
nucleotide hydrolysis ‘arginine fingers’ in GTPases (Hanson & Whiteheart, 2005) and a ‘twin-
arginine’ motif is the signal for translocation of proteins dependent on the ‘TaT’ protein 
transport system (Sargent, 2001). When looking for potential functional regions of proteins 
with no putative conserved domains, like HrpV, a pair of arginine residues may be a 
plausible candidate for a functionally important set of amino acids.  
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In summary, HrpV contains at least two conserved motifs, LAG (in the C-terminus) and LxRR. 
The presence of these motifs can therefore be used to positively identify a sequence as 
HrpV and both may play a role in HrpG and/or HrpS interactions.  
4.4.2.3. HrpV LAG mutant analysis 
Site directed mutagenesis was used to introduce alanine substitutions in the ‘L’ and ‘G’ 
residues of the LAG motif of HrpV with the aim of determining the functionality of this 
motif. The mutant HrpVL108A, G110A (HrpVLAG) was mutated using the template vectors 
pVAM31 and pVAM32 vectors to give pEJ14 and pEJ15 (confirmed by sequencing) and was 
tested for interaction with HrpG (Figure 55). 
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Figure 55: BACTH with HrpG versus HrpV and HrpVLAG 
Protein fusions on T18C and T25 fragments of adenylate cyclase that interact will express lacZ. T18C vs. T25 is the negative 
control, with no protein fusions. Error bars represent standard deviation. Immunoblotting using antibodies against HrpV 
indicates whether proteins are expressed (or not).  Arrow indicates HrpV. Full gel can be seen in Appendix C, Figure 101. 
Figure 55 shows that mutating the leucine and glycine residues in the LAG motif mean that 
HrpV is no longer stably expressed. This implies that the LAG motif is important for the 
integrity of the C-terminal alpha helix which is in line with the truncation mutant analysis. 
The C-terminal helix in HrpV appears critical for functionality – presumably due to gross 
protein instability. The HrpG or HrpS-interaction site could also potentially fall within this 
helix. 
124 
 
4.4.3. HrpG sequences 
HrpG (15.4 kDa and 143 a.a. in Ps. DC3000) is also encoded in the hrpC operon, has no 
putative conserved domains (recognised by the ncbi conserved domains database 
ncbi.nlm.nih.gov/cdd) and only one confirmed function. Kim et al (1997) and Deng et al 
(1998) agree that HrpG of E. amylovora is not very similar to that of Ps. syringae (18% 
identical, 43% similar). This is in line with the findings of Frederick et al (2001) who state 
that HrpG of Pantoea stewartii subsp. stewartii (formerly E. stewartii) does not show 
significant homology to HrpG of Ps. syringae (17% identical, 24% similar). The role of HrpG 
from Erwinia has not been determined although it remains possible that the role is the same 
as in P. syringae given that HrpV and HrpS are present in both cases. Since HrpG may only 
have one function, i.e. to interact with and negatively regulate HrpV activity it may only be 
necessary for HrpG to have one conserved structural motif/protein binding site. The 
following analyses will show that this is potentially the case. The sequences of HrpG, except 
that of P. fluorescens (which was found using Pantoea stewartii subsp. stewartii; see section 
4.4.3.1), were identified by interrogating the database using the HrpG sequences from Ps. 
DC3000 and E. amylovora.  
4.4.3.1. HrpG alignment 
In total 20 sequences of HrpG – some with high conservation to HrpG of Ps. DC3000 and 
some chosen due to their conserved location within the hrpC operon and conserved 
residues (see later) – were aligned in BioEdit (Hall, 1999) with the ClustalW (Thompson et 
al., 1994) accessory application using default parameters (gap open penalty, 10; gap 
extension penalty, 0.05). Initially, the 20 chosen HrpG sequences were aligned using the 
exact sequences corresponding to the accession numbers listed in Appendix C, Table 15. 
This revealed some potential errors in the database. The sequence of HrpG from 
Pectobacterium carotovorum subsp. atroseptica aligned with closest agreement to HrpG of 
Pc. subsp. carotovorum (as expected) however, the first eight amino acids (MTSTELAA) were 
not present. Analysis of the upstream nucleotide sequence and subsequent translation 
revealed their presence; therefore the sequence was corrected to include these N-terminal 
amino acids before later alignment-based analyses were performed. It was also noted that 
the first forty amino acids of the HrpG database sequence of P. viridiflava S-PAI did not align 
with the other HrpG sequences. Therefore these residues were removed from the analysis 
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with revised P. viridiflava HrpV sequence now beginning at the second methionine. The first 
three amino acids of the HrpG sequences from Ps. phaseolicola, Ps. glycinea Ps. syringae 
B728a and P. viridiflava T-PAI are MSS. If these residues are removed the HrpG sequences 
from those organisms containing HrpR and HrpSRS all begin M D/E F. However, these were 
left in the analyses. 
10        20        30        40        50        60        70
                        ....|....|....|....|....|....|....|....|....|....|....|....|....|....|
DC3000 ---MEFSEFTEIVGQWSAQRPAMPLDCWIDDANARLAVVGDGVRCSIELLDPYDAGDPQRLEALLGEGGA 67
tomato T1 ---MEFSEFTEIVGQWSTQRPAMPLDCWIDDANARLAVVGDGVRCSIELLDPYDAGDPQRLEALLGEGGA 67
oryzae ---MEFSDFTEILGQWFAQRPATPLDCWIDEANARLAVIGDGVRCSIELLDPYDADDPQRLEALLSEGGA 67
tagetis ---MEFSDFTEILGQWAEQRPATPLDCWIDDANVRLAAHVNGICCSIELLDPYDAADPQRLEALLSEGGA 67
phaseolicola MSSMDFSEFAEVVGQWCDQRPATALDCWVDDANVRLEVVGHGIRCSIELLDPYDANDSQRIEALLSHGGA 70
glycinea MSSMDFSEFAEVVGQWCDQRPATALDCWVDDANVRLEVVGHGIRCSIELLDPYDANDSQRIEALLSHGGA 70
tabaci ---MDFSEFAEVVGQWCDQRPATALDCWVDDANVRLEVVGHGVRCSIELLDPYDANDSQRIEALLSHGGA 67
syringae B728a MSSMDFSEFEEVVGLWRDQRPASPLDCWVDDANARLERVGGGVRCSIELLDPYDANDPQRIEALLSHGGA 70
viridiflava T-PAI MSSMDFSDFEAVLGQWCAQRPLTPLDCWVDDANARLEVQGDGVRCSIELLDPFDANDPQRIEALLCQGGA 70
mendocina ---MEFSEFSDVIAQWCEAS-ALPLDCWIDDANARLAEMGGGVRCSLEVLNPFEASDQQRLQAVLSQGGA 66
cichorii ---MKSADLIVAVERWLDSN-EPVLLLQIDQQPLSVKRSNAGLIYLAPLSAAWRGGDAGLEAALRLSGPS 66
viridiflava S-PAI ---MKSVDLLATVERWLDSG-TAELLLQIDQQPLRIQRGTNGLIYTAPLSAAWRGDDESLAAALRLSGPS 66
E. amylovora ---MRSTELQQWAQRWLDDV-GTDQQLTVDDGVVWLQRRADRFFALAELTINASLDDELLGRALQLSAPT 66
E. pyrifoliae ---MRSTELLQWAHGWLDNP-GTDQQLTVDDGVVWLQHRAEQFFALAELTVNASLDDELLGRALQLSAPT 66
E. tasmaniensis ---MRSTELQQWVQRWLDNV-GEDQRLTVDDGVVWLQQRAGQYFALAELAQNTPPDEALLGRALQLSAPT 66
Pantoea stewartii ---MRSTKLQHWVRSFLTNP-AEDHQCKVDDGLLWLQQRGGKLFALAELTNKVPLDEMFLAQALRLSAPA 66
P. carotovorum ---MTSTELAAMLERWLNGG-TSTLKLEIDGGAVAMVRQSSGVTCRAVIPLRTLPDESMLTRALQLADAA 66
P. atrosepticum ---MTSTELAAMLERWLNGG-ASMLKLEIDGGAVAIVRQSSGVACSAAIPLHTVPDEPMLARALQLADAA 66
Dickeya zeae ---MTSTELPGVIERWLNSA-AGQLTLHIDDGPVMLTRYHDGVGCSAVVALPAKVDDRLLQKALRYSSAA 66
fluorescens --------MKALIIDWLKSG-KEQITLLEGQDEIIISLQGGGVLVYVSLSSTS-FNNTELQCWMRISFAS 60
                                 80        90       100       110       120       130       140       150
                        ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
DC3000 SLACACD-GALAIDPQTRCVVLVSWMANPCSLGDLLDRLESLANQRAAMLSLMQTTIRNTTPTLSGRSILNHRQPGV  143
tomato T1 SLACACD-GALAIDPQTRCVVLVSWMANPCSLGDLLDRLESLANQRAAMLSLMQTTIRNTTPTLSGRSILNHRQPGV  143
oryzae SLACACE-GAFAIDPQTRCVVLISWIANPCRLDDLLAHLESLANQRAALLSLMQNAIRDTTPALSGRAIFNYRQPGV  143
tagetis SLACACE-GALGIDPETRCVVLVSWIPDPFHLNDLLSRLESLANQRAALLSLMQTSIRNTAPTLLGRANLNNRQPGV  143
phaseolicola SLACACD-GAFAIDPQTRCMVLVTWIPNPCNLADLLARLESLANQRAALLSLMQTTIGDMTPAISGRTTLNHRQPGV  146
glycinea SLACACD-GAFAIDPQTRCMVLVTWIPNPCNLADLLARLERLANQRAALLSLMQTTIGDMTPAISGRTTLNHRQPGV  146
tabaci SLACACD-GAFAIDPQTRCMVLVTWIPNPCNLADLLDRLESLANQRAALLSLMQTTIGDMTPAISGRTTLNHRQPGV  146
syringae B728a SLACACD-GAFAIDPQTRCMVLVSWMPGPCSLADLLNRLESLANQRAALLSLMHTTLVNSVPALAGRTTLNHRQPGV  146
viridiflava T-PAI SLACACD-GALAIDPQTGCMVLVCWIPNPCGLDDLLNYLESLANQRAALLSLMHTTLVTNVSAFSGRTTLNHRQPGV  146
mendocina GLACACD-GAFAIDPDTHALVLVNWHRAPCSVDQLLASLERLANQRAALISLLHVSIR-EAALIAPQPSFNALHPGV  141
cichorii IRRFR---GALALDPETSHLCLVQYQQ-FQSTALVIHDIEDLVNQRDVWESMLEPRKVTPPRQFMRPMALRGSYV  137
viridiflava S-PAI IRRFS---AALALDPQSHRLCLVQFQS-FQGTSPVISIIEALVNQRDVWESMLEAS-ASPAKRPVRPLSLGNSYV  136
E. amylovora LRYFGRDAAALAQ--QGNSLILALAIR-QLEVNAVCQQLESLLNQRDVWQTMLQQPRRKAATHGAVPLHSLAFLPRGNHG 143
E. pyrifoliae LRYFGRDAAALAQ--QGNSLILALAIR-QLEVNAVCQQLESLLNQRDVWQTMLQQPRRKAATHGAVPLHSLAFLPRGNHG 143
E. tasmaniensis LRYFGRDAAALAQ--QGSSLILVLTVR-QPEMNAVCLQLESLLNQRDVWQTMLQQPRRKAVAHSAVPLHSLAFLPGGKHG 143
Pantoea stewartii LRHYGRDSAALAL--QNNSLVLILRLH-EAHSEKIAKQLESLLNQRDVWQGLLQKLPKKAITHCCVPLHSLAFLPGGKHG 143
P. carotovorum HAQFQDDTAILSLSAQDEQLWLWMRPD-ADDVMQLCRSLETLLNQRDVWLSMLTP-RAKVPVSAPLNLNTLAFLQGERHA 144
P. atrosepticum HAQFQEDTAVLSLSPQDEQFWLWMWPD-ADDVMQLCRSLETLLNQRDVWLSLLTP-RTKAAVSAPLNLSTLAFLQGERHA 144
Dickeya zeae VLRLGMDAATLCWSANDEQLWLLMRRE-PDDPIRLCRSLEVLVNQRDVWQSLLAQ-RAKPASPPPLNLKTLAFLQGDQHV 144
fluorescens LAHFQ---GALARAPSSGALWIIQSLQGTPDALRVLASVESLLNQRDTWRAMFARLNKPAHPLKPTSLRALRH  130
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Figure 56: HrpG multiple sequence alignment 
HrpG multiple sequence alignment generated by ClustalW (Thompson et al., 1994). Organisms above the black line have 
HrpSRS, below have HrpSS. Residues highlighted in yellow have 100% conservation. Residues highlighted in blue are broadly 
conserved but not 100%. Residues in boxes are possible conserved motifs. 
Figure 56 shows the amino acid sequence alignment for HrpG. Residues E110, L112, N114, 
Q115 and R116 are strictly (100%) conserved (in Ps. DC3000 these residues are E106, L108, 
N110, Q111 and R112). The presence of this NQR motif could be used as a positive marker 
to identify HrpG proteins in cases where sequence homology is low. For example, if the 
HrpG sequence of Pantoea stewartii is interrogated at blast.ncbi.nlm.nih.gov, the output 
reveals higher sequence homology to a chloroplast sigma factor from Triticum aestivum 
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(32% identities) than the hypothetical protein from P. fluorescens PFLU0722 (27% identities) 
(RspG, equivalent to HrpG). However, PFLU0722 can be designated as HrpG because (i) it 
exists within a hrpC operon and (ii) contains the conserved E_L_NQR motif whereas the 
sequence from T. aestivum is not designated HrpG as it does not contain the conserved 
motif nor does it lie within a hrpC operon. Two other possible conserved regions are 
highlighted in Figure 56 in blue boxes. The first (GALA/GAFA/AALA) (positions 79-82) is 
discussed below in section 4.4.3.2. The second is a patch of four (almost 100%) hydrophobic 
residues (positions 90-94). Interestingly, performing a pBLAST search using RspG identifies a 
putative protein from the fungal species, Enterocytozoon bieneusi, which has 53% identity, 
67% similarity, and all the HrpG conserved regions highlighted above. Adjacent to this gene 
in the E. bieneusi genome is a gene encoding a hrpE homolog with 53% identity and 71% 
similarity to HrpE (RspE) of P. fluorescens SBW25. No other hrp homologues are present in 
this fungal organism, however it is possible that it acquired these bacterial genes by 
horizontal gene transfer and that they confer some advantage, which has been observed in 
other cases (Schmitt & Lumbsch, 2009).  
4.4.3.2. HrpG defining motifs 
Weblogos are used to highlight conserved regions of proteins (or nucleic acid sequences) 
giving a graphical version of a consensus sequence; where the height of the letter stack 
indicates conservation and the height of each letter (within a stack) indicates the relative 
frequency of that residue at each position. Figure 57 clearly shows that HrpG has a highly 
conserved region of 8-9 amino acids (encompassing the NQR motif).  
 
Figure 57: HrpG “E_L_NQR” motif weblogo 
Residues 108-117 of HrpG (numbering from alignment, Figure 56) in Weblogo graphical output. Amino acid conservation at 
each position is indicated by letter height. Positions 110 (E), 112 (L) and 114-116 (NQR) have 100% conservation. Position 
108 is not conserved but is included for completeness to show the start of the region of conservation (position 109). 
Position 117 is always either D or A; this difference reflects the origin of the sequence, those 
from organisms with HrpSRS have D whereas those with HrpSS have A. Position 111 appears 
variable, however it is constrained in that there is only ever one residue spacing between 
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the highly conserved E and L residues at positions 110 and 112, perhaps indicating a possible 
structural feature. Positions 109 and 113 are always hydrophobic residues and positions 
110, 112, 114, 115 and 116 have 100% conservation. If a putative HrpG sequence were 
found, the presence of the above consensus sequence would be necessary, but not 
sufficient, to allow a confident positive identification. A pBLAST search of the sequences 
‘LESLANQRA’ and ‘LESLLNQRD’ identifies HrpG sequences of all organisms identified in 
Figure 56 as well as a diverse range of other proteins.   
 
A less well conserved region of HrpG, which may be of functional importance, consists of 
residues 79-82 (Figure 56). Of the 20 sequences studied 85% have GALA, GAFA or AALA. It 
could also be viewed as a patch of hydrophobic and polar amino acids since those HrpG 
proteins without GALA, GAFA or AALA, e.g. Dickeya zeae, have a mixture of four 
hydrophobic and polar amino acids in this region – ATLC.   
 
Figure 58: “HrpG GALA/GAFA/AALA” motif weblogo 
Amino acid preference for each of the positions 79-82 (from Figure 56) shown in Weblogo form.  
Secondary structure predictions (see Figure 42) indicate that this sequence does not lie 
within any structural motifs, however, since many interaction interfaces lie within surface-
exposed loops, the functional significance of these residues must be determined 
experimentally.  
 
In summary, HrpG proteins can be identified by the presence of specific marker motifs, most 
notably a C-terminal 7-amino acid sequence consisting of E_L_NQR. Since this is the only 
100% conserved motif it is feasible that this could represent the HrpV binding motif, 
however the GALA/GAFA/AALA and/or hydrophobic patch (boxed motifs in Figure 56) may 
also represent HrpV interaction sites. Ortiz-Martín et al (2010b) concluded from their study 
of HrpG of Ps. phaseolicola that HrpG has a HrpV-independent function (Ortiz-Martín et al., 
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2010b). The analyses shown here indicate that HrpG contains more than one conserved 
motif/patch, in line with the proposal of a dual function in HrpG.  
4.4.3.3. HrpG NQR mutant analysis 
Site directed mutagenesis was used to construct alanine substitutions in the residues NQR 
(from the E_L_NQR motif) of HrpG from Ps. DC3000. The mutant HrpGN111A, Q112A, R113A 
(HrpGNQR) was mutated using the template vectors pEJ17 and pEJ18 to give pEJ35 and pEJ36 
(confirmed by sequencing) and tested for interactions with HrpV (Figure 59 and Figure 60). 
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Figure 59: BACTH with HrpV versus HrpG and HrpGNQR on pUT18C 
Protein fusions on T18C and T25 fragments of adenylate cyclase that interact will express lacZ. T18C vs. T25 is the negative 
control, with no protein fusions. Error bars represent standard deviation. Immunoblotting using antibodies against HrpG 
indicates whether proteins are expressed (or not).  Arrows indicate HrpG and HrpGNQR. Full gel can be seen in Appendix C, 
Figure 104. 
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Figure 60: BACTH with HrpV versus HrpG and HrpGNQR on pKT25 
Protein fusions on T18C and T25 fragments of adenylate cyclase that interact will express lacZ. T18C vs. T25 is the negative 
control, with no protein fusions. Error bars represent standard deviation. Immunoblotting using antibodies against HrpG 
indicates whether proteins are expressed (or not).  Arrow indicates HrpG. Full gel can be seen in Appendix C, Figure 105. 
129 
 
Figure 59 shows that HrpGNQR, when fused to T18, is expressed and interacts with HrpV. 
However, when HrpGNQR is fused to T25 (Figure 60) it is not expressed. This implies there is 
inherent instability in the protein when the alpha helix is disrupted (see also Figure 47). The 
T25 subunit is larger than the T18 subunit and may impose more distortion on the fused 
protein. Alternatively, because the pKT25 plasmid is low copy number compared to pUT18C, 
there is not sufficient HrpGNQR being produced to form observable interactions with HrpV. 
Given the results in Figure 59, the interaction with HrpV does not occur through the NQR 
motif. It may be that other residues within the conserved region of HrpG (of Ps. DC3000) – 
comprising residues 105-113 – are important for HrpV interactions. The NQR motif could be 
involved in additional functions of HrpG, as proposed by Ortiz-Martín et al (2010b). It is 
possible that the GALA/GAFA/AALA motif may contain the HrpV-interaction motif.  
4.4.3.4. Pseudomonas mendocina ymp 
Searches for HrpV and HrpG homologues both identified sequences present in 
Pseudomonas mendocina ymp and these were used in the above sequence alignments 
However, its 16S RNA sequence was used to place P. mendocina in the P. aeruginosa group 
(Anzai et al., 2000, Kersters et al., 1996). The U.S. Department of Energy Joint Genome 
Institute (www.jgi.doe.gov) chose to sequence the P. mendocina ymp (ymp – Yucca 
Mountain Project) genome due to its prevalence in the soil and subsurface and because it is 
considered to be a metabolic specialist. Although the ymp strain was isolated from soil, 
there have been cases of P. mendocina acting as an opportunistic pathogen of humans 
(Aragone et al., 1992, Chi et al., 2005) and due to its relatedness to the human pathogen P. 
aeruginosa, it may be interesting to ask why P. mendocina (ymp) contains this plant-
pathogen specific hrp/hrc cluster. The sequences from ymp are often highly divergent when 
compared to the other P. syringae sequences (see alignments above) and ymp is very often 
the “exception to the rule” when looking at conserved residues. Many of the ymp ORFs 
remain hypothetical and unnamed (HrpG – Pmen_0024; HrpV – Pmen_0021; HrpR – 
Pmen_0033; HrpS – Pmen_0032). A search of the ymp genome for HrpL (using Ps. DC3000 
HrpL as a search query) returned no homologous proteins although the closest sequence is 
for an RNA polymerase sigma factor, AlgU (Accession YP_001186964) (probably due to the 
highly conserved DNA-binding regions present in all sigma factors). HrpL is required for 
transcription of hrp genes (at least for all known cases being studied here); therefore the 
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absence of HrpL in ymp would make the presence of functional hrp genes unlikely. The 
presence of hrp genes in ymp could indicate horizontal gene transfer; which have 
subsequently decayed to pseudogenes as a result of the absence of HrpL, or because they 
give no advantage in ymp.  
 
The hrp/hrc cluster from Ps. DC3000 is summarised in Figure 61. Each of the proteins from 
this hrp/hrc cluster were checked for homologues in ymp and all were found except HrpL 
(discussed above) and HrpK1. An initial conclusion would be that ymp acquired an 
incomplete hrp/hrc cluster from, e.g. Ps. DC3000, with the genes from HrpR to HrpJ being 
present in the order shown in Figure 61. Analysis of gene order in the ymp genome revealed 
that this is not the case (Table 8).  
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Figure 61: Graphical depiction of Ps. DC3000 hrp/hrc cluster 
Taken from www.pseudomonas.com. Genes of interest to this study are in colour. Operon directions are shown (adapted 
from (Collmer et al., 2000)). Gene letters refer to hrp or hrc. Size of boxes are not to scale according to gene length. 
 
Pmen_00.. 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 
homologue HrpV HrpT HrcC HrpG HrpF HrpE HrpD HrcJ HrpB HrpZ1 HrpA1 HrpS HrpR   
Pmen_00.. 36 37 38 39 40 41 42 43 44 45 46 47 48 49  
homologue   HrpJ HrcV HrpQ HrcN HrpO HrpP HrcQa HrcQb HrcR HrcS HrcT HrcU 
Table 8: Gene names of P. mendocina ymp 
Gene names of P. mendocina ymp in the order they appear on www.pseudomonas.com with their Ps. DC3000 homologues 
(tested by BLAST). As indicated, Pmen_0034-37 appear not to have hrp gene homologues. 
The protein sequences corresponding to Pmen_0034, Pmen_0036 and Pmen_0037 are 
available on ncbi. Pmen_0034 has no homology to any protein in the database, Pmen_0036 
is transposase IS66 and Pmen_0037 is an IS66 Orf2 family protein. Pmen_0035 in 
pseudomonas.com is an untranslated region of DNA 2622 bp in length, which when 
translated using the expasy translate tool (expasy.org/tools/dna.html) (full outcome in 
Appendix C, Figure 107) and the first methionine (in frame 1 5’-3’) selected as a start codon 
gave an open reading frame that was aligned to HrpL from Ps. DC3000 (Figure 62) with 72% 
identical residues. 
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Figure 62: HrpL alignment from Ps. DC3000 and P. mendocina ymp 
Alignment output from BLASTp (http://blast.ncbi.nlm.nih.gov) of HrpL from Ps. DC3000 and the virtual amino acid 
sequence (VIRT3718) generated from translating a untranslated section of genomic DNA from P. mendocina ymp labelled 
Pmen_0035. The result shows 72% identity and 84% similarity to HrpL from Ps. DC3000. 
Figure 62 shows that P. mendocina ymp contains a well conserved hrpL gene that is not 
interrupted by a transposase. Therefore HrpV and HrpG homologues from this organism 
were included in the following analyses. 
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Figure 63: Graphical depiction of P. mendocina ymp hrp/hrc cluster 
Graphical depiction of P. mendocina ymp hrp/hrc cluster from www.pseudomonas.com (excluding Pmen_0034, 0036 and 
0037). Genes of interest to this study are in colour. Operon directions are adapted from (Collmer et al., 2000). Gene letters 
are either hrp or hrc. Size of boxes are not shown to scale according to gene length. 
In summary, P. mendocina contains a potentially fully-functional hrp/hrc cluster that is 
clearly related to the P. syringae-type hrp/hrc cluster. A comparison of Figure 61 and Figure 
63 show that the hrp/hrc cluster of ymp has a slightly different arrangement to Ps. DC3000, 
indicating that if the hrp/hrc genes of ymp potentially arose as a consequence of a 
horizontal gene transfer event from the P. syringae group, it cannot have been very recent 
as the arrangement of genes has changed. Also, it is the commonly the ‘outlier’ to the other 
HrpSRS group sequences. Despite this, key motifs (e.g. HrpG – NQR; HrpV – LAG; HrpRS – 
GAFTGA – see above) in ymp do not deviate so far as to be considered non-functional, 
therefore its inclusion in the sequence alignments above seems justified. 
4.5. Conclusions 
This chapter began with one clear question – what are the functional regions of HrpV and 
HrpG? This question can be simply answered – in both proteins a C-terminal alpha helix is 
important structurally and functionally; and within both helices it is likely that the key 
residues have been identified: 108-110 ‘LAG’ in HrpV and 110-112 ‘NQR’ in HrpG (see 
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Chapter 5 for additional results regarding these residues in Figure 90 and Figure 91). 
Another question that arose during the in silico analysis was – are HrpG and HrpV from P. 
syringae pathovars (or organisms with HrpSRS) the same proteins (i.e. functional 
homologues) as HrpG and HrpV from the ‘Erwinia’ group of pathogens (or organisms with 
HrpSS)? This question has not been answered experimentally; indeed no experimental 
evidence exists for the functional properties of HrpV and HrpG from HrpSS pathogens, 
except for the transposon mutant of HrpG from P. cichorii (Hojo et al., 2008) and analysis of 
rspV from P. fluorescens (Jackson et al., 2005). However, the sequence alignments show 
clear conservation of some, albeit a small number, of highly conserved residues amongst the 
twenty sequences studied for HrpG and HrpV.  
 
Proteins with apparently low sequence homology have been found to have the same 
function, specifically HrpA of Group I plant pathogens. An alignment by Koebnik (2001), 
recreated below, shows that HrpA sequences from Ps. glycinea, Ps. phaseolicola, Ps. 
syringae, Ps. tomato, E. amylovora and Pantoea stewartii have few identical residues; far 
fewer, in fact, than HrpV or HrpG. However, functional studies revealed that they all form 
the hrp pilus subunit (Koebnik, 2001). 
                 10        20        30        40        50        60
        ....|....|....|....|....|....|....|....|....|....|....|....|
PSESYg ~~~~MSIISSLTNAGRGVVNTVGGAAQGINSVKSSADRNIALTKNTGSTDSIDATRSSIS
PSESYp ~~~~MNIMSSLTNAGRGVVNTVGGAAQGINSVKSSADRNIALTKNTGSTDSIDATRSSIS
PSESYs ~~~~MTIMSSLAGAGRGVVNTIGGAAQGINSVKSSADRNAALVSNTGSTDSIDATRSSIS
PSESYt MVAFAGLTSKLTNLGNSAVGGVGGALQGVNTVASNATLQKNILLGTGDSLSVDAQAKASK
ERWAM ~~MSGIITGMAGSS~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LTSASTSASK
PANST ~~MSGLLTGLMGLGGP~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LSSATSFASK
                 70        80        90       100       110
        ....|....|....|....|....|....|....|....|....|....|...
PSESYg KGDAKSAELDGTANEENGLLRETSMLAGFEDKKEALSNQIVASKIRNS~VVQF
PSESYp KGDAKSAELDGTANEENGLLRETSMLAGFEDKKEALSNQIVASKIRNS~VVQF
PSESYs KGDAKSAELDGTANEENGLLRESSMLAGFEDKKEALSNQIVASKIRNS~VVQF
PSESYt ESDANGAKLIAMQAQETMKKQTMDVLNAIQAGKEDSTNKKISATATNAKGISY
ERWAM TLESAMGQSLTESANAQASKMKMDTQNSILDGKMDSASKSINSGHNAAKAIQF
PANST TLEGAMSDSMAESAVAQAAKMKIDTQNSILDGKMDSATKEINSGHNAAKAIQF  
Figure 64: Multiple sequence alignment of HrpA 
Multiple sequence alignment of HrpA pilin proteins from Ps. glycinea (PSESYg), Ps. phaseolicola (PSESYp), Ps. syringae 
(PSESYs), Ps. tomato (PSESYt), E. amylovora (ERWAM) and Pantoea stewartii (PANST) as constructed by (Koebnik, 2001). 
Identical residues are highlighted in yellow and similar residues are highlighted in blue. 
Various authors, (Kim et al., 1997, Deng et al., 1998, Frederick et al., 2001) have asserted 
that HrpV and HrpG from the two groups, HrpSS and HrpSRS, do not show significant 
sequence homology to each other. This may be interpreted to mean that they have different 
functional roles within these groups. However, the alignments shown above in Figure 52 
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and Figure 56, which use a large representative sample of the available sequences; show 
that there is conservation of HrpV and HrpG between the two groups. These residues, in Ps. 
DC3000 have been shown to lie within predicted secondary structural motifs that have been 
shown experimentally, in this chapter, to be of functional and/or structural importance to 
both proteins. It may therefore be reasonable to consider, that HrpV from HrpSRS organisms 
has the same functional role as, and is homologous to, HrpV from HrpSS organisms. Although 
experimental evidence does exist which shows that the HrpV homologue from P. fluorescens 
does not negatively affect RspR (HrpSS) (Jackson et al., 2005). 
 
Further evidence can be seen from the predicted secondary structures of the E. amylovora 
versions of HrpG and HrpV (see Figure 65). 
 
Figure 65: Aligned secondary structure predictions of HrpG and HrpV from Ps. DC3000 and E. amylovora 
Red boxes are predicted helices and blue boxes are predicted extended regions or beta strands. (A) HrpG. The three 
predicted helices of HrpG from Ps. DC3000 are conserved in E. amylovora as well as 2-3 of the extended regions. (B) HrpV. 
All predicted structures from Ps. DC3000 are conserved in E. amylovora. 
All the predicted secondary structural regions of HrpV from Ps. DC3000 are also predicted 
for E. amylovora. Recall that the JPred3 software used sequences from P. viridiflava S-PAI, P. 
mendocina, Dickeya zeae, Pantoea stewartii, E. tasmaniensis, P. fluorescens and Pc. 
carotovorum to predict the structures of HrpV from Ps. DC3000. For HrpV from E. amylovora 
the software used sequences from P. viridiflava S-PAI, P. mendocina, Dickeya zeae, Pantoea 
stewartii, P. fluorescens, Pc. atrosepticum, P. cichorii, Ps. DC3000 and Ps. tagetis. Due to the 
overlap in homologous proteins used for the secondary structural predictions of HrpV from 
Ps. DC3000 and E. amylovora it is, perhaps, not surprising that the outcomes are very 
similar. However, for HrpG different proteins were used. For Ps. DC3000 the software used 
homologues from Ps. phaseolicola and P. mendocina, whereas for E. amylovora the software 
used sequences from Pantoea stewartii, Pc. atrosepticum, P. viridiflava S-PAI, P. cichorii, Ps. 
syringae B728a and a hypothetical protein from Enterocytozoon bieneusi H348, an obligate 
intracellular parasite of humans, (accession number XP_002650650). This protein has some 
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homology to the other HrpG sequences – it contains the GALA sequence, the hydrophobic 
patch and the conserved E_L_NQR residues. It has most homology to the HrpG sequence of 
P. fluorescens – 52%. However, Enterocytozoon bieneusi H348 does not contain any proteins 
homologous to HrpV, HrpR, HrpS, HrcC or HrpL but there is a HrpE homologue adjacent to 
the HrpG homolog. Despite these differences in proteins used to make the prediction, the 
three helices predicted for Ps. DC3000 are also predicted for E. amylovora – importantly this 
includes the C-terminal helix containing the ‘NQR’ motif. 
 
This chapter has shown that truncated mutants of HrpG and HrpV rarely form stably 
expressed proteins in vivo. This is not due to failure to construct clones as all clones used in 
this study have been confirmed by restriction enzyme digestion (and in some cases colony 
PCR) and by sequencing. Only HrpG1-123 was consistently, stably expressed from both BACTH 
vectors, and interacted with HrpV. This maybe because it was the truncation with the 
fewest deleted residues, so it most closely resembled the full-length form. Alternatively, it 
may have been stable because it was the only mutation that did not disrupt the ‘key’ C-
terminal helix. HrpV95-119 was stably expressed from pUT18C, and interacted with HrpG. 
However, it was not consistently expressed (see immunoblot in Appendix C, Figure 101). 
One question that arises is: why was HrpV95-119 expressed but not the longer truncation 
HrpV41-119? This could be due to the 3D folded structure of the full-length protein (see Figure 
66).  
C
N
HrpV95-119
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HrpV  
Figure 66: Cartoon illustrating a possible folding pattern for HrpV 
Cartoon illustrating a possible folding pattern for HrpV to explain why HrpV95-119 was expressed but not HrpV41-119. In this 
example the first and second helix form a coiled-coil structure, this, along with the third helix is required for full stability of 
the protein. When only the first helix is deleted (HrpV41-119) the second helix is no longer part of a stable structure and 
renders the protein prone to degradation. However, HrpV95-119 is missing both first and second helices so no ‘free-floating’ 
structural regions that could target the protein for degradation are present. 
Truncated mutants and this bacterial two-hybrid system are frequently used to determine 
sites of protein-protein interactions (Karimova et al., 2005, Jovanovic et al., 2011, Login et 
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al., 2010). Similar problems to those experienced in this chapter have been reported by 
other authors. For example, Karimova et al (2005) analysed interactions between Fts 
proteins of E. coli (involved in division septum formation). They were not able to clone flsZ 
into pUT18, although they did clone it into pKT25. They also found that the T25-FtsW 
protein was functional but the T18-FtsW was not (Karimova et al., 2005). This is similar to 
the HrpGNQR which was expressed when fused to T18 but not to T25. They also tested 
truncated mutants of FtsQ and found that one (FtsQ1-60) did not interact with wild-type 
interaction partners. They were not able to determine whether this was due to lack of 
interaction among hybrid proteins or alternatively from the instability of the T18-FtsQ1-
60 fusion or its inability to assemble in the proper manner in the membrane. In this chapter 
the reason behind the lack of interactions between truncated fusion proteins is clear, in all 
cases the protein was not stably expressed or degraded (or was not folded appropriately so 
as to be detectable by the antibodies).  
 
In summary, this chapter has demonstrated that HrpV, HrpG, HrpR and HrpS from Ps. 
DC3000 form a minimal hrpL-regulation system in E. coli in the absence of other Ps. DC3000 
factors. HrpRS activate expression from the hrpL promoter, HrpV is a negative regulator of 
HrpRS, and HrpG relieves the repression by HrpV. This chapter has also demonstrated that 
HrpV and HrpG interact with each other in vivo but that neither protein, in this assay, is able 
to self-associate. In silico analysis has shown that within a predicted helix, in HrpG and HrpV, 
lies a motif that is conserved across all P. syringae pathovars and ‘Erwinia’ species. In HrpV 
this helix is sufficient for HrpG-binding (HrpV95-119) and the motif (‘LAG’) is essential for 
integrity of the helix and protein stability. In HrpG disruption of the helix by truncation 
renders the protein unstable (HrpG1-123 versus HrpG1-111). Mutation of the ‘NQR’ motif does 
not destroy HrpV-binding interactions (seen with T18-HrpG) but the T25-HrpGNQR fusion is 
no longer stably expressed. 
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CHAPTER FIVE 
5. Analysing the functional roles of HrpV and HrpG in the context of HrpR 
and HrpS activities using in vitro methodologies 
5.1. Introduction 
HrpR and HrpS are co-dependent AAA+ enhancer binding proteins (EBPs), from P. syringae 
pathovars, which activate transcription of hrpL from a σ54-dependent promoter. EBPs 
remodel the RNAP closed complex to a transcriptionally active open complex by hydrolysing 
nucleotide (ATP). The ATPase activity of EBPs often relies on formation of hexameric (or 
heptameric) ring-like assemblies from inactive dimers (Schumacher et al., 2006, Meyer et 
al., 2001, Lee et al., 2003). The activity of EBPs is commonly controlled through cis-acting 
regulatory domains either impairing (as in DctD and NtrC1) or promoting (as in NtrC) 
hexamer assembly (De Carlo et al., 2006, Gu et al., 1994, Doucleff et al., 2005). The EBPs 
HrpR and HrpS, like the well-studied EBP PspF, lack cis-acting regulatory domains and 
comprise only the AAA+ and HTH domains. PspF’s activity is directly negatively regulated by 
an additional protein, PspA (Elderkin et al., 2002, Model et al., 1997, Joly et al., 2010). HrpV 
is thought to fulfil a similar regulatory role in the HrpRS and probably HrpS systems (e.g. 
Erwinia spp.) (Preston et al., 1998). The repressive action of HrpV is proposed to be released 
through the action of HrpG (Wei et al., 2005b). These positive and negative regulatory roles 
have been established in this study using an in vivo activity assay (see Chapter 4); however 
the organisation of the HrpV-HrpG regulatory complex(es) remains unknown. 
 
The vast majority of bacterial AAA+ proteins studied so far form homo-hexameric AAA+ 
rings; conversely, in eukaryotes these proteins often function as heteromeric assemblies. 
For instance, the mini chromosomal maintenance (MCM) complex, a processive replicative 
helicase, functions as a typical AAA+ homo-hexameric ring in archaea (Barry et al., 2009) but 
the eukaryotic isoenzyme (MCM: Mcm2-7p) is heteromeric (Schwacha & Bell, 2001). The 
hrpRS genes are transcribed as an operon, and are proposed to form a functional 
heteromeric HrpRS AAA+ complex of unknown quaternary structure (Hutcheson et al., 
2001).  
 
137 
 
In vitro experiments allow the study of proteins in a defined closed environment whereby 
they can interact with only the components added to the reaction. This is in comparison to 
in vivo studies where proteins of interest may be influenced by many factors. Even in the 
HrpRS system where in vivo studies are performed in a non-native environment (i.e. in E. 
coli not in Ps. DC3000) there are still in vivo factors to consider when interpreting results. 
However, when considering in vitro studies it must be taken into account that the proteins 
are being studied in a wholly non-native environment therefore drawing conclusions from 
these studies that are relevant to the native action of these proteins can be problematic. 
Yet, in vitro analysis of proteins permits the same sample to be analysed in a variety of ways, 
for example in protein-protein interaction assays and in activity assays. In vivo these two 
assays are performed with different plasmid expression systems in different E. coli strains. It 
is therefore imperative to be able to replicate outcomes seen in vivo by in vitro methods and 
vice versa. 
5.2.  Objectives 
This chapter aims to deal with some of the questions surrounding the evolution and nature 
of HrpR and HrpS co-dependence and the potential gene duplication event that accounts for 
both HrpR and HrpS being present in P. syringae pathovars. The starting point for this 
question comes from the observation that in other members of Group I, e.g. E. amylovora, 
HrpS exists alone (Wei et al., 2000b) presumably functioning (as does HrpRS) in regulating 
hrpL transcription. HrpRS function as transcriptional activators, therefore full-length in vitro 
transcription assays will be employed to test the activity of HrpRS in the presence and 
absence of HrpV and HrpG. Gel filtration, cross-linking and native mobility shift analysis 
assays will be used to probe the stoichiometry and complex organisations of HrpRS, HrpRS-
HrpV and HrpV-HrpG. 
 
Specifically this chapter aims to: 
I. To use in silico analysis of HrpR and HrpS to identify sequence-based putative 
determinants of HrpV binding and co-dependency. 
II. To develop a full-functioning in vitro recombinant protein regulation system 
consisting of HrpR, HrpS, HrpV and HrpG. 
a. Purify the constituent proteins to a sufficiently high purity and concentration. 
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b. Confirm the activity of HrpR and HrpS in an in vitro transcription assay. 
c. Determine the effects of HrpV and HrpG on HrpRS activity. 
III. To determine the organisation of HrpR, HrpS, HrpV and HrpG complexes in vitro. 
IV. Test the interactions of HrpV and HrpG and the mutants, HrpVLAG and HrpGNQR, in 
vitro. 
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5.3. HrpR and HrpS sequence analysis 
Determining whether the basis for HrpR-HrpSRS co-dependency might be identified from their 
sequences and identifying a possible HrpV interaction site within HrpS (HrpSRS and HrpSS). 
 
HrpR and HrpS (unlike HrpG and HrpV) are relatively well-defined proteins belonging to the 
AAA+ family of transcriptional activators or enhancer binding proteins (EBPs) (see Chapter 
1). In this chapter ‘HrpS’ from organisms with HrpR and HrpS will be denoted as HrpSRS and 
‘HrpS’ from organisms containing only HrpS (or RspR in P. fluorescens) will be denoted as 
HrpSS. In organisms containing a hrpC operon (i.e. hrpF, hrpG, hrcC, hrpT and hrpV) there is 
either a single EBP (HrpSS) within the hrp/hrc gene cluster or two, tandemly arranged EBPs 
(HrpR and HrpSRS). It has been stated that HrpSS of E. amylovora is highly similar to HrpSRS of 
P. syringae (Kim et al., 1997) without mention of HrpR. This may have led to the conclusion 
that the two HrpS proteins are more similar to each other than either is to HrpR. A pairwise 
comparision (using Bioedit pairwise alignment tool, which uses the entire sequence) of HrpR 
(Ps. DC3000) versus HrpSS (E. amylovora) gives identities and similarities of 49% and 62% 
while HrpSRS (Ps. DC3000) versus HrpSS (E. amylovora) gives 48% and 64%. Therefore there is 
no reason to consider HrpR as an outlier of the two versions of HrpS; rather organisms with 
HrpSS have a somewhat different hrpL activation system from those with HrpR and HrpSRS.  
5.3.1. Evidence for a gene duplication event 
Gene duplication is one driving force of evolution; it provides new functional building blocks 
upon which selection can act. Genomes across all domains of life contain much evidence for 
duplicated genes; indeed some whole genomes are duplicated. The fate of a duplicated 
gene can be gene loss, due to redundancy. Some of these genes survive in genomes as 
pseudogenes (Zhang, 2003). Those genes that are maintained after a duplication event 
usually diversify in function either by acquiring a new function (neofunctionalisation) or the 
function of the original copy is split between the two copies (subfunctionalisation) (Innan & 
Kondrashov, 2010). hrpR and hrpS genes have probably evolved from a single ancestral gene 
duplication event given that (i) where present hrpR and hrpS are arranged in tandem and 
transcribed as a single operon (Hutcheson et al., 2001a) and (ii) they show high sequence 
homology to each other, rather than to other EBPs. The organisms selected in the HrpV and 
HrpG sequence analysis (see section 4.4 and Appendix C, Table 15) were used in the HrpRS 
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analysis, shown here. Table 9 and Table 10 show pBLAST searches comparing two 
sequences; these align only the highest conserved sections of the sequence, unlike the 
Bioedit pairwise alignment (which uses the whole sequence). Table 9 shows that HrpR and 
HrpS have between 55-65% sequence identity and 70-79% sequence similarity to each 
other.  
Strain HrpR HrpS % identities % positives 
Ps. DC3000 AAO54901 AAO54902 63 79 
Ps. tomato T1 ZP_03396424 ZP_03396423 64 79 
Ps. oryzae  str. 1_6 ZP_04588445 ZP_04588446 61 76 
Ps. tagetis ABB91663 ABB91662 65 77 
P. mendocina ymp YP_001185540 YP_001185539 55 73 
Ps. tabaci  ZP_05641292 ZP_05641291 64 75 
Ps. phaseolicola 1448A YP_273529 YP_273530 59 72 
Ps. glycinea AAC35799 AAC35800 57 70 
Ps. syringae B728a YP_234282 YP_234283 63 75 
P. viridiflava T-PAI AAT96216 AAT96215 65 78 
Table 9: HrpSRS versus HrpR identities and similarites 
HrpSRS sequences were tested against the corresponding HrpR. Percentage identities and positives were generated by 
BLASTp comparing two sequences (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Protein accession numbers are shown. 
Table 10 shows sequence identities and similarities between HrpR and HrpSRS from Ps. 
DC3000 compared to other well-studied bacterial EBPs, ZraR, PspF, NtrC1, to which they 
have 38-41% identity and 57-62% similarity. When compared to HrpSS from E. amylovora 
HrpR has 57% identity and 70% similarity and HrpSRS has 54% identity and 71% similarity. 
This shows that there is no sequence bias in terms of sequence identity between the two 
HrpS sequences relative to HrpR (in line with the comparison made using Bioedit). Table 9 
and Table 10 demonstrate that HrpR and HrpS are more closely related to each other 
(within the same organism) than they are to other EBPs. 
 
Strain 
 
Protein 
Accession 
number 
To HrpR To HrpS 
% 
identities 
% 
positives 
% 
identities 
% 
positives 
Salmonella typhimurium LT2 ZraR P25852 38 58 38 57 
Escherichia coli PspF AAB02186 41 62 41 60 
Aquifex aeolicus VF5 NtrC1 AAC07159 40 61 38 58 
Erwinia amylovora HrpS AAD24684 57 70 54 71 
Table 10: HrpR and HrpS from Ps. DC3000 versus other EBPs identities and similarities 
 
EBPs from S. typhimurium (ZraR), E. coli (PspF), A. aeolicus (NtrC1) and E. amylovora were compared to HrpR and HrpS 
from Ps. DC3000. Percentage identities and positives were generated by BLASTp comparing two sequences 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
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5.3.2. HrpR and HrpS alignment 
The HrpR/HrpSRS system is unusual and rare – there are no other reported cases of strictly 
co-dependent EBPs functioning in bacteria. The only other known co-dependent EBP pair 
are FleQ and FleT from Rhodobacter sphaerodies. Both are required for full expression of 
the σ54-dependent flagellar operons, however, FleQ (acting alone) activates transcription of 
the fleT operon (which contains 6 other genes) (Poggio et al., 2005). Therefore in this case 
FleQ is an active protein on its own, whereas in the HrpRS system both are strictly required 
for transcription activation from the hrpL promoter, and neither can act alone (Hutcheson et 
al., 2001a, Jovanovic et al., 2011). 
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                              10        20 30        40        50        60        70        80
                     ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
S_DC3000 MSLDERFE------------DDLDEERVPNLGIVAESISQLGIDVLLSGETGTGKDTIARRIHEMSGRKGRLVAM
S_tomato_T1 MSLDERFE------------DDLDEERVPNLGIVAESISQLGIDVLLSGETGTGKDTIARRIHEMSGRKGRLVAM
S_oryzae MSLDATYD------------DDLDEERVPNLGIVAESISQLGIDVLLSGETGTGKDTIARRIHTMSGRKGRLVAM
S_tagetis MELDDGFD------------DDLDQECVPNLGIVAESISQLGIDVLLSGETGTGKDTIAQRIHAMSGRKGRLVAM
S_phaseolicola MDLDEGFD------------DDLDEERVPNLGIVAESISQLGIDVLLSGETGTGKDTIAQRIHTISGRKGRLVAM
S_glycinea MDLDEGFD------------DDLDEERVPNLGIVAESISQLGIDVLLSGETGTGKDTIAQRIHTISGRKGRLVAM
S_tabaci MDLDEGFD------------DDLDEERVPNPGIVAESISQLGIDVLLSGETGTGKDTIAQRIHTMSGRKGRLVAM
S_syringae_B728a MNLDDEFD------------DHLDAERVPNLGIVAESISQLGIDVLLSGETGTGKDTIARRIHNMSGRQGRFVPM
S_viridiflava_T-PAI MIVQDGFD------------DDLH-ERVPNLEIVAESISQLGIDVLLSGETGTGKDTIARRIHTLSGRKGRFVAM
S_mendocina MSEFDWPDA-----------FWMNDGGLPNLEVVASSISELNIDVLLTGETGSGKDTLAQYLHKLSGRKGPFVAM
R_DC3000 MSTGIDKDVR------------ECWGVTALSAGHQIAMNSAFLDMDLLLCGETGTGKDTLANRIHELSSRSGPFVGM
R_tomato T1 MSTGIDKDVR------------ECWGVTALSAGHQIVMNSAFLDMDLLLCGETGTGKDTLANRIHELSSRSGPFVGM
R_oryzae MSTDIDKNVQ------------ECWGVTAVSAGHQIAMNSAFLDMDLLLCGETGTGKDTLANRIHELSSRSGPFVGM
R_tagetis MSTGIDKDAR------------ECWGVTALSAGHQIVMNSAFLDMDLLLCGETGTGKDTLANRVHELSSRSGPFVGM
R_phaseolicola MSTDIDKGVR------------EYWDVTALSAGHQIVMNSAFLDMDLLLCGETGTGKDTLANRIHELSSRSGPFVGM
R_glycinea MSTDIDKGVR------------QYWDVTALSAGHQIVMNSAFLDMDLLLCGETGTGKDTLANRIHELSSRSGPFVCM
R_tabaci MSTDIDKDVR------------ACWDVTALSAGHQIAMNSAFLDMDLLLCGETGTGKDTLANRIHELSSRSGPFVGM
R_syringae_B728a MSTDIDNDVL------------TCCNVTALSAGHQIVMNSVLMDMDLLLCGETGTGKDTLASRIHELSSRTGPFVGM
R_viridiflava_T-PAI MDTKFITDAR------------ERWGITAQSEGHQVVMNGAIMDMDLLLCGETGTGKDTLANTIHNLSSRTGPFVGM
R_mendocina MSRGVAAEKS------------ARRHGGTDVPELGITLSAGHFRMDLLLCGETGTGKDVLARHIHDLSGRTGAFVGI
S_cichorii MDEGSMNNDS---------SQMEHEVLDIFGTLQSFIRKAAPLNVDMVLEGETGTGKDTLARRIHQLSGREGPLVAL
S_viridiflava S-PAI MDECAMNNDS---------LPMEHEVLDIFGTLQSFIRKAAPLNVDMVLEGETGTGKDTLARRIHQLSGREGPLIAI
S_E._amylovora MNIRNSEHSSRPWPGRREHISLTEEQPIDIHDTLAEMIKTVAPLKIDLVLEGETGTGKDTLARKIHQLSGCRGKLVAV
S_E._pyrifoliae MNIRNSEHSSRPWPGRREHISLTEEQPIDIHDTLAEMIKTVAPLKIDLVLEGETGTGKDTLARKIHQLSGCRGKLVAV
S_E._tasmaniensis MSIRNSEFSFRHWPEQGEHISLTEEQPIDIHDTLAEMIKTVAPLKIDLVLEGETGTGKDTLARKIHQLSGCSGKLVAV
S_Pantoea stewartii MNIENNEHSFRPHPELGEHISFTKEQPIDIHDSLASLIETVAPLEIDLVLEGETGTGKDTLARKIHRLSGCSGRLIAV
S_P._carotovorum MNYRQDRQHDSSLEYSSFDHSPVE-TADDIHSSLSPIINVIAPLNVDIVLEGETGTGKDTLANRIHRLSRCSGPLVAV
S_P._atrosepticum MNYRQDRQHYSSLRHSSSENSALENTAEDIHSSLSPIINVIAPLNVDIVLEGETGTGKDTLANRIHQISQCSGPLVAV
S_Dickeya zeae MTLRNSNEFSQSLHCATHHFLSTQ-QSEDIHGSLASLIHTIAPLNVDIVLEGETGTGKDTLARRIHQLSGCAGPLVAV
S_fluorescens MSASDTMDNE------------ADISLLEGPDIEEILSGTAQLNIDILLLGETGTGKDTLAQRIHRLSGRRGSFIAV
ZraR  Salmonella typhimurium GDSGTGKEL
PspF  Escherichia coli GERGTGKEL
NtrC1 Aquifex aeolicus GESGVGKEV
      Walker A
                             90       100       110       120       130       140       150       160
                     ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
S_DC3000 NCAAIPESLAESELFGVVSGAYTGADRSRVGYVEAAQGGTLYLDEIDSMPLSLQAKLLRVLETRALERLGSTSTIKLDIC
S_tomato T1 NCAAIPESLAESELFGVVSGAYTGADRSRVGYVEAAQGGTLYLDEIDSMPLSLQAKLLRVLETRALERLGSTSTIKLDIC
S_oryzae NCAAIPESLAESELFGVVSGAYTGADRSRVGYIEAAQGGTLYLDEIDSMSLNLQAKLLRVLETRALERLGSTSTIKLDIC
S_tagetis NCAAIPESLAESELFGVVSGAYTGADRSRVGYIEAAQGGTLYLDEIDSMPLSLQAKLLRVLETRALERLGSTSTIKLDVC
S_phaseolicola NCAAIPESLAESELFGVVSGAYTGADRSRVGYIEAAQGGTLYLDEIDSMPLSLQAKLLRVLETRALERLGSTSTIKLDVC
S_glycinea NCAAIPESLAESELFGVVSGAYTGADRSRVGYIEAAQGGTLYLDEIDSMPLSLQAKLLRVLETRALERLGSTSTIKLDVC
S_tabaci NCAAIPESLAESELFGVVSGAYTGADRSRVGYIEAAQGGTLYLDEIDSMPLSLQAKLLRVLETRALERLGSTSTIKLDVC
S_syringae B728a NCAAIPESLAESELFGVVSGAYTGADRSRMGYIEAAQGGTLYLDEIDSMPLALQAKLLRVLETRALERLGSTSTINLDIC
S_viridiflava T-PAI NCAAIPESLAESELFGVVSGAYTGADRSRAGYIEAAQGGTLYLDEIDSMPLSLQAKLLRVLETRALERLGSTSSIKLDVC
S_mendocina NCAAIPESLFESELFGVTSGAYTGADHSRMGYVEAAQGGTLYLDEIDSMPAFLQAKLLRVLETRQIERLGSTTPVPLDIC
R_DC3000 NCAAIPESLAESQLFGVVNGAFTGVCRAREGYIEASSGGTLYLDEIDSMPLSLQAKLLRVLESRGIERLGSTEFIPVDLR
R_tomato T1 NCAAIPESLAESQLFGVVNGAFTGVCRAREGYIEASSGGTLYLDEIDSMPLSLQAKLLRVLESRGIERLGSTEFIPVDLR
R_oryzae NCAAIPESLAESQLFGVVNGAFTGVCRAREGYIEASSGGTLYLDEIDSMPMSLQAKLLRVLESRGVERLGSTEFIPVDLR
R_tagetis NCAAIPESLAESQLFGVVNGAFTGVCRAREGYIEASSGGTLYLDEIDSMPLSLQAKLLRVLESRGVERLGSTEFIPLDLR
R_phaseolicola NCAAIPESLAESQLFGVVNGAFTGVCRAREGYIEASSGGTLYLDEIDSMPLSLQAKLLRVLESRGVERLGSTEFIPLDLR
R_glycinea NCAAIPESLAESQLFGVFNGAFTGVCRAREGYIETSSGGTLYLDKIYSMPLILHAKLLRVLESRGVERLGSTEFIPLDLR
R_tabaci NCAAIPESLAESQLFGVVNGAFTGVCRAREGYIEASSGGTLYLDEIDSMPLSLQAKLLRVLESRGVERLGSTEFIPLDLR
R_syringae B728a NCAAIPESLAESQLFGVVNGAFTGVCRAREGYIEASSGGTLYLDEIDSMPLSLQAKLLRVLESRGVERLGSTDFIPLDLR
R_viridiflava T-PAI NCAAIPESLAESQLFGVSSGAFTGVCRSREGYIEASNGGTLYLDEIDSMPMSLQAKLLHVLENRGVERLGSTEFIPVDLR
R_mendocina NCAAIPEALAESQLFGVASGAFTGANRSRQGYIEASNDGTLYLDEIDSMPLQLQAKLLRVLETRGVERLGTTKFIPLNLR
S_cichorii NCAAVPEQLAESELFGVMAGAYTGASKSRAGYIEASHNGTLYLDEIDSMPLLLQAKLLRVLEMRGIERLGSTRFVALNLR
S_viridiflava S-PAI NCAAVPEQLAESELFGVMAGAYTGASKSRAGYIEASHNGTLYLDEIDSMPLLLQAKLLRVLEMRGIERLGSTRFVALNLR
S_E. amylovora NCAAIPETLAESELFGINNGAYTGAGQARAGYVEAADNGILFLDEIDSMPLSLQAKMLRVLENRGVERLGGTRFTPVNMR
S_E. pyrifoliae NCAAIPETLAESELFGINNGAYTGAGQARAGYVEAADNGILFLDEIDSMPLSLQAKMLRVLENRGVERLGGTQFTPVNMR
S_E. tasmaniensis NCAAIPETLAESELFGINNGAYTGAGQARAGYVEAAHNGILFLDEIDSMPLSLQAKMLRVLENRGVERLGGTRFTPVNMR
S_Pantoea stewartii NCAAIPETLAESELFGVNNGAYTGAVQARAGYIEEANNGILFLDEIDSMPLSLQAKLLRVLENRGIERLGGTRFIPVNMR
S_P. carotovorum NCAAVPENLAESELFGVVSGAYTGANRSRAGYLESADKGILFLDEIDSMPMTLQAKMLRVLESRGVKRLGSTQFTPVDMR
S_P. atrosepticum NCAAVPENLAESELFGVVSGAYTGANRSRAGYLESADKGILFLDEIDSMPMTLQAKMLRVLESRGVKRLGSTQFTPVDMR
S_Dickeya zeae NCAAVPETLAESELFGVVSGAYTGASRSRAGYLETADKGILFLDEIDSMPLTLQAKMLRVLESRGIERLGSTQFKPVDMR
S_fluorescens NCAAIPETLAESQLFGVNSGAYTGAVQSRAGFIEAAHLGTLYLDEIDSMPLSLQAKLLRTLESRGVERLGSTRFIPVDMR
ZraR  Salmonella typhimurium GAFTGA DEIGD RVGSNQTIS DVR
PspF  Escherichia coli GAFTGA DELAT RVGGSQPLQ NVR
NtrC1 Aquifex aeolicus GAFTGA DEIGE RLGGRKEIE NVR
                                        GAFTGA             Walker B                  loop 2    SI
HrpSRS
HrpR
HrpSS
HrpSRS
HrpR
HrpSS
 
Figure 67: Figure legend on next page. 
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                            170       180       190       200       210       220       230       240
                     ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
S_DC3000 VIASAQCSLDDAVERGQFRRDLYFRLNVLTLKLPPLRNQSDRIVPLFTRFTAAAARELGVPVPDVCPLLHKVLLGHDWPG
S_tomato T1 VIASAQCSLDDAVERGQFRRDLYFRLNVLTLKLPPLRTQSDRIVPLFTRFTAAAARELGVPVPDVCPLLHKVLLGHDWPG
S_oryzae VIASAQCSLDDAVEDGRFRRDLYFRLNVLTLKLPPLRSQPERIVPSFKRFAAAAGAELNVAVPTVCPALQELLLKHEWPG
S_tagetis VIASAQSCLDDAVEQGRFRRDLYFRLNVLTLQLPALRTQPERILPLFKRFVAAAAKELEAVPPDVCPLLQQVLLGHNWPG
S_phaseolicola VIASAQSSLDDAVEQGKFRRDLYFRLNVLTLQLPPLRTQPERILPLFKRFMAAAAKELNVASADVCPLLQQVLLGHEWPG
S_glycinea VIASAQSSLDDAVEQGKFRRDLYFRLNVLTLQLPPLRTQPERILPLFKRFMAAAAKELNVASADVCPLLQQVLLGHEWPG
S_tabaci VIASAQSSLDDAVEQGKFRRDLYFRLNVLTLQLPPLRTQPERILPLFKRFMAAAAKELDVASADVCPLLQQVLLGHDWPG
S_syringae B728a VIASAQACLDDAVEEGKFRRDLYFRLNVLTLKLPPLRDQPERILPLFTRFVAASAKELSVPIPDVCPLLQQVLTGHHWPG
S_viridiflava T-PAI VIASAQRSLDDAVEEGAFRRDLYFRLNVLTLKLPPLRARQERIVPLFMRFANAVAEELGFQVSRLCPLQQEQLLTHDWPG
S_mendocina VVASAQRSLDALVEQGEFRRDLYFRLNVLTLRLPALRQKREWIIPMFERFAFEASQDMDTALPVIDPAIEHVLLNHDWPG
R_DC3000 IIASAQRPLDELVEQGLFRRDLFFRLNVLTLHLPALRKRREQILPLFDQFTQGIAAEFGRPAPALDSGRVQLLLSHDWPG
R_tomato T1 IIASAQRPLDELVEQGLFRRDLFFRLNVLTLHLPALRKRREQILPLFDQFTQGIAAEFGRPAPALDSGRVQLLLSHDWPG
R_oryzae VIASAQRPLDELVEQGLFRRDLFFRLNVLTLHLPALRKRREQILPLFDQFTQEIAAELGRPAPALDSGRVQVLLSHDWPG
R_tagetis VIASAQRPLDELVEQGLFRRDLFFRLNVLTLHLPALRKRREQILPLFDQFTQEIAAEFQRPVPVLDNGRVQILLSHDWPG
R_phaseolicola VIASAQRPLDELVEQGLFRRDLFFRLNVLTLHLPALRKRREQILPLFDQFTQEIAAEFQRPVPVLDNGRVQILLSHDWPG
R_glycinea VIASAQRPLDELVEQGLFRRDLFFRLNVLTLHLPALRKRREQILPLFDQFTQEIAAEFQRPVPVLDNGRVQILLSHDWPG
R_tabaci VIASAQRPLDELVEQGLFRRDLFFRLNVLTLHLPALRKRREQILPLFDQFTQEIAAEFQRPVPVLDNGRVQILLSHDWPG
R_syringae B728a VIASAQRPLDELVEQGLFRRDLFFRLNVLTLQLPALRKRREQILPLFDQFTQDVAAESGRSVPTLDNRRVQILLSHDWPG
R_viridiflava T-PAI VIASAQRPLDELVEQGLFRRDLYFRLNALTLQLPALRTRREQILPLFDQFTQAIAAEFGRSAPVLDSGRVQLLLSHDWSG
R_mendocina IIASTQRPLEELVEQGLFRRDLLFRLNAMTLSLPPLRQRRELILPLFKRFTRSLGAKQANGAQALDSQLIQLLLSHPWPG
S_cichorii VIVATQTPLEKLVEEGKFRRDLFFRLNVIKIQLPTLRSRLDHLPSLFERFVMETAHKHHQPLPPRDPTVLNRLLSHRWPG
S_viridiflava S-PAI VIVATQTPLEKLVEEGKFRRDLFFRLNVIKIQLPTLRSRLDHLPSLFERFVVETAEKHGQPIPVRDPHVLNRLLSHRWPG
S_E. amylovora VIVATQTPLLTLVERGSFRRDLYFRLNTVSIQLQPLRARIEVIIPMFRSFIQKAASTLQCAPREITQEHYECLLSYSWPG
S_E .pyrifoliae VIVATQTPLLTLVG-GSFRRDLYFRLNTVSIQLQPLRARIEVIIPLFRSFIQKAASTLQCAPREITQEHYECLLSYSWPG
S_E. tasmaniensis VIVATQTPLLTLVERGSFRRDLYFRLNTVSIQLQPLRARIEIIIPLFRYFIQQAATTLQCPQREITQEHYECLLSYGWPG
S_Pantoea stewartii VIVATQKPLLTLVEQGTFRRDLYFRLNTLSIQLQPLRSQVEIIIPLFRHFIAKAATTMQCTPPEITQELCEYLLSYSWPG
S_P. carotovorum VIVATQTPLLQLVEKGLFRRDLYFRLDTVKIQLPTLRSRSDLILPLFQRFSQEAAVRLRMTQPPMTAEIYEQLLTHSWPG
S_P. atrosepticum VIVATQTPLLQLVEKGLFRRDLYFRLDTVKIQLPTLRSRSDLILPLFQRFSQEAAVRLRMTLPPMTAEIDEQLLTHSWPG
S_Dickeya zeae VIVATQTPLQKLVDEGRFRRDLYFRLDTVKIQLPTLRSRTDIILPLFQRFLHDAAARLKLSVPGVSVIMQEQLLMHDWPG
S_fluorescens VIASAQQSLYEMVERGTFRRDLYFRLSVVNIQLPSLRECRDRIIPLFLTMIRQEAESFKCPYPQPPSSLLQQLLCHPWPG
ZraR  Salmonella ty LIAATHR PG
PspF  Escherichia c LVCATNA PG
NtrC1 Aquifex aeoli ILAATNR YG
   Sensor I     SII
                            250       260       270       280       290       300       310       320
                     ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
S_DC3000 NIRELKAAAKRHVLGFPLLGA------EPQGEEHLACGLKSQLRVIEKALIQESLKRHDNCVDSVSLELDVPRRTLYRRI
S_tomato T1 NIRELKAAAKRHVLGFPLLGA------EPQGEEHLACGLKSQLRVIEKALIQESLKRHDNCVDSVSLELDVPRRTLYRRI
S_oryzae NIRELKAAAKRFVLGFPLLGS------EPQGEKYLACGLKSQLRAIEKALIQESLKRHHHCIDAVSQELDMPRRTLYRRI
S_tagetis NIRELKAAAKRHVLGFPVLGV------DPQSEEHLACGLKSQLRAIEKALIQQALKRHRNCIDAASLELDMPRRTLYRRI
S_phaseolicola NIRELKAAAKRHVLGFPVLGV------DPQSEEHLACGLKSQLRAIEKALIQQSLKRHRNCIDAASLELDMPRRTLYRRI
S_glycinea NIRELKAAAKRHVLGFPVLGV------DPQSEEHLACGLKSQLRAIEKALIQQSLKRHRNCIDAASLELDMPRRTLYRRI
S_tabaci NIRELKAAAKRHVLGFPVLGV------DPQSEEHLACGLKSQLRAIEKALIQQSLKRHRNCIDAASLELDMPRRTLYRRI
S_syringae B728a NIRELKAAAKRHVLGFPLLGA------DSQTEEHLACGLKFQLRAIEKALIQQALKRHRNCIDAASLELDIPRRTLYRRI
S_viridiflava T-PAI NIRELKAAAKRFVLGLPLLGA------GPCDDEHQGSGLKTQLRAIEKALIQESLKRHDNCVDSVSQELDMPRRTLYRRL
S_mendocina NLRELKSAAKRHVLGINLLG--------IEAEQPIECDLKCQLRLIEKVLIQESLQRHEHCIEAVLHELDIPRRTLYHRM
R_DC3000 NIRELKSAAKRFVLGFPLLGA------DPVEALDPATGLRTQMRIIEKMLIQDALKRHRHNFDAVLQELELPRRTLYHRM
R_tomato T1 NIRELKSAAKRFVLGFPLLGA------DPVEALDPATGLRTQMRIIEKMLIQDALKRHRHNFDAVLQELELPRRTLYHRM
R_oryzae NVRELKSAAKRFVLNFPLLGC------EPVEDLASATDLRTQMRVIEKMLIQDALKRHRHNVDAVLEELELPRRTLYHRM
R_tagetis NVRELKSAAKRFVLGFPLLGA------EPVDARDPATGLRMQMRVIEKMLIQDALKRHRHNVDAVLQELELPRRTLYHRM
R_phaseolicola NVRELKSAAKRFVLGFPLLGA------EPMDARDPVTGLRMQMRVIEKMLIQDALKRHRHNVDAVLQELELPRRTLYHRM
R_glycinea NVRELKSAAKRFVLGFPLLGA------EPMDARDPVTGLRMQMRVIEKMLIQDALKRHRHNVDAVLQELELPRRTLYHRM
R_tabaci NVRELKSAAKRFVLGFPLLGA------EPMDARDPVTGLRMQMRVIEKMLIQDALKRHRHNVDAVLQELELPRRTLYHRM
R_syringae B728a NVRELKSAAKRFVLGLPLLGA------EPVEARDPVTGLRMQMRVIEKMLIQDALKRHRHNFDAVLEELELPRRTLYHRM
R_viridiflava T-PAI NIRELKSAAKRFVLGFPLLGV------ELLEPEDCDTGLRTQLRVIEKRLIQDALKRHRHNVDAVLQELELPRRTLYHRM
R_mendocina NIRELKSAAKRYVIGLPPIGV------DLEDGDFPHDGLKKRMRAVEKMLIQDALKRHKNGLEAVAEELGISRRTLYQRI
S_cichorii NIRELKCAAERFVLGMSPLG------TDEDPHLERNVHLKGYLRQFEKALIQDCLSRHPKSIESVISELGIPRRTLYHRM
S_viridiflava S-PAI NIRELKCAAERFVLGMPPLS------SENDSQTENSIHLKSYLRQFEKALIQDCLSRHPKSIDSVINELGIPRRTLYHRM
S_E. amylovora NIRELKAAAERFVLGLPPLD-------LPCHCGQERPQLKELMRRIEKNVIYDCLVRHGHSIDDAAQELGIPLRTLYHRI
S_E. pyrifoliae NIRELKAAAERFVLGLPPLG-------LSCHCGQERPQLKELMRRIEKNVIHDCLVRHGHSIDDAAQELGIPLRTLYHRI
S_E. tasmaniensis NIRELKAAAERFVLGLPPLG-------FSCHCEDERPRLKEMMRRIEKSLIHDCLLRHGHSIDDAAQELGIPLRTLYHRI
S_Pantoea stewartii NIRELKTAAKRFTLGLPPLN-------VPRNAERQGPQLKEILRRIEKSLIHDCLVRHGHSIDEAAMELGMPLRTLYHRI
S_P. carotovorum NIRELKAAADRWAMGLSPL-----AEIQPLLHPRPLQ-LKDRLKRIEKFLIQDALRRHGHCIDDVIVELGIPKRTLYHRL
S_P. atrosepticum NIRELKAAADRWAMGLSPL-----AEIQQLLHPRPLQ-LKDRLKRIEKFLIQDALRRHGHCIDDVIVELGIPKRTLYHRL
S_Dickeya zeae NIRELKAAAERWVLGLSPVPIVADGD--GAESDTPLTSLKVRLRRIERFLIQEALQRNDHCIDTVVSELGIPKRTLYHRI
S_fluorescens NVRELSSTAKRFVLGLPPLSV------RGKNPKISEASLKERLQRIEKSLIEESLHRHNGNVDLAAADLRVAKRTFYYRM
ZraR  Salmonella ty NIRELEN
PspF  Escherichia c NIRELKN
NtrC1 Aquifex aeoli NVRELKN
Sensor II
HrpSRS
HrpR
HrpSS
HrpSRS
HrpR
HrpSS
 
Figure 67: HrpR and HrpS multiple sequence alignment 
 
The HrpR and HrpS multiple sequence alignment generated by ClustalW (Thompson et al., 1994) including sequences 
corresponding to the conserved motifs of three other well-studied EBPs from S. typhimurium, E. coli and A. aeolicus (ZraR, 
PspF and NtrC1 respectively). The conserved motifs of EBPs are highlighted in open boxes – Walker A, Walker B, sensor I 
(SI), sensor II (SII), GAFTGA (L1 loop) and L2 loop (also known as pre-SIi). Thin black lines divide HrpSRS, HrpR, HrpSS and the 
other EBPs (ZraR, PspF and NtrC1).  
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The first (approximately) thirty amino acids in Figure 67 were altered from the original 
alignment to improve clarity (for the original alignment of these amino acids see Appendix 
C, Figure 108). Also the last 20 amino acids were removed from Figure 67 as they contain no 
significant conserved domains or regions of interest studied here. In addition, sequence 
comparisons to other HrpR sequences revealed that HrpR from Ps. tagetis (accession 
number ZP_05641292) was missing 25 amino acids at its N-terminus (appearing to begin at 
position 41, Figure 67). This sequence was therefore corrected (by translating the upstream 
nucleotide sequences) for this analysis (see section 2.5.2). In the Walker B motif, all the 
HrpR and HrpS sequences have DEIDS except for HrpR from Ps. glycinea which has DKIYS. 
This would be a substantial deviation from the consensus sequence and would probably 
render HrpR inactive for ATPase hydrolysis (mutations of the ‘E’ in the walker B motif of 
PspF significantly reduced ATPase activity (Joly et al., 2007)). However, the codon for the ‘K’ 
in Ps. glycinea is ‘AAA’, whereas an ‘E’ would be ‘GAA’ so it is possible that a sequencing 
error has occurred.  
 
Inspection of the HrpR and HrpSRS sequences indicates no obvious basis of their co-
dependency or the site in HrpS where HrpV may interact. They show clear congruence with 
other EBPs in that the seven conserved regions (C1-C7) identified for all AAA+ proteins and 
the conserved EBP motifs are present (see Figure 9). Some significant functional motifs of 
EBPs (and to some extent AAA+ proteins) are highlighted in Figure 67 - Walker A, Walker B, 
sensor I (SI), sensor II (SII), GAFTGA (within loop 1) and loop 2; see Chapter 1. Important 
questions regarding HrpR and HrpS are how, and why, do the HrpR and HrpSRS EBP pair act 
co-operatively to activate hrpL transcription when HrpSS performs the same function alone? 
What are the characteristics of these proteins that tie them into co-dependency and/or give 
them an advantage over singly acting EBPs? If all the HrpR proteins lacked a Walker A motif, 
then it would be obvious why they rely on interactions with HrpS for full functionality 
(analogous to FleT, which lacks a DNA-binding domain and was shown to be unable to bind 
promoter DNA in the absence of FleQ, and is therefore dependent on FleQ for functionality, 
(Poggio et al., 2005)). However, this is not the case - from Figure 67 it is clear that none of 
the proteins deviate dramatically from “normal” EBP-like sequences in any of the 
highlighted motifs (Ps. glycinea is an interesting exception).  
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5.3.3. HrpR and HrpS sequences of interest 
Figure 68 examines some specific sequences that may be of significance when comparing 
HrpR, HrpSRS and HrpSS – GAFTGA (within L1 loop), L2 loop (or pre-sensor I insertion) and 
sensor I. 
A 10        20
....|....|....|....|...
S_DC3000 IPESLAESELFGVVSGAYTGADR
S_tomato T1 IPESLAESELFGVVSGAYTGADR
S_oryzae IPESLAESELFGVVSGAYTGADR
S_tagetis IPESLAESELFGVVSGAYTGADR
S_phaseolicola IPESLAESELFGVVSGAYTGADR
S_tabaci IPESLAESELFGVVSGAYTGADR
S_glycinea IPESLAESELFGVVSGAYTGADR
S_syringae B728a IPESLAESELFGVVSGAYTGADR
S_viridiflava T-PAI IPESLAESELFGVVSGAYTGADR
S_mendocina IPESLFESELFGVTSGAYTGADH
R_DC3000 IPESLAESQLFGVVNGAFTGVCR
R_tomato T1 IPESLAESQLFGVVNGAFTGVCR
R_oryzae IPESLAESQLFGVVNGAFTGVCR
R_tagetis IPESLAESQLFGVVNGAFTGVCR
R_phaseolicola IPESLAESQLFGVVNGAFTGVCR
R_tabaci IPESLAESQLFGVVNGAFTGVCR
R_glycinea IPESLAESQLFGVFNGAFTGVCR
R_syringae B728a IPESLAESQLFGVVNGAFTGVCR
R_viridiflava T-PAI IPESLAESQLFGVSSGAFTGVCR
R_mendocina IPEALAESQLFGVASGAFTGANR
S_cichorii VPEQLAESELFGVMAGAYTGASK
S_viridiflava S-PAI VPEQLAESELFGVMAGAYTGASK
S_E. amylovora IPETLAESELFGINNGAYTGAGQ
S_E. pyrifoliae IPETLAESELFGINNGAYTGAGQ
S_E. tasmaniensis IPETLAESELFGINNGAYTGAGQ
S_Pantoea stewartii IPETLAESELFGVNNGAYTGAVQ
S_P. carotovorum VPENLAESELFGVVSGAYTGANR
S_P. atrosepticum VPENLAESELFGVVSGAYTGANR
S_Dickeya zeae VPETLAESELFGVVSGAYTGASR
S_fluorescens IPETLAESQLFGVNSGAYTGAVQ
HrpSRS
HrpR
HrpSS
B 10        20
....|....|....|....|....|.
S_DC3000 TRALERLGSTSTIKLDICVIASAQCS
S_tomato_T1 TRALERLGSTSTIKLDICVIASAQCS
S_oryzae TRALERLGSTSTIKLDICVIASAQCS
S_tagetis TRALERLGSTSTIKLDVCVIASAQSC
S_mendocina TRQIERLGSTTPVPLDICVVASAQRS
S_tabaci TRALERLGSTSTIKLDVCVIASAQSS
S_phaseolicola TRALERLGSTSTIKLDVCVIASAQSS
S_glycinea TRALERLGSTSTIKLDVCVIASAQSS
S_syringae_B728a TRALERLGSTSTINLDICVIASAQAC
S_viridiflava_T-PAI TRALERLGSTSSIKLDVCVIASAQRS
R_DC3000 SRGIERLGSTEFIPVDLRIIASAQRP
R_tomato T1 SRGIERLGSTEFIPVDLRIIASAQRP
R_oryzae SRGVERLGSTEFIPVDLRVIASAQRP
R_tagetis SRGVERLGSTEFIPLDLRVIASAQRP
R_mendocina TRGVERLGTTKFIPLNLRIIASTQRP
R_tabaci SRGVERLGSTEFIPLDLRVIASAQRP
R_phaseolicola SRGVERLGSTEFIPLDLRVIASAQRP
R_glycinea SRGVERLGSTEFIPLDLRVIASAQRP
R_syringae_B728a SRGVERLGSTDFIPLDLRVIASAQRP
R_viridiflava_T-PAI NRGVERLGSTEFIPVDLRVIASAQRP
S_cichorii MRGIERLGSTRFVALNLRVIVATQTP
S_viridiflava S-PAI MRGIERLGSTRFVALNLRVIVATQTP
S_E._amylovora NRGVERLGGTRFTPVNMRVIVATQTP
S_E._pyrifoliae NRGVERLGGTQFTPVNMRVIVATQTP
S_E._tasmaniensis NRGVERLGGTRFTPVNMRVIVATQTP
S_Pantoea stewartii NRGIERLGGTRFIPVNMRVIVATQKP
S_P._carotovorum SRGVKRLGSTQFTPVDMRVIVATQTP
S_P._atrosepticum SRGVKRLGSTQFTPVDMRVIVATQTP
S_Dickeya zeae SRGIERLGSTQFKPVDMRVIVATQTP
S_fluorescens SRGVERLGSTRFIPVDMRVIASAQQS
HrpSRS
HrpR
HrpSS
 
Figure 68: Key sections of the HrpR and HrpS multiple sequence alignment 
 
Sections of the HrpR and HrpS multiple sequence alignment shown in Figure 67. (A) Positions 85-107, including the GAFTGA 
motif (within L1 loop). (B) Positions 143-168, including L2 loop and sensor I regions. Residues highlighted in yellow differ 
across the three groups (HrpR, HrpSRS and HrpSS – separated by thin black lines). Black arrows show positions similar for 
HrpSRS and HrpR. Green arrows show positions similar for HrpSRS and HrpSS. Red arrows show positions similar for HrpSS 
and HrpR. Blue arrows show positions that are different for all three groups - HrpR, HrpSRS and HrpSS. 
 
HrpR and HrpSRS are only found within the P. syringae group of related pathogens and two 
other organisms – P. viridiflava T-PAI and P. mendocina – strongly suggesting that hrpRS in 
P. syringae provides a selective advantage, for these organisms, compared with having a 
singly-acting ‘HrpS’.  Figure 68 examines two important regions of these EBPs and highlights 
residues that are either shared by (i) HrpSS and HrpSRS, (ii) HrpSRS and HrpR or (iii) HrpR and 
HrpSS. The purpose of this analysis was to identify residues that may either enable HrpSS to 
function alone or lock HrpSRS into co-dependency. One theory could be that HrpSS may more 
closely resemble the ancestor of the HrpR/HrpS pair, before a proposed gene duplication 
event had occurred. HrpSS activates hrpL transcription in organisms that also have a hrpC 
operon, that in all cases contains both HrpV and HrpG. HrpSS therefore performs all the 
activities associated with the HrpR and HrpSRS system. The green arrows show residues that 
are similar for HrpSRS and HrpSS. If these two EBPs are assumed to perform the same 
functions, (as could be implied by the nomenclature), with HrpR having a somewhat 
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different function, then it would be expected that green arrows would outnumber positions 
similar for HrpR and HrpSS (red arrows). However, if it is assumed that HrpSS is functionally 
equivalent to HrpSRS and HrpR then the number of red arrows and green arrows should be 
roughly equal. This is the situation seen in Figure 68, where there are three each of red and 
green arrows. One function, binding to HrpV, is a HrpS-specific function (shown 
experimentally for HrpSRS but not for HrpSS). Residues highlighted here by green arrows 
could therefore be involved in this interaction. The black arrows in Figure 68 show residues 
that are similar for HrpSRS and HrpR. If a gene duplication event has occurred from an 
ancestral ‘hrpS’ gene leading in one case to HrpSS and in the other to HrpSRS and HrpR, then 
there should be more black arrows than red or green – there are four black arrows in Figure 
68, in line with a gene duplication event and in agreement with the phylogenetic analysis in 
Figure 69. Black arrowed residues could be responsible for the co-dependency of HrpRS, 
perhaps connected to the interface between subunits – which has been shown to play an 
important role in PspF (Joly & Buck, 2010). 
 
In summary, these analyses have identified a number of candidate residues that could 
potentially lead to HrpR and HrpSRS co-dependency (Figure 68). One clear candidate is the 
phenylalanine residue within the GAFTGA motif that is the optimal ‘F’ in HrpR but ‘Y’ in 
HrpS. This residue could also be involved in HrpV interactions as it lies within a functionally 
important (σ54-interacting and therefore HrpRS activation) motif (thereby particularly useful 
for a negative regulator of HrpL activity). Also it is the same, ‘Y’, for both HrpSRS and HrpSS 
which is important given that HrpV from all these organisms (HrpSRS- and HrpSS-containing) 
could be functionally homologous (see Chapter 4). 
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5.3.4. HrpR and HrpS phylogeny 
Examining the phylogenetic relationship between HrpR, HrpSRS and HrpSS. 
 
Figure 69 is a neighbour joining tree of the HrpR and HrpS sequences analysed in this 
chapter, with the three additional EBPs included as in Figure 67 (ZraR, PspF and NtrC1).  
.
.
.
.
.
 
Figure 69: Neighbour joining tree of HrpR and HrpS 
The tree shows that HrpR and HrpSRS form a separate clade from HrpSS, with the exception of P. fluorescens which falls as 
the outlier of the HrpR and HrpSRS clade. Three “model” EBP sequences have also been included - ZraR, PspF and NtrC1. 
These fall as outliers to all HrpR and HrpS sequences. Generated from align.genome.jp. 
Figure 69 shows that HrpR and HrpSRS are more closely related to each other than either are 
to HrpSS (the only exception being P. fluorescens which appears as the outlier to HrpR and 
HrpSRS, in agreement with Jackson et al (Jackson et al., 2005)). The patterns of relatedness 
for HrpR and HrpSRS are identical, in that P. mendocina is the outlier to both clades. Ps. 
148 
 
DC3000, Ps. tomato T1 and Ps. oryzae form one group whilst the remaining P. syringae 
representatives form a second group in both clades. The identical tree structure of HrpR and 
HrpSRS clades is compelling evidence for co-evolution of the HrpR/HrpSRS system.  
 
In summary, an ancestral PAI probably contained a single ancestral EBP ‘hrp#’ which then 
diverged with one lineage becoming hrpχ which subsequently underwent a gene 
duplication event leading to hrpR and hrpSRS in one case and rspR in the other with the 
other lineage containing hrpSS (see Figure 70, A). It seems unlikely that the ancestral PAI 
contained a duplicated EBP system that the HrpSS lineage subsequently lost given the high 
sequence similarity between HrpR and HrpSS (Table 9 and Table 10) and the co-evolution 
pattern seen in Figure 69; and since this scenario would require an initial single EBP, gene 
duplication and then gene loss which is less parsimonious (see Figure 70, B). It is possible P. 
fluorescens may have subsequently lost one of its duplicated EBPs before co-dependency 
was acquired (a common occurrence after gene-duplication), thus explaining why it contains 
only one (RspR) but aligns closely with HrpR and HrpSRS. 
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Figure 70: HrpRS gene duplication event scenarios 
A) The ancestral Hrp# leads to HrpSS in one lineage and Hrpχ in the other. This then leads to HrpR and HrpSRS in one lineage 
(though gene duplication) and RspR in the other. B) Hrp# duplicates leading to Hrp#a and Hrp#b which leads to Hrpχa and 
Hrpχb. This then leads to HrpR and HrpSRS in one lineage (though gene duplication) and RspR in the other, while HrpSS 
leads from Hrpχa and Hrpχb following gene loss. RspR could also have arisen following gene loss from the HrpR and HrpSRS 
lineage in both cases. 
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5.4. In vitro activity of HrpRS and the roles of HrpG, HrpV 
Developing a full-functioning in vitro recombinant system of HrpR, HrpS, HrpV and HrpG 
regulation  
 
To test the activities of HrpR, HrpS, HrpV and HrpG in vitro, recombinant proteins must be 
purified to sufficiently high concentrations and purity. HrpV and HrpRS from Ps. DC3000 had 
been purified previously by His-Tag Ni-affinity chromatography; however, the 
concentrations yielded did not exceed 14 µM and 20 µM for HrpV and HrpRS respectively. In 
vitro studies of many other EBPs (Fernandez et al., 1994, Wang et al., 2003) have been 
performed using isolated EBP domains (e.g. PspF1-275 is missing the C-terminal helix-turn-
helix domain (HTH) and purifies significantly better than the full-length form),  due to the 
difficulties associated with limited solubility of full-length EBPs (Wedel & Kustu, 1995, 
Schumacher et al., 2004, Chen et al., 2008, Berger et al., 1995). HrpR and HrpS when 
expressed and purified separately resulted in substantially lower protein yields than co-
expressed HrpRS, suggesting that HrpR/HrpS mutually stabilise a soluble heteromeric 
conformation (Jovanovic et al., 2011). In addition, truncated versions of either HrpR or HrpS 
proved inactive in vivo suggesting that only the full-length proteins would be viable for 
functionality assays (Jovanovic et al., 2011). HrpV was purified using the pET system and 
HrpRS were purified using the pQE system. Purifications were performed as described 
(section 2.3) unless otherwise stated. 
5.4.1. Purifying recombinant proteins 
 
HrpG 
Initially purification of HrpG was attempted since this protein had not previously been 
purified, therefore no purification/expression protocol existed at the time. To purify HrpG 
using His-Tag Ni-affinity chromatography, hrpG was cloned into pET28b+ to create pEJ3 (see 
Figure 71). The pET28b+ plasmid enables an N-terminal 6-His tag form of HrpG to be 
created. 
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Figure 71: pET28b
+
-hrpG (pEJ3) DNA 
Restriction digestion using enzymes NheI and HindIII of pEJ3 (pET28b
+
-hrpG) analysed by agarose gel electrophoresis. 
Image shows hrpG (432 bp) successfully cloned into pET28b+ (larger band). DNA ladder in Appendix Figure 100. 
An initial test of the solubility of HrpG was performed using a small-scale on-the-bench 
purification protocol (as opposed to using the FPLC system). A 50 ml culture of BL21 
containing pEJ3 was grown to mid-log phase then induced with 0.5 mM IPTG for 3 hours. 
The cells were pelleted and resuspended in 2 ml Buffer A (containing protease inhibitor 
cocktail, Roche) then sonicated twice using a 2 second pulse on/off programme. Sonicated 
cells were then pelleted at 4oC in a microfuge at 18,000 x g. The supernatant (soluble 
fraction) was then purified using a gravity flow method (as described Burrows et al, 2009b). 
Briefly 400 µl Ni-NTA resin (Qiagen) was equilibrated with Buffer A (50 mM sodium 
phosphate pH 7.0, 50 mM NaCl, 5% (v/v) glycerol), prior adding to the cell supernatant, and 
gently agitated for 30 min at room temperature. The resin was then placed in a gravity flow 
column and washed with 10 ml Buffer A followed by Buffer A plus imidazole at increasing 
concentrations to elute HrpG (see Figure 72). 
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Figure 72: HrpG gravity flow purification 
Gel shows the total cell extract, soluble fraction (supernatant after sonication and centrifugation), insoluble fraction (pellet 
remaining after sonication and centrifugation), unbound protein (sample collected after first column wash with Buffer A, 
and eluted fractions with imidazole concentrations increasing at intervals from 50 mM to 400 mM. Protein ladder in 
Appendix Figure 100. 
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Figure 72 shows that HrpG expressed but remained largely insoluble. Some protein was 
found in the soluble fraction but when purified using the gravity flow method a high 
proportion of contaminant proteins eluted with HrpG. Therefore additional attempts were 
made to improve the solubility and purity of HrpG. PspF is routinely purified in this 
laboratory and cells are subjected to a cold-shock, by surrounding the culture flask with ice, 
before induction, which takes place at 25oC. This method was tried with HrpG but did not 
improve its solubility (data not shown). Insolubility can be caused by the burden placed 
upon cells induced to overexpress a non-native protein. To reduce this burden, BL21 
containing pEJ3 were induced with 10-fold less IPTG (0.05 mM) than above, but this also 
failed to improve the yield of soluble HrpG (data not shown). Many strains of E. coli are 
available for expressing recombinant proteins; some for general use (BL21 and B834), some 
for rare codon usage (Rosetta) and some that enable cloning and purification steps within 
one strain (Acella and NovaBlue). To determined if the bacterial expression strain could 
improve HrpG solubility, B834, BL21, NovaBlue, Acella and Rosetta strains were transformed 
with pEJ3 and protein expression levels and soluble versus insoluble protein levels were 
compared (see Figure 73). No significant differences between the strains were detected, so 
the BL21 strain was used in subsequent purifications. To improve the purity of eluted HrpG, 
increased volumes of Buffer A were used to wash the resin and supernatant (minimally two-
fold higher) – this did not improve the purity of the eluted protein (data not shown). A 
cobalt resin was compared to Ni-NTA since cobalt, whilst it has a lower affinity for histidine 
residues than nickel, binds fewer contaminating proteins (due to reduced affinity), therefore 
the protein should be ‘cleaner’ after purification. However, the purity of HrpG was not 
significantly improved (data not shown).  
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Figure 73: HrpG strains test purification 
Gravity flow purification of HrpG with E. coli expression strains NovaBlue, BL21, B834, Rosetta and Acella. Gel shows the 
total cell extract, soluble fraction (supernatant after sonication and centrifugation), insoluble fraction (pellet remaining 
after sonication and centrifugation), unbound protein (sample collected after first column wash with Buffer A, and eluted 
sample with 500 mM imidazole. Protein ladder in Appendix Figure 100. 
Given that none of the modifications (tried above) to the original protocol improved the 
solubility and/or purity of HrpG, and that the majority of the protein consistently remained 
in the insoluble fraction, a logical next step was purification HrpG from the insoluble fraction 
by urea denaturation. The insoluble cell pellet was resuspended in Buffer A containing 8 M 
urea. The sample was then re-centrifuged to remove any insoluble debris. The urea 
supernatant was then purified using the gravity flow method (as above) with one elution 
concentration of 500 mM imidazole (see Figure 74). 
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Figure 74: HrpG gravity flow urea purification 
Gel shows the insoluble fraction (pellet remaining after sonication and centrifugation) which has been dissolved in 8 M 
urea, unbound protein (sample collected after first column wash with Buffer A, samples collected after resin washed with 
5x resin volumes of Buffer A and eluted fractions with 500 mM imidazole. HrpG (approximately 17.8 kDa) eluted from the 
resin with 500 mM imidazole. Protein ladder in Appendix Figure 100. 
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Figure 74 suggests that HrpG can be purified from the insoluble fraction by urea-
denaturation and subsequent re-folding in the absence of urea. However, the use of re-
folded proteins has its limitations due to potential mis-folding and the possibility that the 
protein will lose its solubility and again become insoluble once the urea has been removed. 
Therefore, an attempt was made to purify HrpG on a larger scale using an ÄTKA FPLCTM (see 
Figure 75).  
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Figure 75: HrpG FPLC purification 
Gel shows the total cell extract, soluble fraction (supernatant after sonication and centrifugation), 0 mM imidazole wash 
(sample collected after 5x column volume washes with Buffer A), and eluted fractions with an imidazole gradient of 0-100% 
(0 mM – 1000 mM) over 20 min with 1 ml fractions collected. The majority of HrpG (approximately 17.8 kDa) eluted 
between 500 mM – 750 mM imidazole. Protein ladder in Appendix Figure 100. 
Figure 75 demonstrates that purification of HrpG from the soluble fraction does not yield 
sufficient quantities of pure HrpG; therefore, despite the limitations of purifying re-folded 
proteins, HrpG was purified from the insoluble fraction by urea denaturisation (see Figure 
76). 
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Figure 76: HrpG urea FPLC purification 
Gel shows the soluble fraction (supernatant after sonication and centrifugation), insoluble fraction (pellet remaining after 
sonication and centrifugation) which has been dissolved in 8 M urea, unbound protein (sample collected while loading 
column with denatured sample), 0 mM imidazole wash (sample collected after 5x column volume washes with Buffer A), 
30 mM imidazole wash and eluted fractions with an imidazole gradient of 0-100% (0 mM – 1000 mM) over 40 min with 1 
ml fractions collected. Protein ladder in Appendix Figure 100. 
Figure 76 shows that HrpG could be purified from the insoluble fraction to a high purity level 
(approximately 90%). A detailed protocol for the purification of HrpG using urea can be 
found in Chapter 2. Briefly, the insoluble fraction was dissolved in 8 M urea then centrifuged 
to remove any undissolved cell debris. This was then loaded onto a 5ml Hi-Trap™ HP Column 
and all subsequent steps were performed in the absence of urea. This allowed HrpG to 
refold as it was eluted from the column. To ensure complete removal of urea, HrpG was 
dialysed against a storage buffer (TGED) which also contained no urea. After concentration, 
HrpG was measured as being approximately 30 µM. Since HrpG was purified at sufficiently 
high concentrations for in vitro studies, a polyclonal antibody was produced using 
Eurogentec’s Speedy 28-day immunisation Protocol. Prior to sending HrpG to Eurogentec for 
rabbit immunisation, HrpG was tested for cross-reactivity with 10 rabbit sera by 
immunoblotting (see section 2.3.9). Two rabbits were selected for immunisation that 
reacted least with HrpG. Approximately 5 mg of HrpG was sent to Eurogentec and anti-HrpG 
antibodies were successfully produced (see Chapter 4 immunoblotting results, e.g. Figure 
47).  
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HrpV 
In an attempt to improve the standard purification yield (approx. 14 µM), the HrpG-urea 
protocol was used with HrpV (see Figure 77). However, this method was not successful for 
HrpV – the protein eluted across a large range of imidazole concentrations (350 mM – 725 
mM) and was not of sufficient purity or yield for further applications. 
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Figure 77: HrpV urea FPLC purification 
Gel shows the total cell extract, soluble fraction (supernatant after sonication and centrifugation), unbound protein 
(sample collected while loading column with denatured sample), insoluble fraction (pellet remaining after sonication and 
centrifugation) which has been dissolved in 8 M urea, 0 mM imidazole wash (sample collected after 5x column volume 
washes with Buffer A), 40 mM imidazole wash, 40 mM imidazole wash impurities peak and eluted fractions with an 
imidazole gradient of 0-100% (0 mM – 1000 mM) over 40 min with 1 ml fractions collected. Protein ladder in Appendix 
Figure 100. 
Since the urea-denaturation method was unsuccessful for improving yield of purified HrpV, 
despite the majority of HrpV remaining insoluble, an alternative protocol was designed. A 2L 
flask with 1L LB was inoculated with freshly transformed BL21 containing pVAV1 (pet28b+-
hrpV) and grown to mid-log phase before being temperature-shifted to 16oC. IPTG (0.5 mM) 
was then added to induce overnight expression of HrpV at 16oC. FPLC purification was then 
performed the next day. This protocol (i) avoids storing either cells or proteins and allows 
longer and slower overexpression of HrpV (rather than 3 hours at 37oC), which may help to 
minimise protein aggregation. The results of this protocol with HrpV can be seen in Figure 
78. 
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Figure 78: HrpV FPLC purification  
Gel shows the total cell extract and eluted fractions with an imidazole gradient of 0-100% (0 mM – 1000 mM) over 20 min 
with 1 ml fractions collected. The majority of HrpV (approximately 15.4 kDa) eluted between 300 mM – 650 mM imidazole. 
Protein ladder in Appendix Figure 100. 
HrpV purified from cells grown using the “overnight at 16oC” protocol yielded a 
concentration of 70 µM which was significantly higher than the previous concentration of 14 
µM. Therefore this protocol was used for future purifications of HrpV.  
 
HrpRS 
HrpRS were cloned by M. Jovanovic as a single operon in the pQE70 vector which encodes a 
C-terminal His-tag on HrpS. HrpR then co-purifies with the His-tagged HrpS. The successful 
protocol that was used for HrpV was also applied to HrpRS in an attempt to increase yield 
concentrations from around 20 µM. Following dialysis, the HrpRS-containing fractions were 
concentrated (see Chapter 2) which resulted in a final concentration of 300 µM. Figure 79 
shows the results of this purification.  
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Figure 79: HrpRS FPLC purification 
Gel shows the total cell extract, soluble fraction (supernatant after sonication and centrifugation), insoluble fraction (pellet 
remaining after sonication and centrifugation), unbound protein (sample collected while loading column with denatured 
sample), 0 mM imidazole wash (sample collected after 5x column volume washes with Buffer A), 60 mM imidazole wash 
and eluted fractions with an imidazole gradient of 0-100% Buffer B (0 mM – 1000 mM imidazole) over 20 min with 1 ml 
fractions collected. Protein ladder in Appendix Figure 100. 
HrpGNQR and HrpVLAG 
Purification of HrpGNQR (vector pEJ37 in BL21) was performed using the urea-denaturation 
method but yielded a higher concentration but slightly reduced purity compared to HrpG. 
Purification of HrpVLAG was attempted, however, no overexpression of this protein was 
detected (data not shown). This is in line with the results shown in Chapter 4 (section 
4.4.2.3) where the HrpVLAG-BACTH fusion proteins were not expressed; further implicating 
the ‘LAG’ motif in the structural stability of HrpV. 
5.4.2. HrpRS transcription activity  
Since all components of the system had been purified (and Eσ54 was available in the 
laboratory), in vitro activity assays could be performed. Initially the transcriptional activity of 
HrpRS in the presence and absence of hydrolysable nucleotide dATP was compared to the 
activity of PspF using the σ54-dependent Sinorhizobium meliloti nifH test promoter (which 
lacks the HrpRS-specific UAS sites present in the hrpL promoter). 
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Figure 80: HrpRS in vitro full-length transcription 
Comparison of PspF1-275 and HrpRS in a full-length (FL) transcription assay using nifH supercoiled promoter, with and 
without dATP. Experiment performed as described in section 2.6.1.   
Figure 80 demonstrates that PspF and HrpRS are capable of activating σ54-dependent 
transcription at the nifH promoter, thus confirming that HrpRS requires nucleotide – here 
dATP – for their activity. Figure 80 also shows that the activity of HrpRS is not limited to the 
hrpL promoter (and the HrpRS-specific UAS sequences). 
5.4.3. Effect of HrpV and HrpG on HrpRS transcription activity 
To establish that HrpV specifically inhibits the action of HrpRS, HrpV was tested for 
inhibition of transcription activation by an alternate EBP (the AAA+ domain of PspF), using 
the nifH test promoter (as used above). As shown in Figure 81 (and Figure 80), whilst PspF 
and HrpRS are both able to activate σ54-dependent transcription at the nifH promoter (in a 
dATP-dependent manner), only the activity of HrpRS is inhibited by HrpV (at equimolar 
concentrations of HrpV to HrpRS dimer). It is clear that the action of HrpV is specific in 
targeting HrpRS, since it does not inhibit the activity of PspF. Further, when HrpG was added 
to the HrpRS-V regulatory complex, it relieved some of the inhibitory action of HrpV (as 
observed in vivo Figure 32), but had no stimulatory effect on transcription activation by 
PspF. These results establish that HrpG functions as a specific suppressor for HrpV activity 
and that HrpG and HrpV can function independently of any P. syringae-specific factors. 
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Figure 81: HrpRS in vitro full-length transcription with HrpV and HrpG 
Comparison of PspF1-275 and HrpRS in a full-length (FL) transcription assay using nifH supercoiled promoter, and in the 
presence or absence of HrpV and HrpG. Experiment performed as described in section 2.6.1.   
Since both the in vivo and in vitro data demonstrate the functional role of HrpV, i.e. to 
specifically inhibit HrpRS activation of Eσ54 the next logical question was how is this 
inhibition achieved? The results shown in Figure 82 panel (a) address whether HrpV acts at 
the stage of open complex formation. To answer this question either HrpV or the regulator 
complex HrpRS-V were added to pre-formed PspF-dependent σ54-RNAP open complexes 
(OCs). In the presence of either HrpRS-V or HrpV the number of OCs (as measured by %-DNA 
bound in a native gel shift mobility assay) remains the same as the original OCs (not 
challenged). The results suggest that HrpV acts prior to OC formation. Further, ATPase 
assays (conducted by J. Schumacher) indicated that HrpV did not inhibit the ATPase activity 
of HrpRS (where the ATPase turnover rate/min for 1 µM HrpRS was: 0.180 ± 0.02 (minus 
HrpV), 0.192 ± 0.02 (plus 1 µM HrpV) and 0.183 ± 0.02 (plus 10 µM HrpV) (Jovanovic et al., 
2011). Control reactions were performed to ensure that the ATPase buffer did not prevent 
HrpS from interacting with HrpV, thereby giving a false negative result. As shown in (Figure 
82 panel b) glutaraldehyde cross-linking performed in either HGNED or ATPase buffers 
indicated that a similar amount of cross-linked HrpS-HrpV complex (see Figure 88) was 
detected in both buffers. Thus Figure 82 panel b demonstrates that the ATPase buffer per se 
does not prevent HrpV from interacting with HrpS; and hence maintains the potential to 
inhibit HrpRS. It appears therefore that the action of HrpV is neither to inhibit ATP hydrolysis 
nor to disrupt OCs. As such, the mechanism of HrpV inhibition appears distinct from any 
other regulators of EBPs studied so far.  
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Figure 82: Controls to test the effect of HrpV on EBP in vitro activities 
Controls to test the effect of HrpV on EBP activities. (a) A bar graph showing the percentage of DNA bound in the closed 
promoter complex (CC) and transcriptionally-proficient open promoter complex (OC; formed by PspF activation) in the 
presence of  HrpRS-V or HrpV.  (b) A bar graph showing relative glutaraldehyde cross-linked HrpRS-HrpV complex 
intensities in ATPase buffer (used to measure the ATPase activity of HrpRS +/- HrpV) or HGNED buffer. The relative amount 
of crosslinked HrpS-V complex was determined by fluorescence scanning. 
 
5.5. Complex organisations of HrpRS, HrpV and HrpG 
Determining the organisation of HrpR, HrpS, HrpV and HrpG complexes in vitro 
 
Sequence analysis of HrpRS show that they are typical EBPs (Figure 67) and the functional 
data indicate they activate transcription from σ54-dependent promoters similar to other 
EBPs (Figure 80) (albeit in a co-dependent manner (Hutcheson et al., 2001a, Jovanovic et al., 
2011)). Since EBPs, like other AAA+ proteins, are active in higher oligomeric forms, usually 
hexamers, it was hypothesised that HrpR and HrpS interact to form hexamers. Mass 
spectrometry, gel filtration, native mobility shift assays and gluteraldehyde cross-linking 
were used to determine the organisation of complexes. These analyses were used to 
delineate the HrpRS complex, and the HrpRS-HrpV regulatory complex. HrpS-HrpV 
interactions have been shown using two-hybrid analyses (Jovanovic et al., 2011, Wei et al., 
2005), but not in the (additional) presence of HrpR. Additionally, the interaction between 
HrpV and HrpG has only been observed in vivo, but has not been visualised using 
recombinant proteins in vitro (Wei et al., 2005b) (see Figure 33).  
5.5.1. Mass spectrometry 
Mass spectrometry is used to determine the mass of particles so it can be used to delineate 
the subunit composition of the HrpRS complex (e.g. whether (i) it exists as a heterohexamer 
or two homohexamers; (ii) sub-complexes co-exist (dimers, trimers etc); (iii) the number of 
HrpRS subunits within a heterohexamer are equivalent). Knowing the organisation of the 
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HrpRS complex will be important for understanding the selective advantage that organisms 
with HrpRS have over those with singly acting EBPs, especially the organisms with HrpSS. 
Since the concentration and purity of HrpRS was improved to 300 µM, a technique known as 
nano electrospray ionisation mass spectrometry (nESI-MS) was employed to analyse the 
composition of HrpRS. These experiments were performed by A. Park in Carol Robinson’s 
laboratory (formally University of Cambridge). This technique allows the mass or a complex 
to be determined down to differences of a few daltons (Da). This is useful for determining 
the stoichiometry of the HrpRS complex because the masses of HrpR (34579 Da) and His-
tagged HrpS (34179 Da) are very similar. Buffers used to stabilise proteins (e.g. TGED protein 
storage buffer, section 2.1.2) are not compatible with nESI-MS due to the salts present, 
which can interfere with and sometimes obstruct the ionisation process (Heck, 2008). 
Therefore, before the HrpRS sample could be ionised it was buffer exchanged into 200 mM 
ammonium acetate, pH 7.0, (an ESI-MS–compatible 'volatile buffer'), using a Vivaspin 
centrifugal concentrator (as was performed with PspF1-125 (Rappas et al., 2005)). This 
process took between 1-2 hours and lead to a significant decrease in sample concentration 
(see Appendix C, Figure 109). Unfortunately the HrpRS sample did not ionise so no results 
could be collected. The procedure was reattempted in (i) the presence of ADP, which is 
known to improve the stability of EBP complexes; and (ii) with HrpV. However, this also 
yielded no results. An alternative method could be to purify HrpRS directly into an 
ammonium acetate-based buffer in order to minimise the post-purification procedures. The 
attempts at nESI-MS were also unsuccessful with HrpG, probably due to the same problems 
experienced with the HrpRS sample or potentially due to the presence of contaminant 
proteins in the HrpG sample (see Appendix C).  
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Figure 83: Mass spectrum of HrpV 
Mass spectrum of HrpV electrosprayed from an aqueous ammonium acetate solution displaying multiple ion signals that 
originate from two monomeric forms of HrpV (15946 Da and 16124 Da) and three dimeric forms (31891 Da, 32069 Da and 
32247 Da). Y-axis is percentage intensity and X-axis (m/z) is the mass to charge ratio. 
However, HrpV ionised and was detected in two monomer forms (given as 15946 Da and 
16124 Da) and three dimer forms (Figure 83). The two monomer forms could correspond to 
HrpV6-His and HrpV6-His-ΔM1 (i.e. loss of the N-terminal methionine) and the three dimers 
(31891 Da, 32069 Da and 32247 Da) represent combinations of the two monomer forms. 
This result is inconsistent with the BACTH assay (Figure 33) which showed that HrpV does 
not self-associate. This could be due to the size and position of the fused cya subunits or 
alternatively, dimerisation is an in vitro property of HrpV that is not observed in vivo, 
perhaps due to the presence of the His-tag which can influence self-association. 
5.5.2. Gel filtration 
Since nESI-MS was unsuccessful, gel-filtration chromatography of co-purified HrpRS was 
carried out (with J. Schumacher) in order to try and determine the organisation/composition 
of the HrpRS complex – and by inference the HrpRS-HrpV and HrpRS-HrpVG complexes. Gel 
filtration demonstrates at least two distinct species with molecular weights (MW) 
corresponding to 212 kD (apparent 6.1 mer) and 52 kD (apparent 1.4 mer) - where the MW 
of HrpR is 34.6 kD and HrpSHis is 34.3 kD (Figure 84 panel a). The lower MW peak does not 
permit assignment of subunit composition(s) and may comprise a mixture of monomers and 
dimers. SDS-PAGE analysis of the fractions demonstrates that HrpR and HrpS are present in 
both peaks (Figure 84 panel b, left). Interestingly, the relative intensities of HrpR and HrpS 
differ significantly between the hexameric (hex) species (where HrpS predominates over 
HrpR) and monomer/dimer (m/d) species (where HrpR predominates over HrpS). The 
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relative HrpR/HrpS fluorescence intensities are consistently scored as approximately 0.5 in 
fractions 5-8; suggesting a fixed HrpR/HrpS stoichiometry in the putative hexameric 
fractions – although precise determination of the stoichiometry of this complex was not 
possible using this approach (Figure 84 panel b, right). Re-produced retention volumes 
(Figure 84 panel a, hex and m/d re-runs) and concentration-independent ATPase turnover 
rates of the re-chromatographed or diluted hexameric HrpRS fraction (fraction 7) (Figure 84 
panel c) indicate that the HrpRS hexamer is stable at least over the purification and assay 
time course and at the concentrations used in this study. 
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Figure 84: HPLC Gel filtration of HrpRS 
a) left – Analytical HPLC gel-filtration vertically offset chromatograms of co-purified HrpRS (top); re-chromatographed 
fraction 7 (hex, middle) and fraction 10 (m/d, bottom). The apparent monomer/dimer (m/d), hexamer (hex), void volume 
(void) retentions are indicated. Right - molecular mass standards and their retention volumes used in calculating the MW 
of the peaks (Ve – elution volume, Vo – void volume, Vt – total column volume (300 mm)). b) left – SDS-PAGE of the 
SYPRO-stained fractions collected during gel-filtration in (a), top chromatogram. Right - the relative fluorescence intensity 
ratios of HrpR/HrpS are plotted in the line graph (black) (superimposed on the gel-filtration profile of HrpRS; grey). c) left - 
Bar chart illustrating the ATPase turnover rates (min-1) of the fractions in (b) (superimposed on the gel-filtration profile of 
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HrpRS; grey). Right - concentration-independent ATP turnover rates in a two-fold dilution series of fraction 7 (hex, dark 
grey) compared to dilutions of fraction 10 (m/d, light grey) 
Taking the relative total HrpRS protein concentrations of the individual gel filtered fractions 
into account, the ATPase turnover rates (of all the fractions) were determined and it was 
found that the hexameric species was the most active (Figure 84 panel c, left). Further, the 
ATPase activity of fraction 7, representing the hexamer, and fraction 10 (the 
monomer/dimer) was compared in a dilution series which demonstrated that the hexamer 
was the active species (Figure 84 panel c, right).  
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Figure 85: HrpRS in vitro full-length transcription with putative hexamer and monomer/dimer fractions 
In vitro transcription assay (as in Figure 80) of the monomer/dimer fraction 10 from panel a (m/d) at 0.2 µM compared to 
an equimolar concentration of HrpRS (0.2 µM), prior to gel filtration. The concentration of the hexamer was too dilute after 
gel-filtration to use in the full-length (FL) transcription assays. 
 The HrpRS concentration in the hexameric fraction (fraction 7) was too low to stimulate 
transcription in vitro (Figure 85) (as was the original load sample diluted to <0.1 µM, data 
not shown). However, the monomer/dimer fraction (fraction 10) was unable to detectibly 
activate σ54-RNAP, whereas the original loading sample (diluted to the same concentration 
as the gel-filtered HrpRS monomer/dimer fraction, 0.2 µM) supported transcription. These 
results suggest that the hexameric HrpRS assembly is the active form and that a defined 
subunit composition of a HrpRS hexamer confers the highest transcription and ATPase 
activities. 
5.5.3. Glutaraldehyde cross-linking 
Glutaraldehyde cross-linking of proteins is a relatively simple procedure, which for example, 
can give information on the quaternary association of proteins (Fang et al., 2007). Cross-
linked products can be subsequently detected by SDS-PAGE (Fadouloglou et al., 2008) and 
either immunoblotting or protein staining (here SYPRO fluorescent staining). The cross-
linking reaction is non-specific – glutaraldehyde can react with any nitrogens and 
preferentially lysine, tyrosine, histidine and arginine residues (Kiernan, 
2000). Glutaraldehyde molecules have two aldehyde groups, separated by a flexible chain of 
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three methylene bridges, which in aqueous solutions are present largely as polymers (Figure 
86, A). It has greater cross-linking potential than formaldehyde (another commonly used 
reagent) because cross-links can form through both aldehyde (-CHO) groups (in the 
monomer) and over variable distances (formaldehyde only has one). The cross-linking 
reaction occurs via the free -CHO groups, which interact with any nitrogens with which they 
come into contact (Figure 86, B). 
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Figure 86: Glutaraldehyde reactions 
 A) Monomers of glutaraldehyde often form polymers in aqueous solutions. B) –CHO groups from glutaraldehyde polymers 
(represented by red O) react with the –NH2 groups of proteins forming a covalent cross-link bond and releasing H2O 
(Kiernan, 2000). 
Cross-linking reactions with co-purified HrpRS were performed in the presence and absence 
of ADP (Figure 87), since ADP has been shown to promoter hexamer formation in EBP PspF 
(Joly et al., 2006b). Reactions were performed using either 2 or 30 min incubation times 
with glutaraldehyde to establish optimal conditions. 
 
 
Figure 87: HrpRS gluteraldehyde cross-linking 
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Glutaraldehyde (Glut.) cross-linking of HrpRS in the presence and absence of ADP, cross-linked for either 2 min or 30 min. 
Cross-linked HrpRS shows oligomeric state corresponding to dimers, approx. 70 kDa (which could be R-S, S-S or R-R), 
hexamer, approx. 209 kDa and dodecamer, approx. 417 kDa (2 linked hexamers). Uncross-linked HrpRS is at 5 µM, cross-
linked at 10 µM.  
As shown in Figure 87, after cross-linking for either 2 or 30 min with glutaraldehyde 
oligomeric forms of HrpRS were clearly present. Comparing the cross-linking with and 
without ADP (especially for 30 min) shows a clear improvement in the definition of the 
higher molecular weight bands (~207 and ~417), consistent with ADP promoting higher-
order oligomerisation. The monomeric forms of HrpR and HrpS are clearly visible – HrpR is 
34.6 kDa and HrpSHis is 34.3 kDa; although they appear to migrate differently in the gel. 
Discernable oligomeric forms of HrpRS were (i) a dimer, with an approximate molecular 
weight of 70 kDa (migrates on the gel slightly higher, at approx. 75 kDa), which could consist 
of R-S, S-S or R-R, or a mixture of all combinations (although HrpR does not self-associate in 
the BACTH assay (Jovanovic et al., 2011)). (ii) A putative hexameric species of HrpRS of 
unknown subunit composition migrates at approximately 209 kDa. A band was apparent 
between 160 kDa and 220 kDa, which could represent a HrpRS hexamer. Since other bands 
migrated slightly higher than expected, this band could be a HrpRS tetramer (which would 
be approximately 138 kDa). (iii) A slower migrating species which was larger than 220 kDa 
was detected – labelled as a HrpRS dodecamer (which would correspond to approximately 
414 kDa). Dodecamers have been reported for other EBPs (Park et al., 2002). 
Glutaraldehyde cross-linking can be ambiguous, requiring optimisation of parameters to 
limit artificial interactions (Fadouloglou et al., 2008) so this dodecameric complex may not 
represent a natural state of HrpRS. Again, due to the slower migration of some bands it is 
also possible that this complex is the hexameric form of HrpRS.  
Given that HrpV has been shown to interact with HrpS in a BACTH assay (Jovanovic et al., 
2011) and that HrpV clearly inhibits transcription activation by HrpRS, (albeit not through 
inhibiting ATPase activity or open-complex formation; see Figure 81 and Figure 82) it 
seemed logical to investigate HrpS-HrpV interactions by glutaraldehyde cross-linking. As 
shown by Figure 88, the ability of HrpS and HrpV to stably interact was further 
demonstrated in vitro by cross-linking. 
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Figure 88: HrpRS gluteraldehyde cross-linking with HrpV 
Glutaraldehyde (Glut.) cross-linking of HrpRS and HrpV in the presence and absence of ADP, cross-linked for 20 min. 
Putative cross-linked species are annotated by arrows Uncross-linked HrpV is at 5 µM, cross-linked at 20 µM. Uncross-
linked HrpRS is at 5 µM, cross-linked at 10 µM. 
In line with the cross-linking experiment in Figure 87, in the presence of HrpV, HrpRS are still 
visible as monomers and as dimeric complexes (approximately 70 kDa) (see Figure 88). A 
possible HrpV-independent tetramer form is also visible (at approximately 138 kDa). Two 
HrpV-dependent bands are visible, one at 50 kDa which could correspond to a HrpS-HrpV 
complex (probably not a HrpR-HrpV complex given the BACTH data, mentioned above). The 
second band is approximately 100 kDa and could correspond to a complex containing two 
HrpV and two HrpS proteins, or alternatively two HrpV proteins and one HrpRS dimer. It is 
also possible that this band is a HrpRS trimer (which would be 103 kDa); although this is 
unlikely given that it is not visible in the absence of HrpV. 
 
Given the BACTH assay data, which showed HrpV binding HrpG (Figure 33), and nESI-MS 
which showed a HrpV dimer organisation, glutaraldehyde cross-linking was used to visualise 
a potential HrpV-HrpG complex and HrpV dimers (see Figure 89). In Figure 89 (A) HrpV 
clearly formed a dimer, both in the absence and presence of HrpG. The dimer concentration 
was largely HrpG-concentration independent, although due to distortion in the last two 
lanes of the gel it is difficult to conclude whether or not the HrpV dimer decreased with 
increasing concentrations of HrpG. A cross-linked species in the HrpG alone lane 
(approximately 40 kDa) increased with increasing concentrations of HrpG. This band 
potentially represents a HrpG dimer (HrpG is 17.8 kDa, so a dimer would be 35.6 kDa), 
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however, given that the HrpG purification contained some visible background proteins, and 
the cross-linked species is not particularly distinct, it is likely that the 40 kDa band is formed 
from some of these background proteins. As shown in Figure 89 (B), increased 
concentrations of HrpV clearly led to increased intensity of the HrpV dimer.  
 
Figure 89: HrpV and HrpG gluteraldehyde cross-linking titrations 
Glutaraldehyde (Glut.) cross-linking of HrpG and HrpV, cross-linked for 20 min. A) Titration of HrpG. B) Titration of HrpV. 
Arrows indicate protein species. Numbers above gels indicate concentrations of HrpV and HrpG in µM. 
The appearance of a HrpV dimer (Figure 89) in the presence of gluteraldehyde is in full 
agreement with the mass spectrometry data (Figure 83) but does not agree with the BACTH 
data (Figure 33). Surprisingly, there is no HrpV-HrpG cross-linked species. This could be due 
to HrpG only forming transient reactions with HrpV that are not detectable in this assay. It 
could also be due to the cross-linking conditions used, possibly pH, buffer, temperature or 
the presence of the His-tags. However, given that HrpG binds HrpV in the BACTH assay 
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(Figure 33) and given that HrpG has been shown to affect the activity of HrpV in vivo and in 
vitro (Figure 32 and Figure 81) there is no doubt that HrpV and HrpG can interact. 
Potentially, HrpG preferentially binds with a HrpRS-HrpV complex. 
5.5.4. Electrophoretic mobility shift assays (EMSA) 
An alternative method of visualising “native” HrpV-HrpG complexes/interactions (other than 
cross-linking) is by running them on a non-denaturing gel, known as EMSA or native mobility 
shift assay. Given the differences in the cross-linking versus BACTH data it seemed necessary 
to try to confirm whether a stable HrpV-HrpG complex exists. EMSA analysis should allow 
any HrpV-HrpG complexes to be distinguished from “free” unbound HrpV or HrpG due to 
differences in their mobility. This method could also be applied to the HrpGNQR and HrpVLAG 
mutants. Recall that HrpGNQR is a triple alanine substitution mutant of residues N110, Q111 
and R112; these residues have 100% conservation amongst all HrpG homologues (see Figure 
56) and HrpGNQR can interact with HrpV in the BACTH assay (Figure 33). When this 
experiment was performed HrpGNQR had been successfully purified (see 5.4.1), albeit at a 
lower purity level than HrpG so it was included in the reactions. The HrpVLAG mutant consists 
of double alanine substitution of L108A and G110A have 100% sequence conservation 
(Figure 52). In the BACTH assays this mutant failed to form stably expressed fusion proteins 
(Figure 55). In line with this attempts to purify HrpVLAG were unsuccessful, probably because 
this protein does not stably express.  
 
Initially assays were performed with an increasing concentration of HrpV incubated with a 
constant HrpG or HrpGNQR concentration. As shown in Figure 90 lane 1, HrpV forms two 
native states, most likely corresponding to a monomer and a dimer (given the cross-linking 
and nESI-MS data, Figure 83 and Figure 89). At 15 µM of HrpV (lane 1), the dimeric species is 
more intense than the monomeric form indicating that at this concentration a dimer is the 
more dominant form. This was not captured in cross-linking, where even at 20 µM HrpV the 
monomeric form was more dominant (Figure 89, A). However, in this case HrpG was present 
which could influence the dimeric form of HrpV. The migration of proteins through native 
gels is dependent on their charge and conformation, and is therefore difficult to predict. 
Unfortunately, the monomeric forms of HrpV, HrpG and HrpGNQR migrate to the same 
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position in the native gel which means visually differentiating between HrpV HrpG and 
HrpGNQR monomers is not possible. 
Interestingly, a slightly faster migrating species was identified when both HrpV and wild-
type HrpG were present, which was labelled as a HrpV-HrpG complex (most clearly visible in 
lanes 4 and 6). This species was also identified as such because it appears more ‘smeared’ 
than the HrpV/HrpG monomer bands (compare lanes 1-4 and 6). This smearing is indicative 
of the dynamic nature of the interactions, which are akin to the observations of interactions 
between PspF and its regulator PspA (Elderkin et al., 2002) – thus interactions between 
HrpV and HrpG appear relatively unstable, potentially transient, which could account for the 
inability to capture the complex by cross-linking. Quantification of intensities in this gel 
proved difficult for the following reasons: (i) there is a smearing effect caused by a potential 
dynamic equilibrium between HrpV monomer and HrpV dimer; (ii) the HrpGNQR sample 
appears ‘dirtier’ than HrpV and HrpG, making the background intensities in lanes 3 and 7-9 
far higher than other lanes and (iii) although there should be a titration of increasing 
amounts of HrpV, there seems to be less overall sample in lane 5 than lane 4, probably due 
to loading errors. Despite these problems it is evident that, when comparing only lanes 1, 6 
and 9 (where there is a constant concentration of HrpV, 15 µM), the intensity of the HrpV 
dimer decreases significantly in the presence of HrpG but not in the presence of HrpGNQR. 
This implies that HrpG forms complexes with HrpV and in so doing reduces the amount of 
HrpV dimer species.  
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Figure 90: HrpV, HrpG and HrpGNQR native mobility shift assay with HrpV titration 
HrpV, HrpG and HrpGNQR pre-incubated for 20 min at room temperature were visualised on a native gel stained with SYPRO 
fluorescent stain. Numbers above the gel refer to concentration of proteins in µM. Yellow boxed region from full gel is 
shown in gel section below graph. Red bars indicate migration position of HrpV and HrpG monomers and HrpV-HrpG 
complex (which is apparent only in the presence of HrpG, not HrpGNQR). 
Due to the two observations, (i) that HrpG is having an effect on the ratio of HrpV 
monomer:HrpV dimer and (ii) a dynamic complex is formed between HrpV and HrpG, and 
that these two effects are not seen with HrpGNQR, an experiment with a constant 
concentration of HrpV was performed. This enabled the intensity of the dimer band to be 
directly compared between lanes (see Figure 91). Figure 91 shows native mobility shift assay 
analysis of increasing concentrations of HrpG and HrpGNQR incubated with a constant level 
of HrpV. As in Figure 90, a dimeric form of HrpV is visible and the HrpV and HrpG monomers 
migrate to approximately the same position in the gel. However, there is a clear difference 
in the concentration of the dimeric form of HrpV both across increasing concentrations of 
HrpG and when comparing HrpG to HrpGNQR. With increasing concentrations of HrpG the 
HrpV dimer band is clearly diminished, even though the concentration of HrpV is the same 
in each lane. At the same time the HrpV-HrpG complex increases in intensity (also present 
as a faster migrating ‘smear’), thus implying that the dimeric form of HrpV disassociates 
back into a monomer and this is then ‘free’ to bind HrpG. However, this phenomenon is not 
seen with increasing concentrations of HrpGNQR, thus implying that HrpGNQR is unable to 
disassociate the dimeric form of HrpV or to stably bind HrpV (in line with the BACTH data, 
(Figure 59 and Figure 60), where HrpGNQR bound HrpV when fused to T18 but not when 
fused to T25). The absence of an apparent HrpV-HrpGNQR complex could be the result of the 
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HrpGNQR mutant not being able to freely migrate into the native gel – as demonstrated by 
the increased amount of protein remaining in the wells of the gel, or potentially due to the 
higher proportion of contaminant proteins present in this sample.  
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Figure 91: HrpV, HrpG and HrpGNQR native mobility shift assay with HrpG and HrpGNQR titration 
HrpV, HrpG and HrpGNQR pre-incubated for 20 min at room temperature were visualised on a native gel stained with SYPRO 
fluorescent stain. Numbers above the gel refer to concentration of proteins in µM. Graph generated using fluorescent band 
intensities of HrpV dimer band and quantified using AIDA software. Bands from each specific lane were corrected for 
background intensity in that lane. Yellow boxed region from full gel is shown in gel section below graph. Red bars indicate 
migration position of HrpV and HrpG monomers and HrpV-HrpG complex. 
The fluorescent intensities of the HrpV dimer band in Figure 91 were quantified and results 
plotted on a graph. The graph clearly demonstrates that increasing concentrations of HrpG 
deplete the intensity (which is related to the concentration level) of the HrpV dimer, and 
that HrpGNQR does not have the same effect. This result has a significant implication both for 
the role of HrpG in interactions with HrpV, and the specific functional role of the ‘NQR’ 
motif (discussed below).  
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5.6. Conclusions 
The sequence analysis of HrpV and HrpG (Chapter 4), which identified conserved sequences 
across P. syringae pathovars (organisms with HrpSRS) and Erwinia spp. (HrpSS organisms), led 
to the conclusion that HrpV and HrpG in all these organisms are potentially functional 
homologues, that is HrpV in Erwinia may have the same role as HrpV in P. syringae (and the 
same holds true for HrpG). In HrpSS organisms, σ
54-dependent transcription of hrpL is 
activated by the single EBP HrpSS. If HrpV negatively regulates HrpSS and HrpG regulates 
HrpV in Erwinia, why does P. syringae have two (strictly co-dependent) EBPs, also regulated 
by HrpV and HrpG? To answer this question, the same organisms studied for sequence 
conservation in HrpV and HrpG were analysed for HrpR, HrpSRS and HrpSS. A number of 
questions can be addressed using this approach: (i) can the sequence alignments and 
phylogenetic tree give any clues as to the evolutionary history of HrpR, HrpSRS and HrpSS? (ii) 
is there any evidence from the HrpR and HrpSRS sequences to explain the reason for their 
co-dependence? and (iii) are there any residues that may be responsible for binding HrpV 
apparent in HrpSRS and HrpSS?  
 
The close sequence similarity between HrpR and HrpSRS is demonstrated by comparing 
Table 9 and Table 10, which show that HrpR and HrpSRS are more similar to each other than 
might be expected for two unrelated EBPs (they have 55-65% identities, 70-79% 
similarities). An example of this would be FleQ and FleT (TorF) from Rhodobacter 
sphaeroides (Poggio et al., 2005). When these were compared using pBLAST (to compare 
two sequences), they showed 50% identities and 64% positives in their most conserved 
region (recall that pBLAST does not compare regions of low sequence homology and FleT is 
missing the DNA-binding domain). This means HrpR and HrpSRS are not simply two EBPs that 
happen to be co-dependent – they are related in their origins from an ancestral gene 
duplication. In addition to this, the phylogenetic tree (Figure 69) constructed from 10 HrpR 
and HrpSRS sequences and 10 HrpSS sequences (and three other EBPs) shows that HrpR and 
HrpSRS have co-evolved, their branching patterns are the same. Also, they form a distinct 
clade, separate from HrpSS organisms (with the exception of P. fluorescens). These results, 
along with the fact that HrpR and HrpSRS form an operon transcribed from a single 
promoter, strongly suggest that they have evolved from a gene duplication event (see 
Figure 70).  
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Co-dependence in EBPs has not been reported other than FleT/FleQ from Rhodobacter 
sphaeroides (Poggio et al., 2005). In this case FleQ can function independently of FleT in 
activating transcription from the fleT promoter, and the reason for FleT’s co-dependence on 
FleQ for functionality is most likely due to the absence of the DNA binding domain in FleT. 
By comparison, the situation with HrpR and HrpSRS is somewhat different and more difficult 
to explain. HrpR and HrpSRS cannot function independently, either in vivo or in vitro 
(Jovanovic et al., 2011, Hutcheson et al., 2001a) and sequence analysis (Figure 67) shows 
that all of the conserved functional motifs found in EBPs are present (they also both have 
DNA binding domains which allow HrpR and HrpSRS from Ps. DC3000 to bind the hrpL 
promoter (Jovanovic et al., 2011)). Perhaps the most striking sequence divergence is the 
presence of tyrosine (Y) in the ‘GAFTGA’ motifs of HrpSRS and HrpSS instead of the highly 
conserved phenylalanine (F) (found in HrpR). The GAFTGA motif, in the L1 loop, directly 
contacts region I of σ54 (De Carlo et al., 2006, Rappas et al., 2005, Bordes et al., 2003). The 
most frequent naturally occurring substitution of the F residue is to Y, which is found in 
approximately 7% of annotated EBP sequences (Zhang et al., 2009). Experimental evidence 
has shown that the F85Y mutant of PspF still retained some transcription activity and was 
not deficient for binding σ54 (Zhang et al., 2009). It has been suggested that the presence of 
the tyrosine at this residue could set the level of transcription activation, that is, the rate 
could be higher if a phenylalanine was present but organisms with tyrosine require a slower 
rate. This is in line with recent data for HrpR and HrpSRS from Ps. DC3000 – mutating Y to F 
in HrpSRS increased transcription activation to 150% of wild-type activity (but did not allow 
transcription in the absence of HrpR) (Jovanovic et al., 2011). The fact that tyrosine is 
conserved for all HrpSRS and HrpSS sequences analysed in this study (Figure 67 and Figure 68) 
implies a strong selective pressure in these organisms for maintaining this otherwise sub-
optimal residue, and suggests that the role of HrpR (which has a GAFTGV motif) may be to 
raise the level of transcription activation in P. syringae above that seen in Erwinia, but not as 
high as may be possible if both had phenylalanine. This tyrosine residue is also a good 
candidate for HrpV binding as it is only present in HrpSRS and HrpSS (for which HrpSRS has 
been shown to bind HrpV and HrpSS probably interacts with HrpV) and is found within a 
motif crucial for EBP function (a good target for a negative regulator).  
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This chapter describes a reproducible method for purifying HrpG from the insoluble fraction 
(of a cell extract). This method involves denaturing the protein in a near-saturating 
concentration of urea (8 M) with subsequent refolding in the absence of urea. Other 
proteins, larger and more complex than HrpG, are commonly purified using this method, for 
example RNA polymerase from archeal Methanocaldococcus jannaschii (Nottebaum et al., 
2008). Often proteins are reconstituted by removal of urea by dialysis against buffers 
containing decreasing concentrations of urea in a time-controlled manner, but in the case of 
HrpG it can be refolded during the purification procedure. One advantage of having purified 
HrpG is the generation of HrpG-specific antibodies. This is useful because no tags are 
needed for immunoblotting which means the wild-type protein can be probed within its 
native environment. Wei et al (2005) used plasmid-borne FLAG-tagged HrpG to probe its 
interactions with HrpV in vivo which would not allow, for example, levels of HrpG 
production to be recorded over time.  
 
HrpV and HrpRS proteins were also purified in this study. Although they had been purified 
previously by M. Jovanovic, improvements were made to the concentration and purity of 
HrpV and HrpRS. HrpRS was particularly difficult to purify since only full-length proteins 
could be purified (due to in vivo evidence that the DNA-binding domain is important for 
function of HrpS; (Jovanovic et al., 2011)) and full-length (FL) proteins need to be 
characterised before truncated forms are analysed. Purification of FL EBPs is notoriously 
difficult. PspF is routinely purified as the DNA-binding domain truncation PspF1-275 since it 
has been shown that 5% of FL PspF remains in the soluble fraction whereas 50% of PspF1-275 
remains in this fraction (Jovanovic et al., 1999). A DNA-binding domain mutant of another 
EBP, NifA, was also more soluble and easier to purify than the FL form (Berger et al., 1995). 
Having the purified components, HrpV, HrpG and HrpRS allowed an in vitro activity assay to 
be developed to probe the roles of these proteins in the absence of any other components 
that may be present in vivo. The results from this assay confirmed the roles of HrpV and 
HrpG and demonstrated that HrpRS can activate transcription from a σ54-dependent 
promoter in a hydrolysable nucleotide-dependent manner. Other in vitro assays could also 
be employed, for example, Elderkin et al (2005) used a gel mobility shift assay to test the 
effect of PspA on PspF’s ability to remodel σ54 bound to a radio-labelled ‘early-melted’ DNA 
probe (which mimics an early stage in open complex formation). In the absence of PspA, 
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PspF remodels σ54 such that the σ54-DNA complex “shifts” (known as the super-shifted 
complex). In the presence of PspA this supershift complex does not form. The effect of HrpV 
and HrpG on the ability of HrpRS to remodel the σ54-DNA complex could be shown using a 
similar method (Elderkin et al., 2002b). DNA probes have proved useful tools for studying 
intermediate complexes (i.e. Eσ54 closed to open complex formation, see Chapter 1 Figure 6) 
(Burrows et al., 2010, Burrows et al., 2009a, Burrows et al., 2004). A set of hrpL promoter 
DNA probes were designed and attempts were made to characterise them with PspF (see 
Appendix C, 7.3.3.3). These probes could be used to analyse Eσ54 activity in the context of 
HrpRS, HrpV and HrpG. 
 
Importantly, this chapter has demonstrated that HrpRS are active as a hetero-hexamer 
(Figure 84 and Figure 85). In one sense this confirms them to be ‘typical’ EBPs and AAA+ 
ATPases which are most often active as hexamers (Rappas et al., 2005, Rappas et al., 2006, 
Sallai & Tucker, 2005, Lenzen et al., 1998). In another sense, this result demonstrates that 
HrpRS are unusual (specifically for bacterial EBPs and AAA+ ATPases, rather than eukaryotic) 
in being heteromeric rather than homomeric. A stacked homo-hexameric ring structure has 
been reported for the archeal mini chromosomal maintainance complex (MCM), which first 
forms a double-hexamer comprising the N-terminal domain hexamer and C-terminal 
domain hexamer, and then forms a dodecamer comprising two stacked double-hexamers 
(Fletcher et al., 2003). Eukaryotic hetero-hexamers include Mcm2-7p and Tip48/Tip49 (Puri 
et al., 2007, Schwacha & Bell, 2001). Since HrpRS form a hetero-hexameric structure the role 
of distinct subunits within the complex can be probed, which is difficult for homomeric 
structures. One distinction is the binding of HrpV to HrpS but not to HrpR (Jovanovic et al., 
2011). 
 
The role of HrpV as a negative regulator of HrpRS activity has been shown in vivo (see 
Chapter 4) (Preston et al., 1998, Wei et al., 2005). Here it has been demonstrated that HrpV 
negatively affects HrpRS activity in vitro (Figure 81), however, it does not affect open 
complex formation (Figure 82) or ATPase activity (Jovanovic et al., 2011). The majority of 
EBPs contain an N-terminal domain that is involved in their regulation (Figure 9) (Studholme 
& Dixon, 2003, Ghosh et al., 2010). Some EBPs do not, including PspF, FleQ, FleT, HrpR and 
HrpS, which means they require additional factors to regulate their activities. PspF is 
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regulated by PspA by inhibition of ATPase activity (Elderkin et al., 2002, Joly et al., 2009b). 
The regulation of FleQ and FleT is not well understood; FleQ activates transcription of fleT 
and FleT inhibits its own transcription by an unknown mechanism (Poggio et al., 2005). HrpV 
seems to regulate HrpRS activity by a previously undescribed mechanism. This mechanism 
could involve the dimeric organisation of HrpV, which has been shown using nESI-MS (Figure 
83), glutaraldehyde cross-linking (Figure 88 and Figure 89) and native mobility shift assay 
(Figure 90 and Figure 91). The role of HrpG could be to destabilise this dimer (Figure 90 and 
Figure 91). A model for the regulation of HrpRS by HrpV and HrpG will be proposed in 
Chapter 6. 
 
BACTH analysis (Figure 59 and Figure 60) showed that the HrpGNQR mutant was able to bind 
HrpV, although only when fused to the T18 subunit expressed from the high-copy number 
vector pUT18C (expression was not detected from the fusion on the low-copy number 
vector pKT25). Recall that the NQR residues are part of a larger motif “E_L_NQR”, which has 
100% conservation across all HrpG sequences, even the P. aeruginosa-related P. mendocina 
and the plant growth-promoting P. fluorescens HrpG-homologues (see Figure 56). Here, 
there is evidence to suggest that HrpGNQR behaves differently from the wild-type-like 
interactions with HrpV. HrpGNQR failed to destabilise the HrpV dimer and HrpGNQR-HrpV 
complexes were not detected (Figure 90 and Figure 91). Binding to HrpV may involve the 
whole “E_L_NQR” motif, explaining why in the BACTH assay this interaction was still 
detected in the presence of HrpGNQR mutant. However, in a native gel tight binding 
interactions must be present for complexes to be detected. Perhaps without NQR the 
binding to HrpV is weaker than wild-type. If the role of HrpG is to destabilise the HrpV dimer 
then the weak interactions found between HrpGNQR and HrpV would not be enough for this 
destabilisation to occur. It is possible that the “E_L_NQR” motif is directly responsible for 
HrpG’s negative effect on the activity of HrpV. Characterisation of additional alanine 
substitution mutants of the “E_L_NQR” motif would be required to further clarify the role of 
this motif in HrpG. 
178 
 
CHAPTER SIX 
6. Final conclusions and overview 
6.1. Introduction 
P. syringae is a broad-host range plant pathogen responsible for economically significant 
crop damage. Ps. DC3000 is a model plant pathogen that is able to infect tomato and 
Arabidopsis. One major determinant of virulence in this pathogen is the ability to secrete 
effector proteins into host cells via a T3SS. In P. syringae the T3SS is encoded by hrp/hrc 
genes, which are under the control of an alternative sigma factor, HrpL. Secreted effector 
proteins are also predominantly HrpL-dependent. Therefore, establishing how hrpL is 
regulated is of significant importance to the overall understanding of virulence in this 
pathogen. Prior to this study it had been established that hrpL expression is dependent on 
two co-dependent EBPs, HrpR and HrpS and that HrpRS are negatively regulated by HrpV, 
the activity of which is relieved by HrpG (Preston et al., 1998, Hutcheson et al., 2001, Wei et 
al., 2005). What remained unknown was (i) whether HrpR and HrpS function as normal 
EBPs; e.g. forming hexameric complexes, binding DNA, hydrolysing ATP and activating 
transcription from σ54-dependent promoters in vitro; (ii) the molecular basis for HrpRS co-
dependency and (iii) how HrpV regulates HrpRS activity. Further, no molecular 
characterisation of HrpV and HrpG had been described, e.g. systematic analysis of their 
sequences to determine functional domains; and, in addition, they had not been studied in 
vitro to establish how they functioned. A simplified version of the current (i.e. without 
including the results obtained in Chapters 3-5) understanding of hrpL regulation is shown in 
Figure 92. 
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Figure 92: The regulation of hrpL in Ps. DC3000 and other P. syringae pathovars (simplified version) 
HrpR and HrpS bind to UAS to activate expression at the σ
54
-dependent hrpL-promoter. HrpL is σ factor which specifies 
transcription from promoters with a ‘hrp-box’ (depicted in yellow). HrpV negatively regulates HrpRS via binding to HrpS 
and HrpG negatively affects HrpV. From Figure 10. 
Recently, Ortiz-Martín et al (2010b) presented a model which proposed an additional HrpV-
independent role for HrpG whereby it is responsible for activation of the hrpC operon (Ortiz-
Martín et al., 2010b). This will be discussed below in the context of the findings of this study. 
6.2. Summary of findings 
This study aimed to increase our understanding of the mechanisms behind the action of 
HrpV and HrpG on HrpRS activity in Ps. DC3000 and to improve, in general terms, knowledge 
of these proteins at a molecular and biochemical level. This was achieved by (i) whole gene 
knockouts of Ps. DC3000 with phenotypic analysis and gene expression analysis; (ii) in silico 
sequence analysis; (iii) truncation mutants used in protein-protein interaction assays and 
the construction of an in vivo activity assay (in E. coli); and (iv) purified protein purification 
and in vitro activity assays (and biochemical techniques) to visualise protein complexes.  
 
Using a bacterial two-hybrid assay (BACTH) and in vivo and in vitro activity assays it was 
established that HrpV binds HrpG; that HrpV inhibits HrpRS (transcription activation activity) 
and that HrpG can relieve this repression (Figure 32, Figure 33 and Figure 81). One of the 
major aims of this study was to characterise the functional domains of HrpV and HrpG. In 
order to do this, their sequences were analysed in two ways. Firstly, secondary structure 
predictions were made based on the primary amino acid sequences (Figure 34 and Figure 
42). This led to the design of N-terminal and C-terminal truncated mutants (of both 
proteins) that were primarily tested for interactions by BACTH (see Chapter 4). The results 
180 
 
showed that for HrpV, the C-terminal 25 amino acids, which form a predicted helix, are able 
to bind HrpG; although this mutant was not reproducibly stable (Figure 41). Further, a HrpG 
mutant in which the C-terminal predicted helix was not disrupted could also bind HrpV 
(HrpG1-123) whereas a mutant with this helix truncated did not stably express (HrpG1-111) 
(Figure 44 and Figure 47). Secondly, multiple sequence alignments were generated using 
HrpV and HrpG sequences from a large representative sample of Group I plant pathogens 
(which all contain a hrpC operon) (Figure 52 and Figure 56). This enabled any conserved 
residues and/or motifs attributable to either HrpV or HrpG to be identified, and 
subsequently used as “defining” motifs for these proteins. The most highly conserved motifs 
for HrpV (“LAG”) and HrpG (“NQR”) lay within the predicted C-terminal helices (Figure 53 
and Figure 57) – in line with the results from the truncation mutant analysis that indicated 
that these helices were important (for functionality and/or stability). Alanine substitution 
mutants motifs of these motifs in HrpV and HrpG were made and the resultant mutants 
tested by BACTH (Figure 55, Figure 59 and Figure 60). However, it was noted that HrpVLAG 
was not stably expressed (either from the BACTH vectors or from the protein expression 
vector pET28b+), further implying the importance of the conserved “LAG” motif (of HrpV) in 
maintaining the structural integrity of the C-terminal helix for the stability, and possibly 
function, of HrpV; and potentially all HrpV homologues.  HrpGNQR maintained the ability to 
interact with HrpV only when fused to the high-copy number vector (but not the low copy 
number vector). This implies that the interaction with HrpV (in the context of this mutant) is 
not as robust as the wild-type interaction. Consistent with the BACTH data, the native gel 
shift mobility assay did not resolve a HrpV-HrpG complex in the presence of HrpGNQR (Figure 
91). 
 
EBPs usually form hexameric ring-like complexes for functional activity. This study has 
shown that HrpR and HrpS form an active hexameric species that contains both HrpR and 
HrpS subunits (Figure 84). BACTH interactions between HrpR and HrpS have shown that 
HrpS can bind itself, HrpR and HrpV whereas HrpR can only bind HrpS (Jovanovic et al., 
2011). Quantification of gel filtered fractions of HrpRS showed that more HrpS is present in 
the hexamer than HrpR, at a fixed ratio of 2:1 (shown as R:S = 0.5 in the figure). Taken 
together these results seem to imply that the most likely hexameric form of HrpRS is one 
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with four HrpS and two HrpR subunits where each HrpS subunit binds one HrpS and one 
HrpR.  
 
Since purified HrpV has been shown to form a dimer in three separate in vitro assays (Figure 
83, Figure 89 and Figure 90), and given that HrpV represses the ability of HrpRS to activate 
transcription in vitro, it can be assumed that in this assay, at least some fraction of HrpV is in 
a dimeric form. It is reasonably to propose that the active species of HrpV is a dimer. HrpG 
has been shown to repress HrpV in vitro and to destabilise the HrpV dimer in vitro (Figure 90 
and Figure 91). Therefore HrpG may act on the active dimeric form of HrpV, and repress it 
by forcing it back into a monomeric form. It is notable that the mutant HrpGNQR was unable 
to destabilise the HrpV dimer, thus implying that the conserved “NQR” motif is of functional 
importance to HrpG and could be important for all HrpG homologues. An updated model for 
HrpRS regulation by HrpV and HrpG is proposed in Figure 93. 
 
ATPase experiments have shown that HrpV does not act on the ATPase activity of HrpRS. 
Also, HrpV does not inhibit transcription by targeting pre-formed open complexes (Figure 
82). A HrpRS-HrpV regulatory complex also does not destabilise pre-formed open complexes 
– suggesting that HrpV acts prior to open complex formation. In a “three-hybrid” BACTH 
assay where un-fused HrpV is co-expressed with a cya-fused HrpS, and binding interactions 
between HrpS-HrpR scored by BACTH, the presence of an extra copy of HrpV increases 
interactions between HrpS-HrpS and HrpS-HrpR (Jovanovic et al., 2011). Potentially, the 
increase in binding interactions between HrpR and HrpS subunits is inhibitory and may be 
the way in which HrpV exerts its negative effect. If it is also true that the active species of 
HrpV is dimeric, then it is possible to imagine that each subunit of a HrpV dimer binds one 
HrpS subunit in the HrpRS hexamer and in so doing “locks” HrpS-HrpS in a conformation 
(evident as an increased binding interaction in the BACTH) that is unfavourable for HrpRS 
activation of Eσ54-dependent transcription. This mode of action may mimic characterised 
mutants of EBPs that are able to hydrolyse ATP but are unable to bind σ54 and activate 
transcription, in that ATPase is uncoupled from open complex formation. 
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Figure 93: Updated model for regulation of hrpL-dependent genes in Ps. DC3000 
HrpR and HrpS hexamer comprising 4 HrpS and 2 HrpS subunits binds an upstream activator sequence to activate 
expression at the σ
54
-dependent hrpL-promoter. HrpV negatively regulates HrpRS via binding to HrpS as a dimer, thus 
restricting the conformational flexibility of the hexamer or by blocking the σ
54
-contacting GAFTGA motifs of HrpS. HrpG 
negatively affects HrpV by: (A) destabilising the HrpV dimer before it binds HrpS, leading to two HrpG-bound monomers; 
(B) preventing HrpV from dimerising or (C) by destabilising the HrpV dimer after it has bound HrpS. (Other features of this 
figure are explained in Figure 10). 
In Chapter 3, three whole gene deletion mutants of Ps. DC3000 were analysed for their 
effects on virulence, growth and gene expression (Figure 18, Figure 19 and Figure 20). They 
were created with a constitutively expressed nptII cassette insertion placed either in the 
same direction as transcription from the operon (ΔhrpV and ΔhrpG) or in the opposite 
direction (ΔhrpG) (where the hrpC operon is 5’-hrpF-hrpG-hrcC-hrpT-hrpV-3’). Broadly 
speaking, results from this chapter demonstrated that whole gene knockouts can cause 
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complicated pleiotropic effects (Figure 24, Figure 25 andFigure 26). ΔhrpG was designed 
to limit the effects of constitutive upregulation of downstream operon genes caused by the 
nptII promoter (which may occur in ΔhrpG; see description of IOM71 (Ortiz-Martín et al., 
2010b)). However, in ΔhrpG, significant transcriptional interference seems to occur, 
rendering the downstream genes hrcC and hrpV untranscribed (at least in the 240 min-post 
induction) and the upstream gene hrpF constitutively expressed (i.e. it is expressed before 
induction). Analysis of hrpT transcription in this mutant would be required to confirm this 
finding. This effect is known as convergent transcription, where two promoters are arranged 
face-to-face, and is a potentially important form of gene regulation (Callen et al., 2004). It is 
usually asymmetric, with a strong promoter reducing the expression of a weak promoter; in 
ΔhrpG the hrpC operon promoter is probably weaker than the constitutively expressed 
nptII promoter. However, expression of genes outside of the hrpC operon, i.e. avrPto and 
corR (recall that avrPto expression is HrpL-dependent, therefore HrpRS-dependent and that 
corR regulation seems to overlap HrpRS regulation (Penaloza-Vazquez et al., 2000)), are 
upregulated in both hrpG mutants; implying that there is an effect of deleting hrpG which is 
unconnected to the level of hrpV or hrcC expression – although it is the opposite effect to 
what might have been expected. If the role of HrpG is to downregulate HrpV, thus 
upregulate HrpRS and hrp gene expression, then in the absence of hrpG there should be a 
decrease in hrp gene expression; whereas with avrPto and corR (and hrpF in ΔhrpG) there 
is an increase. Ortiz-Martín et al (2010b) report that HrpG has a HrpV-independent role in 
Ps. phaseolicola. However, this may be at odds with the results presented here.  Ortiz-
Martín et al (2010b) observed that a hrpG mutant (exactly equivalent to ΔhrpG) was 
virtually indistinguishable from a hrpG-hrpV double mutant.  In this study the ΔhrpG 
mutant had significantly reduced expression of hrpV, and appears as an apparent hrpG-hrpV 
double mutant. Ortiz-Martín et al (2010b) appear not to have tested their ΔhrpG mutant 
for hrpV expression; a possible HrpV-independent role for HrpG cannot therefore be 
concluded from their study. 
 
6.3. Future directions 
This study has addressed the molecular determinants of HrpV and HrpG’s action on HrpR 
and HrpS from Ps. DC3000. In so doing, many more experiments can be conceived and new 
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questions can be asked. This section will detail some of the potential future directions that 
could arise from this work. 
 
In Chapter 3 whole gene knockouts of hrpV and hrpG were used to assess the contribution 
of hrpV and hrpG to virulence and hrp gene expression. Firstly, complementation of these 
mutations should be attempted using plasmid-borne copies of the deleted gene (as 
performed by (Ortiz-Martín et al., 2010b)). However, due to the observed differences 
between ΔhrpG and ΔhrpG it is unlikely that simple gene complementation will restore 
wild-type phenotypes to both these mutants. As described above and in the conclusions to 
Chapter 3, there seems to be a significant problem of transcriptional interference within the 
hrpC operon caused by the insertion of the nptII cassette in ΔhrpG - specifically this strain 
is effectively a hrcC-null mutant, making it unable to produce a T3SS. In order to confirm 
that the phenotypic defects observed in this strain are due to the lack of hrcC, it would be 
important to test complementation of this strain with plasmid-borne hrcC alone. 
Additionally it has been documented that mutants such as strains, ΔhrpG and ΔhrpV 
constructed with cassette promoters driving expression in the same direction as the operon, 
may have constitutive expression of downstream genes (Wei et al., 2005). It may therefore 
be preferable to have unmarked in trans gene deletions, although the operon may, in this 
case, still be disrupted. The hrpC operon could be studied as a regulatory unit in its own 
right. There is increasing evidence for the contribution of all members of the operon in hrp 
gene regulation (Ramos et al., 2007, Deng et al., 1998, Preston et al., 1998, Ortiz-Martín et 
al., 2010b, Lin et al., 2006). Therefore, to examine specific roles of the members of this 
operon, without disrupting its transcription by insertions, a whole-operon deletion strain 
could be complemented by a plasmid-borne hrpC operon harbouring the native promoter. 
In this case, the members of the operon could be individually mutated using site directed 
mutagenesis which would permit complete transcription of the operon but would contain a 
non-functional version of the target gene (i.e. at the protein level). For example, this study 
has shown that mutating residues L108 and G110 of HrpV (to alanines) results in a protein 
that is unstable and therefore not expressed. Any other target residues that are shown to be 
of functional importance using in vivo E. coli methods could be mutated within the hrpC-
plasmid and tested for their effects in Ps. DC3000. 
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In this study, RT-PCR (quantitative real-time PCR) was used to test expression of hrpV, hrcC, 
hrpF, avrPto and corR. Additionally, detection of hrpR, hrpS, hrpA, hrpG and hrpL expression 
was attempted but this proved unsuccessful. It would be important to improve detection 
methods to assess the expression of these genes, and in light of the data regarding the hrpC 
operon, hrpT should also be included in the study. The majority of changes in gene 
expression compared to wild-type for the three mutant strains were seen at 240 mpi. It 
would therefore be interesting to extend the analysis beyond this time point, perhaps to 
480 or 720 mpi (as performed by (Ortiz-Martín et al., 2010b) for selected genes). Since some 
genes were undetected, perhaps because of very low expression levels, it might also be 
useful to compare expression levels between HIM, in planta and in apoplastic fluid (Ps. 
DC3000 grows within the apoplast during in planta colonisation). Thwaites et al (2004) 
observed a difference between HIM and in planta expression with higher expression in 
planta. Rico and Preston (2008) reported that although hrpA expression levels in apoplastic 
fluid were lower than in HIM, the cells grew much better and are therefore probably in a 
more natural growth state (perhaps under less stress) than growth in HIM. Therefore 
comparing these three conditions could give a clearer picture of the patterns of hrp gene 
expression rather than looking at HIM expression alone. The reporter assay developed in 
this study could also be used to monitor activation of hrpL expression in apoplastic fluid, and 
further analysis of different nutrient conditions could also be tested. As an alternative to RT-
PCR, protein production could be monitored quantitatively over-time using mass 
spectrometry analysis. Steps are currently underway in this lab to identify specific peptide 
signals for HrpR, HrpS, HrpV and HrpG which will be used to report protein expression levels 
of hrp-induced Ps. DC3000 strains. Protein production may be a more faithful 
representation of the effects of different mutations and growth conditions than gene 
expression due to the numerous post-transcriptional and post-translational modifications 
that take place before a functional protein is produced as monitoring mRNA levels does not 
necessarily capture the levels of active protein species. 
 
In Chapter 4 attempts were made to define the functional domains of HrpV and HrpG using 
truncation analysis. This approach was fairly unsuccessful due to the sensitivity of these two 
proteins to large deletions which severely affected their stability. Even a two-residue 
mutation of HrpV, HrpVLAG, was not stably expressed. It may therefore be necessary to test 
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single alanine mutations of HrpV and HrpG, which can be based on the conserved residues 
and motifs identified by the multiple sequence alignments. These mutants could tested in 
vivo and in vitro; for example, it would be interesting to see if HrpGNQR maintains its ability 
to repress HrpV using the in vitro FL transcription assay.  As an alternative to site directed 
mutagenesis, a random mutant library could be screened to find mutants of (i) HrpV that no 
longer bind HrpG or HrpS, or that can no longer repress HrpRS activity and (ii) HrpG that no 
longer bind and/or repress HrpV’s activity. Since these mutants of hrpV and hrpG would be 
“loss-of-function” mutants it would be necessary to distinguish them from stop codon 
insertion mutants or other nonsense mutants. This could be achieved by fusing hrpV or hrpG 
to a fluorescence tag (e.g. GFP or YFP) to score expression in live cells and then perfoming a 
BACTH assay using a blue/white screen to identify positive protein-protein interactions. 
Colonies that are both white and fluorescent are candidates for loss-of-function mutations 
and can be tested, following sequencing, using the quantitative BACTH assay.  
 
The in silico analysis of HrpV and HrpG showed sequence conservation across all Group I 
plant pathogens and indicated that there may be conservation of function. It would 
therefore be important to test the function of HrpV and HrpG from a “HrpSS” containing 
organism, for example, E. amylovora. Interactions between the E. amylovora HrpV, HrpG 
and HrpSS homologues could be tested using the BACTH assay and also inter-species 
interactions between, for example, HrpV from E. amylovora and HrpG from Ps. DC3000. It 
would also be very interesting to see if HrpSS could interact with HrpSRS or HrpR. This test 
would help to explain the reason behind HrpR-HrpSRS co-dependency. The E. amylovora 
homologues could also be tested using the in vitro methods used in this study in conjunction 
with the Ps. DC3000 homologues. If it could be established that HrpSS from E. amylovora 
activates expression from the hrpL promoter, and is regulated by HrpV and HrpG (from E. 
amylovora), then differences between the singly-acting HrpSS and co-dependent HrpR-
HrpSRS, would be evident in the comparison of their sequences (other significant regulatory 
differences having been discounted). It is theoretically possible that a HrpSRS-bypass mutant 
of HrpR or a HrpR-bypass mutant of HrpSRS could be designed by altering certain residues to 
mimic those found in HrpSS. The sequence data gathered in this study is currently being 
used to model co-evolution of the (proposed) subunit interfaces of HrpR and HrpSRS in 
comparison to HrpSS by John Pinney’s laboratory at Imperial College London. Preliminary 
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data predicts a HrpSRS-HrpSRS interface and a HrpSRS-HrpR interface co-evolving. This is in 
agreement with the BACTH findings (Jovanovic et al., 2011) and fits with the model 
proposed above (Figure 93). 
 
In Chapter 5 recombinant proteins were purified and used in a number of in vitro assays. 
Purification of HrpRS, although improved in this study, is still problematic and not reliable 
enough for further high-end biochemical work. HrpRS seems to be fairly sensitive to storage 
at -20oC and -80oC (activity in FL transcription dropped significantly after approximately 1 
week storage at -20oC, data not shown). There is also the problem experienced in detection 
of HrpR and HrpS due to their close molecular weights. It is important to confirm the 
number of HrpR and HrpS subunits within the hexamer (by nESI-MS) and if possible to 
obtain a defined structure for HrpRS. Improvements to the purification methods are 
currently being attempted in this laboratory: (i) a pET28b+-based expression vector of HrpRS 
may improve the yield and reproducibility together with optimisation of different 
expression strains and growth conditions and (ii) a maltose binding protein (MBP) fusion of 
co-expressed HrpRS (HrpS-MBP) has been constructed since this method has proved 
successful for purification of other EBPs (Berger et al., 1995, Hwang et al., 1999). 
 
This study has shown that although HrpV represses HrpRS activity in vivo and in vitro (via 
interaction with HrpS) it does not do this through repression of ATPase activity, nor does it 
target pre-formed open complexes. It has also been shown that HrpV forms a dimer and it 
has been proposed that the active species of HrpV may be the dimeric form (with HrpG 
targeting the dimer in order to repress HrpV), although the way in which HrpV represses 
HrpRS is yet to be identified. It may be that HrpV affects hexamerisation, perhaps by altering 
the subunit-subunit interfaces. This could be tested using gel filtration in the presence and 
absence of HrpV to detect differences in the equilibrium ratio between monomer/dimer and 
hexamer forms of HrpRS. For instance, HrpV could prevent HrpRS from contacting σ54 via 
the GAFTGA motif (potentially via the HrpS-conserved “Y” residue, which replaces the “F” in 
HrpS). The GAFTGA motif of EBPs is crucial for transferring the energy from ATP hydrolysis 
to Eσ54 and it is possible that HrpV could somehow prevent this energy transfer. This is 
similar to mutants of EBPs that can hydrolyse ATP but cannot bind σ54 (Joly et al., 2010a). An 
assay exists that “traps” an intermediate complex of Eσ54-DNA with PspF, another EBP, using 
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a non-hydrolysable ATP analog, ADP.AlF. This assay hs been used to demonstrate that en 
route to open complex formation PspF is contacting σ54. This assay could be used with 
HrpRS; however, initial attempts to form a “trapped” complex with PspF on the hrpL 
promoter were unsuccessful (see Appendix C, 7.3.3.3). This may indicate that the hrpL 
promoter is unable to support this “trapped” complex. Additionally, native gel shift assays 
could be used to monitor open complex formation by HrpRS in the presence of HrpV. It has 
been shown that HrpV does not destabilise pre-formed open complexes, which would 
suggest that the effect of HrpV may occur prior to open complex formation. This could be 
tested directly using an order of addition assay, where HrpV is added (i) before Eσ54 binds 
DNA (i.e. a closed complex), (ii) after the Eσ54-DNA complex is formed but before addition of 
HrpRS (i.e. before activation), (iii) with HrpRS pre-incubated together (this is prior to 
activation and would assess whether HrpV’s action is more apparent when HrpRS-HrpV 
regulatory complexes are known to have formed) and (iv) after HrpRS is added (i.e. after 
activation). Further, the same order of addition assay could be used in the context of FL 
transcription assays. This would complement the native gel analysis of open complex 
formation and could be used to monitor not only the stage at which HrpV inhibits HrpRS 
activity but also the relative effect of HrpV at different stages en route to open complex 
formation. 
 
In order to test the hypothesis that HrpV targets HrpRS as a dimer, an artificial constitutive 
HrpV “single-chain” linked dimer could be created using a covalent linker (like that 
constructed for ClpX hexamer subunits (Martin et al., 2005)). If this protein were still able to 
repress HrpRS, but was not negatively affected by HrpG then the mechanistic roles of both 
HrpV and HrpG would be clearly explained. 
 
In conclusion, this study has utilised a number of different molecular approaches to try and 
fully characterise the complex processes of hrpL regulation (and by inference T3SS and 
pathogenicity) of a broad-host range plant pathogen. This study provides clear advancement 
in delineating the roles of HrpV and HrpG in this complex regulatory network and may 
ultimately lead to new avenues for management of P. syringae disease in the field. 
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APPENDICES 
7.1. Appendix A 
7.1.1. Vector maps 
7.1.1.1. pBAD18 – used in in vivo activity assay 
 
Figure 94: Vector map of pBAD18  
From http://www.atcc.org/attachments/1642.gif (Guzman et al., 1995). 
7.1.1.2. pGEM-T Easy – for PCR product cloning 
 
Figure 95: Vector map of pGEM-T Easy from Promega 
190 
 
7.1.1.3. pKT25 - BACTH 
 
Figure 96: Vector map of pKT25  
Derived from sequence from http://www.euromedex.com/shop/pdf/BACTH_vectors.pdf created using 
http://tools.neb.com/NEBcutter2/ (Karimova et al., 1998). 
7.1.1.4. pUT18C -BACTH 
pUT18C
cya subunit T18
ampicillin resistance (beta lactamase)  
Figure 97: Vector map of pUT18C  
Derived as pKT25. 
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7.1.1.5. pBBR1MCS-AmpR – Ps. DC3000 lacZ reporter 
Mob (mobilization protein)
beta lactamase
replication protein
pBBR1MCS-AmpR
beta galactosidase
 
Figure 98: Vector map of pBBR1MCS  
From http://www.lablife.org/p?a=vdb_view&id=g2.hzGOZkU0n0_48DyrztaqVYcKnPo- (Kovach et al., 1994). 
7.1.1.6. pET28b+ - for protein overexpression 
 
Figure 99: Vector map of pET28b
+ 
from Novagen 
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7.1.2. Ladders and markers 
 
Figure 100: Ladders and markers 
BenchMark used for SDS-PAGE; MagicMark used for immunoblotting and 100 bp DNA ladder used for DNA agarose gels (all 
from Invitrogen). 
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7.2. Appendix B 
7.2.1. Oligonucleotides – cloning and mutagenesis 
 
Vector 
construct(s) 
Sequences 5’- 3’ Vector 
construct(s) 
Sequences 5’- 3’ 
pEJ1  
pEJ2 
       KpnI  ribosome binding site (RBS) 
TGCGGTACCAGGAGATATACCATGGAATTCAGTGAATTCACCG 
 
         XbaI 
TGCTCTAGATCATCACACTCCCGGTTGCCG 
pEJ25  
pEJ26 
            XbaI 
TTTTTCTAGAGGAATTCAGTGAATTCACCG 
 
           KpnI   
TTTTGGTACCTCACGGGTCACCGGCGTCGTACGG 
pEJ3                 NheI  
CATATGGCTAGCATGGAATTCAGTGAATTCACCG 
 
               HindIII 
CTGTTTAAGCTTCACACTCCCGGTTGCCGG 
pEJ27  
pEJ28 
          XbaI 
TTTTTTCTAGAGCGTAACACGACGCCC 
    
           KpnI   
TTTTGGTACCTCACACTCCCGGTTGCCG 
pEJ4          XbaI           RBS 
TGCTCTAGAAGGAGATATACCATGATTGAGGTAACGGAAAAG 
 
     HindIII 
CCCAAGCTTTCAGGAACCCGGTTTTTCGTTGACC  
pEJ29  
pEJ30 
            XbaI 
TTTTTTCTAGAGCGCGCGGCCATGC 
 
          KpnI   
TTTTGGTACCTCACACTCCCGGTTGCCG 
pEJ5     XbaI         RBS 
TGCTCTAGAAGGAGATATACCATGATTGAGGTAACGGAAAAG 
 
    HindIII 
CCCAAGCTTTCACCCCCAATCATGGTGTTCG 
pEJ31  
pEJ32 
             XbaI 
 TTTTTTCTAGAGGGTGACCTGCTGCTCG 
 
            KpnI   
TTTTGGTACCTCACACTCCCGGTTGCCG 
pEJ6 
pEJ7 
          XbaI 
TTTTTTCTAGAGATGATTGAGGTAACGG  
 
         KpnI 
TTTTGGTACCTCAGGAACCCGGTTTTTCGTTGACC 
pEJ33  
pEJ34 
            XbaI 
 TTTTTTCTAGAGCAACGGCTCGAAGCC 
 
         KpnI   
TTTTGGTACCTCACACTCCCGGTTGCCG 
pEJ8 
pEJ9 
            XbaI 
 TTTTTTCTAGAGATGATTGAGGTAACGG  
 
         KpnI 
TTTTGGTACCTCACCCCCAATCATGGTGTTCG 
pEJ35  
pEJ36  
pEJ37  
CCTGGCCGCTGCGGCCGCGG 
 
Underlined sequence is mutated sequence  
where wild-type is AATCAGCGC - used in SDM 
pEJ10 
pEJ11 
          XbaI 
TTTTTTCTAGAGTACGCCAGCCTGG 
 
         KpnI 
TTTTGGTACCTCAGTGCATTTCCTCGC 
pEJ38  
pEJ39  
 
          XbaI 
TTTTTTCTAGAGATGATCAGTTTCAACAGCTTGC 
 
        KpnI   
TTTTGGTACCTCACTGAATTCCATCGATGACTGC 
pEJ12 
pEJ13 
       XbaI 
TTTTTTCTAGAGATCGCCTTGCACATAGAAGGC 
          
      KpnI 
TTTTGGTACCTCAGTGCATTTCCTCGC 
pAC1                 KpnI   
CTGTGGGTCTAGATCATTA TTTTTGACACCAGACC 
 
              Sph1 
CTGTTTCGCATGCGAGGAAGAGTCATCCTGC 
pEJ14  
pEJ15  
pEJ16  
        GCATGAGTTGATGGCGGCAGCGCTGG 
 
Underlined sequence is mutated sequence  
where wild-type is CTGGCAGGG - used in SDM 
 
pAVM415               EcoRI  
CTGTTTCGAATTCGAGGAAGAGTCATCCTGA 
 
            BamH1 
CTGACGGGATCCGGTTGAGTCGAGGATCAC 
pEJ17  
pEJ18 
          XbaI 
TTTTTCTAGAGGAATTCAGTGAATTCACCG 
 
           KpnI   
TTTTGGTACCTCACACTCCCGGTTGCCG 
pMJRS      XbaI            RBS 
TGCTCTAGAAGGAGATATACCATGAGTACAGGCATCGATAAGG 
 
           KpnI   
GTGCGGGTACCTCAGATCTGCAATTCTTTG 
pEJ19  
pEJ20 
       XbaI 
TTTTTCTAGAGGAATTCAGTGAATTCACCG 
 
         KpnI   
TTTTGGTACCTCAAATAGTGGTTTGCTACTGGC 
pMJV1         XbaI       RBS 
TGCTCTAGAAGGAGATATACCATGATTGAGGTAACGGAAAAG 
 
      HindIII 
CCGCAAGCTTTCAGTGCATTTCCTCG 
pEJ21  
pEJ22 
        XbaI 
TTTTTCTAGAGGAATTCAGTGAATTCACCG 
 
           KpnI   
TTTTGGTACCTCACTGATTGGCCAGC 
pVAM31  
pVAM32 
           XbaI 
TTTTTTCTAGAGATGATTGAGGTAACGG  
            
         KpnI 
TTTTGGTACCTCAGTGCATTTCCTCGC 
pEJ23  
pEJ24 
        XbaI 
TTTTTCTAGAGGAATTCAGTGAATTCACCG 
           KpnI   
TTTTGGTACCTCAGAGGCTGCTGCAGGGGTTTGCC 
pVAV1                          NdeI   
CGCGGCAGCCATATGATTGAGGTAACGGAAAAGTCGGC 
 
                           HindIII               
GTGCGGCCGCAAGCTTCAGTGCATTTCCTCGCTCAAATGG 
ΔhrpG 
ΔhrpG  
A 
TTGTTAGACGACACCACG    
 B 
GGATCCGTAAAACGACGGCCAGTATCTCGGTGAATTCACTG 
ΔhrpG 
ΔhrpG 
     C   
ACTGGCCGTCGTTTTACGGATCCAGTGTGAAATGCGCAAGG     
     D 
TATTTGAGTGGCAGCACG    
Table 11: List of oligonucleotides used in this work for cloning and mutagenesis 
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7.2.2. Oligonucleotides – real-time PCR 
 Forward Primer Reverse Primer Probe 
Designed by R. Thwaites 
16S CAATGGGCGAAAGCCTGAT  AGTGCTTTACAATCCGAAGACCTT  AGCCATGCCGCGTGTGTGA 
hrpA CCAAGACGCACCCTGTATCA CGGACCTCGCAGAGTATCG CGCTGCAACTCCCAGTTCCTTCATG 
hrcC TCCGGGCGAAGGTCTGA CACCCCAGTCTTTTTTGACGAA TGCGAGCGCTGCCCATCAAG 
hrpR ACGTGCTGACGCTTCACTTG GGTGAACTGGTCGAACAATGG TTGCGCAAACGTCGTGAACAGATCC 
avrPto ACCGTCTCCAGAGCGATTTG CTAGGAGAAAGTGTTGACATTGCAAT TGCGACTATGAACCCGAACGGATCA 
This Study set 1 
hrpV GATCGCCTTGCACATAGAAG AACGCTCTGACTCCATAAAAC TCAACTGCGTGATGCACTGCAACG 
hrpG TGCTCAGCCTGATGCAAAC TGATTGAGGATCGAACGCC TTCGTAACACGACGCCCACTTTG 
corR CGATCTTGCTCATTGATGATCAC CGGCAGCCTTATTTCCAACA CTTGTTCCGTTCAAGCGTGGCCC 
hrpS ACTCAAGCTTCCTCCGCTAC AAACATCGGGAACGGGAAC TCTGATCGCATAGTTCCCCTGTTCACACG 
hrpL TCAACATGCCAGCAAACC CTTCGTCTTCCCAGCTTTC ACCTGATCCGCAATCACTTCCGCA 
This Study set 2 
hrpL AATGTATCGTCAGCCGTATC CCCTCTACCTGATGACTGAC CTGGGAAGACGAAGTGCATT 
hrpR GAGTACAGGCATCGATAAGG AGCAAGTCCATATCCAGAAA AACTGCATTATCAGCGGGTC 
hrpS GATGAAAGGTTTGAGGATGA GATACCCAGTTGCGAAATAC TCCGAATCTGGGGATAGTTG 
hrpG TAGTGCTGGTCAGCTGGAT GAATAGTGGTTTGCATCAGG CTGCTCGATCGTCTGGAAAG 
hrpF TGATCAGTTTCAACAGCTTG CTGGTCCATGTTGGTGTG ATCTCGACAATTCGGTGAGC 
avrPto GCGTAGCGCTATAACTGATT GGTTCATAGTCGCAACAAAT TCTGCAGTACGCAATGGGTA 
hrpA ACAATGAAGAAGCAGACCAT CTGATACCTTTAGCGTTCGT GCCGGCAAAGAAGACTCTAC 
Table 12: Oligonucleotides used in this work for RT-PCR 
Oligonucleotides used in Chapter 3 for TaqMan RT-PCR analysis. 16S, hrpA, hrcC, hrpR and avrPto were designed by R. 
Thwaites and kindly made available for use in this study. Additional genes of interest (Set 1) were designed manually. 
These two sets were used first and expression levels of 16S, hrcC, hrpV and corR were successfully measured. Set 2 were 
designed to improve detection of hrpL, hrpR, hrpS, hrpG, avrPto and hrpA and to include hrpF in the study. They were 
designed using Primer3 software (http://frodo.wi.mit.edu/primer3/). Expression levels of avrPto and hrpF were 
successfully measured. Probes were fluorescently labelled with FAM at 5’ and TAMRA at 3’. Primers and probes were 
synthesised by Eurogentec. 
7.2.3. Vector constructs 
Name Insert Reference 
pEJ1 0.432-kb XbaI-KpnI fragment carrying hrpG ligated into pBAD18 This study 
pEJ2 0.432-kb KpnI-XbaI fragment carrying hrpG ligated into pMJV1 Jovanovic et al 2011 
pEJ3 0.432-kb NheI-HindIII fragment carrying hrpG ligated into pET28b+ Jovanovic et al 2011 
pEJ4 0.282-kb XbaI-KpnI fragment carrying hrpV1-94 ligated into pBAD18 This study 
pEJ5 0.120-kb XbaI-KpnI fragment carrying hrpV1-40 ligated into pBAD18 This study 
pEJ6 0.282-kb XbaI-KpnI fragment carrying hrpV1-94 ligated into pUT18C This study 
pEJ7 0.282-kb XbaI-KpnI fragment carrying hrpV1-94 ligated into pKT25 This study 
pEJ8 0.120-kb XbaI-KpnI fragment carrying hrpV1-40 ligated into pUT18C This study 
pEJ9 0.120-kb XbaI-KpnI fragment carrying hrpV1-40 ligated into pKT25 This study 
pEJ10 0.078-kb XbaI-KpnI fragment carrying hrpV95-119 ligated into pUT18C This study 
pEJ11 0.078-kb XbaI-KpnI fragment carrying hrpV95-119 ligated into pKT25 This study 
pEJ12 0.240-kb XbaI-KpnI fragment carrying hrpV41-119 ligated into pUT18C This study 
pEJ13 0.240-kb XbaI-KpnI fragment carrying hrpV41-119 ligated into pKT25 This study 
pEJ14 0.360-kb XbaI-KpnI fragment carrying hrpVL108A,G110A ligated into 
pUT18C 
This study 
pEJ15 0.360-kb XbaI-KpnI fragment carrying hrpVL108A,G110A ligated into 
pKT25 
This study 
pEJ16 0.360-kb NdeI-HindIII fragment carrying hrpVL108A,G110A ligated into 
pET28b+ 
This study 
pEJ17 0.432-kb XbaI-KpnI fragment carrying hrpG ligated into pUT18C This study 
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Table 13: List of vector constructs used in this work 
pEJ18 0.432-kb XbaI-KpnI fragment carrying hrpG ligated into pKT25 This study 
pEJ19 0.369-kb XbaI-KpnI fragment carrying hrpG1-123 ligated into pUT18C This study 
pEJ20 0.369-kb XbaI-KpnI fragment carrying hrpG1-123 ligated into pKT25 This study 
pEJ21 0.333-kb XbaI-KpnI fragment carrying hrpG1-111 ligated into pUT18C This study 
pEJ22 0.333-kb XbaI-KpnI fragment carrying hrpG1-111 ligated into pKT25 This study 
pEJ23 0.294-kb XbaI-KpnI fragment carrying hrpG1-98 ligated into pUT18C This study 
pEJ24 0.294-kb XbaI-KpnI fragment carrying hrpG1-98 ligated into pKT25 This study 
pEJ25 0.165-kb XbaI-KpnI fragment carrying hrpG1-55 ligated into pUT18C This study 
pEJ26 0.165-kb XbaI-KpnI fragment carrying hrpG1-55 ligated into pKT25 This study 
pEJ27 0.063-kb XbaI-KpnI fragment carrying hrpG124-143 ligated into pUT18C This study 
pEJ28 0.063-kb XbaI-KpnI fragment carrying hrpG124-143 ligated into pKT25 This study 
pEJ29 0.099-kb XbaI-KpnI fragment carrying hrpG112-143 ligated into pUT18C This study 
pEJ30 0.099-kb XbaI-KpnI fragment carrying hrpG112-143 ligated into pKT25 This study 
pEJ31 0.138-kb XbaI-KpnI fragment carrying hrpG99-143 ligated into pUT18C This study 
pEJ32 0.138-kb XbaI-KpnI fragment carrying hrpG99-143 ligated into pKT25 This study 
pEJ33 0.276-kb XbaI-KpnI fragment carrying hrpG56-143 ligated into pUT18C This study 
pEJ34 0.276-kb XbaI-KpnI fragment carrying hrpG56-143 ligated into pKT25 This study 
pEJ35 0.432-kb XbaI-KpnI fragment carrying hrpGN111A,Q112A,R113A ligated into 
pUT18C 
This study 
pEJ36 0.432-kb XbaI-KpnI fragment carrying hrpGN111A,Q112A,R113A ligated into 
pKT25 
This study 
pEJ37 0.432-kb NheI-HindIII fragment carrying hrpGN111A,Q112A,R113A ligated 
into pET28b+ 
This study 
pEJ38 0.225-kb XbaI-KpnI fragment carrying hrpF ligated into pUT18C This study 
pEJ39 0.225-kb XbaI-KpnI fragment carrying hrpF ligated into pKT25 This study 
pAC1 0.6-kb upstream region of hrpL (from pAVM415) cloned as a  XbaI 
and Sph1 fragment into  pBBR1MCS-amp 
This study 
pRS415 pBR322 lacZ operon fusion vector (Simons et al., 1987) 
pAVM415 0.6-kb PCR amplification product of the hrpL 
upstream region cloned as a EcoRI-BamHI fragment into pRS415 
Jovanovic et al 2011 
pMJRS 1.899-kb XbaI-KpnI fragment carrying hrpR and 
hrpS ligated into pAPT110 vector 
Jovanovic et al 2011 
pMJV1 0.376-kb XbaI-HindIII fragment carrying hrpV 
ligated into pBAD18 
Jovanovic et al 2011 
pVAM31 0.357-kb XbaI-KpnI fragment carrying hrpV ligated 
into pUT18C 
Jovanovic et al 2011 
pVAM32 0.357-kb XbaI-KpnI fragment carrying hrpV 
ligated into pKT25 
Jovanovic et al 2011 
pVARS1 1.899-kb BamHI-BamHI fragment carrying hrpR 
and hrpS ligated into pQE70 vector 
Jovanovic et al 2011 
pVAV1 0.36-kb NdeI- HindIII fragment carrying hrpV 
ligated into pET28b+ vector 
Jovanovic et al 2011 
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7.3. Appendix C 
7.3.1. Chapter 3 appendix figures 
7.3.1.1. Bean inoculations 
  Dilution 
Strain Bean 0.05 0.1 0.2 0.4 
 
 
DC 
 
 
 
1 p p p p 
2 l l p p 
3 p p p p 
4 l p p p 
5 p p l l 
6 p p p p 
 
 
ΔHrpV 
 
 
 
1 l l p l 
2 p l p p 
3 p l p/l p 
4 l p p p 
5 p p p p/l 
6 p p p p 
 
 
ΔHrpG 
 
 
 
1 a a l/a l 
2 a a l a 
3 a a a a 
4 a a a l 
5 a a a l 
6 l/a a a l 
  
  
 ΔHrpG 
 
  
  
1 p p p p 
2 p l p l 
3 a p p/l p 
4 a p p p 
5 l p l l 
6 p l p p 
Table 14: HR response in French bean 
Six French beans were inoculated for each dilution of bacteria. Each bean was individually inoculated with the four strains 
and the mock control. ‘p’ – HR response clearly present, brown and/or sunken lesion surrounding infiltration site. ‘l’ – 
limited HR response (in comparison to ‘p’, paler brown, smaller lesion surrounding infiltration site). ‘a’ – HR response 
absent. Dilutions refer to inocula optical densities at 600 nm. 
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7.3.2. Chapter 4 appendix figures 
7.3.2.1. Immunoblots 
λ VV 18
C
zi
p
L
A
G
kDa
50
20
1
-4
0
4
1
-1
1
9
9
5
-1
1
9
1
-9
4
 
Figure 101: HrpV mutants in pUT18C with α-HrpV 
Immunoblot of HrpV (V), HrpVLAG (LAG) and HrpV truncated mutants (1-40, 1-94, 41-119 and 95-119) expressed from 
pUT18C, using HrpV antibodies (α). Zip is positive control (leucine zipper fusion vectors) and 18C is negative control (empty 
vectors). Fusion proteins are indicated by arrows. All other visible bands are background proteins. λ is Invitrogen 
MagicMark
TM
 (Figure 100). 
 
Figure 102: HrpV N-terminal truncation mutants in pUT18C with α-HrpV 
Immunoblot of HrpV (V), and HrpV truncated mutants (41-119 and 95-119) expressed from  pUT18C using HrpV antibodies 
(α). Zip is positive control (leucine zipper fusion vectors) and 18C is negative control (empty vectors). . Fusion proteins are 
indicated by arrows. λ is Invitrogen MagicMark
TM
. 
 
Figure 103: HrpG mutants in BACTH with α-T18 
198 
 
Immunoblot of HrpG (G), HrpGNQR (NQR) and HrpG truncated mutants (1-55, 1-98, 1-111, 1-123, 56-132, 99-132, 112-132, 
and 124-132) expressed from pUT18C using T18 antibodies (α). Zip is positive control (leucine zipper fusion vectors) and 
18C is negative control (empty vectors). Fusion proteins are indicated by arrows. λ is Invitrogen MagicMark
TM
 . 
 
Figure 104: HrpG mutants in BACTH pUT18C with α-HrpG 
Immunoblot of HrpG (G), HrpGNQR (NQR) and HrpG truncated mutants (1-55, 1-98, 1-111, 1-123, 56-132, 99-132, 112-132, 
and 124-132) expressed from  pUT18C using HrpG antibodies (α). Zip is positive control (leucine zipper fusion vectors) and 
18C is negative control (empty vectors). Fusion proteins are indicated by arrows. λ is Invitrogen MagicMark
TM
 . 
 
 
Figure 105: HrpG mutants in BACTH pKT25 with α-HrpG 
Immunoblot of HrpG (G), HrpGNQR (NQR) and HrpG truncated mutants (1-55, 1-98, 1-111, 1-123, 56-132, 99-132, 112-132, 
and 124-132) expressed from  pKT25 using HrpG antibodies (α). Zip is positive control (leucine zipper fusion vectors) and 
18C is negative control (empty vectors). Fusion proteins are indicated by arrows.λ is InvitrogenMagicMark
TM
 . 
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7.3.2.2. Secondary structure predictions 
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7.3.2.3. Table of strains and accession numbers 
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7.3.2.4. P. mendocina ymp HrpL sequence 
M Y A N A A I S I R Q P S A I R Q L N S E Q L K M L R A F I Q K R V M N P D D A D D I L Q 
G T F V E A L R N E H K F Q H A S K P Q T W L C G I A L N L I R N H F R R L Y S Q P Y Q E 
A W E D Q W H L E N E H A D D I G Q Q V D G H R Q L A R V V S A I S D L P N N M Q R V I E 
V S L A M D G R Y P L H K P H L P I A R R S L E A E L P F S P E F I P X C V P T P R C R R 
S T S T Q N P S I S A N P S T A W P L W S S W T S R W K C S T P C C S C S S T A P A V R S 
R S S T G S A M A S A C G S S V W K P N A S R P S P M P A T R P S S S X R S M S X T G C S 
T A S T C G A T V R T R Y X R R V S X P E P V X S T A M I A V P A P L P D D P I L L K H L 
L L L A S E Q A A A K D A R I E Q L Q E Q V A L L R H K L F S P K S E R S P E D A D S P Q 
L A M F N E V E E L I E A A A A P S E A E A E A E A E A E A E A E E I V A P V K R R G K R 
K P L P A N L P R V E V I H D L P E H E L T C A C G A C K Q V I G E E T S E Q L E I I 
P M Q V R V I R H I R K T Y A C K A C E A A P L T A D K P A Q L I E K S L A S P S V L 
A M L L T T K Y A D G I P L Y R F E K M L S R H G V D I P R Q T L A R W V I Q S G E Q L Q 
P L L N L L R D K L L E Y P V L H C D E T R L Q V L H E P G R D P T A Q S W M W V Q S G G 
P P D K P V I L F D Y T A S R A Q E V P L R L L D G Y R G Y L M T D D Y A G Y N A V A A Q 
E G I E R L G C W A H A R R K F V E A Q K V Q P K G K T G R A D M A L N L I N K L Y G I E 
R D L K D A C D T E R L V A R Q Q R S Q P L L D Q L K T W L D K T Q P Q V V G Q T A L G R 
A V N Y L A S N W R K L V R Y V E G G H L P I D N N R A E N A I R P F V I G R K N W L F S 
D T P K G A T A S A Q I Y S L I E T A K A N G Q E P Y A W L R H I L E R L P A A N S V E D 
Y E A L L P W N C S P V S A S X Q T R P I S S R W G L W S G Y D G S Y Q D T A S S L G V P 
I G T V R S R L S R A R E Q L K R Q I D P F A X 
 
Figure 107: Translation of Pmen_0035 from Pseudomonas.com (HrpL from P. mendocina) 
When selecting Pmen_0035 on pseudomonas.com the result is an untranslated section of DNA of 2622 bp. Translating this 
DNA using expasy translate tool (expasy.org/tools/dna.html) gives the following outcome in frame 1 5’-3’ (where X is a stop 
codon and underlined M are putative initial methionines). Selecting the first methionine (in frame 1 5’-3’) as the start 
codon gave an open reading frame that was aligned to HrpL from Ps. DC3000 with 72% identical residues (see Chapter 4). 
 
7.3.3. Chapter 5 appendix figures 
7.3.3.1. HrpRS N-terminal section of sequence alignment 
 
Figure 108: HrpRS sequence alignment showing first 80 residues 
The section of the alignment is the original output that was adjusted for Figure 67. 
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7.3.3.2. Mass spectrometry samples on SDS gel 
 
Figure 109: SDS gel of protein samples tested by nESI-MS  
SDS-PAGE gel (15%) of HrpRS, HrpV and HrpG purified proteinssamples collected from the gel filtration experiment (Figure 
84) HrpRS hexamer, HrpRS with ADP (as in Figure 87) and HrpRS 1.5 mer. Also shown are samples before and after buffer 
exchange using a Vivaspin concentrator. The gel shows that after several rounds of buffer exchange the concentration of 
the samples was significantly reduced. The gel was run and stained (using a standard silver staining method) by A. Park 
(Carol Robinson’s lab). 
7.3.3.3. hrpL promoter probe in vitro analysis 
In order to characterise the hrpL promoter using native gel shift assays (EMSA), linear 
probes were designed to mimic the promoter in three phases of open complex formation. 
The homoduplex is a fully double-stranded DNA probe, as exists in the wild-type promoter. 
The early-melted probe contains a TA to AT substitution on the non-template strand 
immediately downstream of the consensus GC promoter element at the -11 and -10 
positions (with respect to the transcription start-site), which represents the conformation of 
the DNA that occurs upon Eσ54-binding. The late-melted probe contains a mismatched 
region between (and including) positions -10 to -1, which represents the conformation of 
the DNA within the open complex (Wedel & Kustu, 1995). 
 
The hrpL promoter sequence (top strand, non-template)(-60 to 
+28)TTTATAAATCAATCAGTTATTTCTA|T|TTTTAAGCTG|G|CATGGTTATCG|C|TATA
GGG 
                         -35          -24           -12 
CTT|G|TACACCACTAAATCAGGGTAAGCCCATG 
   -1  
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Oligonucleotides – hrpL and nifH promoter probes 
hrpLp vs. nifHp  (top strand, non-template) 
                                                                       -24           -12           -1 
 hrpLp        TTTTAAGCTGGCATGGTTATCGCTATAGGGCTTGTACAC  
 nifH         CAGACGGCTGGCACGACTTTTGCACGATCAGCCCTGGGC 
                                                                       -25           -13            -1 
 
63mers from position -35: 
• 63HrpLB1 (bottom strand) 
AAAAATTCGACCGTACCAATAGCGATATCCCGAACATGTGGTGATTTAGTCCCATTCGG
GTAC  
• 63HrpLT2 (top strand) 
TTTTTAAGCTGGCATGGTTATCGCTATAGGGCTTGTACACCACTAAATCAGGGTAAGCC
CATG  
• 63HrpLT3 (-11 and -10 TA changed to AT) 
TTTTTAAGCTGGCATGGTTATCGCatTAGGGCTTGTACACCACTAAATCAGGGTAAGCC
CATG  
• 63HrpLT4 (-10 to -1 complemented) 
TTTTTAAGCTGGCATGGTTATCGCTtatcccgaacTACACCACTAAATCAGGGTAAGCC
CATG  
 
LB1+LT2 = homoduplex probe 
LB1+LT3 = early melted probe 
LB1+LT4 = late melted probe 
 
Preliminary analysis of the binding activities of Eσ54 on these probes in the presence of the 
well-characterised EBP, PspF, indicated that σ54 was unable to bind this probe in the absence 
of core RNAP (E). Additionally, intermediate complex formation, which requires binding of 
nucleotide metal fluoride analogues, was also not visible using these probes. Open 
complexes formed on these templates appeared more sensitive to heparin than those 
formed on nifH templates. The reasons for the differences in stability and complex 
formation may be intrinsic to the properties of the hrpL promoter probes compared to the 
nifH promoter probes. 
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Figure 110: Eσ
54
 complexes on native gels using nifH and hrpL homoduplex probes 
Gel shows σ
54 
bound to DNA (σ
54
-DNA), σ
54 
trapped in the presence of PspF1-275 and the non-hydrolysable nucleotide 
analogue, ADP.AlF(σ
54
*), the RNAP (E) closed complex (CC), the open complex (OC) with and without heparin (+/- hep) and 
the RNAP holoenzyme trapped in an intermediate state in the presence of PspF1-275 and ADP.AlF(Eσ
54
*). On the nifH 
homoduplex probe a heparin stable open complex (OC) forms but this complex is not apparent on the hrpL probe. Also the 
“trapped” complex (representing an intermediate state between CC and OC formation), formed with the non-hydrolysable 
ATP analog, ADP.AlF, is not visible on the hrpL probe, but is present on the nifH probe. In the absence of core RNAP, σ
54
 can 
bind the nifH probe but not the hrpL probe. 
nifH early melted hrpL early melted
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Figure 111: Eσ
54
 complexes on native gels using nifH and hrpL early melted probes 
Gel shows σ
54 
bound to DNA (σ
54
-DNA), σ
54 
trapped in the presence of PspF1-275 and the non-hydrolysable nucleotide 
analogue, ADP.AlF(σ
54
*), the RNAP (E) closed complex (CC), the open complex (OC) with and without heparin (+/- hep) and 
the RNAP holoenzyme trapped in an intermediate state in the presence of PspF1-275 and ADP.AlF(Eσ
54
*). Results are the 
same as Figure 110 and additionally demonstrate that the “supershifted” complex (σ
54
ss) (formed in the presence of σ
54
-
DNA and PspF+ATP), which represents isomerisation of the σ
54
-DNA complex,
 
does not form on the hrpL probe only on the 
nifH early melted probe. 
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Figure 112: Eσ
54
 complexes on native gels using nifH and hrpL late melted probes 
Gel shows σ
54 
bound to DNA (σ
54
-DNA), σ
54 
trapped in the presence of PspF1-275 and the non-hydrolysable nucleotide 
analogue, ADP.AlF(σ
54
*), the RNAP (E) closed complex (CC), the open complex (OC) with and without heparin (+/- hep) and 
the RNAP holoenzyme trapped in an intermediate state in the presence of PspF1-275 and ADP.AlF(Eσ
54
*). Results are the 
same as Figure 110. 
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Figure 113: Trapping reactions on hrpL promoter probes using difference nucleotide  
Trapped complexes (representing an intermediate state between the closed and open complex formation) do not form on 
the hrpL probes tested in the presence of PspF1-275 with any of the available nucleotide analogues – ADP.AlF (transition 
state), ADP.BeF (ground state) or AMP.AlF (ground state). The visible band is RNAP holoenzyme bound to DNA (Eσ
54
-DNA). 
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nifH hrpL
CC CC
+PspF
5’ 10’ 30’ 60’ 120’90’ 5’ 10’ 30’ 60’ 120’90’
+PspF
 
Figure 114: Time course reaction of addition of activator on nifH and hrpL late melted probes 
Open complex formation (as judged by heparin stable complex formation, where CC is the closed complex and is heparin 
sensitive) is increased with increasing activation time on the nifH probe (where 5’ is 5 minutes etc). For the hrpL promoter, 
a clear increase in complex formation was obtained after 60 min activation time (circled). 
CC OC
OC+hep
1/
1
0
0
0
1/
5
0
0
1/
1
0
0
1/
5
0
1/
1
0
 
Figure 115: Heparin challenge titration on hrpL late melted probe 
This assay was used to determine the sensitivity of open complexes (OC) (formed on the hrpL probe) to the competitor 
heparin (judged by the number of complexes which survive heparin challenge, compared to closed complexes, CC). The 
standard final concentration of heparin was 100 µg/ml (used in the OC lane) therefore 1/1000 represents a final 
concentration of 0.1 µg/ml. 
C
C
O
C
O
C
+h
ep
O
C
+h
ep
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/1
0
C
C
O
C
O
C
+h
ep
37oC 25oC
 
Figure 116: Temperature comparison on hrpL homoduplex  
Since the native hrpL promoter complexes would naturally form at 25
o
C, complexes were analysed at both 37
o
C and 25
o
C 
to determine whether stability is affected by temperature. As shown, although more complexes were formed at 25
o
C, all 
were extremely sensitive to heparin. OC is open complex, CC is closed complex, hep is heparin. 
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